Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3051714	p-fidd	mg/l (mg/l)	57874	102716	0.69%
3051714	p-fidd	— (—)	28666	38117	100.00%	Distribution not available
3051714	p-fidd-o	mg/l (mg/l)	10037	12262	0.00%
3051714	p-fidd-o	— (—)	2479	2803	100.00%	Distribution not available
3051714	b-fidd	mg/l (mg/l)	1389	1790	0.00%
3051714	b-fiddp	mg/l (mg/l)	704	776	0.00%
3051714	b-fidd-o	mg/l (mg/l)	624	811	0.00%
3051714	p-fidd-lb	mg/l (mg/l)	612	805	0.00%
3051714	b-fidd	— (—)	333	396	100.00%	Distribution not available
3051714	oma-b-fidd	mg/l (mg/l)	323	365	0.00%
3051714	b-fidd-o	— (—)	277	315	100.00%	Distribution not available
3051714	p-fiddpik	mg/l (mg/l)	275	310	0.00%
3051714	p-tkfiddo	— (—)	158	180	100.00%	Distribution not available
3051714	p-tkfiddo	mg/l (mg/l)	146	192	0.00%
3051714	p-fiddpik	— (—)	122	130	100.00%	Distribution not available
3051714	b-fiddp	— (—)	110	121	100.00%	Distribution not available
3051714	b-fidd-pt	mg/l (mg/l)	69	74	0.00%
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	mg/l (mg/l)	63	73	0.00%
3051714	p-fidd-lb	— (—)	54	60	100.00%	Distribution not available
3051714	fiddpika	— (—)	54	75	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti(fidd-o)	mg/l (mg/l)	40	42	0.00%
3051714	oma-b-fidd	— (—)	30	31	100.00%	Distribution not available
3051714	p-fidd-os	— (—)	25	28	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(23283b-fidd-pt)	mg/l (mg/l)	24	25	0.00%
3051714	b-fidd-pika	mg/l (mg/l)	24	26	0.00%
3051714	b-fidd-p	mg/l (mg/l)	24	27	0.00%
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	— (—)	19	19	100.00%	Distribution not available
3051714	p-fiddp	mg/l (mg/l)	19	32	0.00%
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	mg/l (mg/l)	19	19	0.00%
3051714	p-fiddhoi	— (—)	18	19	100.00%	Distribution not available
3051714	p-fiddhoi	mg/l (mg/l)	17	17	0.00%
3051714	fibriinind-dimeerit,pikatesti(3939b-fidd-o)	mg/l (mg/l)	16	16	0.00%
3051714	p-fidd-hoi	— (—)	15	17	100.00%	Distribution not available
3051714	b-fidd-pt	— (—)	14	15	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	— (—)	12	14	100.00%	Distribution not available
3051714	p-fidd-poc	mg/l (mg/l)	11	13	0.00%
3051714	p-fidd-ospkl	mg/l (mg/l)	11	12	0.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(fidd)	mg/l (mg/l)	10	10	0.00%
3051714	fibriinind-dimeerit,plasmasta(fidd)	— (—)	10	10	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	— (—)	9	10	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	mg/l (mg/l)	9	10	0.00%	Distribution not available
3051714	p-fidd-hoi	mg/l (mg/l)	8	8	0.00%
3051714	p-fidd-po	mg/l (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(3939b-fidd-pt)	mg/l (mg/l)	7	7	0.00%
3051714	p-fidd-p	mg/l (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	p-fidd-po	— (—)	5	6	100.00%	Distribution not available	Distribution not available
3051714	p-fidd-poc	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity, other/unspecified

5000

29628

1.99

323.01

2.1

1.7

1.01

1.05

mg/l

0.33

3896

22291

Dental caries

3727

19961

2.20

321.59

3.5

1.7

1.54

1.22

mg/l

3.75

3001

15177

Disorders of gallbladder, biliary tract and pancreas

13828

64446

1.50

320.66

1.9

1.7

1.27

1.18

mg/l

1.84

10787

49217

Any mental disorder

16472

60796

1.46

319.72

1.9

1.7

1.13

1.19

mg/l

1.33

12301

46406

Other disorders of fluid, electrolyte and acid-base balance

4016

21498

2.13

317.90

2.1

1.7

1.60

1.34

mg/l

2.94

3264

16455

Undetermined asthma, excluding more controls

1893

7913

3.04

316.99

2.0

1.5

0.94

1.18

mg/l

3.71

1461

5890

Genitourinary diseases

8821

28963

1.66

312.92

2.0

1.8

1.26

1.18

mg/l

0.85

6629

21540

Temporomandibular joint disorders

2292

10415

2.66

312.26

1.8

1.6

0.81

1.16

mg/l

9.56

1694

7922

Early onset COPD, excluding more controls

2696

13108

2.46

309.88

2.1

1.5

1.18

1.31

mg/l

1.29

2133

10017

Other diseases of pleura

5694

30953

1.86

309.28

2.2

1.7

1.65

1.42

mg/l

3.90

4660

23896

Coagulation defects, purpura and other haemorrhagic conditions

2900

14771

2.47

309.27

3.1

1.8

1.70

1.17

mg/l

6.92

2277

11203

Asthma, including avohilmo

19888

70116

1.88

307.65

1.9

1.8

0.99

1.24

mg/l

21.02

15023

52947

Benzodiazepine use

14284

73885

1.49

307.65

1.9

1.7

1.15

1.19

mg/l

0.67

10634

56210

Heart failure, not strict

12288

43709

2.36

307.65

2.7

1.6

1.53

1.22

mg/l

13.65

10018

33460

Other heart diseases, wide

15666

56309

2.00

307.65

2.4

1.6

1.16

1.11

mg/l

1.11

11753

42612

Dorsalgia

17289

54104

1.99

307.65

1.9

1.7

1.00

1.26

mg/l

20.07

12910

40758

Renal failure

5816

30409

2.04

307.65

2.9

1.7

2.13

1.35

mg/l

23.37

4946

23392

Hypothyroidism (congenital or acquired)

4245

10688

2.66

307.65

2.1

1.4

1.00

0.81

mg/l

2.18

3122

7718

Syncope and collapse

6641

29953

2.33

307.65

2.0

1.6

1.24

1.31

mg/l

0.76

4992

22789

Cystitis

13178

52467

1.71

307.65

1.9

1.7

1.04

1.21

mg/l

8.51

9998

39783

Cardiac arrhythmias

10519

36625

2.24

307.65

2.2

1.6

1.08

0.96

mg/l

2.57

7685

27347

Other heart diseases

8516

24801

2.78

307.65

2.7

1.5

1.25

0.84

mg/l

17.47

6499

18089

Asthma (diagnoses ohter than nonallergic)

14500

72243

2.00

307.65

2.0

1.7

1.02

1.22

mg/l

11.63

11056

54473

Inflammatory bowel disease treatment related agents

19970

66682

1.96

307.65

2.2

1.7

1.16

1.18

mg/l

0.25

15485

49913

ILD medications: prednisolone, methylprednisolone, prednisone

19669

62652

2.07

307.65

2.2

1.6

1.20

1.17

mg/l

0.65

15318

46853

Other/unspecified dorsalgia

5674

31004

2.14

307.65

2.0

1.7

1.02

1.27

mg/l

7.79

4259

23570

ILD medications

19939

63607

1.98

307.65

2.2

1.6

1.20

1.16

mg/l

0.55

15477

47453

Codeine

17312

50998

2.19

307.65

1.9

1.6

1.04

1.16

mg/l

4.16

13221

37972

Accidents

12686

44614

1.54

307.65

1.9

1.7

1.11

1.19

mg/l

1.88

9534

33676

Gonarthrosis,primary

12107

53540

1.56

307.65

1.7

1.23

1.25

mg/l

0.30

9571

41458

Codeine or tramadol medication

20095

65162

1.97

307.65

1.9

1.7

1.07

1.21

mg/l

6.07

15391

49065

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

9149

23305

3.21

307.65

2.2

1.4

1.30

0.81

mg/l

27.69

7249

17247

Infections, IBD-co-morbidities

2500

6424

3.52

307.65

2.5

1.6

1.39

1.40

mg/l

0.03

1992

4845

Viral Sepsis

3042

13445

2.97

307.65

2.9

1.7

1.47

1.24

mg/l

2.18

2497

10163

Other specific joint derangements/joint disorders

12028

46694

1.99

307.65

1.9

1.8

0.92

1.19

mg/l

23.14

9004

34714

Arthropathies

14163

48072

1.64

307.65

1.8

1.03

1.22

mg/l

8.67

10645

35680

Acute upper respiratory infections

16203

67107

1.68

307.65

2.0

1.7

1.02

1.24

mg/l

11.01

12106

51034

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1707

3750

4.41

307.65

2.5

1.5

1.55

1.66

mg/l

0.36

1406

2890

Gastrointestinal diseases

9646

30158

1.76

307.65

2.1

1.6

1.15

1.08

mg/l

0.92

7115

22301

DVT of lower extremities and pulmonary embolism

8743

32350

4.03

307.65

2.5

1.6

2.13

1.20

mg/l

62.94

7146

24868

Explicit Sepsis

5955

32255

2.07

307.65

2.6

1.6

1.94

1.24

mg/l

23.38

4908

24557

COPD/asthma/ILD related infections

17586

53007

1.88

307.65

2.0

1.6

1.17

1.16

mg/l

0.05

13489

39709

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

16410

60371

2.08

307.65

2.0

1.7

1.41

1.12

mg/l

16.54

12918

45948

Constipation

12126

60407

1.58

307.65

1.9

1.7

1.24

1.23

mg/l

0.13

9240

46348

Asthma-related infections

9884

51052

2.31

307.65

2.2

1.8

1.04

1.25

mg/l

9.57

7626

38550

General symptoms and signs

20668

53287

2.30

307.65

2.1

1.6

1.14

1.15

mg/l

0.14

15625

40029

Hypothyroidism, levothyroxine purchases

4201

10649

2.64

307.65

2.1

1.4

0.99

0.81

mg/l

2.08

3087

7697

Pulmonary heart disease, diseases of pulmonary circulation

6280

23790

3.90

307.65

2.9

1.6

2.25

1.26

mg/l

49.68

5189

18297

Persons encountering health services in other circumstances, wide

18701

66511

1.60

307.65

2.1

1.7

1.19

mg/l

0.02

14156

50332

Major coronary heart disease event excluding revascularizations

8448

38325

1.70

307.65

2.2

1.7

1.33

1.38

mg/l

0.53

6624

29795

ILD medications: immunosuppressive drugs

8862

53778

1.78

307.65

2.6

1.6

1.44

1.14

mg/l

8.58

7047

40208

ILD differential diagnosis

13457

38293

2.00

307.65

2.0

1.6

1.11

1.16

mg/l

1.06

10250

28695

Diseases of the respiratory system

10253

30874

1.85

307.65

1.9

1.6

1.11

1.23

mg/l

2.84

7823

23091

Cardiovascular diseases

11840

28350

2.76

307.65

2.3

1.5

1.06

0.87

mg/l

5.96

8767

20341

Implicit bacterial Sepsis

5974

26772

2.53

307.65

2.6

1.6

1.89

1.31

mg/l

14.06

4923

20554

Intestinal infectious diseases

13564

74039

1.56

307.65

2.1

1.7

1.15

1.19

mg/l

0.58

10288

55794

Other disorders of veins

6003

32330

2.26

307.65

1.9

1.6

1.12

1.08

mg/l

0.63

4641

24743

Pain in throat and chest

17828

42871

3.28

307.65

2.0

1.6

0.90

1.26

mg/l

42.75

13169

32563

Bacterial infection, other or unspecified

7838

37671

2.25

307.65

2.5

1.6

1.80

1.24

mg/l

22.71

6443

28583

Medical observation and evaluation for suspected diseases and conditions

11466

32845

2.04

307.65

2.1

1.6

1.14

1.24

mg/l

1.76

8467

25099

Other special examinations and investigations of persons without complaint or reported diagnosis

10607

32850

1.81

307.65

2.0

1.6

1.15

1.24

mg/l

1.50

7946

25102

Bronchitis

17297

71175

1.80

307.65

2.1

1.7

1.06

1.21

mg/l

6.92

12953

53904

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6460

13062

2.88

307.65

1.9

1.5

1.06

1.11

mg/l

0.52

4756

9908

Persons encountering health services for other counselling and medical advice, not elsewhere classified

16951

66145

1.61

307.65

2.0

1.7

1.17

1.19

mg/l

0.21

12858

50071

Symptoms and signs involving the digestive system and abdomen

16864

50440

1.89

307.65

2.0

1.7

1.16

1.24

mg/l

1.77

12590

38282

Other diseases of intestines

16875

63851

1.71

307.65

2.0

1.7

1.15

1.16

mg/l

0.05

12846

48027

Condition for Implicit Sepsis (Organ dysfunction codes)

13206

57605

1.91

307.65

2.4

1.6

1.58

1.12

mg/l

22.98

10333

43620

DVT of lower extremities

3702

13458

4.14

307.65

2.3

1.7

1.88

1.20

mg/l

16.97

2961

10354

Cardiovascular diseases (excluding rheumatic etc)

12485

32683

2.69

307.65

2.4

1.5

1.13

0.84

mg/l

13.23

9501

23499

Chronic lower respiratory diseases

19949

68103

1.78

307.65

1.9

1.7

1.03

1.22

mg/l

13.14

15231

51174

Soft tissue disorders

18377

52564

2.10

307.65

1.9

1.7

1.01

1.27

mg/l

20.66

13817

39368

Depression or dysthymia

10655

38083

1.73

307.65

1.8

1.05

1.29

mg/l

10.70

7869

29316

Symptoms and signs involving the circulatory and respiratory systems

20915

45340

2.85

307.65

2.0

1.6

1.02

1.25

mg/l

14.63

15508

34262

Diseases of oesophagus, stomach and duodenum

16988

66048

1.76

307.65

1.9

1.7

1.15

1.19

mg/l

0.98

12843

50194

All pneumoniae

16607

68767

1.92

307.65

2.3

1.7

1.37

1.11

mg/l

12.97

13349

51119

Spinal stenosis

6832

31794

1.92

307.65

1.8

1.7

1.17

1.45

mg/l

11.65

5436

24779

Metabolic disorders

14583

57622

1.77

307.65

2.1

1.7

1.31

1.15

mg/l

4.53

11369

43746

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

13745

65808

1.55

307.65

2.6

1.6

1.34

1.14

mg/l

7.25

10757

49758

Other diseases of urinary system

15449

59500

1.60

307.65

1.9

1.7

1.10

1.21

mg/l

4.05

11807

45152

Asthma, unspecified (mode)

9437

34211

2.70

307.65

2.0

1.6

1.05

1.19

mg/l

4.42

7243

25800

Atrial fibrillation and flutter

4765

13772

2.71

307.65

2.4

1.4

1.36

0.87

mg/l

11.03

3571

10362

Acute upper respiratory infections of multiple and unspecified sites

11838

54588

1.84

307.65

2.1

1.7

0.99

1.17

mg/l

7.42

8787

41194

Arthrosis

10509

37738

1.69

307.65

1.7

1.10

1.24

mg/l

3.78

8193

28675

Examination and observation for other reasons

10380

32534

2.28

307.65

2.2

1.6

1.16

1.24

mg/l

1.12

7879

24871

Coronary atherosclerosis

9056

37024

1.78

307.65

2.3

1.7

1.25

1.36

mg/l

2.13

7036

28731

Asthma-related pneumonia

5590

27727

2.49

307.65

2.3

1.8

1.19

1.34

mg/l

2.61

4486

21132

Covid-19 confirmed case

6236

22302

4.42

307.65

2.8

1.7

1.33

1.21

mg/l

2.08

5276

16676

Codes for special purposes

8985

39216

3.12

307.65

2.6

1.7

1.22

1.13

mg/l

1.53

7389

29135

Polyarthropathies

10172

41344

1.85

307.65

1.9

1.8

1.30

1.24

mg/l

0.89

8025

31149

Influenza and pneumonia

17605

69177

1.92

307.65

2.3

1.7

1.33

1.11

mg/l

10.54

14051

51366

Complications of procedures, not elsewhere classified

12082

67136

1.76

307.65

2.0

1.7

1.32

1.17

mg/l

3.64

9465

50815

Episodal and paroxysmal disorders

18921

58313

1.88

307.65

1.9

1.7

0.99

1.27

mg/l

20.44

14069

44093

Complications of surgical and medical care, not elsewhere classified

15329

69940

1.78

307.65

2.1

1.7

1.32

1.16

mg/l

5.34

12094

52837

COPD (mode)

3987

16503

2.24

307.65

2.0

1.5

1.37

1.42

mg/l

0.36

3233

12631

Non-ischemic cardiomyopathy

3984

16635

2.37

307.65

2.5

1.6

1.62

1.49

mg/l

0.99

3283

12781

Diseases of arteries, arterioles and capillaries (FINNGEN)

3804

10087

3.33

307.65

2.4

1.4

1.63

0.94

mg/l

16.54

3106

7593

Hypothyroidism and >3 levothyroxin purchases

4201

10649

2.64

307.65

2.1

1.4

0.99

0.81

mg/l

2.08

3087

7697

Asthma (only as main-diagnosis)

12743

38048

2.40

307.65

2.0

1.6

0.96

1.16

mg/l

10.27

9609

28510

Allergic asthma (mode), excluding more controls

3469

17702

2.23

307.65

1.9

1.5

0.90

1.06

mg/l

1.89

2602

12963

Bleeding

11224

55552

1.62

307.65

2.3

1.7

1.36

1.25

mg/l

2.41

8825

42444

Pneumonia, organism unspecified

14452

62671

1.91

307.65

2.2

1.7

1.41

1.14

mg/l

12.03

11584

46753

Other functional intestinal disorders

6201

35242

1.91

307.65

2.0

1.7

1.17

1.29

mg/l

1.49

4802

26837

Depression medications

5005

11233

2.58

307.65

1.8

1.4

0.90

0.80

mg/l

1.44

3585

8012

Malaise and fatigue

8288

31675

2.70

307.65

2.2

1.6

1.32

1.27

mg/l

0.53

6417

24113

Gout

3545

16137

2.39

307.65

2.1

1.7

1.45

1.56

mg/l

0.87

2846

12573

Pain (limb, back, neck, head abdominally)

12306

32003

2.20

307.65

1.9

1.7

1.14

1.34

mg/l

6.20

9198

24404

Falls/tendency to fall

16756

60778

1.49

307.65

1.9

1.8

1.10

1.16

mg/l

1.30

12661

45604

All anxiety disorders

9016

48660

1.65

307.65

2.0

1.7

0.95

1.03

mg/l

2.03

6422

36385

Non-rheumatic valve diseases

6177

26345

1.95

307.65

2.2

1.6

1.31

1.34

mg/l

0.33

4762

20490

Asthma, unspecified (mode), excluding more controls

9251

32152

2.81

307.65

2.0

1.5

1.03

1.15

mg/l

3.30

7092

24147

15344

52931

2.12

307.65

2.3

1.6

1.36

1.16

mg/l

6.97

12326

39665

Intracranial trauma

8417

37583

1.87

307.65

1.9

1.7

1.12

1.23

mg/l

2.61

6277

28297

Nerve, nerve root and plexus disorders

15747

68771

1.58

307.65

1.8

1.7

1.06

1.22

mg/l

6.91

12087

52298

COPD differential diagnosis

13466

38305

2.00

307.65

2.0

1.6

1.11

1.16

mg/l

1.05

10255

28707

Other embolism and thrombosis

2323

8820

3.83

307.65

2.6

1.7

1.81

1.21

mg/l

8.39

1835

6769

Exposure to unspecified factor

14339

76104

1.61

307.65

1.9

1.8

1.11

1.19

mg/l

2.41

10878

57415

Viral pneumonia

2289

8462

3.94

307.65

3.1

1.7

1.34

1.20

mg/l

0.97

1957

6282

Disorders of thyroid, IBD co-morbidities

2745

8232

2.90

307.65

2.5

1.5

0.91

1.32

mg/l

10.06

2047

6127

Pain in joint

9952

30462

2.59

307.65

1.9

1.7

0.94

1.30

mg/l

27.61

7422

23246

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

15523

68767

1.85

307.65

2.4

1.6

1.49

1.13

mg/l

21.21

12181

52035

Venous thromboembolism

11400

42532

3.77

307.65

2.4

1.6

1.94

1.16

mg/l

63.34

9276

32603

Implicit Sepsis

11671

50346

2.13

307.65

2.4

1.6

1.61

1.18

mg/l

17.20

9243

38213

Sleep apnoea, including avohilmo

14744

62001

1.74

307.65

1.9

1.7

0.94

1.23

mg/l

27.87

11161

47370

Provisional assignment of new diseases of uncertain etiology

8976

39157

3.12

307.65

2.6

1.7

1.22

1.13

mg/l

1.53

7382

29088

Obesity

9549

57782

1.90

307.65

2.0

1.7

1.04

1.11

mg/l

1.36

7447

43498

Lumbar disc prolapse

9120

46136

1.76

307.65

1.8

1.7

0.95

1.26

mg/l

20.60

6963

35275

Hypertension, essential

12431

42340

1.91

307.65

1.9

1.6

1.12

1.07

mg/l

0.74

9742

31793

Asthma

14432

38048

2.43

307.65

2.0

1.6

1.00

1.16

mg/l

7.08

10987

28510

Viral pneumonia (unknown virus, not influenza)

1413

4454

5.61

307.65

3.7

1.8

1.35

1.10

mg/l

1.71

1259

3298

Certain infectious and parasitic diseases

16374

52168

1.75

307.65

2.0

1.6

1.22

1.09

mg/l

4.12

12563

38915

Injuries to the knee and lower leg

17250

72377

1.47

307.65

1.8

1.09

1.20

mg/l

4.01

13251

54425

Other arthrosis

7168

32035

1.80

307.65

1.8

1.7

1.05

1.27

mg/l

9.51

5548

24620

Mood disorders

15166

70957

1.53

307.65

1.9

1.7

1.06

1.17

mg/l

3.57

11138

53781

Any gastric operation

13964

40826

1.93

307.65

2.1

1.5

1.26

0.97

mg/l

12.48

10494

30047

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

8562

51602

1.73

307.65

2.0

1.7

1.35

1.28

mg/l

0.79

6840

39648

Disorders of lipoprotein metabolism and other lipidaemias

11791

48048

1.72

307.65

1.9

1.7

1.26

1.21

mg/l

0.70

9208

36907

Other septicaemia

4976

26605

2.16

307.65

2.7

1.6

2.01

1.29

mg/l

19.93

4134

20188

Other soft tissue disorders, not elsewhere classified

19356

51845

2.96

307.65

2.0

1.7

1.02

1.28

mg/l

20.49

14754

38936

Renal tubulo-interstitial diseases

12666

63974

1.70

307.65

2.3

1.7

1.66

1.13

mg/l

30.29

10201

48295

Diarrhoea and gastroenteritis of presumed infectious origin

10287

62096

1.67

307.65

2.1

1.7

1.16

1.18

mg/l

0.32

7859

46670

Disorders of synovium and tendon

7279

40768

1.80

307.65

1.8

1.7

0.94

1.25

mg/l

22.37

5642

30962

Bacterial Sepsis

6752

30644

2.38

307.65

2.5

1.6

1.85

1.29

mg/l

15.48

5538

23450

Pulmonary embolism

5885

21787

4.08

307.65

2.7

1.6

2.31

1.25

mg/l

50.80

4873

16748

18741

61550

1.81

307.65

2.0

1.7

1.07

1.23

mg/l

7.45

14111

46652

Recurrent or chronic depression

6148

26322

1.91

307.65

1.8

0.95

1.13

mg/l

3.83

4448

20042

Rotator cuff syndrome

8342

38704

1.80

307.65

1.7

1.05

1.31

mg/l

9.66

6440

29862

Hypertensive diseases (excluding secondary)

8939

24900

2.48

307.65

2.3

1.5

1.08

0.81

mg/l

9.00

6961

18257

Gonarthrosis [arthrosis of knee](FG)

11097

42766

1.70

307.65

1.7

1.17

1.21

mg/l

0.68

8809

32690

Low back pain

12373

52445

2.13

307.65

1.9

1.7

1.00

1.26

mg/l

19.23

9308

39695

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

15344

52931

2.12

307.65

2.3

1.6

1.36

1.16

mg/l

6.97

12326

39665

Tramadol

13772

45809

2.30

307.65

2.0

1.6

1.17

1.18

mg/l

0.04

10705

34497

Pneumonias (Asthma/COPD co-morbidities)

16485

68586

1.91

307.65

2.3

1.7

1.37

1.11

mg/l

13.11

13262

50983

Sleep disorders (combined)

15547

64916

1.77

307.65

1.9

1.7

0.95

1.23

mg/l

27.82

11707

49444

Sciatica+with lumbago

7841

41864

2.09

307.65

1.9

1.7

0.96

1.26

mg/l

16.42

5984

32028

Spondylopathies

11893

44766

1.81

307.65

1.8

1.7

1.09

1.30

mg/l

11.34

9240

34391

Erysipelas

8253

41473

2.14

307.65

1.9

1.6

1.36

1.20

mg/l

4.65

6595

31494

Atrial fibrillation and flutter with reimbursement

3812

10071

2.96

307.65

2.3

1.4

1.38

0.95

mg/l

5.44

2827

7643

Migraine

7981

37721

2.12

307.65

2.0

1.7

0.80

1.09

mg/l

16.33

5830

28151

GASTRO-related operations

13964

40826

1.93

307.65

2.1

1.5

1.26

0.97

mg/l

12.48

10494

30047

Migraine with aura

3660

19610

2.24

307.65

2.0

1.7

0.80

1.06

mg/l

7.93

2671

14556

Other bacterial diseases

15498

61617

2.03

307.65

2.3

1.7

1.63

1.11

mg/l

42.23

12545

46270

Diseases of the skin and subcutaneous tissue

15520

55659

1.51

307.65

1.9

1.7

1.11

1.20

mg/l

2.33

11761

41936

Lower back pain or/and sciatica

17053

72011

1.88

307.65

1.9

1.7

0.99

1.22

mg/l

19.30

12884

54556

Gonarthrosis

9588

34191

1.80

307.65

1.7

1.15

1.27

mg/l

2.88

7626

26206

Heart failure,strict

7727

28058

2.42

307.65

2.9

1.6

1.51

1.36

mg/l

2.64

6383

21551

All-cause Heart Failure

8062

31941

2.16

307.65

2.7

1.6

1.50

1.42

mg/l

0.99

6649

24688

Septicaemia

5582

29616

2.13

307.65

2.6

1.6

2.00

1.28

mg/l

21.91

4629

22446

Sleep apnoea

13868

60375

1.76

307.65

1.9

1.7

0.95

1.23

mg/l

24.16

10526

46276

Phlebitis and thrombophlebitis (not including DVT)

4502

16797

4.04

307.65

2.3

1.7

1.60

1.12

mg/l

12.96

3608

12841

Pulmonary heart disease

5885

21863

4.07

307.65

2.7

1.7

2.31

1.25

mg/l

51.04

4873

16810

Implicit viral Sepsis

3041

13423

2.97

307.65

2.9

1.7

1.47

1.24

mg/l

2.19

2496

10149

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

15688

68302

1.84

307.65

2.2

1.7

1.39

1.12

mg/l

13.27

12558

50981

Shoulder lesions

11332

42617

1.83

307.65

1.8

1.7

1.02

1.29

mg/l

15.00

8679

32635

Myalgia

3736

16965

2.81

307.65

2.0

1.7

0.87

1.18

mg/l

8.19

2735

12743

STROKE

8069

34454

1.84

307.65

2.3

1.6

1.25

1.18

mg/l

1.00

6248

26450

Asthma, hospital admission 2, infections

9884

51052

2.31

307.65

2.2

1.8

1.04

1.25

mg/l

9.57

7626

38550

Asthma, excluding more controls

14066

35717

2.52

307.65

2.0

1.5

0.99

1.13

mg/l

5.70

10696

26650

Diseases of the musculoskeletal system and connective tissue

8984

24557

2.06

307.65

2.0

1.8

1.05

1.33

mg/l

7.75

6597

18181

Obesity due to excess calories

6935

41713

1.94

307.65

2.0

1.8

1.05

1.10

mg/l

0.63

5397

31416

Pain in limb

16982

49709

3.31

307.65

2.1

1.7

1.06

1.28

mg/l

13.87

13128

37494

Cerebrovascular diseases (FINNGEN)

4668

15326

2.60

307.65

2.6

1.4

1.22

0.84

mg/l

15.31

3633

11512

Diverticular disease of intestine

10036

42368

1.77

307.65

1.9

1.6

1.24

1.26

mg/l

0.32

7798

32870

Other headache syndromes

7116

36973

2.35

307.65

2.0

1.7

0.91

1.19

mg/l

9.94

5315

28010

Asthma, hospital admissions , main diagnosis only

13159

72766

1.85

307.65

2.0

1.7

0.97

1.21

mg/l

18.14

9935

54864

Other CVD (FINNGEN)

1556

4230

3.74

307.65

2.0

1.4

1.31

1.06

mg/l

1.96

1232

3136

Heart failure and bmi 25plus

4783

18750

2.09

307.65

2.7

1.6

1.42

1.39

mg/l

0.27

3899

14537

Other intervertebral disc disorders

12810

49210

1.79

307.65

1.8

1.7

0.98

1.27

mg/l

23.11

9778

37512

Symptoms and signs involving the skin and subcutaneous tissue

9964

64880

1.72

307.65

2.0

1.7

1.09

1.21

mg/l

2.50

7500

49440

Other dorsopathies, not elsewhere classified

17128

54276

1.89

307.65

1.8

1.7

1.01

1.26

mg/l

18.58

12799

40855

Psychiatric diseases

16232

59574

1.47

307.65

1.9

1.7

1.13

1.19

mg/l

1.09

12112

45424

Neurological diseases, wide definition

5461

11416

2.81

307.65

2.2

1.6

1.01

1.30

mg/l

5.03

3954

8306

Hard cardiovascular diseases

10765

45555

1.69

307.65

2.3

1.7

1.27

1.26

mg/l

0.08

8375

35186

Excluding asthma or asthma-COPD overlap

13557

38425

2.01

307.65

2.0

1.6

1.11

1.16

mg/l

1.15

10323

28783

Care involving use of rehabilitation procedures

8991

56382

1.69

307.65

2.1

1.7

1.23

1.14

mg/l

1.52

7103

42598

Valvular heart disease excluding rheumatic fever

6252

26514

1.97

307.65

2.2

1.6

1.32

1.34

mg/l

0.19

4824

20613

Asthma, hospital admissions 3, pneumonia

5600

27805

2.48

307.65

2.3

1.8

1.19

1.35

mg/l

2.64

4493

21189

Asthma (mode)

14036

38293

2.39

307.65

2.0

1.6

0.99

1.16

mg/l

7.57

10649

28695

Other antidepressants

16131

56272

1.65

307.65

1.8

1.7

1.10

1.23

mg/l

4.72

11998

42810

Anxiety disorders, excluding more controls

12837

55735

1.70

307.65

2.0

1.7

1.05

1.14

mg/l

1.75

9415

42318

Continuous positive airway pressure

2714

10120

2.82

307.65

2.5

1.6

1.35

1.13

mg/l

2.17

2054

7839

Oxicams

3364

9283

2.37

307.65

1.7

2.0

1.14

1.68

mg/l

11.22

2537

7215

Fall on same level

17263

69153

1.51

307.65

1.9

1.8

1.17

1.15

mg/l

0.19

13126

51946

Neurological diseases

14494

44360

1.84

307.65

2.0

1.7

1.05

1.25

mg/l

7.82

10731

33440

Any reimbursement code in KELA

9413

29260

1.78

307.65

2.1

1.5

1.09

0.90

mg/l

5.12

6990

21163

Acute sinusitis

7659

45408

1.77

307.65

1.9

1.7

0.97

1.11

mg/l

3.77

5697

34131

Asthma-related pneumonia or sepsis

5600

27805

2.48

307.65

2.3

1.8

1.19

1.35

mg/l

2.64

4493

21189

Acetic acid derivatives and related substances

4098

10613

2.28

307.65

1.7

2.0

1.13

1.66

mg/l

10.05

3094

8100

Oral corticosteroids

18794

64595

2.05

307.65

2.1

1.7

1.15

1.18

mg/l

0.48

14614

48549

Parasetamol

14186

37676

2.21

307.65

1.9

1.7

1.03

1.19

mg/l

7.19

10647

27869

First line medication for Crohn's disease

19548

61685

1.99

307.65

2.2

1.6

1.23

1.13

mg/l

2.87

15222

45871

Spondylosis

7360

38394

1.87

307.65

1.8

1.7

1.03

1.33

mg/l

16.16

5702

29778

Other external causes of accidental injury

12760

44614

1.55

307.65

1.9

1.7

1.10

1.19

mg/l

2.21

9593

33676

Finngen Rheumatological endpoints

15055

57683

1.64

307.65

1.9

1.7

1.12

1.15

mg/l

0.31

11694

42958

Ischaemic heart disease, wide definition

11095

42682

1.86

307.65

2.2

1.6

1.19

1.30

mg/l

2.35

8598

33094

Heart failure and antihypertensive medication

4281

10471

3.54

307.65

3.8

1.5

1.52

1.23

mg/l

4.61

3571

8022

Obesity and other hyperalimentation

9599

58015

1.90

307.65

2.0

1.7

1.04

1.11

mg/l

1.36

7480

43680

Other arrhythmias

9829

44118

1.96

307.65

2.0

1.6

1.02

1.15

mg/l

4.01

7192

33771

Hypertension

12369

43533

1.81

307.65

2.2

1.6

1.15

1.08

mg/l

1.25

9691

32606

Coxibs

4328

10699

2.49

307.65

1.8

2.0

1.07

1.65

mg/l

18.57

3242

8144

Opioids

17797

51690

2.09

307.65

1.9

1.7

1.10

1.16

mg/l

1.31

13566

38403

Gastro-oesophageal reflux disease

9984

55878

1.79

307.65

1.9

1.7

1.05

1.23

mg/l

6.97

7400

42890

Follow-up examination after treatment for conditions other than malignant neoplasms

6587

26534

1.82

307.65

1.8

1.6

1.13

1.23

mg/l

1.64

4992

20315

Oxycodone

4870

24665

2.26

307.65

2.1

1.6

1.71

1.36

mg/l

7.62

3993

18925

Concussion

7299

36421

1.96

307.65

2.0

1.7

1.02

1.24

mg/l

8.01

5418

27452

Neurotic, stress-related and somatoform disorders

13497

65115

1.63

307.65

2.0

1.7

1.04

1.11

mg/l

1.58

9836

49191

Mood disorders, excluding more controls

14199

59364

1.60

307.65

1.9

1.7

1.07

1.17

mg/l

2.67

10490

45220

Ischemic heart diseases

11176

43608

1.82

307.65

2.2

1.7

1.20

1.29

mg/l

1.91

8672

33773

Anxiety (asthma-related co-morbidities)

8879

46417

1.68

307.65

2.0

1.8

0.95

1.04

mg/l

1.96

6327

34766

Angina pectoris

8029

33318

1.85

307.65

2.0

1.6

1.12

1.41

mg/l

13.55

6289

25876

Other joint disorders

14106

47985

1.73

307.65

1.8

0.97

1.21

mg/l

13.93

10530

35610

Other disorders of urethra and urinary system

10203

49546

1.73

307.65

1.9

1.7

1.15

1.22

mg/l

1.20

7892

37629

Other pulmonary diagnosis

13692

38425

2.03

307.65

2.0

1.6

1.10

1.16

mg/l

1.44

10430

28783

Anaemias

4266

9598

3.78

307.65

2.9

1.4

1.37

0.83

mg/l

13.17

3330

6987

Obesity related asthma

5538

27073

2.62

307.65

2.2

1.7

0.93

1.19

mg/l

11.90

4314

20642

Symptoms and signs involving cognition, perception, emotional state and behaviour

14873

67460

1.73

307.65

1.9

1.7

1.10

1.21

mg/l

3.40

11221

51421

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8502

55341

1.73

307.65

2.1

1.7

1.39

1.21

mg/l

3.80

6798

42193

Anxiety disorders

13620

65613

1.63

307.65

2.0

1.7

1.03

1.12

mg/l

1.82

9931

49574

Abdominal and pelvic pain

17043

50428

1.92

307.65

2.0

1.7

1.13

1.24

mg/l

3.28

12728

38270

Depression

14114

68516

1.55

307.65

1.9

1.7

1.03

1.15

mg/l

4.02

10330

51834

Mood [affective] disorders

15132

70884

1.53

307.65

1.9

1.7

1.06

1.17

mg/l

3.55

11111

53729

Dorsopathies

16795

54460

1.75

307.65

1.9

1.7

0.99

1.26

mg/l

23.87

12561

40977

Headache

12074

48097

2.58

307.65

2.0

1.6

0.86

1.12

mg/l

18.39

8879

36042

Dizziness and giddiness

11433

56927

1.87

307.65

1.9

1.7

1.05

1.25

mg/l

8.33

8591

43648

Pure hypercholesterolaemia

9933

43494

1.71

307.65

1.9

1.7

1.30

1.25

mg/l

0.57

7819

33511

Antihypertensive medication - note that there are other indications

10356

31720

2.03

307.65

2.2

1.6

0.99

1.01

mg/l

0.25

7710

22902

Endocrine, nutritional and metabolic diseases

12883

43281

1.66

307.65

2.0

1.7

1.13

1.10

mg/l

0.39

9731

31895

Cough

6014

27655

2.50

307.65

2.1

1.6

1.10

1.36

mg/l

5.54

4520

21193

Complications of medical and surgical care

10744

65159

1.78

307.65

2.1

1.7

1.36

1.18

mg/l

4.60

8516

49550

Asthma/COPD (KELA code 203)

14866

67830

1.72

307.65

1.9

1.7

1.01

1.22

mg/l

14.79

11382

50977

Heart failure, strict

8227

32447

2.17

307.65

2.9

1.6

1.50

1.42

mg/l

1.18

6783

25067

Paroxysmal tachycardia

3230

12161

2.71

307.65

3.1

1.5

1.08

0.89

mg/l

3.64

2446

9003

Nausea and vomiting

3839

18999

2.38

307.65

2.4

1.7

1.38

1.32

mg/l

0.42

2984

14445

Dyspnoea

19155

60829

3.26

307.65

2.2

1.7

1.14

1.23

mg/l

3.50

14908

46139

Acute bronchitis

6103

33864

2.07

307.65

2.2

1.8

1.12

1.28

mg/l

2.89

4599

25671

Disturbances of skin sensation

4291

23413

2.24

307.65

2.0

1.7

0.86

1.07

mg/l

3.19

3155

17636

Artrosis, including avohilmo

12200

46760

1.56

307.65

1.7

1.8

1.06

1.21

mg/l

4.52

9434

35552

Persons encountering health services for examination and investigation

10096

32850

1.68

307.65

1.9

1.6

1.15

1.24

mg/l

1.39

7572

25102

COPD/asthma related infections

17586

53007

1.88

307.65

2.0

1.6

1.17

1.16

mg/l

0.05

13489

39709

Oedema, not elsewhere classified

6201

22028

4.05

307.65

2.1

1.6

1.23

1.30

mg/l

1.07

5004

16805

Other acute lower respiratory infections

7835

45028

1.90

307.65

2.2

1.8

1.12

1.26

mg/l

3.10

5938

33953

Abnormalities of breathing

19705

45169

3.37

307.65

2.1

1.6

1.07

1.25

mg/l

10.41

15082

34164

Fever of other and unknown origin

8873

40521

2.44

307.65

2.4

1.6

1.43

1.21

mg/l

4.89

6998

30612

Persons encountering health services for specific procedures and health care

16749

68862

1.67

307.65

2.2

1.7

1.41

1.10

mg/l

18.26

13198

51391

7489

37988

2.40

307.65

2.2

1.8

0.94

1.18

mg/l

10.10

5678

28449

Haemorrhage from respiratory passages

4850

19923

2.74

307.65

2.4

1.6

1.31

1.53

mg/l

3.13

3782

15488

Other nutritional deficiencies

10090

59788

1.92

307.65

2.0

1.7

1.04

1.12

mg/l

1.73

7850

44984

Hypertensive diseases

12382

43573

1.81

307.65

2.2

1.6

1.15

1.08

mg/l

1.28

9699

32632

Abnormalities of heart beat

5966

23878

3.18

307.65

2.1

1.6

0.96

1.36

mg/l

14.91

4299

18259

General examination and investigation of persons without complaint and reported diagnosis

9838

32803

1.76

307.65

2.1

1.6

1.06

1.24

mg/l

7.24

7323

25072

Asthma (only as main-diagnosis), excluding more controls

12505

35717

2.50

307.65

2.0

1.5

0.96

1.13

mg/l

7.70

9426

26650

Pain, not elsewhere classified

4545

20305

2.85

307.65

2.3

1.6

1.06

1.18

mg/l

1.74

3472

15278

Allergic asthma (mode)

3469

18080

2.18

307.11

1.9

1.6

0.90

1.08

mg/l

2.17

2602

13266

Aplastic and other anaemias

5772

33861

1.84

306.54

2.4

1.7

1.70

1.37

mg/l

5.63

4664

26117

Hernia of abdominal wall, postoperative

2482

11809

2.56

305.70

2.0

1.5

1.34

1.05

mg/l

3.63

1941

8987

Non-allergic asthma (mode), excluding more controls

2664

12815

2.44

305.37

2.0

1.5

1.10

1.21

mg/l

1.18

2042

9555

Myocardial infarction, without ST-elevation

4984

27403

1.93

304.22

2.0

1.7

1.43

1.50

mg/l

0.66

3984

21356

Selective serotonin reuptake inhibitors

14669

56412

1.47

302.18

1.8

1.09

1.23

mg/l

4.26

10858

42903

Dermatitis and eczema

15406

75032

1.45

301.24

1.9

1.8

1.09

1.20

mg/l

2.62

11572

56765

Abnormal findings on diagnostic imaging of lung

6066

37245

1.80

299.84

2.0

1.7

1.42

1.36

mg/l

0.53

4917

28853

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7795

52074

1.68

299.42

2.1

1.7

1.38

1.21

mg/l

3.12

6216

39762

Diseases of arteries, arterioles and capillaries

8505

42763

1.65

297.24

2.1

1.7

1.71

1.28

mg/l

14.88

6867

32929

All influenza

3457

18716

2.19

296.99

2.3

1.7

1.17

1.22

mg/l

0.35

2676

13892

Undetermined asthma

1893

8167

2.93

296.33

2.0

1.6

0.94

1.19

mg/l

3.73

1461

6104

Factors influencing health status and contact with health services

4665

13103

1.97

294.64

1.8

1.5

1.21

1.20

mg/l

0.02

3474

9954

Soft tissue disorders related to use, overuse and pressure

3536

19400

2.14

290.21

2.0

1.7

1.06

1.28

mg/l

4.11

2746

14852

Symptoms and signs involving the urinary system

10170

55128

1.56

289.66

1.9

1.7

1.28

1.27

mg/l

0.09

7782

42235

Infections of the skin and subcutaneous tissue

7841

52497

1.65

288.93

2.1

1.8

1.16

1.17

mg/l

0.16

6006

39353

Hyperlipidaemia, other/unspecified

4902

27974

1.90

287.56

1.9

1.6

1.31

1.39

mg/l

0.77

3818

21607

External causes of morbidity and mortality

10213

35223

1.57

287.42

1.9

1.7

1.10

1.17

mg/l

1.27

7672

26451

Osteopathies and chondropathies

7407

46768

1.68

287.09

2.0

1.7

1.21

1.22

mg/l

0.10

5816

35544

Irritable bowel syndrome

4019

23099

2.05

286.61

1.9

1.6

0.96

1.10

mg/l

1.53

2891

17371

Other diseases of upper respiratory tract

15941

62155

1.43

283.95

1.8

1.06

1.27

mg/l

10.18

11972

47265

COPD

5496

28033

1.83

283.47

2.0

1.7

1.36

1.48

mg/l

1.71

4435

21712

Non-invasive ventilation

2820

13439

2.29

282.41

2.0

1.5

1.48

1.07

mg/l

5.16

2364

10146

Functional dyspepsia

3818

21753

2.08

282.28

1.9

1.7

0.93

1.16

mg/l

6.73

2873

16623

Major coronary heart disease event

8984

41115

1.61

282.16

2.2

1.7

1.31

1.36

mg/l

0.74

7057

31957

Symptoms and signs involving the nervous and musculoskeletal systems

7751

52318

1.65

282.01

2.0

1.7

1.04

1.25

mg/l

6.43

5788

39993

Chronic kidney disease

3693

20632

2.08

281.73

3.0

1.7

2.05

1.39

mg/l

11.03

3149

15884

Autoimmune diseases related-to ILD

11771

75061

1.50

281.11

1.9

1.7

1.16

1.17

mg/l

0.02

9099

56529

Presence of cardiac and vascular implants and grafts

5668

26711

1.81

281.00

3.1

1.6

1.43

1.45

mg/l

0.15

4492

20765

Other anaemias

5292

31625

1.84

280.30

2.4

1.7

1.67

1.37

mg/l

4.52

4277

24414

Transplanted organ and tissue status

1552

6413

3.37

279.49

6.1

1.7

2.22

1.21

mg/l

9.57

1377

4864

Other and unspecified anaemias

5240

31358

1.84

279.09

2.4

1.7

1.67

1.38

mg/l

4.43

4232

24196

Dentinal caries

3238

17442

2.20

279.02

3.2

1.7

1.55

1.23

mg/l

3.10

2606

13291

Diaphragmatic hernia

4801

29212

1.91

278.76

2.0

1.7

1.32

1.29

mg/l

0.20

3736

22536

Other neurological diseases

9369

52552

1.57

277.01

2.0

1.7

1.22

1.30

mg/l

1.00

7217

40476

Benign neoplasm of colon, rectum, anus and anal canal

7198

33960

1.69

275.46

2.0

1.7

1.26

1.11

mg/l

4.00

5627

26055

Used for control exclusion in common control thyroid runs

15379

58153

1.43

275.37

1.9

1.7

1.16

1.18

mg/l

0.20

11660

43605

Autoimmune diseases excluding thyroid diseases

14912

61645

1.44

275.32

1.9

1.8

1.26

1.17

mg/l

2.34

11554

46280

Non-allergic asthma (mode)

2664

13352

2.33

274.01

2.0

1.6

1.10

1.25

mg/l

1.75

2042

9992

Visual disturbances and blindness

6748

44580

1.70

273.56

2.1

1.7

1.10

1.26

mg/l

3.46

5051

33952

Paracetamol of NSAID medication

2504

5736

2.44

273.44

1.9

2.2

1.12

1.61

mg/l

6.73

1827

4275

Acute renal failure

2726

14118

2.36

272.01

3.3

1.7

2.40

1.36

mg/l

16.82

2335

10837

Myocardial infarction

6241

28732

1.75

271.13

2.3

1.6

1.46

1.44

mg/l

0.17

4957

22331

Conduction disorders

3661

17005

2.06

270.98

2.2

1.6

1.44

1.41

mg/l

0.13

2820

13228

Oter anti-inflammatory and antirheumatic agents, non-steroids

2967

8243

2.27

270.82

1.7

2.0

1.31

1.72

mg/l

5.65

2317

6489

Visual disturbances

6310

41203

1.73

270.80

2.2

1.7

1.08

1.24

mg/l

3.27

4727

31352

Dysphagia

3166

17159

2.18

270.15

2.0

1.6

1.16

1.33

mg/l

2.10

2391

13255

Type 2 diabetes, wide definition

10581

49151

1.53

267.46

2.0

1.7

1.35

1.21

mg/l

3.06

8449

37611

Other anxiety disorders

6513

37823

1.71

267.20

2.0

1.7

0.92

1.02

mg/l

1.94

4614

28078

Chronic sinusitis

5986

38707

1.74

265.49

1.8

1.7

0.99

1.19

mg/l

4.49

4463

29485

Injuries to the head

15268

75139

1.42

265.15

1.9

1.8

1.20

1.18

mg/l

0.36

11521

56797

Autoimmune diseases excluding thyroid diseases, strict definition

14472

60157

1.43

264.23

1.8

1.7

1.27

1.17

mg/l

2.44

11217

45143

Acute tubulo-interstitial nephritis

8179

49933

1.60

262.44

2.0

1.7

1.51

1.17

mg/l

9.07

6437

37782

Autoimmune diseases

16048

62029

1.41

261.32

1.9

1.8

1.18

1.17

mg/l

0.12

12217

46561

Diseases of pulp and periapical tissues

4778

29439

1.85

259.47

2.6

1.7

1.29

1.20

mg/l

0.92

3711

22617

Diseases of the eye and adnexa

12399

45143

1.47

259.44

1.9

1.8

1.07

1.13

mg/l

0.82

9290

33817

Other chronic obstructive pulmonary disease

5215

27068

1.80

258.99

2.0

1.7

1.35

1.48

mg/l

2.15

4203

20977

Dialysis, with operation codes

1876

8677

2.83

258.80

5.5

1.8

2.82

1.26

mg/l

20.68

1690

6603

Gout, FINNGEN

3545

20187

2.05

258.13

2.1

1.7

1.45

1.48

mg/l

0.19

2846

15753

Iron deficiency anaemia

5436

34324

1.78

257.89

2.5

1.7

1.40

1.26

mg/l

2.01

4251

26263

Cholelithiasis, broad definition with cholecystitis

11845

59471

1.48

256.70

1.9

1.7

1.18

1.19

mg/l

0.15

9193

45471

Other disorders of skin and subcutaneous tissue

8903

57439

1.56

255.46

2.0

1.7

1.22

1.25

mg/l

0.39

6949

43942

Cholelithiasis

11442

58559

1.48

255.03

1.8

1.7

1.16

1.19

mg/l

0.43

8868

44761

Other enthesopathies

3958

23334

1.94

252.64

1.7

0.92

1.20

mg/l

5.59

2967

17822

Gout, idiopatic and unspecified

3032

16671

2.17

251.27

2.1

1.7

1.45

1.48

mg/l

0.20

2422

13049

Meniscus derangement

7474

34521

1.62

251.25

1.7

1.09

1.25

mg/l

3.46

5815

26338

Benign neoplasm: Colon

6185

30990

1.71

251.12

2.0

1.7

1.28

1.14

mg/l

2.90

4835

23805

Hypertensive heart and/or renal disease

3124

13126

2.12

250.12

1.9

1.6

1.41

1.44

mg/l

0.15

2510

10057

Neoplasms

11377

44072

1.49

250.10

2.0

1.8

1.18

1.01

mg/l

5.07

8644

32400

Disorders of eyelid, lacrimal system and orbit

11327

65244

1.47

247.37

1.9

1.7

1.12

1.23

mg/l

2.60

8627

49843

Other reaction to severe stress, and adjustment disorders

5265

33646

1.77

247.20

2.2

1.7

1.16

1.02

mg/l

1.29

3876

25134

Hypertensive Heart Disease

2821

12188

2.20

246.89

1.9

1.6

1.38

1.46

mg/l

0.69

2243

9328

Benign neoplasms

11233

46089

1.48

245.98

2.0

1.7

1.08

1.01

mg/l

1.61

8520

34009

Unstable angina pectoris

4732

24282

1.84

245.49

1.9

1.6

1.12

1.49

mg/l

15.16

3631

18946

Benign neoplasms

14090

59168

1.42

243.83

1.9

1.7

1.14

1.17

mg/l

0.41

10733

44422

Nutritional anaemias

6216

40139

1.68

243.65

2.4

1.7

1.45

1.30

mg/l

2.38

4864

30794

Benign neoplasm of colon, rectum, anus and anal canal

7619

47483

1.60

243.32

2.0

1.7

1.28

1.34

mg/l

0.83

5959

36901

Exposure to other specified factors

9951

67544

1.50

243.07

1.9

1.8

1.10

1.16

mg/l

0.92

7381

50899

Varicose veins

8043

42136

1.58

241.61

1.7

1.6

1.28

1.16

mg/l

1.87

6260

32495

Hernia

12727

64491

1.44

241.08

1.9

1.7

1.28

1.17

mg/l

2.14

9786

48926

Internal derangement of knee

5022

31696

1.77

240.70

1.8

0.98

1.24

mg/l

9.55

3733

24004

Statin medication

9951

39811

1.51

240.08

2.2

1.6

1.07

1.11

mg/l

0.50

7582

30078

Other coagulation defects

1280

5266

3.58

238.73

3.8

1.7

1.29

1.04

mg/l

1.63

968

3973

Hypothyroidism, drug reimbursement

1983

6552

2.50

236.06

1.9

1.4

0.90

0.77

mg/l

1.46

1492

4852

Migraine without aura

2930

16216

2.14

235.89

2.1

1.7

0.76

0.99

mg/l

5.13

2122

11980

Injury, poisoning and certain other consequences of external causes

8175

28054

1.57

235.05

1.9

1.7

1.11

1.19

mg/l

1.15

6123

21030

Excessive, frequent and irregular menstruation

5878

21153

1.73

234.78

1.8

1.7

0.87

1.14

mg/l

12.93

4389

15775

Intracranial injury

7486

50095

1.58

233.85

2.0

1.8

1.19

1.25

mg/l

0.80

5613

37889

Nephropathy related operations

1783

8439

2.76

233.10

5.5

1.8

2.76

1.28

mg/l

19.17

1614

6468

Dental pulpitis 4

15427

61400

1.39

232.10

1.9

1.7

1.12

1.23

mg/l

4.02

11502

46546

Dental pulpitis 1

15422

61419

1.39

231.30

1.9

1.7

1.11

1.23

mg/l

4.10

11495

46561

Triptan medication for migraine, single purchase ok

10838

53892

1.47

230.93

1.8

0.84

1.09

mg/l

18.89

8090

40204

Migraine, single triptan purchase ok & required. ICD-code if available is included

10838

53892

1.47

230.93

1.8

0.84

1.09

mg/l

18.89

8090

40204

Other and unspecified coagulation defects

949

3450

4.58

230.74

4.0

1.7

1.32

0.99

mg/l

2.07

723

2585

Pain in thoracic spine

2189

11114

2.41

230.61

2.0

1.7

0.83

1.20

mg/l

12.38

1611

8386

Diseases of pulp and periapical tissues, including avohilmo

15397

61336

1.39

230.21

1.9

1.7

1.12

1.23

mg/l

3.77

11486

46488

Persons encountering health services in other circumstances

5095

32777

1.74

229.16

2.0

1.7

1.10

1.17

mg/l

0.93

3718

24661

Diseases of the ear and mastoid process

16840

66152

1.37

228.43

1.9

1.8

1.07

1.17

mg/l

3.06

12536

50111

Diseases of oral cavity, salivary glands and jaws

12931

49611

1.43

228.10

2.1

1.6

1.17

1.23

mg/l

1.10

9703

37944

Gonarthrosis, primary, with knee surgery

6790

37836

1.62

227.29

1.7

1.37

1.38

mg/l

0.08

5465

29442

Artificial joint operation, meniscal resection

11911

59175

1.44

227.18

1.7

1.8

1.23

mg/l

0.07

9411

45305

Use of hypnotics and sedatives

14790

65622

1.39

226.39

1.8

1.7

1.16

1.18

mg/l

0.42

11233

49965

Other and unspecified iron deficiency

4231

26270

1.85

225.28

2.2

1.7

1.31

1.26

mg/l

0.53

3304

20050

Gout, unspecified

2499

13398

2.25

224.95

2.2

1.7

1.49

1.48

mg/l

0.04

1993

10455

Dermatitis

7957

56434

1.54

221.92

2.0

1.7

1.14

1.22

mg/l

1.25

6047

43051

Injuries to the ankle and foot

9328

61900

1.49

218.27

1.9

1.8

0.97

1.11

mg/l

4.95

6937

46290

Disorders of the thyroid gland

13126

65286

1.41

218.19

2.0

1.7

1.07

1.20

mg/l

3.97

9893

49673

Cholecystectomy

9271

59702

1.49

217.88

1.8

1.7

1.18

1.20

mg/l

0.25

7223

45741

Other chronic obstructive pulmonary disease, including avohilmo

6376

36026

1.63

217.72

2.0

1.7

1.35

1.40

mg/l

0.43

5122

27920

Cervicobrachial syndrome

3043

17502

2.03

215.31

1.8

1.7

0.81

1.19

mg/l

16.84

2299

13346

Ovarian cyst

5406

20302

1.72

215.11

1.8

1.7

0.96

1.15

mg/l

2.90

4052

15232

Other diseases of hard tissues of teeth

8612

46024

1.51

214.09

2.2

1.6

1.02

1.18

mg/l

5.15

6338

35168

Myocardial infarction, strict

5591

26942

1.68

212.88

2.3

1.6

1.43

1.45

mg/l

0.20

4456

20970

Bacterial pneumoniae

5087

29301

1.71

212.57

2.2

1.6

1.43

1.26

mg/l

2.70

4176

22011

Chronic rhinitis, nasopharyngitis and pharyngitis

4269

26927

1.80

212.21

1.9

1.8

0.91

1.17

mg/l

4.68

3151

20472

Propionic acid derivatives

3821

11164

1.87

211.99

1.8

2.1

1.16

1.64

mg/l

11.17

2815

8445

Coxarthrosis

6142

27923

1.63

211.59

1.8

1.7

1.33

1.36

mg/l

0.20

4981

21640

Later onset COPD, excluding more controls

2360

9639

2.22

210.66

1.9

1.5

1.50

1.61

mg/l

0.66

1944

7407

Cardiomyopathy

2174

11289

2.28

210.01

4.5

1.6

1.51

1.39

mg/l

0.71

1710

8808

L04AD Calcineurin inhibitors

1606

7659

2.76

207.49

5.5

1.8

2.11

1.14

mg/l

9.86

1408

5768

Bacterial pneumonia, not elsewhere classified

4816

27549

1.72

207.26

2.2

1.6

1.43

1.27

mg/l

2.25

3960

20696

Other and unspecified dermatitis

6632

46127

1.59

206.82

2.0

1.7

1.13

1.20

mg/l

0.80

5038

35198

Dental pulpitis 4, only avohilmo

15518

63129

1.36

206.32

1.8

1.09

1.24

mg/l

6.64

11535

47930

Heartburn

1501

6900

2.76

205.98

2.1

1.7

0.97

1.21

mg/l

2.01

1079

5241

Vocal cord dysfunction

1871

8535

2.40

205.91

2.0

1.5

1.06

mg/l

0.01

1416

6467

Benign neoplasm: Colon

6277

42354

1.61

205.82

2.0

1.7

1.29

1.37

mg/l

1.17

4911

32990

ILD, hospital admission 2, with pulmonary infections

1272

5446

3.02

205.48

2.7

1.6

1.68

1.41

mg/l

1.25

1065

4188

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6723

45840

1.57

205.38

1.9

1.8

0.99

1.23

mg/l

10.21

5017

34999

Other systemic involvement of connective tissue (FG)

3388

20219

1.91

203.76

1.9

1.6

1.16

1.20

mg/l

0.38

2663

15258

Any operation in hilmo

660

803

4.76

203.38

1.8

1.2

1.03

0.55

mg/l

5.00

477

565

Other bursopathies

1752

8568

2.51

203.26

2.0

1.6

1.12

1.35

mg/l

2.55

1379

6518

Inflammatory diseases of female pelvic organs

8481

46373

1.51

202.29

1.8

1.7

0.87

1.07

mg/l

9.58

6282

34948

Ulcer of lower limb, not elsewhere classified

1830

9213

2.48

199.95

2.2

1.7

1.52

1.41

mg/l

0.78

1517

7109

Gingivitis and periodontal diseases

12566

49303

1.40

199.43

2.0

1.6

1.17

1.22

mg/l

0.96

9408

37703

Dental pulpitis 1, only avohilmo

15507

63368

1.35

199.29

1.8

1.08

1.24

mg/l

7.40

11517

48126

Covid-19 suspected case

2935

17159

2.00

197.71

2.1

1.7

0.97

1.04

mg/l

0.69

2301

12581

Other diseases of the respiratory system

2517

14054

2.11

196.60

2.5

1.7

1.48

1.46

mg/l

0.11

2062

10851

Other respiratory disorders and diseases

2517

14054

2.11

196.60

2.5

1.7

1.48

1.46

mg/l

0.11

2062

10851

Superficial injury of lower leg

3284

19802

1.91

195.85

1.9

1.8

1.05

1.15

mg/l

1.25

2495

14747

Speech therapy

3570

22092

1.88

195.77

2.0

1.7

1.21

1.22

mg/l

0.05

2964

16875

Secondary hypertension

995

3796

3.23

193.15

2.1

1.5

1.65

0.97

mg/l

2.86

803

2780

Other symptoms and signs involving the circulatory and respiratory systems

919

3449

3.51

192.94

2.3

1.7

1.07

1.36

mg/l

1.45

717

2636

Hypothyroidism, strict autoimmune

10192

50389

1.44

192.54

1.8

1.7

1.12

1.17

mg/l

0.64

7678

38124

Other specified/unspecified arthritis

3399

20689

1.86

192.33

1.9

1.7

1.20

1.23

mg/l

0.26

2692

15669

Migraine with aura and triptan purchases

2254

12369

2.21

190.64

2.1

1.7

0.75

0.94

mg/l

3.54

1659

9089

Primary gonarthrosis, bilateral

6034

36486

1.60

190.59

1.7

1.32

1.35

mg/l

0.33

4799

28304

Fenamates

2044

7001

2.26

190.30

1.8

2.0

1.00

1.59

mg/l

13.14

1554

5401

Type 2 diabetes

13385

61644

1.37

189.83

1.9

1.7

1.20

1.16

mg/l

0.79

10496

46618

Injuries to the thorax

5505

37552

1.62

188.79

2.0

1.8

1.30

1.28

mg/l

0.15

4257

28697

AV-block

2027

9576

2.23

188.62

2.1

1.6

1.60

1.62

mg/l

0.06

1596

7524

Carpal tunnel syndrome

7923

52046

1.50

188.31

1.7

1.01

1.19

mg/l

7.41

6153

39883

Polycystic ovarian syndrome, consortium definition

10014

45214

1.45

187.91

1.8

1.7

0.92

1.07

mg/l

5.56

7441

34031

COPD, hospital admissions

5235

29802

1.65

187.85

2.0

1.7

1.34

1.45

mg/l

1.46

4215

23159

Systemic connective tissue disorders

4569

30171

1.71

187.40

2.0

1.7

1.25

1.21

mg/l

0.32

3613

23008

Subjective visual disturbances

3222

19645

1.91

187.20

2.1

1.7

0.95

1.19

mg/l

6.83

2367

14921

Synovial cyst of popliteal space [Baker]

1077

4491

3.19

186.62

2.0

1.6

1.14

1.38

mg/l

1.77

858

3401

Cerebrovascular diseases

8981

47527

1.46

186.38

2.2

1.7

1.39

1.31

mg/l

1.37

7019

36765

Transient ischemic attack

6207

35819

1.58

186.32

2.1

1.6

1.22

1.40

mg/l

3.36

4849

27761

Cervical disc disorders

4517

29622

1.69

186.19

1.8

1.7

1.02

1.31

mg/l

8.64

3428

22881

Diseases of the digestive system

5574

38129

1.61

185.59

2.4

1.7

1.38

1.32

mg/l

0.59

4361

29160

Pain and other conditions associated with female genital organs and menstrual cycle

2849

16044

1.97

185.32

1.9

1.7

0.72

1.03

mg/l

11.59

2001

11842

Other disorders of lacrimal gland

4377

28732

1.73

185.06

2.0

1.7

0.99

1.20

mg/l

5.08

3357

21925

Coxarthrosis [arthrosis of hip](FG)

6563

33200

1.55

184.97

1.8

1.7

1.34

1.31

mg/l

0.28

5326

25576

Trochanteric bursitis

1794

9175

2.38

184.84

2.0

1.6

0.97

1.25

mg/l

5.74

1394

7012

COPD, early/later onset

5258

29996

1.64

184.40

2.0

1.7

1.35

1.45

mg/l

1.38

4234

23322

Hypothyroidism, other/unspecified

12123

61690

1.38

183.95

1.9

1.7

1.10

1.20

mg/l

1.81

9137

46934

Diabetes mellitus

13978

65397

1.35

181.87

2.0

1.7

1.19

1.15

mg/l

0.70

10909

49135

Diabetes, varying definitions

13892

65097

1.35

180.33

2.0

1.7

1.20

1.15

mg/l

0.82

10847

48925

Asthma and allergy, excluding more controls

1793

9037

2.28

178.86

2.0

1.5

0.73

0.97

mg/l

5.35

1304

6513

COPD related to multimorbidity

4445

24574

1.70

178.72

2.0

1.7

1.39

1.49

mg/l

1.15

3595

19161

Other diseases of anus and rectum

3624

22843

1.78

177.41

2.1

1.7

1.32

1.31

mg/l

0.07

2732

17498

Rheumatism, unspecified

1873

9866

2.29

176.87

1.8

1.6

0.96

1.20

mg/l

3.82

1426

7552

Polyarthrosis

2432

13248

2.04

176.75

1.8

1.6

1.15

1.35

mg/l

2.68

1913

10221

Bacterial pneumonia (organism specified)

5405

33744

1.60

176.73

2.2

1.7

1.45

1.31

mg/l

1.75

4439

25623

Disorders of conjunctiva

10824

69542

1.39

176.37

1.9

1.8

1.04

1.16

mg/l

2.59

8066

52313

COPD, hospital admission 2, with asthma infections

3700

19969

1.78

175.35

2.1

1.7

1.36

1.49

mg/l

1.43

3012

15524

Cervicalgia

2643

15469

1.97

174.71

1.9

1.7

1.01

1.26

mg/l

3.05

1970

11788

Heart failure and coronary heart disease

3673

17235

1.79

173.93

2.9

1.6

1.54

1.63

mg/l

0.76

3009

13470

Asthma and allergy

1792

9121

2.26

173.93

2.0

1.6

0.73

0.99

mg/l

5.62

1303

6608

Primary_lymphoid and hematopoietic malignant neoplasms

2845

17035

1.92

173.53

2.7

1.7

1.89

1.23

mg/l

6.76

2343

13001

Anti-inflammatory and antirheumatic products, non-steroids

3662

11168

1.78

173.51

1.8

2.1

1.17

1.64

mg/l

10.71

2693

8449

Hypothyreosis and Thyroxine purchase for inclusion criteria

12456

64199

1.36

171.36

1.9

1.7

1.11

1.19

mg/l

1.47

9382

48862

Respiratory insufficiency

1008

4164

3.01

170.98

2.7

1.6

1.42

1.55

mg/l

0.41

830

3191

Irregular menses

6552

38066

1.53

170.45

1.9

1.7

0.80

0.99

mg/l

9.56

4835

28531

Other and unspecified effects of external causes

3633

23265

1.77

170.17

2.0

1.8

1.00

1.11

mg/l

1.07

2658

17285

Other disorders of teeth and supporting structures

2748

16407

1.93

170.09

2.5

1.6

1.29

1.24

mg/l

0.31

2127

12647

Gout, strict definition

2082

11509

2.16

169.93

2.3

1.7

1.49

1.51

mg/l

0.08

1652

9017

Substance abuse, excluding more controls

6924

43634

1.50

169.82

1.8

1.7

1.28

1.20

mg/l

1.14

5308

33319

Glucagon-like peptide-1 (GLP-1) analogues

6568

38701

1.52

169.05

1.9

1.7

1.47

1.34

mg/l

1.78

5268

29970

Other arthritis (FG)

3884

25224

1.72

168.32

1.9

1.7

1.20

1.16

mg/l

0.36

3064

18985

Disorders of lacrimal system

5255

36455

1.60

167.90

2.0

1.7

1.02

1.22

mg/l

6.05

4025

27860

Personality disorders, excluding more controls

3445

21778

1.78

167.74

1.9

1.7

0.97

1.01

mg/l

0.27

2473

16323

Type 2 diabetes, definitions combined, including avohilmo

12708

58924

1.35

166.84

2.0

1.7

1.21

1.16

mg/l

0.73

9982

44728

Other symptoms and signs involving cognitive functions and awareness

5171

33426

1.59

165.64

1.9

1.7

1.33

1.37

mg/l

0.31

3979

25934

Hernia of abdominal wall

5542

38881

1.57

165.45

1.9

1.7

1.28

1.24

mg/l

0.36

4327

29845

Adjustment and management of implanted device

2213

12541

2.06

164.33

3.0

1.6

1.55

1.47

mg/l

0.34

1754

9611

Dentofacial anomalies [including malocclusion]

3667

23399

1.74

163.90

2.3

1.7

0.94

1.06

mg/l

1.33

2745

17682

Other diseases of the digestive system

3755

24348

1.72

163.80

2.7

1.7

1.43

1.39

mg/l

0.31

2965

18742

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3679

23761

1.73

162.72

2.0

1.7

1.04

1.03

mg/l

0.11

2705

17858

Non-selective monoamine reuptake inhibitors

4896

32575

1.61

162.30

1.8

1.7

1.09

1.25

mg/l

3.85

3759

25253

Injuries to the shoulder and upper arm

10475

67801

1.38

162.17

1.8

1.12

1.24

mg/l

4.37

8087

51377

Enthesopathies of lower limb, excluding foot

2825

17175

1.88

162.04

1.9

1.7

1.01

1.19

mg/l

2.05

2156

13064

Fibromyalgia

1273

6054

2.67

161.78

2.0

1.6

0.75

0.98

mg/l

4.02

938

4539

Chronic periapical parodontitis

2651

15896

1.92

161.60

3.0

1.6

1.48

1.22

mg/l

2.97

2089

12297

Enlarged lymph nodes

1976

10841

2.12

161.04

2.2

1.6

1.39

1.22

mg/l

0.96

1583

8137

Convulsions, not elsewhere classified

2759

16356

1.86

160.22

2.2

1.6

1.43

1.22

mg/l

1.71

2089

12135

Type 2 diabetes, definitions combined

12540

58850

1.35

159.67

1.9

1.7

1.24

1.17

mg/l

1.16

9859

44732

Pacemaker

3683

23256

1.72

159.34

2.7

1.7

1.49

1.54

mg/l

0.25

2869

18185

Panic disorder

2108

11922

2.08

158.87

2.1

1.7

0.97

0.99

mg/l

0.09

1474

8731

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

4495

19599

1.67

158.84

2.0

1.7

0.92

0.79

mg/l

2.39

3362

14122

Peripheral artery disease

4920

27135

1.60

158.70

1.9

1.7

1.65

1.40

mg/l

3.98

4027

21001

Other gastritis (incl. Duodenitis)

2807

17149

1.87

158.42

2.1

1.7

1.28

1.31

mg/l

0.20

2206

13253

Type 2 diabetes, strict (exclude DM1)

12563

59081

1.34

157.84

1.9

1.7

1.24

1.17

mg/l

1.14

9876

44927

Polyneuropathies and other disorders of the peripheral nervous system

2617

15789

1.93

157.35

2.3

1.8

1.27

1.36

mg/l

0.61

2076

12212

Menorrhagia

4888

18339

1.63

156.97

1.8

1.7

0.91

1.16

mg/l

8.27

3648

13909

Hypo-osmolality and hyponatraemia

2080

11708

2.08

156.94

2.0

1.6

1.69

1.36

mg/l

2.12

1704

8926

1860

10197

2.19

156.91

3.6

1.7

1.35

1.06

mg/l

2.70

1435

7666

Migraine without aura and triptan purchases

2292

13377

2.02

156.51

2.1

1.8

0.72

0.93

mg/l

4.99

1657

9825

Injuries to the abdomen, lower back, lumbar spine and pelvis

4788

32784

1.60

155.63

1.9

1.8

1.30

1.26

mg/l

0.44

3680

24703

Other obstetric conditions, not elsewhere classified

4583

20165

1.65

155.53

2.0

1.7

0.92

0.79

mg/l

2.40

3430

14540

Valvular operations

1664

8725

2.23

155.41

2.6

1.6

1.41

1.56

mg/l

1.08

1281

6853

GI-bleeding

3720

24351

1.70

155.00

2.7

1.7

1.43

1.40

mg/l

0.23

2961

18767

Symptoms and signs involving speech and voice

4100

27549

1.67

154.84

2.1

1.7

1.01

1.21

mg/l

4.92

3139

21076

Somatoform disorder

2251

13125

2.03

154.61

2.1

1.7

0.92

1.08

mg/l

2.16

1648

9944

Other symptoms and signs involving the nervous and musculoskeletal systems

5260

37015

1.56

154.22

2.1

1.7

0.93

1.19

mg/l

9.81

3867

28156

Dislocation, sprain and strain of joints and ligaments of knee

7820

54341

1.44

154.21

1.8

0.93

1.11

mg/l

8.33

5888

40635

Dental pulpitis 2

9552

37051

1.40

153.92

1.9

1.7

1.20

1.32

mg/l

2.72

7195

28679

Persons encountering health services for specific procedures, not carried out

1138

5307

2.78

153.56

2.1

1.7

1.19

1.03

mg/l

1.11

863

3913

Other respiratory diseases principally affecting the interstitium

2114

12104

2.05

153.01

2.5

1.7

1.61

1.43

mg/l

1.13

1739

9379

Unspecified fall

5927

42252

1.51

152.35

1.9

1.8

1.28

1.26

mg/l

0.11

4535

31991

Urticaria and erythema

4710

32592

1.60

152.03

2.1

1.8

1.04

1.11

mg/l

0.74

3461

24566

Other CVD

2252

13141

2.00

151.81

2.0

1.7

1.47

1.49

mg/l

0.07

1784

10182

Transport accidents

5823

36779

1.51

151.67

1.9

1.7

1.05

1.19

mg/l

3.17

4356

27659

Paralytic ileus and intestinal obstruction

2984

18642

1.80

151.42

2.0

1.7

1.57

1.37

mg/l

2.52

2442

14326

Unspecified haematuria

4756

28053

1.59

150.81

1.9

1.7

1.47

1.38

mg/l

0.82

3677

21722

Primary_lymphoid and hematopoietic malignant neoplasms

2845

17708

1.84

150.18

2.7

1.7

1.89

1.35

mg/l

4.67

2343

13589

Dental pulpitis 2, only avohilmo

9709

37873

1.39

149.97

1.8

1.7

1.20

1.32

mg/l

2.79

7319

29347

Conjunctivitis

9722

65568

1.38

149.54

1.8

1.02

1.13

mg/l

2.10

7214

49173

ILD, hospital admissions

1794

9873

2.18

149.49

2.4

1.7

1.60

1.43

mg/l

0.80

1478

7655

Dental caries 1 and operation codes

11745

47163

1.35

149.46

1.9

1.7

1.21

1.28

mg/l

1.27

8825

36336

Second line medication for Crohn's disease

7128

53000

1.45

149.42

2.2

1.7

1.34

1.13

mg/l

4.35

5598

40063

Sequelae of external causes of morbidity and mortality

3099

19751

1.79

149.32

2.0

1.8

1.35

1.24

mg/l

1.29

2518

15080

Dental caries, including avohilmo

10564

41690

1.37

149.07

1.9

1.7

1.20

1.30

mg/l

1.83

7935

32240

Dental caries 1

10568

41727

1.37

148.36

1.9

1.7

1.20

1.30

mg/l

1.81

7938

32272

Deforming dorsopathies

3422

22210

1.72

148.16

1.8

1.7

1.10

1.27

mg/l

2.67

2641

16808

Disorders of vestibular function (Vertigo)

5627

40143

1.53

147.76

1.8

1.7

1.07

1.27

mg/l

5.11

4240

30986

Other and unspecified polyneuropathies, also in other diseases

2288

13565

1.97

147.33

2.3

1.8

1.30

1.38

mg/l

0.45

1815

10495

ILD, hospital admissions 3, with pneumonia sepsis

1050

4790

2.79

147.16

2.8

1.7

1.77

1.43

mg/l

1.40

901

3686

Cellulitis

2701

16685

1.85

147.00

2.1

1.8

1.20

1.22

mg/l

0.19

2104

12601

Temporomandibular joint disorders, including avohilmo

5494

39275

1.53

146.79

1.8

1.7

0.76

1.04

mg/l

14.85

3983

29252

L04AX Other immunosuppressants

6931

51493

1.46

146.18

2.2

1.7

1.34

1.13

mg/l

4.45

5446

38970

Other interstitial pulmonary diseases

1804

10013

2.15

145.93

2.4

1.7

1.61

1.43

mg/l

0.89

1485

7772

Dental caries 3 and operation codes

12256

49639

1.34

145.76

1.9

1.7

1.19

1.27

mg/l

1.41

9166

38161

Interstitial lung disease

1804

10017

2.15

145.75

2.4

1.7

1.61

1.43

mg/l

0.88

1485

7775

Interstitial lung disease endpoints

1804

10017

2.15

145.75

2.4

1.7

1.61

1.43

mg/l

0.88

1485

7775

Cutaneous abscess, furuncle and carbuncle

3201

20624

1.75

145.45

2.2

1.8

1.20

1.13

mg/l

0.64

2433

15446

Special screening examination for infectious and parasitic diseases

3360

16067

1.71

144.27

1.9

1.6

0.98

1.00

mg/l

0.12

2313

11860

Adverse effects, not elsewhere classified

2611

16127

1.87

144.05

2.1

1.8

0.91

1.10

mg/l

3.10

1923

12039

L04AA Selective immunosuppressants

2808

17672

1.83

143.90

3.6

1.8

1.65

1.09

mg/l

7.71

2340

13333

Other diseases of blood and blood-forming organs, wide

2731

17059

1.85

143.81

2.5

1.8

1.58

1.20

mg/l

4.73

2160

13012

Other bacterial intestinal infections

2235

13242

1.95

142.49

2.3

1.7

1.27

1.28

mg/l

0.10

1769

10096

Chronic gastritis

3275

21287

1.72

141.74

1.9

1.7

1.25

1.38

mg/l

1.69

2480

16569

Triptan medication for migraine, min. 3 purchases

7458

44237

1.44

141.44

1.8

1.7

0.79

0.99

mg/l

8.96

5569

32933

Early onset COPD

2696

16819

1.83

141.13

2.1

1.7

1.18

1.30

mg/l

1.26

2133

12979

Noninfective enteritis and colitis

5808

42100

1.50

141.06

2.0

1.8

1.18

1.16

mg/l

0.25

4425

31612

Hypotension

1906

10859

2.06

139.72

2.0

1.7

1.49

1.53

mg/l

0.14

1516

8424

Dental caries 3

11126

44586

1.35

139.41

1.8

1.7

1.19

1.28

mg/l

1.85

8358

34388

Nonorganic sleeping disorders, excluding more controls

2331

14039

1.90

138.83

2.0

1.7

0.87

1.09

mg/l

4.57

1673

10538

Cardiomyopathies, Primary/intrinsic

1446

7533

2.26

138.39

5.8

1.6

1.58

1.41

mg/l

0.86

1169

5904

Atherosclerosis, excluding cerebral and coronary sclerosis

4509

24965

1.58

137.04

2.0

1.6

1.69

1.43

mg/l

3.93

3718

19364

Diabetes medication

13602

66823

1.30

136.71

1.9

1.7

1.21

1.16

mg/l

0.85

10619

50300

Other systemic involvement of connective tissue

3462

23073

1.69

136.27

2.0

1.7

1.15

1.21

mg/l

0.49

2723

17592

Radiculopathy

2007

11655

1.98

135.97

2.0

1.7

1.07

1.39

mg/l

4.78

1518

8945

COPD, hospital admissions 1, only main diagnosis

3845

22081

1.63

135.93

2.0

1.7

1.34

1.50

mg/l

2.49

3098

17199

Behavioural syndromes associated with physiological disturbances and physical factors

4098

28178

1.61

135.69

2.1

1.8

0.94

1.05

mg/l

1.29

2934

20901

Voice disturbances

3308

21893

1.71

135.26

1.9

1.7

0.94

1.17

mg/l

5.77

2517

16738

Stroke, excluding SAH

6791

37535

1.45

134.87

2.2

1.7

1.42

1.39

mg/l

0.30

5350

29091

Dental operations

8761

34293

1.39

134.70

1.9

1.7

1.25

1.32

mg/l

0.93

6629

26571

Other medical care

4658

32014

1.55

134.19

2.1

1.6

2.15

1.28

mg/l

23.92

3851

24237

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

12417

60816

1.31

133.82

1.9

1.7

1.22

1.17

mg/l

0.93

9676

45921

ILD, hospital admissions 1, main diag only

1604

8843

2.19

133.61

2.5

1.7

1.58

1.41

mg/l

0.74

1336

6870

Presence of other functional implants

6472

33813

1.46

133.52

1.8

1.6

1.32

1.37

mg/l

0.59

5019

26182

Rheumatoid arthritis

3818

23467

1.62

133.17

1.8

1.7

1.43

1.28

mg/l

1.69

3050

17909

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4726

33439

1.54

132.09

2.0

1.8

0.91

1.04

mg/l

2.58

3452

24608

Endometriosis

4716

19601

1.57

131.72

1.8

1.7

0.92

1.15

mg/l

4.07

3517

14758

Polyuria

2608

16421

1.80

130.91

1.9

1.7

1.07

1.38

mg/l

7.14

1961

12619

Impingement syndrome of shoulder

2813

17966

1.75

130.30

1.8

1.7

1.00

1.30

mg/l

6.65

2148

13876

Dental caries 3, only avohilmo

11265

45630

1.33

130.04

1.8

1.18

1.29

mg/l

2.92

8443

35248

Stroke, including SAH

7179

40084

1.42

129.49

2.2

1.7

1.43

1.37

mg/l

0.77

5656

31045

Noninflammatory disorders of female genital tract

5906

21497

1.49

129.42

1.9

1.7

0.96

1.14

mg/l

4.44

4381

16002

Dental caries 1, only avohilmo

10651

42880

1.34

129.24

1.8

1.18

1.31

mg/l

3.49

7983

33225

Diseases of inner ear

6429

47120

1.44

128.96

1.8

1.7

1.11

1.27

mg/l

2.66

4851

36384

Myocarditis

631

2387

3.34

128.19

3.2

1.5

1.44

0.84

mg/l

1.48

484

1720

COPD, hospital admissions 3, with asthma pneumonia sepsis

2937

16085

1.73

128.19

2.2

1.7

1.43

1.54

mg/l

0.95

2427

12547

Diseases of liver

4009

27795

1.59

127.98

2.2

1.7

1.65

1.18

mg/l

11.78

3223

21300

Disorders of other endocrine glands

5367

38480

1.49

127.56

2.1

1.8

1.20

1.19

mg/l

0.11

4063

28999

Mycoses

3188

21161

1.69

127.46

2.2

1.8

1.18

1.19

mg/l

0.04

2422

16068

Other shoulder lesions

1217

6187

2.38

127.25

1.9

1.7

0.91

1.17

mg/l

2.64

909

4643

Insulin, intermediate and long-acting

6461

47500

1.43

127.01

2.0

1.7

1.26

1.28

mg/l

0.19

5144

36111

Other (not insulin) diabetes medications

12507

60912

1.30

126.62

1.9

1.7

1.23

1.18

mg/l

0.85

9819

46369

Chronic diseases of tonsils and adenoids

10381

52033

1.33

125.37

1.8

0.87

1.17

mg/l

19.66

7799

39214

Malignant neoplasm, wide definition for exclusion

11661

55333

1.31

124.77

1.9

1.8

1.48

1.01

mg/l

30.56

9205

41836

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

11658

55321

1.31

124.73

1.9

1.8

1.48

1.01

mg/l

30.54

9204

41826

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

11660

55329

1.31

124.70

1.9

1.8

1.48

1.01

mg/l

30.57

9204

41831

Sequelae with surgical and medical care as external cause

2419

15244

1.83

123.39

2.0

1.7

1.38

1.26

mg/l

1.13

1990

11680

Viral hepatitis, IBD co-morbidity

679

2694

3.04

123.20

1.9

1.5

1.36

1.16

mg/l

0.34

525

1924

Care involving dialysis

1036

5072

2.57

122.62

3.6

1.8

2.35

1.24

mg/l

6.88

925

3845

Injuries to the neck

2853

18628

1.73

122.60

1.9

1.8

0.92

1.10

mg/l

2.34

2101

13921

Spontaneous rupture of synovium and tendon

1030

5000

2.54

122.56

2.0

1.7

1.23

1.36

mg/l

0.75

815

3806

Cardiomyopathy (excluding other)

1466

7990

2.14

122.41

5.7

1.6

1.61

1.37

mg/l

1.32

1182

6228

Hypothyroidism, strict autoimmune, 3 medication purchases required

11051

60481

1.32

121.91

1.8

1.7

1.14

1.18

mg/l

0.52

8321

46031

Peripheral arterial reconstruction

1865

10960

1.96

121.80

2.1

1.7

1.77

1.56

mg/l

1.69

1555

8569

Urticaria

3779

26171

1.60

121.71

2.2

1.8

1.00

1.09

mg/l

0.97

2755

19587

Other enthesopathy of foot (+metatarsalgia)

1290

6801

2.27

121.27

1.8

1.7

0.95

1.18

mg/l

2.16

962

5140

All influenza (not pneumonia)

1842

10777

1.96

121.24

2.2

1.7

1.09

1.16

mg/l

0.31

1389

7905

COPD-related respiratory insufficiency

1351

7237

2.22

120.75

2.5

1.7

1.48

1.57

mg/l

0.35

1099

5650

Fracture of rib(s), sternum and thoracic spine

3387

22971

1.63

120.50

2.0

1.7

1.38

1.30

mg/l

0.66

2659

17651

Injuries to the wrist and hand

12683

75007

1.29

120.13

1.8

1.03

1.18

mg/l

5.88

9381

56810

Other or unspecified ileus, impaction or obstruction

2075

12548

1.87

120.06

2.1

1.7

1.63

1.38

mg/l

2.57

1742

9637

Deposits [accretions] on teeth

941

4313

2.63

118.50

6.1

1.8

1.63

1.37

mg/l

0.78

770

3301

Mental and behavioural disorders due to psychoactive substance use

7149

51713

1.39

118.17

1.8

1.28

1.19

mg/l

1.47

5468

39050

Diabetes, insulin treatment (Kela reimbursement)

12922

64554

1.28

117.97

1.9

1.8

1.24

1.18

mg/l

1.09

10088

48933

Hallux valgus (acquired)

4082

20622

1.56

117.53

1.7

1.07

1.20

mg/l

2.14

3166

15748

Injuries to the hip and thigh

5333

35875

1.47

117.47

1.9

1.7

1.41

1.31

mg/l

1.04

4226

27416

Bacterial intestinal infections, IBD co-morbidities

2201

13669

1.84

117.43

2.3

1.7

1.26

1.28

mg/l

0.13

1747

10438

Insulin medication

7110

46539

1.39

117.29

2.0

1.7

1.27

1.26

mg/l

0.08

5669

35200

Ischaemic Stroke, excluding all haemorrhages

6234

35355

1.43

117.21

2.2

1.6

1.40

1.41

mg/l

0.12

4903

27430

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1191

6247

2.36

116.58

2.6

1.8

1.18

1.16

mg/l

0.08

918

4683

Substance abuse

6924

50616

1.39

116.51

1.8

1.28

1.20

mg/l

1.24

5308

38209

Metatarsalgia

1197

6240

2.31

116.45

1.9

1.7

0.95

1.20

mg/l

2.18

898

4712

Hypokalaemia

1420

7878

2.14

114.65

2.0

1.7

1.43

1.27

mg/l

0.78

1123

6007

Dislocation, sprain and strain of joints and ligaments at neck level

1985

12120

1.90

114.37

1.9

1.8

0.75

1.03

mg/l

7.71

1444

8937

Vasomotor and allergic rhinitis

4743

33909

1.49

114.36

1.9

1.8

0.88

1.13

mg/l

6.91

3461

25324

Retention of urine

3633

21157

1.58

114.15

1.8

1.7

1.53

1.46

mg/l

0.45

2894

16425

Purpura and other haemorrhagic conditions

1661

9689

2.02

113.90

2.6

1.8

1.92

1.23

mg/l

5.61

1336

7369

Other complications of surgical and medical care, not elsewhere classified

1283

6943

2.25

113.65

2.3

1.8

1.16

1.11

mg/l

0.27

1017

5214

Dental operations, only avohilmo

9187

36964

1.34

113.52

1.7

1.8

1.23

1.32

mg/l

1.48

6933

28714

Biguanides

12101

60791

1.29

113.01

1.8

1.7

1.23

1.18

mg/l

0.74

9490

46359

Benign paroxysmal vertigo

3379

23285

1.62

112.95

1.9

1.7

1.07

1.27

mg/l

2.79

2573

17951

Ventral hernia

2807

18590

1.69

112.76

2.0

1.7

1.30

1.25

mg/l

0.46

2208

14281

Symptoms and signs concerning food and fluid intake

1191

6226

2.25

112.50

2.0

1.7

1.36

1.32

mg/l

0.10

856

4687

Viral infections characterized by skin and mucous membrane lesions

4978

36589

1.47

111.96

2.1

1.8

1.21

1.17

mg/l

0.22

3787

27748

Inflammatory disease of uterus

1948

11950

1.91

111.89

2.0

1.7

0.74

0.96

mg/l

4.40

1461

8924

Other pulmonary heart/vessel disease

629

2604

3.25

111.53

5.0

1.7

1.48

1.34

mg/l

0.40

511

2026

Gastroduodenal ulcer

2842

18787

1.66

110.55

2.1

1.7

1.57

1.46

mg/l

0.77

2285

14652

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2928

19695

1.67

110.50

2.0

1.7

0.95

1.13

mg/l

3.29

2294

15060

Poisoning by drugs, medicaments and biological substances

3021

20417

1.65

109.84

1.9

1.8

1.13

1.03

mg/l

0.71

2204

15128

Intestinal stricture

3433

23794

1.59

109.29

2.1

1.7

1.69

1.30

mg/l

6.76

2813

18315

Osteoporosis

2873

18353

1.67

109.20

2.1

1.7

1.43

1.37

mg/l

0.42

2317

14120

Other noninfective gastroenteritis and colitis

2903

19499

1.65

107.72

2.1

1.9

1.22

1.20

mg/l

0.18

2226

14705

Secondary right heart disease

578

2343

3.38

107.67

5.2

1.6

1.51

1.35

mg/l

0.44

469

1819

Complications of internal orthopaedic prosthetic devices, implants and grafts

2512

16430

1.72

106.89

1.8

1.7

1.49

1.35

mg/l

1.39

2069

12663

Sleep disorders

2660

17633

1.69

106.80

2.0

1.8

0.88

1.10

mg/l

5.26

1920

13133

Personality disorders

3445

24033

1.58

106.42

1.9

1.8

0.97

1.00

mg/l

0.26

2473

17817

Fibroblastic disorders

2506

16298

1.69

105.90

1.8

1.6

1.22

1.43

mg/l

1.97

1951

12586

Other cataract

4858

27596

1.47

105.67

1.8

1.7

1.33

mg/l

0.01

3816

21363

Other viral diseases

3579

25065

1.56

105.60

2.3

1.9

1.21

1.06

mg/l

1.08

2679

18525

Other disorders of ear

11364

61833

1.28

105.43

1.8

1.27

1.21

mg/l

0.62

8571

47521

Misadventures to patients during surgical and medical care

1728

10415

1.94

105.13

2.1

1.7

1.45

1.20

mg/l

1.64

1359

7916

Reimbursement for rheumatic diseases

7042

54762

1.37

105.07

1.9

1.7

1.32

1.17

mg/l

3.17

5550

41582

Cervicocranial syndrome

1363

7665

2.09

104.74

1.8

1.6

0.86

1.25

mg/l

6.13

1046

5805

Other disorders of bone

2502

16451

1.71

104.55

2.0

1.8

0.96

1.08

mg/l

1.14

1874

12405

Pleural effusion

1704

10194

1.92

104.46

2.1

1.7

1.97

1.49

mg/l

5.50

1425

7866

Abnormal involuntary movements

1639

9761

1.97

104.46

2.1

1.7

1.06

1.24

mg/l

1.29

1238

7458

Chronic periodontitis

1755

10608

1.91

104.18

2.9

1.6

1.56

1.30

mg/l

1.92

1448

8261

ILD medications: azathioprine

1814

11028

1.87

103.92

2.8

1.7

1.58

1.06

mg/l

3.58

1429

8164

Need for other prophylactic measures

790

3752

2.78

103.66

3.3

1.9

1.46

1.15

mg/l

1.14

653

2868

Other disorders of patella

2198

14021

1.76

103.58

1.8

1.7

0.87

1.05

mg/l

2.68

1648

10488

Superficial injury of head

2660

17697

1.67

103.49

1.8

1.17

1.24

mg/l

0.47

2050

13378

Calcific aortic valvular stenosis, operated

3056

20450

1.61

103.00

1.8

1.7

1.44

1.59

mg/l

1.52

2442

15995

Calcific aortic valvular stenosis

3056

20450

1.61

103.00

1.8

1.7

1.44

1.59

mg/l

1.52

2442

15995

Disorders of muscles

1211

6577

2.16

102.99

2.0

1.7

1.05

1.25

mg/l

1.67

943

4941

Disorders of lens

7908

39202

1.35

102.15

1.9

1.7

1.30

1.25

mg/l

0.65

6186

30458

Poisoning by medicine

2725

18314

1.66

102.05

1.9

1.8

1.08

1.01

mg/l

0.46

1993

13578

Operations 2 for CAVS

3045

20416

1.60

101.59

1.7

1.44

1.59

mg/l

1.51

2434

15965

Calcific aortic valvular stenosis, diagnosis (helper)

3045

20416

1.60

101.59

1.7

1.44

1.59

mg/l

1.51

2434

15965

Umbilical hernia

3104

21412

1.60

101.58

1.9

1.8

1.29

1.19

mg/l

0.61

2415

16447

Appendectomy

8201

62904

1.33

101.53

1.8

1.09

mg/l

0.07

6200

47355

Coronary revascularization (ANGIO or CABG)

4879

25088

1.46

101.06

2.1

1.6

1.39

1.47

mg/l

1.05

3880

19535

Epilepsy

3444

24043

1.54

100.76

2.0

1.8

1.27

1.33

mg/l

0.41

2669

18309

Direct fill therapy

1661

10011

1.93

100.72

3.5

1.9

1.37

1.17

mg/l

1.22

1336

7515

Calcific aortic valvular stenosis, including rheumatic fever

3051

20498

1.60

100.25

1.7

1.44

1.58

mg/l

1.51

2438

16025

Insulin, combination of fast acting with intermediate-acting or long-acting

7122

51427

1.35

99.75

2.0

1.8

1.27

1.29

mg/l

0.17

5678

39073

Use of pramipexole

2524

16834

1.69

99.45

1.9

1.7

1.12

1.29

mg/l

2.40

1932

12992

Other and unspecified drugs and medicaments

1100

5944

2.28

99.30

2.6

1.8

1.19

1.15

mg/l

0.12

854

4486

Glomerular diseases

2101

13442

1.77

99.22

2.2

1.8

1.75

1.27

mg/l

5.12

1772

10258

Congenital malformations, deformations and chromosomal abnormalities

7340

55400

1.35

98.97

2.0

1.8

1.11

1.06

mg/l

0.58

5531

41084

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

5848

39236

1.41

98.82

1.9

1.7

1.14

0.95

mg/l

4.16

4555

29327

Mouth breathing

4696

34889

1.45

98.79

1.8

1.9

0.94

1.19

mg/l

8.31

3545

26723

Aortic aneurysm

2349

15049

1.69

98.48

2.1

1.7

2.35

1.45

mg/l

13.17

1884

11690

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3528

24785

1.54

98.09

2.5

1.8

1.03

1.00

mg/l

0.23

2653

18242

Disorders of adult personality and behaviour

3583

25537

1.54

98.03

1.9

1.8

0.97

1.00

mg/l

0.21

2559

18896

Gastric ulcer

1957

12283

1.78

97.74

2.2

1.7

1.64

1.45

mg/l

1.16

1578

9565

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3679

26361

1.53

97.64

2.0

1.8

1.04

1.01

mg/l

0.28

2705

19578

Substance use, excluding alcohol

2364

15568

1.70

97.03

2.0

1.8

1.17

1.07

mg/l

0.96

1760

11483

Azathioprine

1814

11243

1.83

96.53

2.8

1.7

1.58

1.07

mg/l

3.50

1429

8322

Other disorders of eye and adnexa

1741

10772

1.87

95.85

2.1

1.8

1.28

1.12

mg/l

0.51

1258

8101

Haemorrhage, not elsewhere classified

486

1898

3.40

95.79

3.1

1.6

2.49

1.48

mg/l

2.09

388

1475

Spondylolisthesis/Spondylolysis

2085

13383

1.75

95.73

1.8

1.7

1.13

1.26

mg/l

1.13

1628

10252

Malignant neoplasm

11396

55703

1.27

95.43

1.9

1.8

1.50

1.04

mg/l

28.82

9010

42291

Nonorganic sleeping disorders

2331

15399

1.70

95.34

2.0

1.8

0.87

1.06

mg/l

3.73

1673

11404

Specific personality disorders

2976

20643

1.59

95.05

1.9

1.8

0.97

1.00

mg/l

0.18

2140

15338

Other maternal disorders predominantly related to pregnancy

7318

36257

1.35

94.56

1.8

1.7

0.87

0.98

mg/l

3.34

5525

27052

Open wound of lower leg

1695

10410

1.86

94.17

2.0

1.8

1.22

1.25

mg/l

0.23

1317

7787

Benign neoplasm: Colon, unspecified

2557

17140

1.65

94.02

1.9

1.7

1.28

1.25

mg/l

0.20

1986

13220

Abnormal findings on examination of blood, without diagnosis

5043

35622

1.42

93.98

2.1

1.8

1.52

1.32

mg/l

2.17

4035

27441

Enterocolitis due to Clostridium difficile

1266

7204

2.06

93.75

2.7

1.8

1.45

1.35

mg/l

0.55

1028

5531

Streptococcal septicaemia

991

5220

2.27

93.62

2.3

1.7

2.01

1.26

mg/l

4.41

820

3926

Lateral epicondylitis

1577

9505

1.89

93.35

1.7

1.6

0.93

1.09

mg/l

0.78

1185

7243

Fungal Sepsis

524

2179

3.31

93.26

3.7

1.6

1.82

1.22

mg/l

1.62

432

1678

False labour

4003

18233

1.51

93.21

1.8

1.7

0.72

0.81

mg/l

1.79

2874

13368

Other diseases of liver

2111

13747

1.74

93.07

2.1

1.8

1.34

1.13

mg/l

1.61

1633

10474

Benign neoplasm of other and ill-defined parts of digestive system

1990

12788

1.77

92.63

2.2

1.7

1.18

1.16

mg/l

0.07

1559

9750

Disorders of skin appendages

5712

44031

1.38

92.30

2.0

1.8

0.96

1.12

mg/l

5.49

4241

32998

Other diseases of intestine

1371

7996

1.98

92.26

2.2

1.7

1.51

1.32

mg/l

1.08

1080

6156

Generalized anxiety disorder

1903

12068

1.78

92.16

1.9

1.7

1.02

0.98

mg/l

0.15

1299

8798

Exclusions for E4_PCOS_CONSORTIUM

9438

48105

1.30

91.71

1.8

1.04

1.07

mg/l

0.46

7067

36137

Senile cataract

7045

34291

1.35

91.56

1.8

1.7

1.37

1.31

mg/l

0.67

5505

26713

Thoracic aortic aneurysm

1488

8926

1.93

91.34

2.1

1.7

1.82

1.37

mg/l

2.64

1160

6884

Hyperkalaemia

651

2959

2.75

91.28

2.7

1.6

1.66

1.43

mg/l

0.61

562

2251

Other diseases of pericardium

576

2501

2.99

91.18

2.4

1.6

1.86

1.32

mg/l

2.49

471

1953

Coxarthrosis, primary

6443

43769

1.36

91.15

1.7

1.36

1.37

mg/l

0.11

5214

33998

Glomerular disorders in diseases classified elsewhere

1373

8086

1.99

91.05

2.3

1.8

1.80

1.28

mg/l

3.70

1184

6169

Cardiomyopathy, other and unspecified

924

4789

2.31

91.05

4.8

1.6

1.51

1.34

mg/l

0.54

715

3721

Explicit bacterial Sepsis

1180

6607

2.08

91.04

2.4

1.6

1.93

1.24

mg/l

4.95

969

4989

Volume depletion

1035

5568

2.18

90.32

2.3

1.7

1.74

1.41

mg/l

1.11

839

4238

Other retinal disorders

6970

44216

1.34

89.93

1.8

1.7

1.40

1.34

mg/l

0.61

5427

33987

Sulfasalazine

3374

24101

1.52

89.76

1.7

1.6

1.23

1.12

mg/l

1.29

2646

18145

Implicit fungal Sepsis

487

1996

3.40

89.75

3.7

1.6

1.79

1.24

mg/l

1.28

398

1530

Certain disorders involving the immune mechanism

2275

15170

1.69

89.66

2.6

1.8

1.32

1.18

mg/l

0.67

1808

11585

Conjunctivitis (acute, non atopic)

3265

23170

1.54

89.60

2.0

1.9

1.01

1.14

mg/l

1.37

2423

17400

Abnormalities of gait and mobility

1344

7897

1.99

89.60

2.0

1.8

1.49

1.43

mg/l

0.15

1037

6120

Fall on same level involving ice and snow

6671

52680

1.34

89.51

1.8

1.7

1.14

1.20

mg/l

0.88

5104

40020

Striking against or struck by other objects

3730

27138

1.49

88.88

1.9

1.05

1.15

mg/l

1.13

2711

20139

Emphysema

798

3956

2.43

88.69

2.2

1.7

1.40

1.57

mg/l

0.68

656

3075

Other symptoms and signs involving the digestive system and abdomen

1860

11832

1.76

88.02

1.9

1.6

1.21

1.22

mg/l

0.03

1397

9088

Bipolar affective disorders

2342

15717

1.66

87.94

1.9

1.7

1.06

1.02

mg/l

0.20

1704

11733

Unspecified privation

1338

7908

1.99

87.92

2.5

1.8

1.36

1.20

mg/l

1.03

1065

5939

Deviated nasal septum

3707

26972

1.48

87.89

1.8

1.13

1.28

mg/l

1.55

2760

20764

Other and unspecified tonsillitis

4050

25244

1.46

87.60

2.1

1.8

0.96

1.04

mg/l

0.74

2898

18557

Pregnancy hypertension

5251

36395

1.40

87.51

2.0

1.7

1.16

0.92

mg/l

5.14

4077

27181

Other viral diseases, not elsewhere classified

2213

14670

1.68

87.20

2.4

1.9

1.22

1.09

mg/l

0.71

1679

10942

Unspecified acute lower respiratory infection

1758

11118

1.79

86.65

2.4

1.8

1.13

1.20

mg/l

0.34

1425

8407

Other hammer toe(s) (acquired)

1892

11359

1.75

86.57

1.7

1.20

1.40

mg/l

2.41

1467

8748

Kidney transplant status

702

3417

2.66

86.06

3.0

2.0

2.09

1.22

mg/l

3.03

633

2575

Disorders of choroid and retina

9204

54826

1.28

85.26

1.9

1.7

1.35

1.28

mg/l

0.99

7121

42182

Any event in cancer register

11947

59304

1.25

84.94

1.9

1.8

1.42

1.04

mg/l

22.92

9326

44903

Disorders of vitreous body

5323

40308

1.39

84.83

1.8

1.7

1.13

1.31

mg/l

3.33

4083

31336

Other general symptoms and signs

645

2970

2.65

84.81

2.3

1.7

1.20

1.17

mg/l

0.05

471

2214

Disorders of vitreous body and globe

5464

41374

1.38

84.53

1.8

1.7

1.14

1.31

mg/l

3.27

4189

32154

Candidiasis

1632

10273

1.83

83.98

2.4

1.7

1.08

1.15

mg/l

0.60

1228

7725

Maternal care for other conditions predominantly related to pregnancy

2671

18363

1.59

83.90

1.9

1.7

0.76

0.86

mg/l

1.71

2011

13517

Open wound of head

5753

44177

1.36

83.75

1.8

1.34

1.28

mg/l

0.66

4368

33546

Other/unspecified synovitis and tenosynovitis

1331

7895

1.92

83.49

1.9

1.7

1.06

1.25

mg/l

1.75

1027

5944

Missing teeth due to accident, extraction or parodontitis

1348

8084

1.93

82.91

2.7

1.6

1.31

1.29

mg/l

0.12

1077

6271

Extrapyramidal and movement disorders

3998

29814

1.45

82.62

1.8

1.7

1.20

1.32

mg/l

1.42

3042

23033

Disorders of sclera, cornea, iris and ciliary body

6371

50520

1.34

82.59

1.8

1.12

1.17

mg/l

0.70

4859

38324

Problems related to lifestyle

1278

7546

1.95

82.54

2.0

1.7

1.02

1.10

mg/l

0.55

955

5640

Iron deficiency anaemia secondary to blood loss (chronic)

1824

11786

1.74

82.26

3.5

1.7

1.62

1.28

mg/l

2.45

1440

9079

Alcohol use disorder, Swedish definition

6266

45935

1.34

82.07

1.9

1.8

1.43

1.21

mg/l

4.58

4841

34887

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

6661

52214

1.33

82.06

1.7

1.02

1.09

mg/l

0.74

4937

39077

Disorder of lipoprotein metabolism, unspecified

1481

9101

1.85

81.85

1.9

1.6

1.46

1.40

mg/l

0.21

1158

7021

Neuralgia and neuritis, unspecified

651

3107

2.61

81.55

1.9

1.7

0.97

1.26

mg/l

1.79

493

2325

Cardiodefibrillation

3756

27764

1.46

81.32

2.7

1.7

1.33

1.46

mg/l

1.21

2774

21814

Ocular pain

1058

6016

2.13

81.07

2.3

1.8

0.94

1.07

mg/l

0.65

760

4502

Female infertility

3823

17314

1.47

80.94

1.8

1.7

1.01

1.05

mg/l

0.27

2903

12916

Other abnormal uterine and vaginal bleeding

2744

13641

1.57

80.45

1.8

1.6

1.12

1.25

mg/l

1.10

2067

10426

Plantar fascial fibromatosis

1141

6574

2.01

80.33

1.7

1.6

1.06

1.16

mg/l

0.40

876

5010

Chondrocostal junction syndrome [Tietze]

562

2600

2.96

80.28

2.4

1.7

0.72

1.10

mg/l

6.19

419

1961

Idiopathic gout

994

5531

2.14

79.86

1.9

1.7

1.39

1.48

mg/l

0.39

801

4350

Insulin, fast-acting

4084

30647

1.43

79.85

2.0

1.8

1.17

1.24

mg/l

0.91

3239

23055

Adhesive capsulitis of shoulder

1811

11711

1.72

79.67

1.9

1.7

1.03

1.28

mg/l

2.90

1394

8992

Postmenopausal bleeding

3211

12592

1.53

79.19

1.9

1.7

1.24

1.28

mg/l

0.22

2399

9822

Ganglion

2367

16203

1.60

78.96

1.7

0.84

1.14

mg/l

9.24

1785

12190

6962

50046

1.31

78.87

1.9

1.8

1.40

1.20

mg/l

4.51

5366

37896

Inflammatory bowel disease

3723

27645

1.45

78.81

2.0

1.8

1.15

1.11

mg/l

0.35

2841

20643

Other local infections of skin and subcutaneous tissue

1202

7099

1.98

78.79

2.2

1.8

1.24

mg/l

0.01

942

5367

Unspecified kidney failure

1061

6016

2.05

78.76

2.6

1.6

1.79

1.45

mg/l

3.09

894

4643

Diseases of external ear

3742

27848

1.45

78.38

1.8

1.09

1.23

mg/l

1.94

2780

21203

Fissure and fistula of anal and rectal regions

2753

19445

1.54

78.29

1.8

1.7

1.08

1.18

mg/l

0.62

2015

14780

Coronary angioplasty

3806

21618

1.45

78.16

2.0

1.6

1.35

1.52

mg/l

2.30

2990

16837

Unspecified/other endometriosis

1201

7089

1.96

78.06

1.9

1.6

0.80

1.01

mg/l

2.28

873

5246

Intestinal adhesions without obstruction

953

5258

2.14

78.02

2.0

1.7

1.55

1.36

mg/l

1.00

785

4028

Other and unspecified local infections of skin and subcutaneous tissue

1131

6594

2.02

77.76

2.2

1.8

1.27

1.26

mg/l

0.02

891

4981

Extreme obesity with alveolar hypoventilation

570

2679

2.85

77.60

2.0

1.8

1.12

1.17

mg/l

0.14

457

2050

Parodontitis or operation codes

10879

67285

1.24

77.48

1.9

1.7

1.27

1.18

mg/l

1.84

8319

51525

Other disorders of eyelid

4753

35366

1.39

77.39

1.8

1.7

1.29

1.36

mg/l

0.51

3660

27476

Childhood asthma (age<16), excluding more controls

1530

7459

1.77

77.24

2.1

1.6

0.96

mg/l

0.03

1042

5135

Fracture of lower leg, including ankle

6284

49895

1.32

77.08

1.8

1.28

1.22

mg/l

0.60

4873

37709

Parodontitis

10864

67272

1.24

77.05

1.9

1.7

1.27

1.18

mg/l

1.84

8309

51516

Diagnoses used for exclusion with ILD

2804

19953

1.53

76.97

2.1

1.7

1.41

1.30

mg/l

0.63

2212

15367

Zoster [herpes zoster]

1951

12988

1.68

76.95

2.2

1.7

1.38

1.31

mg/l

0.22

1516

9987

Excessive attrition of teeth

4876

20237

1.40

76.82

1.8

1.7

0.93

1.07

mg/l

2.44

3536

15148

Diseases of male genital organs

5704

22358

1.35

76.69

1.9

1.25

1.36

mg/l

1.28

4277

16996

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2069

13983

1.66

76.54

1.9

1.7

0.74

1.00

mg/l

7.79

1485

10353

Haemorrhoids and perianal venous thrombosis

3099

22378

1.49

76.43

1.8

1.6

1.14

1.36

mg/l

2.80

2386

17206

Diseases of salivary glands

2207

15045

1.62

76.37

1.9

1.6

1.06

1.19

mg/l

1.37

1674

11588

6573

48320

1.31

76.37

1.9

1.8

1.42

1.21

mg/l

4.48

5080

36590

Extracorporeal dialysis

744

3852

2.41

76.29

4.1

1.8

2.51

1.29

mg/l

5.45

662

2943

Chronic periodontitis, including avohilmo

10808

67221

1.24

76.14

1.9

1.7

1.26

1.18

mg/l

1.71

8268

51477

Insomnia

1917

12762

1.69

76.06

2.0

1.8

0.90

1.06

mg/l

2.16

1376

9500

Allergic conjunctivitis

6920

55041

1.31

75.84

1.8

1.02

1.08

mg/l

0.78

5126

41159

Noninfectious colitis NAS

1599

10232

1.77

75.63

2.0

1.8

1.13

1.19

mg/l

0.38

1220

7686

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

911

5020

2.16

75.56

2.2

1.7

1.50

1.35

mg/l

0.62

755

3890

Arterial embolism and thrombosis

681

3391

2.42

75.12

2.9

1.6

2.10

1.42

mg/l

4.70

570

2620

Other extrapyramidal and movement disorders in other diseases

2479

17396

1.58

75.07

1.8

1.7

1.12

1.26

mg/l

1.10

1862

13356

Childhood asthma (age<16)

1530

7520

1.76

74.96

2.1

1.7

0.96

0.97

mg/l

0.00

1042

5181

Superficial injury of abdomen, lower back and pelvis

1755

11485

1.71

74.53

2.0

1.8

1.03

1.17

mg/l

1.06

1300

8542

Mental and behavioural disorders due to alcohol

5753

44303

1.33

74.51

1.8

1.32

1.22

mg/l

1.38

4433

33536

Parodontitis and operation codes

10180

66343

1.25

74.51

1.9

1.7

1.25

1.18

mg/l

1.33

7776

50854

Trigger finger

1545

9794

1.76

74.45

1.9

1.7

0.82

1.23

mg/l

12.26

1196

7472

Post-traumatic stress disorder

1064

6159

2.02

74.41

2.1

1.7

0.75

0.92

mg/l

1.69

769

4465

Benign neoplasm of other and ill-defined parts of digestive system

1990

13432

1.67

74.38

2.2

1.7

1.18

1.28

mg/l

0.83

1559

10357

Fracture of foot, except ankle

2757

19696

1.53

74.33

2.0

1.8

1.03

1.09

mg/l

0.60

2109

14672

Thrombocytopenia, unspecified

846

4596

2.23

74.32

2.7

1.7

1.94

1.25

mg/l

6.42

703

3517

Acute pancreatitis

2123

14442

1.62

74.29

2.0

1.7

1.62

1.27

mg/l

2.71

1667

11048

Atopic dermatitis

6819

46905

1.31

74.27

1.8

0.96

1.05

mg/l

1.03

4960

34878

Superficial injury of wrist and hand

2293

15851

1.59

74.09

2.0

1.9

0.86

1.11

mg/l

6.56

1668

11774

Other and unspecified visual disturbances

1141

6781

1.98

74.01

2.4

1.7

1.14

1.17

mg/l

0.05

870

5176

Localized swelling, mass and lump of skin and subcutaneous tissue

3490

25923

1.45

73.96

2.0

1.8

1.25

1.20

mg/l

0.29

2655

19811

Other skin changes

1854

12351

1.68

73.18

2.0

1.7

1.17

1.30

mg/l

0.92

1427

9486

Recurring oral aphthae, including avohilmo

1590

10286

1.76

72.44

2.2

1.8

1.11

1.19

mg/l

0.54

1189

7722

Emotionally unstable personality disorder

1581

10227

1.75

71.77

1.9

1.8

0.96

0.92

mg/l

0.14

1112

7437

Endocarditis

440

1880

3.00

71.66

3.0

1.7

1.98

1.42

mg/l

2.06

380

1455

Benign neoplasm: Colon, unspecified

2557

18175

1.54

71.52

1.9

1.7

1.28

1.39

mg/l

0.91

1986

14148

Fracture of lumbar spine and pelvis

2287

15891

1.58

71.42

1.9

1.7

1.50

1.37

mg/l

1.21

1833

12175

Appendicitis, broad definition

9066

69114

1.25

71.41

1.8

1.04

1.14

mg/l

2.67

6809

52285

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4945

38607

1.36

71.40

1.8

1.35

1.23

mg/l

1.78

3817

29308

Diseases of appendix

9132

69442

1.25

71.21

1.8

1.05

1.15

mg/l

2.22

6856

52548

Congenital malformations of the circulatory system

1614

10143

1.73

71.20

3.0

2.0

1.24

1.17

mg/l

0.37

1206

7544

Chronic laryngitis and laryngotracheitis

1585

10261

1.74

70.92

1.9

1.7

0.94

1.27

mg/l

6.11

1159

7906

Superficial injury of hip and thigh

1605

10393

1.73

70.92

1.9

1.7

1.32

1.30

mg/l

0.06

1238

7870

Injury of muscle and tendon at shoulder and upper arm level

3795

28729

1.42

70.85

1.7

1.8

1.05

1.32

mg/l

7.30

2945

22247

Cerebral palsy and other paralytic syndromes

1325

8237

1.84

70.69

2.5

1.8

1.27

1.19

mg/l

0.29

1035

6246

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

4354

29417

1.39

70.39

1.7

2.34

1.18

mg/l

34.30

3636

22584

Lung transplantation

171

469

9.30

68.76

6.3

2.0

1.52

1.25

mg/l

0.58

150

362

Cardiac murmurs and other cardiac sounds

941

5237

1.99

68.64

2.2

2.0

1.31

1.33

mg/l

0.04

715

3896

Conductive and sensorineural hearing loss

9060

52308

1.25

68.63

1.7

1.32

1.26

mg/l

0.68

6948

40542

Diplopia

1475

9491

1.77

68.56

2.1

1.7

1.11

1.24

mg/l

0.91

1140

7267

Other and unspecified urticaria

2296

16143

1.57

68.52

2.1

1.8

1.08

1.09

mg/l

0.08

1681

12109

Chronic Coagulation defects

399

1713

3.36

68.52

3.7

1.9

0.75

0.93

mg/l

1.12

292

1271

Female infertility, cervigal, vaginal, other or unspecified origin

3393

16826

1.45

68.45

1.8

1.7

1.00

1.06

mg/l

0.39

2580

12582

Lung transplant status

170

466

9.28

68.38

5.9

2.0

1.48

1.25

mg/l

0.49

149

362

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3272

24347

1.45

68.35

1.8

0.84

1.11

mg/l

10.80

2363

18207

Seropositive rheumatoid arthritis

2758

19903

1.49

68.15

1.8

1.6

1.48

1.22

mg/l

3.39

2229

15132

Benign neoplasm: Sigmoid colon

1854

12513

1.65

68.14

2.0

1.7

1.24

1.21

mg/l

0.12

1447

9608

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3800

28986

1.41

67.80

2.2

1.8

1.09

1.15

mg/l

0.48

2890

21996

Allergic rhinitis

3680

27603

1.41

67.80

1.9

0.83

1.04

mg/l

3.91

2653

20401

Sensorineural hearing loss

8485

49287

1.26

67.61

1.7

1.32

1.29

mg/l

0.29

6502

38338

Insulin, fast-acting or short human

4102

31567

1.38

66.98

2.0

1.8

1.17

1.24

mg/l

0.99

3255

23778

Idiopathic pulmonary fibrosis

821

4546

2.14

66.98

2.6

1.6

1.85

1.56

mg/l

0.73

672

3533

Otitis externa

2461

17612

1.53

66.18

1.9

1.8

0.98

1.17

mg/l

2.47

1831

13319

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2000

13796

1.61

66.14

1.9

1.8

1.07

0.98

mg/l

0.63

1451

10168

Vascular disorders of the intestines

711

3750

2.23

66.11

2.9

1.6

2.02

1.52

mg/l

1.90

597

2924

Other and unspecified disorders of vitreous body

4300

33287

1.38

66.04

1.8

1.7

1.12

1.31

mg/l

2.88

3273

25944

Coronary artery bypass grafting

2655

14480

1.50

65.98

2.0

1.6

1.54

1.66

mg/l

0.83

2149

11288

Pain associated with micturition

1330

8427

1.80

65.88

2.2

1.8

1.04

1.21

mg/l

1.17

988

6375

Acute pharyngitis

1674

11013

1.66

65.77

2.1

1.8

0.89

1.07

mg/l

1.24

1183

8081

Suicide or other Intentional self-harm

2871

21083

1.48

65.65

1.9

1.8

1.10

1.05

mg/l

0.37

2095

15734

Procreative management

3665

23448

1.41

65.06

2.2

1.8

1.22

1.00

mg/l

2.54

2796

17073

Other/unspecified enthesopathies of lower limb, excluding foot

858

4849

2.07

65.01

2.0

1.7

0.87

1.13

mg/l

2.68

631

3635

Other and unspecified nerve root and plexus disorders, also in other diseases

2099

14680

1.57

64.32

1.8

0.96

1.15

mg/l

2.20

1625

11223

Disorders of breast

5878

44109

1.31

64.09

1.7

0.95

1.07

mg/l

2.06

4446

33381

Acute appendicitis

8450

66754

1.25

63.86

1.8

1.03

1.13

mg/l

2.35

6340

50499

Familial hypercholesterolemia, with ischemic heart disease

971

5706

1.95

63.56

1.8

1.6

1.37

1.72

mg/l

1.91

791

4461

Alcohol use disorder, ICD-based

4547

35698

1.35

63.55

1.8

1.34

1.21

mg/l

1.66

3502

27084

Faecal incontinence

982

5802

1.95

63.51

1.7

1.6

1.31

1.32

mg/l

0.04

736

4478

Other necrotizing vasculopathies (FG)

682

3619

2.26

63.39

2.2

1.7

1.61

1.33

mg/l

1.09

556

2743

Superficial injury of thorax

1663

11147

1.66

63.27

2.1

1.7

1.11

1.21

mg/l

0.54

1278

8427

Polyp of the female genital tract

3790

16757

1.41

63.24

1.7

1.09

1.17

mg/l

0.55

2884

12819

Other pleural conditions

1060

6396

1.89

62.89

2.0

1.6

1.78

1.51

mg/l

1.69

873

4963

Gestational [pregnancy-induced] hypertension

3153

23686

1.44

62.35

2.0

1.7

1.11

0.86

mg/l

5.95

2453

17476

Pericarditis

443

2015

2.75

62.31

2.2

1.6

1.29

1.26

mg/l

0.10

365

1561

Artificial opening status

624

3250

2.36

62.30

2.6

1.7

2.48

1.40

mg/l

3.24

532

2512

Endometriosis of pelvic peritoneum

1907

12983

1.59

62.14

1.8

1.7

0.81

1.04

mg/l

4.18

1398

9755

Chondropathies

1801

12334

1.62

62.02

2.0

1.8

0.84

1.11

mg/l

5.90

1333

9307

Female genital prolapse

3498

15209

1.42

61.90

1.7

0.96

1.20

mg/l

5.68

2701

11725

Ulcerative colitis

2807

20721

1.46

61.88

2.0

1.8

1.17

1.12

mg/l

0.37

2162

15518

Acute appendicitis, no complications

6682

54806

1.28

61.80

1.8

0.92

1.09

mg/l

6.25

4984

41348

Bronchiectasis

853

4889

2.04

61.76

2.2

1.7

1.21

1.45

mg/l

1.46

665

3785

Injuries to unspecified part of trunk, limb or body region

1125

6967

1.86

61.55

2.4

1.8

1.32

1.20

mg/l

0.58

896

5238

Benign neoplasm: Ascending colon

1324

8524

1.76

61.22

2.1

1.7

1.29

1.24

mg/l

0.19

1017

6537

Pregnancy examination and test

2079

9022

1.58

61.08

1.8

1.6

0.83

0.76

mg/l

0.75

1512

6419

Sequelae of injuries, of poisoning and of other consequences of external causes

2636

19326

1.48

61.07

1.8

1.08

1.12

mg/l

0.26

1998

14642

Degeneration of macula and posterior pole

4636

30164

1.34

60.74

1.7

1.50

1.48

mg/l

0.09

3619

23510

Left bundle-branch block

751

4144

2.10

60.72

2.1

1.6

1.35

1.44

mg/l

0.21

558

3241

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1568

10482

1.67

60.67

1.9

1.7

1.25

1.27

mg/l

0.08

1179

8008

Glucosamine medication

5279

33794

1.32

60.60

1.7

1.33

1.40

mg/l

0.94

4120

26326

Ascites

769

4291

2.09

60.51

2.4

1.6

2.91

1.44

mg/l

10.78

674

3319

Emergency coronary revascularization (for ACS)

5560

32124

1.31

60.50

2.0

1.7

1.43

1.47

mg/l

0.34

4424

25087

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1104

6856

1.87

60.34

2.4

1.8

1.59

1.26

mg/l

1.77

919

5209

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3171

23922

1.42

60.24

1.9

1.8

0.99

1.18

mg/l

4.66

2422

18027

Acute gastritis

877

5099

1.99

60.22

1.8

1.19

1.26

mg/l

0.25

679

3925

Alcohol abuse, main dg, excluding more controls

1608

10783

1.64

59.96

1.9

1.8

1.27

1.15

mg/l

0.53

1245

8175

Other sleep disorders

1199

7549

1.78

59.86

1.7

0.89

1.28

mg/l

7.78

900

5767

Cardiac arrest

584

2501

2.26

59.66

3.2

1.4

2.97

1.21

mg/l

4.82

478

1871

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1382

9033

1.71

59.12

2.1

1.7

1.83

1.23

mg/l

3.87

1129

6897

Acute pancreatitis (for exclusion)

2123

15099

1.54

59.00

2.0

1.8

1.62

1.26

mg/l

2.84

1667

11632

Budesonide

1503

9996

1.67

58.97

1.8

1.7

1.17

1.06

mg/l

0.65

1160

7445

Peripheral artery operations in Hilmo

1252

7956

1.74

58.97

2.1

1.6

1.66

1.45

mg/l

1.38

1039

6133

Exclusions for E4_PCOS_BROAD

1909

13334

1.58

58.89

2.2

1.9

1.10

1.14

mg/l

0.20

1464

10023

Other and unspecified injuries of lower leg

882

5182

1.98

58.88

2.0

1.8

0.87

1.07

mg/l

2.25

686

3831

Suggestive for eosinophilic asthma

1020

6227

1.88

58.78

1.8

1.7

0.96

1.28

mg/l

2.13

780

4786

Cluster headache, strict

484

2352

2.59

58.75

1.9

1.7

0.84

1.05

mg/l

1.07

346

1748

Flat foot [pes planus] (acquired)

1050

6444

1.86

58.68

1.8

1.7

0.98

1.21

mg/l

2.15

803

4853

ILD-related respiratory insufficiency

401

1820

2.91

58.66

3.3

1.7

1.76

1.45

mg/l

0.48

346

1426

Chronic ulcer of skin, not elsewhere classified

764

4316

2.09

58.64

2.0

1.7

1.48

1.40

mg/l

0.23

606

3327

Urolithiasis

3351

25574

1.40

58.61

1.8

1.31

1.34

mg/l

0.15

2600

19760

Cluster headache, wide

511

2534

2.51

58.51

1.9

1.7

0.91

1.07

mg/l

0.69

368

1888

Achilles tendinitis

1147

7197

1.80

58.41

1.9

1.7

1.11

1.24

mg/l

0.59

899

5522

Haemorrhage in early pregnancy

3340

24937

1.41

58.39

1.8

1.7

0.82

0.94

mg/l

3.14

2466

18590

Other problems related to primary support group, including family circumstances

1370

8741

1.71

58.24

3.6

1.9

1.18

0.96

mg/l

1.07

1034

6351

Abnormal blood-pressure reading, without diagnosis

489

2363

2.47

57.81

1.8

1.6

0.84

1.26

mg/l

3.71

371

1812

Failure and rejection of transplanted organs and tissues

220

760

4.61

57.77

5.4

1.9

1.72

1.06

mg/l

1.74

195

565

Arterial embolism and thrombosis of lower extremity artery

412

1876

2.73

57.63

3.1

1.6

2.04

1.37

mg/l

3.20

351

1454

Nonalcoholic fatty liver disease

1078

6737

1.85

57.55

1.9

1.8

1.14

1.13

mg/l

0.03

819

5091

Lung cancer and mesothelioma

1714

9942

1.59

57.34

1.6

1.5

2.01

1.49

mg/l

2.73

1431

7617

Osteoporosis with pathological fracture (FG)

722

4032

2.11

57.27

2.1

1.7

1.49

1.34

mg/l

0.48

581

3071

Familial hypercholesterolemia

1589

10740

1.63

57.25

1.8

1.6

1.31

1.43

mg/l

0.77

1264

8295

Hyperkinetic disorders, excluding more controls

1070

6393

1.80

57.24

2.1

1.9

0.82

0.97

mg/l

0.90

707

4420

Postprocedural disorders of nervous system

946

5737

1.93

57.15

1.9

1.7

0.80

0.91

mg/l

0.65

686

4229

Other diseases of lip and oral mucosa

1721

11842

1.60

57.06

1.9

1.6

1.27

1.25

mg/l

0.06

1320

9161

Adenomyosis (Endometriosis of uterus)

1514

10183

1.66

56.86

1.8

1.6

0.81

1.22

mg/l

10.96

1160

7809

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1766

11829

1.59

56.55

2.8

2.0

1.50

1.15

mg/l

1.67

1332

8782

Other diseases of oesophagus

1031

6353

1.84

56.38

1.9

1.7

1.09

1.34

mg/l

2.79

796

4911

Any event in hilmo or specialist outpatient

109

8.15

56.22

1.6

1.1

0.92

0.32

mg/l

1.70

Amiodarone users

1055

6581

1.84

56.21

5.1

1.7

1.57

1.48

mg/l

0.25

807

5175

5-aminosalicylic acid

2336

16971

1.48

56.14

1.9

1.7

1.14

1.08

mg/l

0.38

1793

12592

Fall on and from stairs and steps

2746

20535

1.44

56.08

1.8

1.14

1.19

mg/l

0.37

2128

15639

Cramp and spasm

596

3191

2.32

55.92

2.1

1.8

0.87

1.12

mg/l

1.82

457

2429

Hallux rigidus

1437

9565

1.66

55.72

1.7

1.12

1.32

mg/l

1.86

1086

7352

Left ventricular outflow tract obstruction (LVOTO), broad definition

1136

7230

1.80

55.70

3.0

2.0

1.39

1.16

mg/l

1.16

857

5516

Lesion of ulnar nerve

1533

10382

1.64

55.62

2.0

1.8

1.17

1.18

mg/l

0.02

1173

7960

Other metabolic disorders

1495

10088

1.65

55.52

2.5

1.7

1.28

1.04

mg/l

0.83

1163

7594

Otalgia

917

5546

1.93

55.50

2.1

2.0

1.06

1.14

mg/l

0.12

668

4164

Viral and other specified intestinal infections

2304

16291

1.48

55.49

2.5

1.8

1.08

1.12

mg/l

0.17

1684

11575

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3336

25657

1.39

55.42

1.9

1.8

1.23

1.15

mg/l

0.62

2596

19297

Disorders of mineral metabolism

896

5371

1.93

55.42

1.9

1.7

1.40

1.24

mg/l

0.86

685

4071

Tonsillectomy and adenotomy

7010

40578

1.26

55.31

1.9

1.8

0.84

1.00

mg/l

3.41

5168

29724

Fitting and adjustment of other devices

3488

25019

1.37

55.29

1.8

1.6

1.29

1.37

mg/l

0.65

2763

19150

Other or ill-defined heart diseases

586

3069

2.23

55.28

3.1

1.6

1.08

1.23

mg/l

0.83

436

2304

Other disorders of kidney and ureter

1349

8945

1.69

54.73

2.1

1.8

1.68

1.31

mg/l

1.99

1095

6906

Reactive arthropathies

988

6069

1.84

54.68

1.8

1.17

1.22

mg/l

0.23

776

4556

Complications associated with artificial fertilization

293

1200

3.44

54.63

2.3

1.6

1.04

0.83

mg/l

1.46

241

861

Restless leg syndrome

1350

8982

1.70

54.60

1.8

1.17

1.20

mg/l

0.08

1001

6853

Injuries to the elbow and forearm

8028

61304

1.23

54.50

1.8

1.21

1.17

mg/l

0.61

6090

46143

Myeloid leukaemia

335

1448

3.06

54.44

3.2

1.7

3.22

1.23

mg/l

3.71

290

1089

Calculus of kidney and ureter

3113

23773

1.40

54.41

1.8

1.31

1.34

mg/l

0.16

2417

18337

Persistent mood disorders

2198

15935

1.50

54.39

1.9

1.7

1.12

1.15

mg/l

0.20

1611

12071

Excessive vomiting in pregnancy

1034

6503

1.83

53.74

1.9

1.7

0.77

0.91

mg/l

1.02

769

4784

Other specified/unspecified soft tissue disorders

565

2969

2.25

53.55

2.0

1.6

1.12

1.33

mg/l

1.09

425

2224

Overexertion and strenuous or repetitive movements

1158

7476

1.76

53.40

2.0

1.8

1.02

1.12

mg/l

0.58

885

5579

Other noninfective disorders of lymphatic vessels and lymph nodes

450

2212

2.57

53.35

2.4

1.7

1.35

1.01

mg/l

1.30

346

1683

TMD related operations

1915

13673

1.54

53.00

2.0

1.8

0.85

1.02

mg/l

2.83

1407

10293

Rheumatoid arthritis, including avohilmo

4212

33567

1.33

52.97

1.8

1.7

1.39

1.21

mg/l

2.75

3347

25712

Supervision of high-risk pregnancy

2599

11632

1.46

52.85

1.8

1.7

0.87

0.80

mg/l

0.67

1943

8526

Neuromuscular dysfunction of bladder

985

6131

1.83

52.36

2.0

1.8

1.23

1.29

mg/l

0.21

761

4715

Benign neoplasm: Sigmoid colon

1854

13176

1.55

52.35

2.0

1.7

1.24

1.35

mg/l

0.83

1447

10251

Keratitis

3866

30524

1.34

52.29

1.9

1.8

1.10

1.16

mg/l

0.55

2908

23054

Medical abortion

7961

36506

1.24

52.19

1.7

0.96

1.09

mg/l

3.81

5955

27471

KRA_PSY_EATING, excluding more controls

992

6139

1.81

52.18

2.3

1.7

0.85

0.95

mg/l

0.34

664

4450

Invasive ventilation

803

4765

1.96

51.93

2.8

1.8

2.36

1.32

mg/l

6.52

656

3641

Cholecystitis

1421

9577

1.63

51.89

1.8

1.7

1.41

1.39

mg/l

0.08

1115

7361

Benign neoplasm: Transverse colon

1018

6415

1.81

51.87

1.9

1.7

1.27

mg/l

0.00

824

4968

Superficial injury of ankle and foot

1335

8913

1.67

51.80

2.0

1.9

0.93

1.03

mg/l

0.69

956

6507

2746

18316

1.42

51.65

1.6

1.54

1.58

mg/l

0.18

2155

14374

Other inflammation of eyelid

1420

9632

1.64

51.59

1.9

1.8

0.97

1.23

mg/l

3.32

1045

7311

Asthma and opportunity respiratory infection

535

2828

2.32

51.49

2.1

1.6

1.14

1.29

mg/l

0.71

417

2193

Preparatory care for dialysis

513

2690

2.38

51.22

2.7

1.8

2.01

1.24

mg/l

2.84

468

2069

Assault

1482

10121

1.61

51.18

1.8

1.9

1.17

0.99

mg/l

0.59

1051

7355

Sequelae of cerebrovascular disease

3441

23474

1.36

51.18

2.4

1.7

1.45

1.46

mg/l

0.07

2720

18226

Type of accident

3058

23504

1.39

51.13

2.0

1.8

1.25

1.16

mg/l

0.68

2369

17726

Brachial plexus disorders

1128

7316

1.75

51.08

1.8

1.7

0.73

0.96

mg/l

3.61

815

5478

Later onset COPD

2594

15192

1.43

51.07

1.9

1.6

1.53

1.68

mg/l

1.34

2128

11913

Pruritus

1229

8117

1.70

50.83

2.0

1.7

1.03

1.17

mg/l

1.01

930

6185

Benign lipomatous neoplasm

3044

23408

1.39

50.66

1.7

1.10

1.08

mg/l

0.10

2337

17809

3953

29522

1.33

50.54

1.7

1.44

1.48

mg/l

0.21

3024

23092

Persons with potential health hazards related to communicable diseases

4396

35050

1.31

50.53

2.2

1.8

1.10

1.02

mg/l

0.65

3134

25842

Benign neoplasm: Stomach

1027

6530

1.79

50.49

2.4

1.7

1.13

1.16

mg/l

0.12

796

4983

Pre-eclampsia or eclampsia

2570

19385

1.44

50.44

2.2

1.7

1.38

0.90

mg/l

6.73

1994

14515

Injury of unspecified body region

854

5197

1.91

50.44

2.5

1.8

1.31

1.21

mg/l

0.39

686

3922

Benign neoplasm: Rectum, anus and anal canal

1937

13935

1.51

50.30

1.9

1.7

1.23

1.22

mg/l

0.04

1532

10710

Speech and linguistic disorders, excluding more controls

833

4666

1.87

50.19

3.2

2.0

1.62

1.15

mg/l

1.20

598

3249

Other necrotizing vasculopathies

793

4747

1.95

50.07

2.4

1.8

1.60

1.32

mg/l

1.29

653

3670

Agranulocytosis

1215

8050

1.71

49.94

2.6

1.8

1.88

1.19

mg/l

4.53

962

6121

Special screening examination for other diseases and disorders

883

5355

1.83

49.87

2.1

1.6

1.06

1.25

mg/l

1.57

655

4050

Adrenocortical insufficiency

468

2407

2.47

49.87

2.8

1.8

1.05

1.16

mg/l

0.32

357

1844

Pneumonia due to other infectious organisms, not elsewhere classified

395

1891

2.63

49.81

2.5

1.6

1.69

1.20

mg/l

0.91

333

1413

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1504

10369

1.60

49.77

1.8

1.7

2.04

1.18

mg/l

7.22

1250

7874

Coxarthrosis, primary, with hip surgery

4664

35841

1.30

49.65

1.7

1.42

1.41

mg/l

0.08

3783

27877

Benign neoplasm: Ascending colon

1324

8937

1.66

49.58

2.1

1.7

1.29

1.39

mg/l

0.40

1017

6939

Polymyalgia rheumatica

1317

8856

1.65

49.57

1.8

1.7

1.41

1.43

mg/l

0.06

1055

6924

Papulosquamous disorders

4259

34244

1.31

49.47

1.8

1.17

1.18

mg/l

0.08

3337

26151

Chronic periodontitis, complicated

1023

6544

1.79

49.37

2.9

1.7

1.47

1.27

mg/l

1.35

857

5062

Mental and behavioural disorders due to sedatives or hypnotics

811

4896

1.92

49.37

2.2

1.8

1.25

0.97

mg/l

1.79

611

3601

Other benign neoplasms of skin

3824

29758

1.33

49.30

1.7

1.18

1.11

mg/l

0.73

2898

22658

Tinnitus

2513

18922

1.43

49.29

1.7

1.18

1.20

mg/l

0.09

1832

14552

Multiple myeloma, excluding all cancers (controls excluding all cancers)

505

2645

2.31

49.23

2.5

1.6

1.56

1.33

mg/l

0.64

417

2064

Skin changes due to chronic exposure to nonionizing radiation

3684

27551

1.34

48.92

1.7

1.45

1.51

mg/l

0.25

2819

21596

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

396

1898

2.55

48.84

2.6

1.7

2.69

1.25

mg/l

3.49

345

1472

Other disorders of the musculoskeletal system and connective tissue

1558

10879

1.59

48.81

1.9

1.7

1.24

1.23

mg/l

0.04

1276

8342

Allergic urticaria

970

6138

1.81

48.78

2.5

1.9

1.01

1.08

mg/l

0.25

700

4582

Diseases of the myoneural junction and muscle

1257

8414

1.67

48.56

2.0

1.8

1.57

1.28

mg/l

1.66

967

6452

Other disorders of adrenal gland

554

3026

2.24

48.55

2.7

1.9

1.05

1.14

mg/l

0.27

416

2301

Superficial injury of shoulder and upper arm

1227

8167

1.68

48.49

2.0

1.8

1.01

1.19

mg/l

1.60

921

6116

Actinic keratosis

3569

26719

1.34

48.41

1.7

1.47

1.52

mg/l

0.21

2732

20985

Elevated blood glucose level

913

5705

1.83

48.27

2.5

1.8

1.27

1.26

mg/l

0.03

735

4284

Aortic valve malfunction, age under 60 years

1039

6713

1.76

47.96

2.8

1.9

1.31

1.16

mg/l

0.61

789

5129

Pre-eclampsia

2390

17973

1.44

47.93

2.3

1.7

1.40

0.88

mg/l

7.07

1863

13412

Disorders of parathyroid gland

2150

15666

1.47

47.91

2.1

1.7

1.41

1.33

mg/l

0.38

1665

12045

Infections with a predominantly sexual mode of transmission

3563

28151

1.34

47.82

1.8

0.83

0.99

mg/l

4.73

2563

20715

Fentanyl

945

5888

1.77

47.82

2.0

1.6

1.86

1.49

mg/l

1.36

789

4481

Inflammatory diseases of prostate (prostatitis)

1242

8279

1.65

47.67

1.8

1.04

1.50

mg/l

8.28

927

6484

Psoriatic and enteropathic arthropathies

1282

8632

1.64

47.63

1.7

1.05

1.08

mg/l

0.14

1016

6478

Schizophrenia or delusion, excluding more controls

3275

25356

1.35

47.63

1.8

1.7

1.24

1.09

mg/l

1.42

2445

19036

Multiple myeloma and malignant plasma cell neoplasms

497

2621

2.28

47.47

2.5

1.6

1.49

1.33

mg/l

0.47

410

2054

Benign neoplasm: Rectum

1705

12150

1.53

47.03

1.9

1.7

1.23

1.22

mg/l

0.01

1347

9335

Benign neoplasm: Caecum

1006

6475

1.76

46.82

2.0

1.7

1.36

1.26

mg/l

0.32

795

4988

Cluster headache, strict, including avohilmo

622

3571

2.10

46.42

1.9

1.7

0.85

0.95

mg/l

0.44

456

2643

Unspecified misadventure during surgical and medical care

631

3637

2.08

46.41

2.2

1.8

1.48

1.18

mg/l

0.81

509

2772

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2097

14014

1.46

46.37

2.3

2.0

1.05

0.97

mg/l

0.33

1411

9714

Myeloid leukaemia

335

1557

2.81

46.34

3.2

1.7

3.22

1.20

mg/l

3.82

290

1211

Congenital malformations of heart and great arteries

1359

9011

1.61

46.25

3.0

2.1

1.25

1.18

mg/l

0.35

993

6720

Other disorders of bladder

1189

7927

1.66

46.23

1.9

1.7

1.38

1.43

mg/l

0.13

877

6138

Other/unspecified enthesopathies, not elsewhere classified

900

5622

1.79

46.18

1.7

0.96

1.32

mg/l

3.16

685

4254

Other diseases of pancreas

794

4845

1.89

46.18

2.0

1.7

1.66

1.36

mg/l

0.76

646

3725

Reactive arthropathies, FINNGEN

808

4943

1.87

46.05

1.9

1.8

1.12

1.08

mg/l

0.17

636

3654

Ulcerative colitis, NAS

1550

10908

1.56

45.99

2.2

1.8

1.22

1.10

mg/l

0.75

1191

8159

Thyrotoxicosis, other and/or unspecified

2189

16320

1.45

45.95

2.7

1.7

1.03

1.12

mg/l

0.89

1642

12407

Colonic or urogenital fistula

2901

22505

1.38

45.56

1.8

1.15

1.18

mg/l

0.14

2126

17203

Spondyloarthritis

1973

14475

1.47

45.03

1.9

1.7

1.13

mg/l

0.01

1531

10905

Other noninflammatory disorders of vulva and perineum

1020

6624

1.72

45.00

1.8

1.6

0.88

1.15

mg/l

3.87

758

4946

Other disorders of nervous system

732

4415

1.93

44.93

2.0

1.7

1.08

1.22

mg/l

0.83

549

3412

Cluster headache, wide,, including avohilmo

649

3806

2.03

44.86

1.9

1.7

0.90

0.97

mg/l

0.26

478

2825

Psoriatic arthropathies

1074

7048

1.69

44.84

1.7

1.08

1.18

mg/l

0.62

854

5310

Other specified and unspecified personality disorders

1087

7195

1.70

44.80

1.9

1.8

0.94

0.97

mg/l

0.14

789

5316

1958

13572

1.47

44.78

1.7

1.50

1.57

mg/l

0.35

1539

10623

Hemiplegia

597

3401

2.06

44.44

2.6

1.7

0.88

1.21

mg/l

3.71

459

2584

Primary coxarthrosis, bilateral

2807

21750

1.38

44.43

1.7

1.38

1.41

mg/l

0.18

2262

16889

Myeloproliferative diseases

894

5682

1.80

44.27

2.0

1.7

1.20

1.39

mg/l

1.06

698

4382

Bronchitis, not specified as acute or chronic

933

5947

1.75

44.23

1.9

1.8

1.12

1.26

mg/l

0.74

724

4493

Other noninflammatory disorders of uterus, except cervix

2388

12259

1.43

44.22

1.7

1.6

1.18

1.28

mg/l

0.94

1836

9493

Unspecified mental disorder

4621

37885

1.28

44.16

1.9

1.8

1.09

1.10

mg/l

0.07

3457

28328

Spondylopathies (FG)

1524

10759

1.54

43.94

1.8

1.7

0.96

1.05

mg/l

0.72

1155

7992

Methotrexate

1577

11205

1.53

43.94

1.9

1.6

1.42

1.13

mg/l

2.51

1243

8457

Car occupant injured in other and unspecified transport accidents

2083

15503

1.45

43.88

2.0

1.8

0.99

1.08

mg/l

0.81

1566

11466

Hyperplasia of prostate

3557

15980

1.33

43.86

1.8

1.38

1.47

mg/l

0.77

2766

12725

Hydronephrosis

1142

7653

1.65

43.38

1.9

1.7

2.01

1.24

mg/l

4.68

944

5830

Pyogenic arthritis

685

4056

1.91

43.35

1.8

1.45

1.34

mg/l

0.39

569

3072

Pollen allergy

2071

15244

1.44

43.33

2.0

0.83

0.98

mg/l

1.33

1440

10960

Colectomy operation

1692

12236

1.51

43.07

2.2

1.7

1.74

1.34

mg/l

4.11

1396

9414

Non-follicular lymphoma, hilmo, excluding all cancers

928

5967

1.75

42.95

2.2

1.7

1.99

1.27

mg/l

2.93

755

4559

Diabetes mellitus in pregnancy

3941

20574

1.31

42.88

1.8

1.7

0.91

0.81

mg/l

1.36

2994

14979

Stomatitis and related lesions

916

5880

1.75

42.62

2.5

1.7

1.10

1.17

mg/l

0.36

713

4455

Crohn disease

1442

10174

1.55

42.30

1.9

1.8

1.12

1.07

mg/l

0.27

1073

7567

Artificial joint re-operation

733

4503

1.90

42.30

1.9

1.8

1.51

1.36

mg/l

0.87

601

3519

Pneumocystosis

230

959

3.49

42.26

2.5

1.7

2.18

1.41

mg/l

0.85

200

742

Preparation and fitting of bite rail to mouth

1537

10996

1.54

42.24

2.0

1.8

0.83

1.00

mg/l

2.50

1128

8266

Other postsurgical states

692

4172

1.92

42.19

2.6

1.7

1.34

1.28

mg/l

0.13

535

3200

Drug-induced adrenocortical insufficiency

256

1122

3.24

42.13

3.3

1.7

1.14

1.10

mg/l

0.06

203

869

Radial styloid tenosynovitis [de Quervain]

627

3671

1.97

42.06

1.7

1.6

0.78

1.07

mg/l

2.57

484

2748

Other diseases of jaws

779

4839

1.83

41.94

2.0

1.7

0.96

1.18

mg/l

1.82

590

3724

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

503

2777

2.16

41.86

2.0

1.6

1.37

1.33

mg/l

0.10

419

2159

Benign neoplasm of other and unspecified endocrine glands

1311

9124

1.59

41.74

1.8

1.7

1.06

1.08

mg/l

0.08

1013

6884

Hypertrophy of breast in women and men

2192

16601

1.43

41.73

1.7

0.83

0.97

mg/l

2.46

1685

12558

Other diseases of arteries and capillaries

940

6104

1.73

41.68

2.1

1.7

1.41

1.24

mg/l

0.60

740

4642

Atypical facial pain

606

3554

2.02

41.68

1.9

1.8

0.87

1.08

mg/l

1.11

432

2676

Benign neoplasm: Transverse colon

1018

6755

1.70

41.67

1.9

1.7

1.27

1.41

mg/l

0.71

824

5278

Sarcoidosis

1454

10327

1.55

41.66

2.2

1.8

1.33

1.16

mg/l

0.54

1132

7874

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1333

9309

1.58

41.61

2.4

1.7

1.15

1.04

mg/l

0.45

1030

7032

Fracture at wrist and hand level

3605

28944

1.31

41.60

1.8

1.06

1.17

mg/l

1.26

2681

21635

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

776

4839

1.84

41.46

2.0

1.8

1.10

1.04

mg/l

0.21

579

3553

Open wound of wrist and hand

4664

38111

1.27

41.45

1.8

1.12

1.17

mg/l

0.41

3401

28598

Amputation

940

6087

1.71

41.44

2.2

1.7

1.73

1.48

mg/l

1.40

781

4743

Thyrotoxicosis

2736

21354

1.37

41.42

2.5

1.7

1.09

1.12

mg/l

0.27

2063

16256

Other/unspecified soft tissue disorders related to use, overuse and pressure

359

1775

2.49

41.36

1.7

1.6

0.91

1.09

mg/l

0.75

261

1314

Sicca syndrome [Sjögren]

988

6543

1.72

41.33

1.9

1.7

1.13

1.12

mg/l

0.02

774

4973

Abnormal findings on diagnostic imaging of other body structures

1346

9448

1.58

41.22

1.9

1.7

1.26

1.21

mg/l

0.28

1083

7190

Osteonecrosis

648

3882

1.96

41.20

2.4

1.8

1.20

1.27

mg/l

0.30

547

3001

Disorders of calcium metabolism

660

3957

1.93

41.01

2.0

1.7

1.41

1.29

mg/l

0.44

510

2999

Collagenous colitis

963

6338

1.72

41.00

2.3

1.8

1.20

mg/l

0.03

749

4830

Dialysis

465

2531

2.22

40.88

2.8

2.0

2.30

1.17

mg/l

2.28

423

1919

Oesophageal varices

435

2308

2.26

40.85

3.0

1.7

3.33

1.22

mg/l

7.10

381

1788

Nonischemic cardiomyopathy

599

3504

1.98

40.59

6.1

1.6

1.72

1.37

mg/l

0.94

494

2692

Immunodeficiency with predominantly antibody defects

353

1771

2.57

40.59

2.9

1.9

1.40

1.07

mg/l

0.67

290

1334

Salpingitis and oophoritis

2000

15027

1.45

40.50

1.8

1.7

0.97

1.04

mg/l

0.53

1509

11531

Hyperparathyroidism

1862

13637

1.46

40.44

1.9

1.7

1.42

1.36

mg/l

0.29

1437

10513

Right bundle-branch block

386

1962

2.34

40.41

2.1

1.6

1.28

1.42

mg/l

0.44

297

1543

Abnormal results of function studies

930

6090

1.72

40.25

2.2

1.8

1.21

1.16

mg/l

0.24

689

4574

Dissociative [conversion] disorders

493

2746

2.15

40.18

1.9

1.6

0.78

1.04

mg/l

1.67

349

2022

Scoliosis

892

5750

1.72

40.17

1.9

1.8

1.17

1.22

mg/l

0.25

685

4227

Molar incisor enamel hypoplasia, with caries

102

259

5.74

40.16

9.7

3.1

3.28

2.45

mg/l

0.22

177

Parkinson's disease, excluding more controls

1185

7857

1.59

40.16

1.7

1.6

1.43

1.69

mg/l

1.75

951

6165

Hypoplasia of dental enamel, including avohilmo

114

317

5.27

40.14

11.2

4.6

3.42

2.21

mg/l

0.42

101

214

Blepharochalasis

2911

22974

1.35

40.09

1.7

1.20

1.36

mg/l

1.16

2233

17847

Panniculitis affecting regions of neck and back

452

2443

2.20

40.00

2.1

1.7

1.00

1.13

mg/l

0.47

356

1849

Immunodeficiencies

573

3351

2.03

39.98

2.7

1.8

1.26

1.14

mg/l

0.30

471

2518

TMD related pain

469

2605

2.24

39.95

2.1

1.7

0.59

0.94

mg/l

5.56

324

1935

Disorders of ocular muscles, binocular movement, accommodation and refraction

5192

43118

1.25

39.85

1.9

1.8

1.05

1.11

mg/l

0.69

3858

32327

Viral pneumonia (known virus, not influenza)

292

1364

2.77

39.81

2.2

2.1

1.75

1.30

mg/l

0.71

243

1047

Other and unspecified mood [affective] disorders

827

5270

1.77

39.79

2.0

1.8

1.13

0.93

mg/l

0.66

588

3823

Unspecified urinary incontinence

949

6262

1.71

39.76

1.9

1.8

1.16

1.24

mg/l

0.33

651

4749

Seronegative rheumatoid arthritis

1234

8549

1.58

39.71

1.8

1.6

1.35

1.20

mg/l

1.05

983

6455

Mental and behavioural disorders due to opioids

467

2566

2.18

39.63

2.1

1.9

1.22

0.93

mg/l

1.41

351

1819

Other female pelvic inflammatory diseases

1816

13492

1.47

39.61

1.8

1.7

1.02

1.07

mg/l

0.19

1347

10247

Lymphoid leukaemia

552

3171

2.02

39.60

4.2

1.8

1.41

1.32

mg/l

0.32

447

2430

Otitis externa, unspecified

1181

8146

1.61

39.55

1.9

1.8

0.90

1.10

mg/l

1.74

886

6115

Chronic pancreatitis

1205

8322

1.59

39.51

1.9

1.8

1.56

1.28

mg/l

2.03

962

6405

IBD patients in KELA-register

2506

19415

1.37

39.48

1.9

1.8

1.13

1.07

mg/l

0.45

1889

14418

Dental pulpitis 3

1334

6649

1.55

39.45

2.2

0.87

1.09

mg/l

1.51

879

4350

Traumatic subdural haemorrhage

1117

7410

1.60

39.44

1.8

1.6

1.80

1.68

mg/l

0.38

892

5789

Herpesviral [herpes simplex] infections

1265

8846

1.58

39.43

2.1

1.8

1.08

1.12

mg/l

0.15

958

6685

Suppurative and unspecified otitis media

4051

29324

1.28

39.40

2.1

1.8

1.00

1.06

mg/l

0.48

2857

21286

Opening and dilatation of root channel of tooth

746

4680

1.84

39.35

2.2

1.8

1.07

0.98

mg/l

0.38

571

3461

Myeloproliferative diseases (CML excluded)

801

5105

1.79

39.27

2.1

1.7

1.16

1.35

mg/l

1.10

622

3940

Acute suppurative otitis media

2908

21395

1.34

39.15

2.1

1.8

0.95

1.00

mg/l

0.32

2031

15276

Disorders of continuity of bone

1043

7040

1.66

39.15

2.0

1.8

1.05

1.07

mg/l

0.11

828

5279

Muscle strain

373

1902

2.36

39.13

2.0

1.7

0.93

1.05

mg/l

0.44

281

1417

Pre-eclampsia or poor fetal growth

3564

28830

1.31

39.00

2.1

1.7

1.25

0.88

mg/l

6.41

2711

21432

201

4710

0.39

38.99

1.5

1.7

3.14

1.42

mg/l

2.14

158

3707

Multiple myeloma and malignant plasma cell neoplasms

497

2800

2.11

38.95

2.5

1.6

1.49

1.39

mg/l

0.26

410

2186

Cirrhosis of liver, NAS

535

3085

2.06

38.94

2.3

1.7

2.66

1.26

mg/l

6.89

477

2400

Fibrosis and cirrhosis of liver

769

4865

1.81

38.91

2.3

1.8

2.34

1.25

mg/l

6.99

666

3765

Benign neoplasm: Stomach

1027

6931

1.67

38.91

2.4

1.7

1.13

1.28

mg/l

0.96

796

5358

Parkinson's disease, strict definition, excluding more controls

1098

7272

1.60

38.69

1.7

1.6

1.45

1.72

mg/l

1.68

882

5701

Venous complications and haemorrhoids in pregnancy

287

1368

2.84

38.50

2.2

1.7

0.79

0.70

mg/l

0.53

223

996

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

851

5535

1.75

38.44

2.2

1.8

1.41

1.19

mg/l

1.02

658

4221

Ovarian hyperstimulation (induction)

275

1294

2.93

38.36

2.3

1.7

1.04

0.69

mg/l

4.13

226

935

Amenorrhoea

796

5062

1.76

38.31

2.1

1.7

0.85

1.02

mg/l

1.27

613

3638

Benign neoplasm: Adrenal gland

757

4795

1.81

38.23

1.7

1.05

1.15

mg/l

0.65

594

3677

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1383

9860

1.53

38.22

2.3

1.8

2.36

1.25

mg/l

12.50

1184

7684

Atopic dermatitis, strict definition with reimbursement

3395

26518

1.30

38.15

1.8

1.9

0.98

1.00

mg/l

0.09

2458

19521

Decubitus ulcer and pressure area

565

3298

1.96

38.13

3.1

1.7

1.73

1.53

mg/l

0.67

462

2559

Additional codes for the location of defect, injury or illness

638

3886

1.92

38.04

1.8

1.09

1.15

mg/l

0.17

500

2954

Unknown and unspecified causes of morbidity

740

4614

1.78

37.98

1.7

1.5

0.90

1.23

mg/l

2.43

550

3471

Postmenopausal atrophic vaginitis

2702

12680

1.36

37.92

1.6

1.7

0.87

1.25

mg/l

14.36

2072

9886

Arthropathies in other diseases classified elsewhere

413

2211

2.24

37.87

1.8

1.18

1.28

mg/l

0.32

322

1662

Injury of muscle and tendon at hip and thigh level

1024

6949

1.65

37.48

2.0

1.7

0.95

1.12

mg/l

1.67

820

5275

Other dialysis

361

1870

2.41

37.46

2.6

2.0

2.24

1.20

mg/l

1.80

329

1437

Other and unspecified myopathies

851

5545

1.72

37.36

2.0

1.7

1.70

1.37

mg/l

1.22

664

4271

Other hearing loss

2637

20326

1.35

37.16

1.8

1.7

1.39

1.45

mg/l

0.28

1975

15811

Benign neoplasm: Caecum

1006

6825

1.65

37.01

2.0

1.7

1.36

1.39

mg/l

0.07

795

5318

Early lumbar disc prolapse, operated

1092

7483

1.60

36.95

1.8

1.7

0.70

0.89

mg/l

2.45

794

5500

Dermatophytosis

1299

9227

1.54

36.87

1.9

1.8

1.28

1.31

mg/l

0.07

1003

7073

Other diseases of blood and blood-forming organs

729

4616

1.81

36.84

2.2

1.7

1.20

1.21

mg/l

0.02

563

3525

Dental caries 2 and operation codes

8892

61931

1.18

36.81

2.0

1.8

1.04

1.09

mg/l

0.64

6413

46503

Other disorders of white blood cells

609

3695

1.92

36.75

2.4

1.8

1.18

1.16

mg/l

0.04

478

2823

In situ neoplasms

3594

27924

1.29

36.69

1.8

1.7

1.48

1.12

mg/l

3.61

2756

21245

Disorders resulting from impaired renal tubular function

417

2284

2.24

36.62

2.2

1.8

2.21

1.25

mg/l

1.91

364

1751

Alcohol abuse, main dg

1608

11828

1.47

36.62

1.9

1.27

1.14

mg/l

0.60

1245

8895

Other disorders of conjunctiva

1393

10024

1.52

36.61

2.1

1.7

1.28

1.31

mg/l

0.08

1068

7785

Complications predominantly related to the puerperium

2975

23829

1.33

36.57

1.9

1.7

1.02

0.95

mg/l

0.59

2248

17845

Hypertrophy of breast

1932

14690

1.42

36.14

1.7

0.77

0.92

mg/l

3.45

1479

11102

Nontoxic multinodular goitre

2087

16015

1.40

36.10

1.7

1.07

1.26

mg/l

2.96

1611

12351

Diabetic nephropathy, excluding more controls

1447

8748

1.51

36.03

1.9

1.49

1.23

mg/l

1.85

1213

6760

Olecranon bursitis

588

3516

1.89

36.00

1.8

1.7

1.38

1.34

mg/l

0.06

469

2688

Other and unspecified injuries of head

656

4064

1.84

35.94

2.2

1.9

1.20

1.18

mg/l

0.05

496

3049

Benign neoplasm: Rectum, anus and anal canal

1937

14713

1.42

35.86

1.9

1.7

1.23

1.35

mg/l

1.20

1532

11421

Diseases of middle ear and mastoid

6577

46304

1.20

35.85

2.0

1.8

1.05

1.11

mg/l

0.74

4756

34310

Calcific tendinitis of shoulder

612

3714

1.87

35.84

1.8

1.6

0.82

1.16

mg/l

3.91

456

2832

Fracture of skull and facial bones

2158

16593

1.38

35.79

1.9

1.8

1.18

mg/l

0.03

1626

12474

Algoneurodystrophy

432

2417

2.20

35.73

1.9

1.7

1.04

0.95

mg/l

0.18

322

1803

Phobic anxiety disorders

1413

10191

1.49

35.70

2.0

1.8

1.10

0.96

mg/l

0.57

1001

7346

Anosmia

220

909

2.79

35.64

1.8

1.4

1.26

0.79

mg/l

1.09

165

670

Injury of muscle and tendon at lower leg level

1507

11022

1.48

35.63

2.0

1.8

1.05

1.22

mg/l

1.69

1193

8415

Other infectious diseases

817

5340

1.72

35.45

2.3

1.7

1.34

1.27

mg/l

0.20

655

4095

Pregnancy with abortive outcome

8112

36943

1.19

35.36

1.7

0.98

1.09

mg/l

3.03

6095

27757

Psoriasis

2981

23935

1.32

35.30

1.8

1.15

mg/l

0.01

2359

18237

Inflammatory bowel disease, strict (require KELA)

2506

19705

1.35

35.26

1.9

1.8

1.13

1.06

mg/l

0.55

1889

14630

Hereditary deficiency of other clotting factors

154

581

4.14

35.01

4.4

1.8

0.90

mg/l

0.01

110

449

Dental caries 2

9040

62554

1.17

34.93

2.0

1.8

1.05

1.09

mg/l

0.56

6512

47002

Acute laryngitis and tracheitis

1236

8586

1.52

34.82

2.3

1.8

1.09

1.01

mg/l

0.24

876

6070

Other disorders of glucose regulation and pancreatic internal secretion

870

5787

1.67

34.55

2.0

1.8

1.36

1.19

mg/l

0.50

664

4337

Benign neoplasm: Rectum

1705

12793

1.44

34.53

1.9

1.7

1.23

1.35

mg/l

1.10

1347

9936

Female infertility, associated with anovulation

914

6138

1.64

34.39

1.9

1.6

0.88

0.92

mg/l

0.29

718

4444

Sequelae of other external causes

582

3543

1.89

34.34

2.2

1.7

1.37

1.16

mg/l

1.39

475

2711

Bicipital tendinitis

493

2856

1.99

34.31

2.0

1.7

0.92

1.26

mg/l

2.79

358

2178

Endometriosis of rectovaginal septum and vagina

860

5728

1.68

34.21

1.7

1.6

0.93

1.23

mg/l

2.55

650

4316

Dysplasia of cervi uteri

2661

16278

1.33

34.21

1.7

0.99

1.06

mg/l

0.47

1969

12187

Osteomyelitis

648

4049

1.82

34.21

2.1

1.7

1.39

1.34

mg/l

0.18

527

3127

Other condition

1440

10541

1.48

34.19

2.0

1.8

1.24

1.14

mg/l

0.43

1123

7925

Oligomenorrhoea

439

2473

2.09

34.18

1.9

1.7

0.76

1.05

mg/l

1.88

314

1808

Nasal polyp

1913

14573

1.40

34.12

1.7

1.8

1.09

1.29

mg/l

1.82

1474

11249

L01XX Other antineoplastic agents

570

3462

1.91

34.10

2.6

1.6

1.26

1.47

mg/l

0.84

443

2715

Congenital malformations of cardiac chambers and connections

101

295

5.37

34.00

5.7

4.6

1.89

1.24

mg/l

0.92

214

Sequelae of injuries of lower limb

1021

7055

1.60

33.96

2.0

1.8

1.04

1.09

mg/l

0.24

796

5326

Other peripheral vertigo

954

6517

1.64

33.95

1.8

1.7

0.92

1.27

mg/l

4.93

713

5004

conjunctival haemorrhage

750

4871

1.74

33.85

2.2

1.8

1.23

1.34

mg/l

0.40

562

3805

Benign lipomatous neoplasm

3044

24621

1.31

33.85

1.7

1.10

1.21

mg/l

1.36

2337

18931

Anaemia in chronic diseases classified elsewhere

282

1383

2.57

33.81

3.4

1.8

2.84

1.30

mg/l

2.21

248

1080

Maternal care for other known or suspected fetal problems

2819

14403

1.33

33.79

1.9

1.7

0.90

0.77

mg/l

1.98

2111

10419

Cytomegalovirus infection, IBD co-morbidity

284

1408

2.60

33.76

3.6

2.0

2.28

1.17

mg/l

1.16

247

1074

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

322

1643

2.36

33.73

6.0

1.9

1.99

1.32

mg/l

1.05

271

1245

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

862

5739

1.66

33.72

1.9

1.8

1.03

mg/l

0.02

642

4211

Medial epicondylitis

424

2371

2.09

33.57

1.6

1.7

0.94

1.11

mg/l

0.57

309

1790

Weight loss

962

6584

1.62

33.55

1.9

1.8

1.33

1.29

mg/l

0.13

692

5041

Non-follicular lymphoma

928

6318

1.63

33.24

2.2

1.7

1.99

1.38

mg/l

2.22

755

4922

Paralytic ileus

389

2119

2.14

33.18

2.1

1.7

1.56

1.39

mg/l

0.43

321

1648

Congenital malformations of cardiac septa

702

4346

1.76

33.16

3.1

2.3

1.21

1.19

mg/l

0.08

524

3229

Lung diseases due to external agents

1276

9167

1.50

33.03

2.0

1.7

1.53

1.47

mg/l

0.23

1026

7101

Ptosis of eyelid

1065

7460

1.58

32.98

1.9

1.7

1.28

1.38

mg/l

0.31

814

5769

Alcohol dependence

2713

21687

1.32

32.94

1.9

1.8

1.40

1.24

mg/l

1.38

2127

16617

Other/unspecified cytomegaloviral diseases

247

1176

2.78

32.82

3.8

2.0

2.32

1.16

mg/l

1.05

220

887

Any prescribed medicine buy

7.17

32.71

2.7

2.0

1.19

1.26

mg/l

0.05

Other benign neoplasms of skin

3824

31746

1.26

32.67

1.7

1.18

1.25

mg/l

0.86

2898

24353

Thyroiditis, ILD-related definition

1265

9155

1.51

32.50

1.9

1.7

1.02

1.04

mg/l

0.09

936

6869

Polycythaemia vera

368

1997

2.20

32.46

2.2

1.6

1.18

1.34

mg/l

0.50

288

1539

Amputation of toe

661

4196

1.77

32.42

1.8

1.7

1.44

1.51

mg/l

0.21

543

3276

Cholangitis (primary sclerosing, PSC)

617

3856

1.81

32.38

2.5

1.8

2.11

1.31

mg/l

2.41

513

2941

Pneumothorax

690

4422

1.74

32.31

2.1

1.7

1.59

1.37

mg/l

0.81

551

3363

Diseases of peritoneum

1031

7198

1.58

32.26

2.2

1.8

1.62

1.24

mg/l

2.96

808

5524

Convalescence

601

3752

1.84

32.24

2.0

1.6

1.04

1.03

mg/l

0.04

454

2829

Dental pulpitis 3, only avohilmo

1202

6197

1.51

32.12

2.0

2.2

0.81

1.11

mg/l

4.37

779

4037

Mixed connective tissue disease

730

4789

1.74

32.10

2.0

1.8

1.12

1.08

mg/l

0.15

587

3642

Superficial injury of forearm

1024

7145

1.57

32.07

1.9

1.02

1.10

mg/l

0.33

776

5226

Gestational diabetes (for exclusion)

4348

25820

1.25

32.04

1.8

1.7

0.90

0.83

mg/l

0.95

3303

18955

Other aneurysm

526

3161

1.89

32.00

3.1

1.7

2.08

1.42

mg/l

3.48

432

2445

Hypertension, Pulmonary Arterial

129

456

4.11

31.87

8.9

1.6

1.60

1.40

mg/l

0.23

100

348

Other abnormal products of conception

3820

21093

1.27

31.80

1.7

0.80

0.88

mg/l

1.33

2833

15730

Abnormal weight loss

871

5913

1.64

31.76

1.8

1.30

1.32

mg/l

0.05

633

4526

Other symptoms and signs involving the urinary system

994

6902

1.58

31.70

1.9

1.8

1.20

1.32

mg/l

0.59

794

5296

Essential (haemorrhagic) thrombocythaemia

403

2274

2.11

31.57

2.0

1.6

1.12

1.23

mg/l

0.25

311

1737

Diseases of tongue

669

4297

1.76

31.54

1.8

1.7

1.00

1.26

mg/l

1.85

490

3346

Palmar fascial fibromatosis [Dupuytren]

1319

9571

1.47

31.53

1.7

1.36

1.62

mg/l

1.35

1043

7439

Diseases of spleen

227

1060

2.83

31.52

2.4

1.7

1.57

1.20

mg/l

1.19

187

814

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1845

13951

1.40

31.41

1.7

1.91

1.11

mg/l

11.54

1511

10595

Melanocytic naevi

2964

24088

1.29

31.25

2.1

1.7

1.15

1.01

mg/l

1.02

2235

17969

Assault by bodily force

816

5472

1.65

31.23

1.9

1.8

0.87

0.92

mg/l

0.31

575

3919

Kela-code for severe mental illness

4011

33565

1.25

31.22

1.8

1.14

1.10

mg/l

0.33

3003

25090

Suppurative and necrotic conditions of lower respiratory tract

540

3299

1.87

31.21

2.2

1.7

1.61

1.38

mg/l

0.83

465

2559

Other (seronegative) rheumatoid arthritis, wide

1977

15365

1.38

31.13

1.8

1.7

1.36

1.23

mg/l

1.22

1577

11788

Disorders of psychological development

1141

7502

1.51

31.09

2.9

2.2

1.34

1.07

mg/l

1.03

818

5135

Von Willebrand disease

204

926

3.06

31.05

3.2

1.8

0.61

0.83

mg/l

1.97

154

698

Cytomegaloviral disease

291

1501

2.46

31.00

3.5

2.0

2.24

1.15

mg/l

1.17

252

1144

Hepatic failure, not elsewhere classified

397

2247

2.10

30.90

2.8

1.7

2.64

1.21

mg/l

7.73

342

1739

Nonpyogenic thrombosis of intracranial venous system

150

594

3.78

30.89

3.9

1.8

2.25

1.18

mg/l

0.92

114

442

Benign neoplasm: Adrenal gland

757

5043

1.70

30.85

1.7

1.8

1.05

1.24

mg/l

1.58

594

3934

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

4923

28656

1.22

30.76

1.7

1.49

1.20

mg/l

4.42

3800

22052

Lymphoid leukaemia

552

3406

1.85

30.76

4.2

1.8

1.41

1.47

mg/l

0.15

447

2641

Other menopausal disorders

2954

13744

1.30

30.73

1.6

1.7

0.83

1.14

mg/l

9.51

2228

10624

Oesophagitis

560

3466

1.84

30.70

2.0

1.9

0.89

1.27

mg/l

5.71

455

2687

Benign neoplasm of other and unspecified endocrine glands

1311

9645

1.48

30.65

1.8

1.7

1.06

1.22

mg/l

1.36

1013

7365

Trigeminal neuralgia

633

4048

1.77

30.60

1.8

0.82

1.14

mg/l

3.03

457

3063

Nontoxic goitre/thyroid nodule

3104

25456

1.29

30.59

1.8

1.7

1.04

1.23

mg/l

4.12

2411

19551

Delirium, not induced by alcohol and other psychoactive substances

1018

7126

1.55

30.58

1.8

1.7

1.82

1.46

mg/l

1.39

825

5520

SLE (Finngen)

424

2461

2.05

30.52

2.4

1.8

1.55

1.02

mg/l

3.07

342

1861

Open wound of ankle and foot

1022

7190

1.55

30.49

2.0

1.8

1.07

1.18

mg/l

0.81

787

5350

Focal epilepsy

2097

16425

1.35

30.38

2.0

1.9

1.20

1.21

mg/l

0.04

1610

12437

Fracture of femur

2416

17521

1.32

30.27

1.8

1.7

1.75

1.45

mg/l

3.11

1940

13482

Monoamine oxidase A inhibitors

1224

8893

1.49

30.19

1.9

1.7

1.03

1.22

mg/l

1.78

917

6866

Other arterial embolism and thrombosis

296

1521

2.31

30.18

2.7

1.6

2.17

1.40

mg/l

2.60

246

1174

Speech and linguistic disorders

843

5462

1.61

30.16

3.2

2.3

1.62

1.12

mg/l

1.37

607

3773

Mental and behavioural disorders due to tobacco

884

6092

1.62

30.14

1.9

1.8

1.12

mg/l

0.04

681

4648

Charcot foot

206

932

2.82

30.09

1.9

1.6

1.16

1.05

mg/l

0.39

171

709

Hypertensive Renal Disease

333

1769

2.15

30.07

1.8

1.6

1.74

1.45

mg/l

0.50

282

1382

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

786

5279

1.65

30.04

2.0

1.7

1.66

1.39

mg/l

0.72

647

4058

Personal history of other diseases and conditions

1189

8573

1.50

29.95

2.7

1.8

1.05

0.98

mg/l

0.35

887

6259

Vascular diseases of the intestine

373

2073

2.09

29.92

2.3

1.6

2.59

1.40

mg/l

3.26

321

1598

Smoking dependency

884

6101

1.61

29.92

1.9

1.8

1.12

mg/l

0.03

681

4664

Recurrent dislocation of patella

598

3781

1.78

29.90

1.8

0.80

0.93

mg/l

1.05

433

2707

Complications following infusion, transfusion and therapeutic injection

205

942

2.90

29.69

3.4

1.7

1.45

1.14

mg/l

0.77

168

718

Speech disturbances, not elsewhere classified

842

5747

1.62

29.66

2.9

1.7

1.27

1.36

mg/l

0.38

657

4409

Iridocyclitis

2315

18433

1.33

29.58

1.9

1.8

1.20

1.16

mg/l

0.23

1808

14007

Ankylosing spondylitis

902

6222

1.58

29.55

1.8

1.7

1.00

1.25

mg/l

1.98

681

4678

Fracture of shoulder and upper arm

3544

29455

1.25

29.39

1.9

1.8

1.29

1.28

mg/l

0.14

2770

22280

Other puerperal infections

909

6338

1.60

29.33

2.0

1.7

0.86

0.81

mg/l

0.32

680

4565

Other diseases of biliary tract

816

5544

1.62

29.29

2.4

1.7

2.18

1.36

mg/l

3.16

667

4240

Other and unspecified disorders of white blood cells

447

2663

1.97

29.13

2.2

1.7

1.08

1.22

mg/l

0.68

351

2035

Portal vein thrombosis

188

833

2.95

29.11

4.6

1.8

2.62

1.15

mg/l

4.85

157

654

Haemolytic anaemias

384

2193

2.08

29.04

4.9

1.7

2.57

1.32

mg/l

1.81

313

1677

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

4708

27605

1.22

29.02

1.7

1.53

1.21

mg/l

3.95

3626

21258

Other bursitis of hip

239

1165

2.56

29.01

2.7

1.6

0.99

1.20

mg/l

0.86

178

872

Rash and other nonspecific skin eruption

1012

7188

1.54

28.98

1.9

1.8

1.14

1.20

mg/l

0.26

775

5462

Secondary and unspecified malignant neoplasm of lymph nodes

815

5559

1.63

28.97

2.0

1.8

2.04

1.30

mg/l

2.36

664

4275

Abscess of anal and rectal regions

854

5857

1.60

28.95

1.9

1.7

1.34

1.13

mg/l

1.00

643

4371

Ulcer of oesophagus

678

4446

1.70

28.81

1.9

1.7

1.20

1.40

mg/l

1.25

547

3470

Other specified/unspecified systemic involvement of connective tissue

656

4305

1.74

28.79

2.0

1.8

1.09

1.07

mg/l

0.07

516

3270

Meralgia paraesthetica

387

2233

2.07

28.49

2.0

1.7

1.18

1.10

mg/l

0.20

305

1680

Presbycusis

1207

8751

1.47

28.48

1.6

1.53

1.63

mg/l

0.34

902

6861

Other degenerative diseases of the nervous system

2489

15087

1.30

28.35

1.6

1.51

1.45

mg/l

0.26

1872

11617

Disturbance of activity and attention

1011

7072

1.52

28.32

2.1

0.80

0.95

mg/l

0.91

669

4836

Diabetic retinopathy, excluding more controls

2552

11546

1.32

28.32

1.9

1.32

1.19

mg/l

0.92

2016

8925

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5194

26236

1.21

28.29

1.7

0.88

0.89

mg/l

0.19

3888

19526

ILD medications: pirfenidone

128

482

3.79

28.28

2.5

1.6

1.77

1.28

mg/l

0.40

107

384

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

4789

28107

1.21

28.26

1.7

1.53

1.21

mg/l

3.94

3694

21642

Other specified/unspecified spondylopathies

273

1401

2.33

28.24

1.9

1.6

1.26

1.45

mg/l

0.39

219

1094

Injury of eye and orbit

1422

10672

1.42

28.24

1.9

1.8

1.12

1.13

mg/l

0.02

1025

7988

Glomerulonephritis

998

7101

1.54

28.20

2.2

1.9

1.71

1.26

mg/l

3.21

829

5388

Type 1 diabetes, wide definition, subgroup 1

2165

17148

1.33

28.18

1.8

1.02

1.08

mg/l

0.66

1648

12549

Hypermobility syndrome

646

4249

1.74

28.16

1.9

1.7

0.67

0.83

mg/l

1.87

487

3110

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

280

1447

2.29

28.14

2.3

1.6

1.80

1.31

mg/l

1.84

242

1124

Ethmoidectomy

1347

10076

1.45

28.10

1.7

0.94

1.12

mg/l

1.08

979

7650

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2089

16533

1.34

28.04

1.7

2.46

1.22

mg/l

20.27

1766

12747

Maternal care for known or suspected abnormality of pelvic organs

2872

16186

1.29

27.97

1.9

1.7

0.93

0.83

mg/l

1.13

2175

11952

Mixed and other personality disorders

902

6327

1.58

27.95

1.9

1.8

0.94

0.93

mg/l

0.04

628

4659

Protozoal diseases

317

1737

2.24

27.94

2.4

1.7

1.88

1.23

mg/l

1.01

268

1344

Hyperkinetic disorders

1073

7609

1.50

27.82

2.1

0.82

0.98

mg/l

1.09

709

5214

Follicular cysts of skin and subcutaneous tissue

1838

14361

1.36

27.61

1.8

0.97

1.17

mg/l

3.20

1392

10975

Other eating disorders

589

3790

1.75

27.57

2.4

1.9

0.80

0.90

mg/l

0.47

388

2688

Eating disorders

1189

8731

1.47

27.56

2.3

1.8

0.92

0.99

mg/l

0.26

813

6282

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

5542

32730

1.19

27.45

1.7

1.48

1.16

mg/l

5.14

4276

25193

Basal cell carcinoma

5373

36998

1.20

27.37

1.7

1.55

1.41

mg/l

1.19

4165

28868

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

432

2600

1.96

27.36

2.0

1.8

1.04

0.98

mg/l

0.23

319

1937

Retinal detachments and breaks

3378

28187

1.25

27.32

1.9

1.7

1.27

1.35

mg/l

0.62

2608

21850

Basal cell carcinoma, including avohilmo

5515

37616

1.19

27.22

1.7

1.55

1.40

mg/l

1.35

4274

29336

Obsessive-compulsive disorder

684

4543

1.66

27.16

1.9

1.8

0.92

0.98

mg/l

0.26

459

3234

Rare circulating lymphoid malignancy

322

1774

2.15

27.11

6.0

2.0

1.99

1.44

mg/l

0.78

271

1366

Other fall from one level to another

2199

17562

1.32

27.06

2.0

1.9

1.19

1.21

mg/l

0.06

1637

13136

Biological medication for rheuma

1622

12508

1.39

27.03

1.9

1.8

1.10

0.99

mg/l

1.08

1232

9291

Hyperhidrosis

335

1863

2.09

26.99

1.8

1.5

0.75

1.02

mg/l

1.97

245

1374

Recurrent dislocation and subluxation of joint

734

4956

1.63

26.95

1.9

1.8

1.00

0.97

mg/l

0.08

541

3612

Left ventricular outflow tract obstruction, narrow definition

499

3107

1.83

26.92

3.5

2.2

1.42

1.20

mg/l

0.72

358

2322

Atopic dermatitis, strict definition

3210

26152

1.26

26.91

1.8

1.9

1.02

0.99

mg/l

0.13

2319

19184

Progressive vascular leukoencephalopathy

332

1853

2.12

26.88

1.7

1.6

1.47

mg/l

0.00

244

1445

Seropositive rheumatoid arthritis, wide

2757

22627

1.28

26.85

1.8

1.7

1.48

1.20

mg/l

3.89

2228

17389

Right ventricular outflow tract obstruction

116

423

3.82

26.84

4.5

4.4

1.69

1.92

mg/l

0.16

306

Dermatitis due to substances taken internally

583

3768

1.74

26.82

2.0

1.8

1.15

1.18

mg/l

0.08

459

2861

Contraceptive management

4621

27779

1.21

26.78

1.9

1.7

0.89

0.97

mg/l

0.99

3448

20795

Abnormal findings on antenatal screening of mother

931

6606

1.54

26.77

1.9

1.7

0.99

0.80

mg/l

2.09

700

4726

Crohn's disease of small intestine

741

5046

1.63

26.76

2.0

1.8

1.06

1.02

mg/l

0.21

538

3713

Other/unspecified seropositive rheumatoid arthritis

2728

22379

1.28

26.70

1.8

1.7

1.49

1.20

mg/l

3.88

2204

17192

Conotruncal defects

171

753

2.93

26.68

4.0

1.54

1.46

mg/l

0.09

123

541

Other congenital malformations

904

6380

1.55

26.68

2.2

1.42

1.07

mg/l

1.33

694

4689

Type 1 diabetes

2602

21154

1.28

26.62

1.9

1.8

1.15

mg/l

0.01

1984

15556

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2689

22039

1.29

26.61

1.8

1.7

1.47

1.20

mg/l

3.76

2177

16926

Other noninflammatory disorders of vagina

809

5594

1.59

26.57

1.8

1.6

0.83

1.15

mg/l

5.47

607

4228

Antenatal screening

2693

12315

1.29

26.54

1.7

0.86

0.79

mg/l

0.73

2019

9001

Other/unspecified reactive arthropathies

710

4810

1.65

26.53

1.9

1.7

1.17

1.07

mg/l

0.56

560

3609

Nail disorders

850

5948

1.57

26.52

2.2

1.9

1.14

1.11

mg/l

0.13

648

4447

Endometriosis of ovary

1776

13832

1.36

26.50

1.8

1.6

1.14

1.13

mg/l

0.03

1305

10503

Psychotic depression

615

4010

1.69

26.38

1.8

0.98

1.13

mg/l

0.85

444

3059

Mixed hyperlipidaemia

416

2483

1.92

26.37

1.8

1.6

1.13

1.37

mg/l

1.20

312

1911

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

308

1708

2.21

26.31

1.7

2.37

1.23

mg/l

6.23

275

1310

Acute alcohol intoxication, ICD10

1950

15419

1.34

26.30

1.9

1.8

1.27

1.15

mg/l

0.68

1497

11644

1122

8260

1.48

26.28

1.8

1.7

0.84

0.77

mg/l

0.25

822

5981

Corneal ulcer

1845

14509

1.35

26.24

1.9

1.8

1.01

1.12

mg/l

1.15

1394

10922

Other disorders of gingiva or/and edentulous alveolar ridge

510

3212

1.79

26.12

3.3

1.8

1.43

1.34

mg/l

0.28

408

2479

Acute posthaemorrhagic anaemia

358

2052

2.02

26.09

2.6

1.6

1.60

1.28

mg/l

0.77

276

1583

Hypopituitarism

693

4669

1.65

26.09

2.1

1.06

1.13

mg/l

0.23

536

3468

Redundant prepuce, phimosis and paraphimosis

1802

14005

1.34

26.01

1.8

1.9

1.15

1.31

mg/l

1.35

1350

10375

Other crystal arthropathies

196

920

2.63

25.87

1.7

1.6

1.27

1.44

mg/l

0.54

154

716

FESS (DNB20)

1286

9677

1.44

25.82

1.7

0.91

1.12

mg/l

1.39

933

7343

Somnolence, stupor and coma

451

2762

1.85

25.74

2.1

1.7

1.25

1.18

mg/l

0.21

369

2106

Duodenal ulcer

965

6894

1.50

25.73

2.0

1.7

1.47

mg/l

0.01

771

5421

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

486

3029

1.80

25.73

1.9

1.7

0.86

1.11

mg/l

1.48

389

2230

Persons encountering health services in circumstances related to reproduction

6301

37421

1.17

25.72

2.0

1.8

1.07

1.04

mg/l

0.23

4732

27836

Combinations of oral blood glucose lowering drugs

2672

21946

1.28

25.63

1.8

1.7

1.28

1.31

mg/l

0.16

2145

16935

Benign neoplasm of mouth and pharynx

1046

7624

1.49

25.54

1.7

1.19

1.13

mg/l

0.23

800

5779

Disorders of tooth development and eruption

520

3198

1.75

25.53

4.9

1.8

1.74

1.12

mg/l

1.35

407

2350

Benign neoplasm: Descending colon

610

4026

1.69

25.51

2.1

1.8

1.23

1.26

mg/l

0.09

502

3124

Cerebral cysts

591

3879

1.71

25.47

2.2

1.7

1.21

1.11

mg/l

0.30

437

2904

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5237

35856

1.19

25.42

1.6

1.7

1.51

1.42

mg/l

0.88

4054

27962

Memory loss

869

6154

1.55

25.37

1.9

1.7

1.38

1.41

mg/l

0.09

643

4785

Open wound of forearm

911

6494

1.53

25.34

2.1

1.7

1.16

1.14

mg/l

0.04

686

4826

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1297

9790

1.43

25.33

1.7

1.02

1.03

mg/l

0.03

1000

7402

Crohn's disease NAS

694

4716

1.64

25.30

1.9

1.16

1.01

mg/l

0.71

524

3475

Leiomyoma of uterus

5521

27044

1.19

25.27

1.7

0.96

0.89

mg/l

1.12

4153

20423

Tobacco use

564

3687

1.74

25.22

1.9

1.7

1.08

1.09

mg/l

0.03

429

2773

Other specified/unspecified dorsopathies

384

2272

1.95

25.17

1.9

1.7

1.15

1.24

mg/l

0.14

298

1718

Other disorders of breast

1351

10295

1.42

25.15

1.8

1.7

1.03

1.01

mg/l

0.04

995

7755

Eating disorder

992

7184

1.50

25.14

2.3

1.8

0.85

0.94

mg/l

0.30

664

5116

Sacrococcygeal disorders, not elsewhere classified

350

2024

2.02

25.14

1.9

1.6

0.81

1.05

mg/l

1.96

264

1507

Disorders of oesophagus in diseases classified elsewhere

231

1177

2.42

25.03

2.3

1.6

1.19

1.24

mg/l

0.13

175

919

Orchitis and epididymitis

794

5503

1.56

25.01

2.5

1.9

1.47

1.45

mg/l

0.05

613

4213

Malignant neoplasm of skin

6063

40023

1.17

25.01

1.6

1.7

1.53

1.38

mg/l

1.47

4712

31194

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

719

4915

1.61

24.99

2.0

1.9

1.22

0.95

mg/l

1.71

527

3489

Barrett oesophagus

472

2957

1.82

24.98

1.8

1.7

1.29

1.32

mg/l

0.06

367

2297

Hypoglycaemia, other or unspecified

679

4600

1.63

24.91

2.1

1.9

1.43

1.17

mg/l

0.67

518

3467

Disorders of refraction and accommodation

2711

22271

1.27

24.88

2.0

1.9

0.98

1.08

mg/l

0.99

1969

16557

Acute alcohol intoxication

2471

20163

1.28

24.85

1.8

1.27

1.24

mg/l

0.16

1902

15323

Benign neoplasm: Small intestine

389

2325

1.94

24.81

2.2

1.8

1.16

1.29

mg/l

0.44

312

1797

Erosion of teeth

201

977

2.58

24.77

4.7

1.8

1.65

1.16

mg/l

0.70

158

722

Dermatographic urticaria

737

5104

1.61

24.75

2.1

1.7

0.70

0.96

mg/l

5.14

520

3808

Asthma mixed form (mode), excluding more controls

500

3141

1.74

24.75

1.9

1.5

0.97

1.18

mg/l

1.25

380

2337

Wet age-related macular degeneration

1481

11183

1.38

24.72

1.6

1.7

1.66

1.63

mg/l

0.08

1158

8733

Other and unspecified immunodeficiencies with predominantly antibody defects

171

790

2.90

24.69

3.5

1.9

1.59

1.09

mg/l

0.52

142

606

Other viral hepatitis

673

4569

1.64

24.68

2.1

1.8

1.40

0.94

mg/l

1.12

515

3327

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1662

13006

1.36

24.61

1.9

1.8

1.15

1.07

mg/l

0.51

1284

9681

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1858

14736

1.33

24.60

1.9

1.8

1.17

1.06

mg/l

0.75

1438

10987

Other specified/unspecified bacterial intestinal infections

653

4414

1.65

24.52

1.9

1.8

1.05

1.20

mg/l

0.68

501

3366

Heart failure and hypertrophic cardiomyopathy

204

1007

2.58

24.46

9.4

1.7

1.64

1.33

mg/l

0.52

162

793

Allergic contact dermatitis

1448

11157

1.39

24.45

1.9

1.7

0.93

1.04

mg/l

0.98

1092

8468

Systemic lupus erythematosus

424

2621

1.90

24.45

2.4

1.7

1.55

1.02

mg/l

3.05

342

1987

Biomechanical lesions, not elsewhere classified

504

3235

1.78

24.39

1.9

1.7

1.32

1.23

mg/l

0.20

398

2492

Ulcerative colitis (strict definition, require KELA)

1722

13553

1.35

24.34

1.9

1.8

1.14

1.06

mg/l

0.51

1330

10103

Atrial septal defect

407

2456

1.89

24.34

3.2

2.5

1.23

1.26

mg/l

0.08

295

1837

In situ neoplasms

3594

30495

1.23

24.30

1.8

1.7

1.48

1.26

mg/l

1.62

2756

23380

Infective dermatitis

1135

8449

1.45

24.26

2.0

1.7

1.21

1.23

mg/l

0.07

893

6466

Other disorders of penis

837

5905

1.53

24.17

2.1

1.23

1.42

mg/l

0.71

631

4544

Acquired haemolytic anaemia

269

1464

2.23

24.10

4.0

1.7

3.11

1.34

mg/l

1.99

229

1142

Filling of root of tooth

353

2085

2.01

24.08

2.4

1.7

1.41

1.13

mg/l

0.76

289

1572

Crystal arthropathies, rheuma endpoint

196

948

2.54

24.07

1.8

1.6

1.27

1.41

mg/l

0.46

154

743

Gingival hyperplasia

336

1941

2.01

24.05

4.1

1.8

1.55

1.41

mg/l

0.33

259

1511

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1002

7293

1.47

24.03

1.6

1.96

1.49

mg/l

1.29

767

5682

Drug-induced cataract

281

1560

2.21

24.01

2.5

1.8

1.48

1.18

mg/l

0.78

219

1197

Acute and subacute iridocyclitis

1940

15519

1.32

24.01

1.9

1.8

1.11

1.14

mg/l

0.13

1524

11805

Tubulo-interstitial nephritis, not specified as acute or chronic

694

4749

1.60

24.00

2.0

1.7

1.22

1.19

mg/l

0.08

541

3565

Emotional disorders starting during childhood or adolecense, excluding more controls

435

2603

1.79

23.93

2.5

2.0

1.49

1.04

mg/l

0.57

269

1771

Other peripheral vascular diseases

791

5563

1.56

23.92

1.9

1.7

1.19

1.14

mg/l

0.14

591

4204

Spontaneous abortion

5192

30749

1.19

23.92

1.7

0.90

1.03

mg/l

3.58

3952

23102

Other congenital malformations of heart

100

361

3.98

23.90

6.6

3.4

1.68

1.17

mg/l

0.71

282

Thyroiditis

765

5372

1.58

23.88

1.8

1.7

0.84

1.08

mg/l

2.71

569

4068

Vitreous haemorrhage

941

6822

1.50

23.86

1.8

1.7

1.29

1.33

mg/l

0.11

761

5225

Other specified disorders of muscle

306

1722

2.07

23.85

2.3

1.7

0.88

1.13

mg/l

1.95

241

1288

Seborrhoeic keratosis

2085

16832

1.31

23.78

1.8

1.7

1.12

1.33

mg/l

3.05

1640

12998

Inflammatory diseases of the central nervous system

843

6012

1.54

23.72

1.8

1.19

1.10

mg/l

0.42

655

4510

Retinal vascular occlusion

1066

7884

1.46

23.63

1.9

1.7

1.46

1.49

mg/l

0.08

840

6137

Other and unspecified diseases of blood and blood-forming organs

284

1583

2.17

23.62

2.5

1.6

1.48

1.14

mg/l

1.09

238

1220

Small fibre neuropathy

298

1691

2.12

23.46

2.3

1.7

1.56

1.24

mg/l

0.36

239

1305

Other diseases of stomach and duodenum

607

4068

1.65

23.43

1.9

1.7

1.43

1.33

mg/l

0.30

472

3147

Other blood glucose lowering drugs, excl. Insulins

1588

12434

1.36

23.42

1.7

1.33

1.34

mg/l

0.03

1255

9574

Pyothorax

407

2495

1.86

23.41

2.0

1.7

1.59

1.35

mg/l

0.93

347

1940

Total colectomy

450

2840

1.82

23.40

2.8

1.7

1.68

1.11

mg/l

1.68

380

2128

Total colectomy operation

450

2840

1.82

23.40

2.8

1.7

1.68

1.11

mg/l

1.68

380

2128

Maternal care for known or suspected fetal abnormality and damage

1733

12197

1.34

23.39

1.8

1.7

0.95

0.81

mg/l

1.11

1297

8919

Other epidermal thickening

449

2827

1.81

23.38

2.2

1.7

1.05

1.20

mg/l

0.74

353

2153

Strabismus

2686

22232

1.26

23.36

1.9

1.14

mg/l

0.04

2031

16670

Other follicular disorders

746

5226

1.58

23.31

2.1

1.7

0.87

0.96

mg/l

0.66

566

3873

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1024

7539

1.46

23.18

1.7

1.68

1.30

mg/l

2.70

842

5810

Congenital malformations of aortic and mitral valves

414

2558

1.85

23.15

3.4

2.1

1.27

1.19

mg/l

0.22

292

1906

Postprocedural musculoskeletal disorders, not elsewhere classified

673

4640

1.61

23.07

1.9

1.8

1.37

1.27

mg/l

0.32

580

3601

Morphin

170

783

2.60

23.05

2.1

1.6

1.14

1.43

mg/l

0.93

140

616

Carbimazole or st.post thyroidectomy, condition for graves disease

2145

17457

1.30

22.99

2.6

1.7

1.00

1.06

mg/l

0.53

1632

13224

Dislocation, sprain and strain of joints and ligaments of thorax

362

2174

1.94

22.97

2.1

1.8

0.93

1.17

mg/l

1.49

263

1627

Dental caries 2, only avohilmo

8696

61798

1.14

22.94

1.8

1.01

1.09

mg/l

1.47

6214

46419

Toxic effects of substances chiefly nonmedicinal as to source

1131

8488

1.43

22.92

1.9

1.8

1.16

1.12

mg/l

0.16

828

6320

Acute myeloid leukaemia, helper endpoint

128

533

3.21

22.90

3.2

1.7

4.42

1.18

mg/l

2.44

115

400

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

128

533

3.21

22.90

3.2

1.7

4.42

1.18

mg/l

2.44

115

400

Septal defects

627

4161

1.63

22.88

2.8

2.5

1.22

1.20

mg/l

0.04

467

3105

Complex cardiac defects

357

4.08

22.85

6.3

3.5

1.81

0.98

mg/l

1.57

270

Pure hyperglyceridaemia

242

1287

2.25

22.84

2.0

1.7

1.04

1.31

mg/l

1.22

194

972

Correction of physiology of bite - demanding therapy visit

761

5383

1.57

22.84

2.1

1.8

0.87

0.98

mg/l

0.60

546

4026

Focal epilepsy, strict definition

1875

15009

1.32

22.83

2.1

1.9

1.23

1.22

mg/l

0.03

1440

11408

Arthropathic psoriasis

1134

8538

1.43

22.76

1.7

1.8

1.13

1.15

mg/l

0.06

904

6493

Other specified/unspecified inflammatory spondylopathies

508

3300

1.72

22.71

1.8

1.7

0.93

1.00

mg/l

0.28

385

2422

Peritonsillar abscess

2153

17489

1.29

22.70

1.9

1.8

1.05

1.11

mg/l

0.37

1610

13093

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

409

2531

1.84

22.68

2.0

1.7

1.90

1.33

mg/l

1.25

325

1963

Diffuse large B-cell lymphoma, helper endpoint

409

2531

1.84

22.68

2.0

1.7

1.90

1.33

mg/l

1.25

325

1963

Discitis, unspecified

179

858

2.58

22.64

3.2

1.6

1.36

1.48

mg/l

0.32

151

673

Residual foreign body in soft tissue

473

3019

1.74

22.51

1.6

1.7

0.92

1.13

mg/l

1.69

361

2224

Retinal vascular disorders

1076

8026

1.44

22.51

1.9

1.7

1.45

1.50

mg/l

0.12

847

6253

Idiopathic thrombocytopenic purpura

326

1916

2.00

22.38

2.4

1.9

1.87

1.24

mg/l

0.96

255

1457

Endometriosis ASRM stages 1,2

1951

15780

1.31

22.35

1.8

1.7

0.81

0.91

mg/l

1.22

1428

11813

Giant cell arteritis

401

2487

1.85

22.34

2.0

1.6

1.33

1.41

mg/l

0.19

323

1950

Erosion of teeth, including avohilmo

2033

15895

1.30

22.32

2.2

1.7

1.04

1.03

mg/l

0.05

1479

11813

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1569

12343

1.35

22.30

1.6

1.7

2.41

1.22

mg/l

16.80

1319

9477

Dissection of aorta

302

1723

2.01

22.27

2.9

1.6

3.34

1.40

mg/l

3.43

257

1329

Postprocedural disorders of digestive system, not elsewhere classified

344

2055

1.96

22.27

2.4

1.8

1.74

1.21

mg/l

0.83

276

1572

Asthma mixed form (mode)

500

3224

1.69

22.26

1.9

1.6

0.98

1.23

mg/l

1.50

380

2411

Chronic viral hepatitis

562

3763

1.67

22.10

2.0

1.8

1.44

0.93

mg/l

1.01

431

2717

Anterior Iridocyclitis

2033

16515

1.30

21.94

1.9

1.8

1.20

1.15

mg/l

0.24

1587

12561

Vitamin deficiency, wide

483

3133

1.73

21.94

2.2

1.7

1.23

1.18

mg/l

0.14

374

2385

Vitamin deficiency

483

3133

1.73

21.94

2.2

1.7

1.23

1.18

mg/l

0.14

374

2385

Burns and corrosions

1347

10417

1.38

21.91

1.9

1.13

1.14

mg/l

0.02

999

7780

Atrophic disorders of skin

1432

11194

1.37

21.83

1.9

1.7

1.08

1.13

mg/l

0.31

1095

8480

Causalgia

217

1143

2.37

21.79

2.0

1.7

0.86

1.03

mg/l

0.59

169

872

SLE, ICD10

402

2527

1.86

21.79

2.4

1.7

1.56

1.02

mg/l

2.90

324

1917

SLE, strict definition

402

2527

1.86

21.79

2.4

1.7

1.56

1.02

mg/l

2.90

324

1917

Viral hepatitis

761

5417

1.54

21.72

2.0

1.8

1.41

0.97

mg/l

1.18

585

3965

Drug-induced neutropenia

701

4930

1.58

21.71

2.2

1.8

2.06

1.18

mg/l

4.45

551

3798

Abdominal aortic aneurysm (AAA)

802

5648

1.50

21.71

1.9

1.6

3.74

1.64

mg/l

20.11

684

4425

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

901

6577

1.48

21.63

1.7

1.60

1.31

mg/l

1.62

735

5092

Other specified and unspecified disorders of eye and adnexa

418

2646

1.81

21.50

2.0

1.7

1.79

1.07

mg/l

0.81

310

2004

Acute generalized exanthematous pustulosis

470

3057

1.74

21.46

2.1

1.8

1.34

1.15

mg/l

0.79

374

2324

Focal epilepsy, mode (most common among epilepsy diagnosis)

1782

14288

1.31

21.45

1.9

1.24

1.22

mg/l

0.08

1374

10831

Carcinoma in situ of skin of other and unspecified parts of face

649

4484

1.58

21.40

1.7

1.6

1.99

1.49

mg/l

0.99

501

3516

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

615

4211

1.61

21.39

1.9

1.8

2.08

1.21

mg/l

3.58

499

3216

Systemic lupus erythematosus, unspecified

355

2177

1.93

21.34

2.5

1.7

1.43

0.97

mg/l

2.64

286

1643

Nonspecific lymphadenitis

629

4338

1.60

21.25

1.8

0.97

0.91

mg/l

0.27

473

3234

Nephrotic syndrome

335

2014

1.93

21.15

2.4

2.1

1.76

1.29

mg/l

1.65

289

1542

Congenital malformation of biliary tract

159

7.34

21.09

14.2

4.5

1.88

2.15

mg/l

0.08

129

Diabetic nephropathy

1460

11364

1.36

21.01

1.9

1.52

1.35

mg/l

0.92

1222

8933

Vulvovaginal ulceration/inflammation in other diseases

646

4505

1.59

20.95

1.9

1.8

0.63

0.88

mg/l

5.51

459

3309

Non-allergic asthma

867

6337

1.48

20.86

1.9

2.0

1.04

1.26

mg/l

1.78

680

4870

Inguinal hernia

6154

36788

1.16

20.77

1.9

1.8

1.33

1.25

mg/l

0.77

4722

27928

Other congenital malformations of peripheral vascular system

169

827

2.59

20.75

3.0

2.1

1.12

1.02

mg/l

0.20

127

633

Melanocytic naevi

2964

25094

1.23

20.67

2.1

1.7

1.15

1.12

mg/l

0.17

2235

18873

Lesion of lateral popliteal nerve

488

3218

1.70

20.66

2.2

1.7

1.22

1.15

mg/l

0.27

391

2434

Crushed, pushed or stepped on by crowd or human stampede

716

5074

1.53

20.61

2.1

2.0

1.35

0.97

mg/l

0.78

511

3612

Anogenital herpesviral [herpes simplex] infection

696

4936

1.56

20.59

1.9

1.7

0.73

0.86

mg/l

1.11

481

3591

Schizophrenia or delusion

3275

27938

1.22

20.57

1.8

1.24

1.07

mg/l

1.83

2445

20741

Other inflammatory liver diseases

652

4562

1.58

20.56

2.1

1.7

1.64

1.11

mg/l

3.50

525

3463

Other predominantly sexually transmitted diseases, not elsewhere classified

1832

14829

1.30

20.51

1.8

0.79

0.92

mg/l

2.19

1327

10842

Effects of foreign body entering through natural orifice

2341

19406

1.26

20.41

1.8

1.9

1.11

1.19

mg/l

0.51

1725

14595

Other secondary gonarthrosis

501

3331

1.68

20.40

1.8

1.35

1.30

mg/l

0.15

418

2556

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6440

46945

1.15

20.35

1.7

0.94

1.07

mg/l

3.86

4836

35588

Other disorders starting during childhood or adolecense, excluding more controls

426

2602

1.71

20.25

3.0

2.3

1.84

1.14

mg/l

0.88

292

1776

Tumor necrosis factor alpha inhibitors

1428

11253

1.35

20.25

1.9

1.8

1.09

0.98

mg/l

0.96

1084

8351

Tongue abnormality

602

4174

1.61

20.20

1.8

1.00

1.25

mg/l

1.69

439

3211

Seborrhoeic dermatitis

906

6706

1.46

20.20

2.0

1.7

1.13

1.27

mg/l

0.52

695

5103

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

313

1868

1.94

20.18

1.9

1.6

0.91

1.07

mg/l

0.41

241

1402

Visual field defects

793

5752

1.50

20.15

2.2

1.7

1.24

1.29

mg/l

0.15

597

4432

Spinal instabilities

308

1830

1.94

20.12

1.7

1.6

0.98

1.05

mg/l

0.22

236

1367

238

1312

2.14

20.10

2.1

1.6

1.30

1.46

mg/l

0.36

198

1017

Diabetic neuropathy

1036

7817

1.43

20.08

1.8

1.9

1.10

1.36

mg/l

3.70

830

6169

Schizophrenia, schizotypal and delusional disorders

3280

28044

1.21

20.04

1.8

1.23

1.07

mg/l

1.57

2445

20831

Prepatellar bursitis

417

2662

1.74

19.97

2.1

1.7

1.01

1.26

mg/l

1.91

328

2031

Drug-induced osteoporosis with pathological fracture

185

957

2.47

19.92

2.4

1.6

1.81

1.22

mg/l

0.86

155

757

Other and unspecified abdominal hernia

401

2556

1.78

19.86

1.9

1.7

1.11

1.27

mg/l

0.76

313

1986

Gluteal tendinitis

368

2297

1.82

19.79

1.6

1.7

0.85

1.10

mg/l

1.75

272

1748

Use of disulfiram, acamprosate or naltrexone

877

6491

1.46

19.79

1.8

1.7

1.27

1.08

mg/l

0.51

665

4885

Viral warts

984

7403

1.43

19.79

2.1

1.9

1.01

1.10

mg/l

0.60

722

5518

Complications of cardiac and vascular prosthetic devices, implants and grafts

205

1082

2.25

19.76

3.7

1.7

1.79

1.47

mg/l

0.93

179

850

Mental disorders, not otherwise specified

878

6504

1.46

19.71

2.0

1.8

0.83

0.95

mg/l

1.39

665

4763

Psoriatic arthropathies, ICD10

1047

7964

1.42

19.71

1.7

1.8

1.08

1.14

mg/l

0.31

828

6070

Failed induction of labour

637

4483

1.57

19.71

1.9

1.7

1.25

0.72

mg/l

5.55

504

3177

Vasculitis limited to skin, not elsewhere classified

278

1626

2.02

19.63

1.9

1.7

1.18

1.24

mg/l

0.24

232

1237

Exposure to other and unspecified inanimate mechanical forces

682

4849

1.54

19.61

2.0

1.8

1.02

1.11

mg/l

0.45

493

3593

Mucosal proctocolitis

1279

9977

1.36

19.59

2.1

1.8

1.28

1.05

mg/l

1.63

978

7406

Amyloidosis, other/unspecified

181

922

2.40

19.59

2.1

1.6

1.82

1.35

mg/l

0.39

141

705

Leisure time condition

1696

13675

1.31

19.58

1.9

1.8

1.26

1.21

mg/l

0.28

1293

10267

Urethritis and urethral syndrome

252

1429

2.08

19.56

2.0

1.7

0.83

1.17

mg/l

2.71

192

1069

Acute myeloid leukaemia and myelodysplastic syndromes

192

997

2.32

19.54

2.8

1.7

3.79

1.44

mg/l

2.57

167

783

Congenital malformations and deformations of the musculoskeletal system

865

6355

1.46

19.46

2.3

2.2

1.31

1.08

mg/l

0.57

636

4610

Gangrene, not elsewhere classified

308

3.60

19.46

2.3

1.6

1.39

1.41

mg/l

0.03

250

Sacroiliitis, not elsewhere classified

495

3308

1.65

19.43

1.8

1.7

1.01

0.95

mg/l

0.20

365

2397

Eosinophilic disease (BM)

162

789

2.47

19.42

2.0

1.6

1.40

1.19

mg/l

0.37

127

614

Other mental disorders due to brain damage and dysfunction and to physical disease

1010

7644

1.42

19.41

1.7

1.8

1.27

1.38

mg/l

0.61

786

5916

Abnormal serum enzyme levels

2631

21858

1.24

19.36

1.8

1.59

1.43

mg/l

0.86

2102

16999

Other Crohn's disease

718

5167

1.52

19.28

1.9

1.8

1.24

0.95

mg/l

1.69

520

3792

Leukaemia of unspecified cell type

109

457

3.16

19.26

6.7

1.7

3.72

1.14

mg/l

1.52

350

Recurring oral aphthae

472

3147

1.69

19.25

3.1

1.8

1.16

mg/l

0.01

362

2375

Benign neoplasm of mouth and pharynx

1046

7976

1.41

19.22

1.7

1.8

1.19

1.22

mg/l

0.14

800

6097

Mental and behavioural disorders due to use of other stimulants, including caffeine

313

1891

1.90

19.21

1.9

2.0

1.11

0.88

mg/l

1.10

227

1306

Type 1 diabetes, wide definition

2222

18400

1.26

19.20

1.8

1.03

1.12

mg/l

1.03

1693

13513

Other interventions on the root canals of the tooth

219

1206

2.21

19.16

2.8

1.8

1.24

1.00

mg/l

0.53

169

890

Specific development disorders of scholastic skills

408

2581

1.72

19.13

3.3

2.3

1.59

0.98

mg/l

0.71

272

1758

Other infective otitis externa

597

4169

1.58

19.10

1.7

1.14

mg/l

0.01

451

3165

Lesion of radial nerve

381

2422

1.78

19.10

1.9

1.7

1.47

1.12

mg/l

0.70

282

1821

Myositis

258

1477

2.02

19.07

2.0

1.7

1.34

1.33

mg/l

0.03

201

1121

Bursitis of shoulder

262

1510

2.01

19.05

1.8

1.6

0.90

1.14

mg/l

1.10

206

1138

Other symptoms and signs involving general sensations and perceptions

380

2411

1.78

19.05

1.8

1.09

1.26

mg/l

0.56

294

1816

Preterm labour and delivery

2720

23061

1.23

18.97

1.8

1.7

0.97

0.93

mg/l

0.24

2085

17399

Polycystic ovarian syndrome, broad definition

1229

9601

1.37

18.95

1.9

1.7

0.80

0.85

mg/l

0.42

944

6907

Early complications of trauma

424

2768

1.72

18.94

2.3

1.8

1.31

1.18

mg/l

0.31

324

2090

!Aliquae complicationes praecoces traumatis

424

2768

1.72

18.94

2.3

1.8

1.31

1.18

mg/l

0.31

324

2090

Intestinal malabsorption

467

3119

1.68

18.88

2.0

1.7

1.17

1.08

mg/l

0.29

352

2350

Mixed disorders of conduct and emotions, excluding more controls

223

1211

2.07

18.86

2.0

2.1

0.88

0.99

mg/l

0.37

154

798

Benign neoplasm: Skin of other and unspecified parts of face

997

7561

1.41

18.84

1.7

1.12

1.17

mg/l

0.26

742

5735

Nonsuppurative otitis media

2313

16624

1.25

18.84

2.2

1.9

1.14

mg/l

0.01

1687

11841

Viral infections of the central nervous system

735

5336

1.50

18.79

1.9

1.8

0.85

1.09

mg/l

1.99

533

3985

Benign neoplasm: Descending colon

610

4292

1.57

18.79

2.1

1.8

1.23

1.40

mg/l

0.61

502

3359

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1630

13128

1.30

18.76

1.8

1.7

1.82

1.29

mg/l

6.33

1333

10107

Other psoriatic arthropathies

1015

7743

1.41

18.74

1.7

1.8

1.09

1.13

mg/l

0.24

805

5906

Otitis media, unspecified

1068

7500

1.39

18.72

2.5

2.0

1.18

1.08

mg/l

0.27

759

5320

Presence of other devices

2018

16606

1.27

18.64

1.7

1.6

1.23

1.46

mg/l

3.22

1578

12866

Other abnormalities of plasma proteins

172

884

2.43

18.56

3.8

1.7

1.48

1.20

mg/l

0.81

143

690

Female infertility, tubal origin

530

3631

1.61

18.55

1.9

1.6

1.23

0.96

mg/l

0.37

394

2718

Acute myeloid leukaemia

128

590

2.84

18.46

3.2

1.8

4.42

1.31

mg/l

2.27

115

452

Hodgkin lymphoma

297

1793

1.91

18.40

1.9

1.8

1.95

1.03

mg/l

1.23

242

1312

Hepatomegaly and splenomegaly, not elsewhere classified

118

522

2.90

18.37

3.5

1.6

2.00

1.06

mg/l

1.07

101

395

ILD medications: nintedanib

297

3.88

18.37

2.5

1.5

1.54

1.17

mg/l

0.52

234

Contusion of other and unspecified parts of foot

510

3479

1.62

18.36

2.0

1.9

0.86

0.95

mg/l

0.27

365

2516

Lichen simplex chronicus and prurigo

614

4339

1.55

18.36

1.8

1.31

1.23

mg/l

0.17

484

3325

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

842

6287

1.46

18.29

2.2

1.7

0.80

0.73

mg/l

0.64

658

4641

Acute lymphadenitis

611

4313

1.55

18.29

1.9

1.8

0.90

0.99

mg/l

0.56

468

3199

Postmenopausal osteoporosis with pathological fracture

560

3908

1.59

18.28

2.0

1.8

1.35

1.37

mg/l

0.04

446

2993

Psoriasis vulgaris

1800

14723

1.28

18.26

1.8

1.15

1.19

mg/l

0.18

1405

11221

Hypertrophic cardiomyopathy

394

2558

1.74

18.19

5.7

1.8

1.36

1.32

mg/l

0.07

296

1985

Generalized skin eruption due to drugs and medicaments

408

2675

1.73

18.09

2.0

1.8

1.25

1.17

mg/l

0.27

330

2028

Fracture of forearm

5723

47899

1.15

18.07

1.7

1.8

1.27

1.19

mg/l

0.88

4366

36172

Ectopic pregnancy

1816

14904

1.28

18.06

1.7

0.97

0.96

mg/l

0.04

1360

11278

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

366

2328

1.76

18.01

2.0

1.8

1.85

1.29

mg/l

1.36

301

1787

Benign neoplasm: Small intestine

389

2530

1.75

17.94

2.2

1.6

1.16

1.31

mg/l

0.64

312

1965

Congenital malformations of pulmonary and tricuspid valves

410

3.19

17.93

5.5

3.7

1.45

1.13

mg/l

0.50

301

Myocardial infarction, with ST-elevation

1502

12042

1.31

17.92

2.2

1.7

1.61

1.52

mg/l

0.43

1223

9417

Benign neoplasm: Skin of eyelid, including canthus

1378

10971

1.33

17.91

1.7

1.20

1.16

mg/l

0.21

1048

8360

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

928

7050

1.43

17.90

1.9

1.7

0.96

0.93

mg/l

0.17

743

5286

Other and unspecified aplastic anaemias

136

649

2.67

17.85

2.9

1.7

1.32

1.17

mg/l

0.37

105

493

Event of undetermined intent

610

4324

1.54

17.85

2.1

1.8

1.03

mg/l

0.02

442

3176

Monoarthritis, not elsewhere classified

419

2757

1.68

17.73

2.1

1.8

1.03

1.18

mg/l

0.53

317

2054

Acute peritonitis

589

4152

1.55

17.71

2.3

1.8

1.92

1.24

mg/l

4.50

493

3192

Follow-up examination after treatment for malignant neoplasms

860

6415

1.42

17.64

1.7

1.6

1.64

1.46

mg/l

0.53

695

5011

Other strabismus

2189

18250

1.25

17.61

1.9

1.07

1.10

mg/l

0.13

1635

13579

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1297

10294

1.34

17.60

1.7

1.02

1.16

mg/l

0.84

1000

7879

Other disorders involving the immune mechanism, not elsewhere classified

318

1979

1.84

17.60

4.2

2.0

1.54

1.11

mg/l

1.62

266

1494

Acidosis

198

1077

2.18

17.54

2.1

1.7

1.73

1.34

mg/l

1.00

169

822

Temporal arteritis

349

2224

1.79

17.53

1.9

1.6

1.38

mg/l

0.01

279

1750

Pleural plaque

782

5769

1.45

17.53

1.6

1.29

1.68

mg/l

3.80

623

4531

Cyst of kidney

621

4439

1.53

17.49

1.9

1.7

1.25

1.40

mg/l

0.77

495

3473

Other specified congenital malformation syndromes affecting multiple systems

179

944

2.26

17.37

3.1

3.5

2.35

1.05

mg/l

2.01

135

710

Peroneal tendinitis

189

1023

2.24

17.36

2.0

1.7

1.04

0.99

mg/l

0.10

149

763

Hydrocele

948

7182

1.39

17.35

1.9

1.51

1.60

mg/l

0.22

720

5595

L04AC Interleukin inhibitors

504

3480

1.61

17.29

2.0

1.8

1.06

0.94

mg/l

0.67

388

2568

Single delivery by caesarean section

2089

10027

1.26

17.17

2.0

1.8

1.07

0.87

mg/l

2.28

1620

7232

Other and unspecified nonorganic psychotic disorders

1930

15978

1.26

17.15

1.9

1.8

1.17

0.98

mg/l

2.34

1409

11650

Simple and mucopurulent chronic bronchitis

371

2381

1.71

17.13

2.1

1.9

1.22

1.47

mg/l

0.62

281

1847

Thyrotoxicosis with diffuse goitre

1432

11527

1.31

17.10

2.1

1.7

0.96

1.05

mg/l

0.82

1072

8715

Bell's palsy

1111

8667

1.36

17.08

2.0

1.7

1.30

1.21

mg/l

0.19

846

6578

Cystic fibrosis with intestinal manifestations

10.78

17.05

5.0

1.5

1.34

0.72

mg/l

0.41

Melanocytic naevi of trunk

1101

8586

1.36

17.03

2.0

1.7

1.14

1.03

mg/l

0.52

813

6392

Other specified/unspecified necrotizing vasculopathies

163

847

2.38

17.02

2.0

1.7

1.53

1.19

mg/l

0.62

131

661

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

642

4647

1.52

17.02

1.8

1.7

2.12

1.06

mg/l

8.73

545

3523

Squamous cell neoplasms and carcinomas of the skin

1002

7700

1.38

17.01

1.6

1.96

1.58

mg/l

0.95

767

6043

Lack of expected normal physiological development

178

796

2.15

16.99

4.3

2.7

2.57

1.59

mg/l

0.75

138

517

Special screening examination for neoplasms

382

2473

1.69

16.97

1.8

1.7

2.36

1.32

mg/l

1.76

296

1924

Dronedarone medication

268

1605

1.91

16.95

1.8

1.6

0.86

1.46

mg/l

4.07

169

1289

Diffuse large B-cell lymphoma

409

2718

1.69

16.94

2.0

1.7

1.90

1.39

mg/l

1.09

325

2106

Visual impairment including blindness (binocular or monocular)

605

4313

1.52

16.93

1.9

1.7

1.29

1.36

mg/l

0.21

442

3280

Benign neoplasm: Rectosigmoid junction

359

2314

1.74

16.88

1.8

1.7

1.32

mg/l

0.01

290

1802

Exclusion endpoint for clefts

211

1184

2.08

16.83

2.8

3.2

2.18

1.04

mg/l

2.08

159

874

Early lumbar disc prolapse operation

1120

8776

1.36

16.82

1.8

0.71

0.84

mg/l

1.44

816

6452

Leiomyoma of uterus

7134

36756

1.13

16.82

1.7

1.04

mg/l

0.04

5379

28103

Disorders of speech understanding and production

368

2329

1.71

16.78

3.2

2.7

1.76

1.35

mg/l

0.81

281

1641

Ingrowing nail

544

3827

1.56

16.77

2.0

1.8

1.13

1.12

mg/l

0.03

410

2840

Maltreatment syndromes

533

3730

1.57

16.76

1.8

1.9

1.19

0.92

mg/l

0.37

384

2680

Sleep disorders, other/unspecified

356

2302

1.75

16.75

1.9

0.79

1.00

mg/l

1.24

248

1675

Disorders of optic nerve and visual pathways

930

7120

1.40

16.74

2.0

1.8

1.33

1.10

mg/l

0.51

703

5327

Haemangioma and lymphangioma, any site

836

6301

1.43

16.69

1.9

1.8

1.27

1.07

mg/l

0.75

640

4685

Amyloidosis

202

1122

2.11

16.69

2.1

1.6

1.88

1.33

mg/l

0.55

155

862

Other congenital malformations of the digestive system

416

2753

1.66

16.68

4.5

2.4

1.68

1.27

mg/l

0.82

303

2048

Other disorders of optic [2nd] nerve and visual pathways

599

4290

1.53

16.67

2.1

1.8

1.64

1.21

mg/l

0.66

460

3223

Unspecified chronic bronchitis

320

1996

1.76

16.63

2.5

1.6

1.02

1.34

mg/l

1.65

237

1546

Other and unspecified injuries of shoulder and upper arm

314

1977

1.81

16.60

1.9

1.8

1.12

mg/l

0.01

239

1492

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2394

19590

1.23

16.55

1.7

1.90

1.27

mg/l

10.03

1963

15099

Other other unspecified disorders of the circulatory system

360

2341

1.74

16.51

2.2

1.8

1.31

1.23

mg/l

0.20

278

1815

Cardiomyopathy in other diseases

250

3.92

16.45

2.2

1.9

0.85

1.51

mg/l

2.44

205

Nummular dermatitis

749

5569

1.45

16.40

1.9

1.8

1.17

1.28

mg/l

0.42

553

4271

Cerebral aneurysm, nonruptured

825

6235

1.43

16.35

1.9

1.7

1.13

1.23

mg/l

0.46

657

4796

Corns and callosities

658

4804

1.49

16.34

1.7

1.8

1.25

1.24

mg/l

0.03

489

3675

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

248

1468

1.93

16.31

1.8

1.6

1.90

1.28

mg/l

1.00

206

1136

Chronic lymphocytic leukaemia, helper endpoint

248

1468

1.93

16.31

1.8

1.6

1.90

1.28

mg/l

1.00

206

1136

Haemangioma, any site

779

5833

1.44

16.30

1.9

1.8

1.29

1.07

mg/l

0.83

598

4342

Parodontitis or/and operation codes

7449

40282

1.13

16.30

1.9

1.8

1.19

1.06

mg/l

2.49

5669

30168

Secondary uncertain malignant neoplasm

1102

8637

1.35

16.26

1.9

1.7

2.04

1.35

mg/l

3.18

888

6688

Infection of intervertebral disc (pyogenic)

132

641

2.52

16.23

1.9

1.7

2.05

1.51

mg/l

0.60

114

504

Leukaemia of unspecified cell type

109

496

2.87

16.21

6.7

1.7

3.72

1.34

mg/l

1.34

388

Giant cell arteritis with polymyalgia rheumatica

349

2267

1.75

16.21

1.9

1.6

1.38

1.30

mg/l

0.16

279

1774

Scleritis and episcleritis

621

4507

1.51

16.20

2.0

1.7

0.86

0.99

mg/l

1.03

492

3373

Other and unspecified vascular occlusions

793

5951

1.43

16.14

1.8

1.7

1.52

1.44

mg/l

0.20

624

4613

Ovarian dysfunction

811

6132

1.43

16.11

2.0

1.7

0.74

0.84

mg/l

1.00

600

4441

Benign neoplasm: Duodenum

244

1453

1.95

16.08

2.0

1.6

1.26

1.23

mg/l

0.07

191

1123

Other and unspecified injuries of ankle and foot

420

2833

1.64

16.03

1.8

0.73

1.02

mg/l

4.79

303

2057

Foreign body in alimentary tract

515

3615

1.56

16.01

1.8

1.9

1.27

mg/l

0.01

379

2721

Other/unspecified rheumatoid arthritis

1173

9299

1.34

15.98

1.9

1.7

1.45

1.28

mg/l

1.16

938

7141

Nonhereditary hypogammaglobulinemia

136

683

2.56

15.94

2.9

1.7

1.47

1.10

mg/l

0.30

116

527

Cystic fibrosis with pulmonary manifestations

11.67

15.94

5.5

1.3

0.67

0.69

mg/l

0.06

Deep endometriosis

1009

7883

1.38

15.92

1.7

0.94

1.02

mg/l

0.43

749

5871

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

512

3581

1.55

15.90

1.7

1.8

2.29

1.39

mg/l

2.30

430

2791

Outcome of delivery

1859

9522

1.27

15.89

1.7

0.92

0.76

mg/l

1.33

1366

6867

D07AA Corticosteroids, weak (group I)

1530

12473

1.29

15.83

1.9

2.0

1.17

1.09

mg/l

0.31

1141

9203

Poisoning by narcotics and psychodysleptics [hallucinogens]

183

1006

2.16

15.81

1.8

1.53

0.91

mg/l

1.09

127

710

Respiratory conditions due to other external agents

209

1200

2.06

15.80

2.7

1.6

1.58

1.30

mg/l

0.58

170

937

Other and/or unspecified nontoxic goitre

801

6061

1.43

15.80

1.9

1.7

1.07

1.15

mg/l

0.36

627

4672

Other erythematous conditions

352

2304

1.73

15.79

2.1

1.7

1.30

1.15

mg/l

0.31

262

1756

Spirochaetal infections, other/unspecified

780

5885

1.43

15.74

1.7

1.8

1.11

1.17

mg/l

0.19

573

4527

Post-traumatic wound infection, not elsewhere classified

267

1639

1.88

15.71

1.9

1.7

1.04

1.15

mg/l

0.46

203

1242

Carcinoma in situ of skin of other and unspecified parts of face

649

4749

1.48

15.71

1.7

1.6

1.99

1.52

mg/l

0.90

501

3726

Emotional disorders and disorders of social functioning with onset specific to childhood

477

3244

1.56

15.69

2.6

2.2

1.27

0.97

mg/l

0.41

298

2186

Glaucoma

5370

42307

1.14

15.68

1.7

1.37

1.36

mg/l

0.13

4135

32854

Other and specified injuries of hip and thigh

225

1318

1.98

15.68

2.0

1.7

1.69

1.25

mg/l

0.51

175

998

Correction of physiology of bite - very demanding therapy visit

322

2079

1.78

15.66

2.0

1.7

0.80

0.95

mg/l

0.79

221

1565

Disease of hard tissues of teeth, NOS

135

677

2.51

15.66

4.0

1.7

0.86

1.13

mg/l

1.11

531

Unspecified lump in breast

1584

13029

1.28

15.65

1.8

1.7

1.01

1.07

mg/l

0.45

1208

9918

Specific development disorders of speech and language

506

3397

1.54

15.61

3.1

2.5

1.53

1.24

mg/l

0.80

384

2364

Sequelae of injuries of upper limb

934

7222

1.38

15.58

1.7

1.8

0.96

1.12

mg/l

1.04

710

5450

Other keratitis

1070

8416

1.35

15.55

2.0

1.8

1.06

1.11

mg/l

0.24

787

6305

Other inflammation of vagina/vulva

413

2813

1.65

15.53

1.8

1.7

0.86

0.87

mg/l

0.02

299

2089

191

1059

2.06

15.51

2.2

1.20

0.84

mg/l

0.88

139

686

Polyarthritis, unspecified

349

2276

1.70

15.51

2.0

1.9

1.35

1.21

mg/l

0.40

291

1727

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

291

1831

1.81

15.45

4.4

1.9

1.56

1.10

mg/l

1.54

243

1381

Carcinoma in situ of skin of upper limb, including shoulder

200

1136

2.05

15.43

1.7

1.6

2.48

1.45

mg/l

0.72

160

888

Other disorders of the genitourinary system

1190

9505

1.33

15.42

1.8

1.7

1.11

1.23

mg/l

1.01

935

7298

Cholangitis (primary sclerosing, PSC), with reimbursement 202

200

1142

2.07

15.41

3.7

2.1

1.84

1.18

mg/l

1.33

168

862

L01XE Protein kinase inhibitors

527

3753

1.55

15.40

2.2

1.8

2.31

1.31

mg/l

3.23

456

2907

Subacute thyroiditis

383

2570

1.68

15.39

1.6

1.7

0.71

1.04

mg/l

4.29

286

1964

Postzoster neuralgia

160

854

2.28

15.36

2.1

1.7

1.18

1.34

mg/l

0.42

133

671

Infarction of spleen

342

3.45

15.34

2.7

1.8

1.99

1.55

mg/l

0.62

277

Hereditary factor VIII deficiency

143

5.35

15.32

8.0

2.5

0.78

0.84

mg/l

0.13

115

Congenital malformations of great arteries

208

1172

2.01

15.30

4.6

3.4

1.93

1.54

mg/l

0.50

146

881

Vitamin D deficiency

200

1145

2.07

15.29

2.3

1.8

1.17

1.02

mg/l

0.34

153

841

Agoraphobia

333

2160

1.72

15.24

2.0

1.7

0.94

0.90

mg/l

0.10

220

1559

Erythema nodosum

323

2095

1.76

15.24

2.0

1.6

1.11

1.05

mg/l

0.16

251

1597

Acute nasopharyngitis (common cold)

1134

8929

1.33

15.21

1.8

0.94

1.08

mg/l

1.11

864

6725

Benign neoplasm of eye and adnexa

877

6747

1.39

15.15

1.9

1.7

1.04

1.13

mg/l

0.63

659

5133

Contusion of ankle

388

2607

1.65

15.14

2.1

1.8

1.05

1.00

mg/l

0.12

277

1909

Other and unspecified trigeminal disorders

181

1012

2.15

15.09

2.1

1.6

0.71

1.16

mg/l

4.04

130

773

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

312

2011

1.77

15.07

1.9

1.7

0.84

1.01

mg/l

0.98

232

1499

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

187

1054

2.10

14.98

2.7

2.3

2.21

1.02

mg/l

0.78

134

791

Other and unspecified vasculitis limited to skin

244

1485

1.91

14.98

1.9

1.7

1.20

1.24

mg/l

0.13

204

1127

Biological medicines for asthma

160

866

2.27

14.96

2.0

1.7

0.76

1.04

mg/l

0.83

122

646

Ménière disease

888

6862

1.38

14.96

1.9

1.8

1.14

1.28

mg/l

0.56

673

5286

Impotence

455

3154

1.57

14.93

2.1

1.8

1.61

1.45

mg/l

0.36

354

2477

Hidradenitis suppurativa

390

2643

1.66

14.92

1.8

1.7

0.78

0.91

mg/l

0.64

292

1962

Bicuspidal aortic valve syndrome

345

2272

1.70

14.92

3.0

2.0

1.24

1.12

mg/l

0.32

245

1710

Kela reimbursement Agammaglobulinemia (D80-84)

113

545

2.72

14.85

2.9

1.8

1.04

0.94

mg/l

0.22

401

Pneumonia due to Streptococcus pneumoniae

385

2588

1.63

14.73

2.1

1.7

1.43

1.19

mg/l

1.05

310

1913

Other maltreatment syndromes

328

2142

1.72

14.71

1.9

1.7

1.03

0.95

mg/l

0.32

237

1568

Lesion of plantar nerve

598

4382

1.49

14.69

1.7

0.93

1.18

mg/l

2.10

452

3370

Attention to artificial openings

333

2173

1.69

14.67

3.0

1.8

1.92

1.37

mg/l

1.63

276

1678

Other encephalitis

286

1819

1.80

14.67

2.1

1.9

1.02

1.16

mg/l

0.36

226

1364

Varicose veins of other sites

576

4174

1.49

14.64

1.9

1.8

1.21

1.17

mg/l

0.14

420

3106

Other and unspecified erythematous conditions

315

2048

1.75

14.64

2.1

1.7

1.37

1.18

mg/l

0.38

234

1557

Lactose intolerance

319

2073

1.73

14.61

1.9

1.8

1.78

1.06

mg/l

1.03

232

1538

Acute bronchiolitis

493

3101

1.52

14.57

3.1

2.8

1.43

1.30

mg/l

0.18

340

2138

Hordeolum and other deep inflammation of eyelid

537

3867

1.52

14.56

2.0

1.8

0.88

1.11

mg/l

2.01

398

2880

Other diseases of peritoneum

449

3139

1.58

14.55

2.1

1.6

1.15

1.12

mg/l

0.10

319

2401

Viral meningitis

389

2647

1.64

14.55

2.1

1.8

0.79

1.03

mg/l

0.93

271

1969

Coeliac disease

1176

9431

1.32

14.54

1.8

1.13

1.12

mg/l

0.04

902

7089

Polyarteritis nodosa and related conditions

158

855

2.22

14.52

1.9

1.8

1.23

1.19

mg/l

0.08

128

666

Carcinoma in situ of skin of trunk

244

1484

1.86

14.50

1.7

1.6

1.44

1.36

mg/l

0.25

187

1149

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

391

2659

1.63

14.45

1.7

1.6

1.82

1.31

mg/l

1.50

329

2050

Other and unspecified mononeuropathies, also in other diseases

299

1922

1.76

14.44

1.7

0.86

1.23

mg/l

3.95

218

1466

Abnormal findings in secretions and smears from cervix uteri vagina vulva

5423

38464

1.14

14.41

1.7

0.85

0.97

mg/l

3.37

4038

28921

Hodgkin lymphoma, hilmo

297

1912

1.77

14.41

1.9

1.8

1.95

1.12

mg/l

1.05

242

1426

Symptoms and signs involving emotional state

303

1953

1.74

14.40

2.2

1.9

1.01

1.06

mg/l

0.09

231

1465

Supervision of normal pregnancy

2447

11943

1.22

14.38

1.6

1.7

0.72

0.79

mg/l

0.89

1820

8720

Benign neoplasm: Skin of other and unspecified parts of face

997

7857

1.35

14.31

1.7

1.8

1.12

1.28

mg/l

1.20

742

6047

Other/unspecified disorders of vestibular function

371

2510

1.65

14.24

2.0

1.6

1.13

1.21

mg/l

0.27

284

1938

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

177

987

2.05

14.22

1.8

1.30

1.00

mg/l

0.85

135

703

Other ulcerative colitis

575

4205

1.49

14.22

1.8

1.15

0.99

mg/l

0.77

445

3117

Other diseases of gallbladder

418

2887

1.59

14.20

2.2

1.7

1.06

1.27

mg/l

1.01

327

2225

Behavioural disorders, excluding more controls

206

1198

1.93

14.16

2.4

1.8

0.84

0.85

mg/l

0.04

151

839

Cauda equina syndrome

153

833

2.26

14.12

2.0

1.6

0.91

1.14

mg/l

0.41

121

647

Other otitis externa (chronic)

615

4554

1.46

14.07

2.1

1.8

1.13

1.18

mg/l

0.12

435

3467

TMD muscular pain linked with fibromyalgia

121

612

2.55

14.05

2.6

1.7

0.70

0.77

mg/l

0.15

469

Ankle and foot

109

528

2.66

14.04

1.5

1.7

0.91

1.05

mg/l

0.38

407

Testicular dysfunction

339

2253

1.68

14.02

2.1

1.9

0.90

1.16

mg/l

0.91

254

1656

Haemophagocytic lymphohistiocytosis

10.12

14.02

9.3

1.8

4.33

1.32

mg/l

1.48

Other overlap syndromes

208

1240

1.98

14.00

1.9

1.6

1.14

1.06

mg/l

0.18

183

956

Intracerebral haemorrhage

1028

8123

1.33

14.00

2.5

1.6

1.61

1.51

mg/l

0.42

844

6308

Pneumonitis due to solids and liquids

657

4890

1.43

13.97

1.9

1.7

1.71

1.42

mg/l

1.06

542

3775

Bulimia nervosa (incl. atypical)

384

2626

1.63

13.97

2.0

1.7

1.02

0.81

mg/l

0.29

263

1878

Bruxism

223

1358

1.94

13.94

2.1

1.8

0.70

0.91

mg/l

1.08

155

1030

Alcohol-induced chronic pancreatitis

588

4326

1.47

13.93

1.7

1.8

1.46

1.24

mg/l

0.85

460

3343

Need for immunization against other single viral diseases

216

1301

1.95

13.93

2.4

1.8

1.34

1.13

mg/l

0.56

163

998

Intentional self-harm by unspecified means

141

745

2.29

13.92

2.2

1.9

0.69

0.87

mg/l

0.96

102

524

Encephalitis

301

1961

1.74

13.91

2.0

1.8

1.05

1.14

mg/l

0.21

234

1455

Astigmatism

564

4114

1.48

13.89

2.4

2.2

1.05

1.21

mg/l

0.45

410

3044

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

568

4130

1.47

13.88

2.0

1.6

1.59

1.51

mg/l

0.17

435

3193

Examination and encounter for administrative purposes

364

2445

1.62

13.86

1.6

1.13

1.35

mg/l

0.94

281

1893

Hirsutism in women

228

1399

1.92

13.82

1.8

1.7

0.65

0.75

mg/l

0.52

165

1023

Campylobacter enteritis

281

1805

1.77

13.82

1.9

1.7

0.91

1.10

mg/l

0.94

225

1356

Hypertrichosis

255

1608

1.84

13.80

1.8

0.66

0.77

mg/l

0.61

184

1178

Heterophoria

781

5999

1.39

13.80

1.9

2.0

0.91

1.10

mg/l

1.51

577

4458

Injuries involving multiple body regions

376

2565

1.63

13.79

1.9

1.7

1.10

1.03

mg/l

0.21

288

1909

Shock, not elsewhere classified

100

463

2.63

13.78

8.4

1.6

3.07

1.33

mg/l

1.69

359

Polycystic ovarian syndrome

597

4425

1.47

13.69

2.0

1.7

0.67

0.82

mg/l

2.32

442

3176

Erythema intertrigo

237

1466

1.87

13.66

2.1

1.7

1.09

1.13

mg/l

0.11

181

1139

Lichen ruber planus, wide definition including periferal and oral lichen planus

1960

16635

1.23

13.66

1.7

1.10

1.21

mg/l

1.28

1491

12773

Disorders of synovium and tendon in diseases classified elsewhere

207

1230

1.93

13.65

1.9

1.6

1.07

1.24

mg/l

0.48

156

926

Vestibular neuronitis

812

6283

1.38

13.62

1.8

1.7

0.95

1.24

mg/l

2.40

592

4836

Iron deficiency

230

1412

1.88

13.62

2.7

1.8

1.00

0.89

mg/l

0.37

171

1015

Ulcerative colitis (strict definition, all Crohn cases excluded)

1391

11430

1.28

13.61

1.9

1.8

1.07

mg/l

0.03

1082

8522

Torsion of ovary, ovarian pedicle and fallopian tube

247

1540

1.83

13.60

1.7

1.6

0.95

0.91

mg/l

0.10

190

1131

Disorder of external ear, unspecified

316

2091

1.71

13.59

1.6

1.7

1.03

1.15

mg/l

0.46

243

1585

Vasomotor rhinitis (mode)

700

5316

1.42

13.56

1.6

1.8

0.96

1.14

mg/l

0.91

517

4050

Complications of other internal prosthetic devices, implants and grafts

358

2424

1.64

13.54

2.2

1.7

1.13

1.27

mg/l

0.62

283

1829

Rosacea

1087

8725

1.32

13.53

1.8

1.7

0.97

1.08

mg/l

0.96

801

6666

Postpartum care and examination

1533

8068

1.27

13.50

2.1

1.6

1.06

0.75

mg/l

3.07

1144

5705

Dislocation, sprain and strain of joints and ligaments of head

412

2869

1.58

13.47

1.9

0.85

0.97

mg/l

0.70

305

2131

Secondary thrombocytopenia

137

729

2.31

13.47

4.4

1.8

4.20

1.20

mg/l

2.18

120

574

Cystic fibrosis, other manifestations/unspecified

104

7.49

13.45

4.9

1.6

1.47

0.93

mg/l

0.32

Acute lymphocytic leukaemia, helper endpoint

357

2.98

13.43

11.8

2.0

1.79

0.88

mg/l

1.39

258

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

357

2.98

13.43

11.8

2.0

1.79

0.88

mg/l

1.39

258

Ankylosing spondylitis, ICD10

874

6842

1.36

13.40

1.9

1.7

1.00

1.08

mg/l

0.44

655

5113

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

105

508

2.60

13.38

2.2

1.6

3.31

1.10

mg/l

0.70

390

Somnolence

150

822

2.20

13.38

2.1

1.9

1.05

1.04

mg/l

0.01

111

614

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

721

5502

1.41

13.37

1.9

1.8

1.04

1.06

mg/l

0.07

552

4137

Postviral fatigue syndrome

107

526

2.62

13.34

2.2

1.8

0.33

0.61

mg/l

9.23

383

Episcleritis

528

3860

1.50

13.30

2.0

1.7

0.86

0.96

mg/l

0.71

419

2891

Bitten or struck by other mammals

1071

8594

1.32

13.30

1.9

1.8

1.01

0.99

mg/l

0.08

770

6360

Other and unspecified epidermal thickening

271

1740

1.77

13.30

2.2

1.7

1.07

1.14

mg/l

0.17

205

1314

Other articular cartilage disorders

243

1516

1.81

13.27

1.7

0.93

1.28

mg/l

2.38

196

1156

Tibial collateral bursitis [Pellegrini-Stieda]

128

667

2.34

13.24

1.7

1.6

1.59

1.21

mg/l

0.20

517

Abnormal findings on examination of urine, without diagnosis

407

2839

1.58

13.21

1.9

1.8

1.60

1.24

mg/l

1.07

333

2144

Schizoaffective disorder

761

5863

1.39

13.21

1.9

1.8

1.09

0.96

mg/l

0.81

555

4335

Sequelae of injuries of neck and trunk

297

1949

1.71

13.20

2.0

1.8

1.18

1.09

mg/l

0.27

225

1477

Exposure to other and unspecified animate mechanical forces

303

2001

1.71

13.16

1.8

1.23

0.98

mg/l

0.34

223

1469

Abnormal findings in nipple discharge synovial fluid wound secretions

179

1045

2.06

13.14

2.1

1.8

1.31

1.10

mg/l

0.31

141

806

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

176

1018

2.05

13.11

1.9

1.6

2.31

1.14

mg/l

3.05

152

791

Other surgical follow-up care

328

2198

1.66

13.11

1.8

0.98

1.02

mg/l

0.13

255

1634

Other deformities of toe(s)

323

2153

1.66

13.07

1.6

1.8

1.03

1.19

mg/l

0.61

234

1612

Testicular hypofunction

302

1991

1.70

13.04

2.1

1.8

0.90

1.13

mg/l

0.69

226

1471

Other spirochaetal diseases

2408

20844

1.20

13.03

1.7

1.04

1.19

mg/l

1.47

1767

15942

Bacterial, viral and other infectious agents

836

6528

1.36

13.03

2.3

1.9

1.06

1.02

mg/l

0.19

636

4901

Multiple myeloma

232

1442

1.84

12.99

2.9

1.6

1.43

1.34

mg/l

0.17

191

1140

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

232

1442

1.84

12.99

2.9

1.6

1.43

1.34

mg/l

0.17

191

1140

Cardiomyopathy, Hypertrophic obstructive

176

1011

2.00

12.98

7.2

1.6

1.40

1.33

mg/l

0.08

136

804

Congenital malformations of trachea and bronchus

112

565

2.51

12.98

3.7

2.2

1.33

1.22

mg/l

0.11

445

Habitual aborter

228

1410

1.84

12.95

2.0

1.6

0.70

0.79

mg/l

0.45

186

1015

Dislocation, sprain and strain of joint and ligaments of hip

332

2237

1.65

12.92

1.9

1.7

1.38

1.24

mg/l

0.50

277

1707

Abrasion of teeth

2749

17616

1.19

12.91

1.7

1.6

0.99

1.07

mg/l

1.14

2004

13387

Lichen planus

1171

9528

1.30

12.86

1.7

1.18

1.28

mg/l

0.53

895

7324

Enteropathic arthropathies

240

1508

1.81

12.85

1.8

1.7

0.88

1.08

mg/l

0.93

192

1097

Cystic fibrosis

152

5.06

12.85

4.4

1.6

1.29

0.93

mg/l

0.26

105

Lichen planus, including avohilmo

1673

14087

1.24

12.84

1.7

1.12

1.23

mg/l

1.08

1273

10822

severe traumatic brain injury, does not include concussion

1876

15910

1.22

12.81

1.7

1.70

1.40

mg/l

2.07

1429

12243

Autoimmune hyperthyroidism

619

4656

1.43

12.80

1.9

1.7

0.92

0.98

mg/l

0.35

444

3528

Aneurysms, operations, SAH

1483

12340

1.26

12.78

1.9

1.7

1.34

1.27

mg/l

0.36

1181

9538

Fluid overload

162

4.65

12.77

2.5

1.6

1.22

1.53

mg/l

0.54

125

Other immunodeficiencies

131

700

2.30

12.76

2.8

2.1

0.86

1.13

mg/l

0.87

116

527

Allergic purpura

309

2060

1.68

12.74

2.0

1.8

1.02

1.05

mg/l

0.08

234

1527

Benign lipomatous neoplasm of other sites/unspecified

765

5915

1.38

12.72

1.6

1.7

1.28

1.22

mg/l

0.16

601

4489

Congenital malformations of the musculoskeletal system, not elsewhere classified

171

993

2.06

12.72

2.9

2.1

1.42

0.75

mg/l

0.69

126

737

Endometriosis diagnosis and infertility diagnosis occurring together

1115

9056

1.31

12.63

1.8

1.7

0.85

0.83

mg/l

0.09

841

6709

Follicular lymphoma

362

2490

1.60

12.63

2.0

1.8

1.27

1.26

mg/l

0.01

296

1911

Burns and corrosions of external body surface, specified by site

992

7928

1.32

12.62

1.9

1.26

1.15

mg/l

0.25

735

5917

Hypertrophic disorders of skin

576

4299

1.45

12.59

1.9

1.7

0.92

0.99

mg/l

0.26

427

3172

Other and unspecified paralytic syndromes

157

890

2.10

12.57

2.7

1.8

0.92

1.16

mg/l

0.75

130

676

Osteonecrosis due to drugs

136

742

2.26

12.54

3.0

1.8

1.21

1.31

mg/l

0.25

113

581

Uterine polyps

895

7076

1.34

12.53

1.7

1.6

1.06

1.14

mg/l

0.44

684

5438

Other and unspecified disorders of skin and subcutaneous tissue

594

4453

1.44

12.52

1.7

1.8

0.99

1.21

mg/l

1.89

416

3409

Unspecified jaundice

405

2832

1.54

12.51

2.4

1.7

1.70

1.30

mg/l

1.56

317

2179

Other disorders of amniotic fluid and membranes

1396

11478

1.26

12.50

1.7

0.80

0.82

mg/l

0.12

1052

8401

therapeutic use

282

1855

1.72

12.49

2.0

1.7

1.64

1.29

mg/l

0.65

217

1435

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1233

9486

1.28

12.48

1.6

1.7

1.85

1.34

mg/l

3.28

1036

7354

Etanercept

614

4636

1.43

12.46

1.9

1.8

1.17

0.99

mg/l

0.86

474

3449

6-mercaptopurine

295

1950

1.67

12.43

3.9

1.8

1.18

0.96

mg/l

0.52

221

1403

Other and unspecified injuries of wrist and hand

376

2619

1.58

12.42

1.7

1.8

0.78

1.07

mg/l

3.12

259

1946

Wegener granulomatosis

170

990

2.03

12.42

2.6

1.7

1.99

1.26

mg/l

1.56

146

775

Benign neoplasm of meninges

872

6887

1.34

12.42

1.9

1.7

1.46

1.12

mg/l

0.79

672

5256

Benign neoplasm: Pancreas

236

1492

1.80

12.41

2.0

1.6

1.53

1.26

mg/l

0.48

184

1161

Retinal haemorrhage

229

1436

1.82

12.41

2.0

1.7

1.35

1.27

mg/l

0.08

183

1120

Benign neoplasm: Liver

228

1434

1.83

12.39

2.2

1.7

1.05

0.91

mg/l

0.35

179

1061

Adalimumab

861

6795

1.35

12.39

1.9

1.07

0.98

mg/l

0.65

657

5003

Endometriosis of intestine

184

1093

1.96

12.36

1.9

1.6

0.80

0.85

mg/l

0.13

136

786

Intercostal neuropathy

100

494

2.61

12.35

1.8

1.7

0.99

1.39

mg/l

1.43

382

Benign neoplasm: Liver/bile ducts

248

1591

1.78

12.34

2.1

1.7

1.02

0.96

mg/l

0.15

195

1180

Lyme disease

2369

20570

1.19

12.33

1.7

1.8

1.05

1.19

mg/l

1.41

1737

15746

Other and unspecified mononeuropathies of upper limb

307

2062

1.67

12.29

1.8

1.7

1.46

1.07

mg/l

0.44

230

1538

Benign neoplasm of ovary

1633

13779

1.24

12.28

1.7

1.06

1.01

mg/l

0.36

1280

10464

Benign neoplasm of middle ear and respiratory system

671

5121

1.39

12.26

1.9

1.8

1.28

1.18

mg/l

0.32

538

3914

Degenerative macular diseases

1030

8296

1.31

12.25

1.8

1.7

1.51

1.42

mg/l

0.28

805

6440

Benign neoplasm: Cerebral meninges

790

6178

1.36

12.21

1.9

1.7

1.50

1.11

mg/l

0.84

608

4712

Other and unspecified rosacea

800

6278

1.36

12.18

1.8

1.7

0.96

1.10

mg/l

1.03

599

4802

Infective bursitis

247

1575

1.74

12.12

1.9

1.7

1.19

1.39

mg/l

0.73

195

1218

Carcinoma in situ of skin

631

4789

1.41

12.11

1.8

1.7

1.62

1.36

mg/l

1.12

488

3718

Contusion of toe(s) without damage to nail

253

1636

1.75

12.07

2.0

1.9

0.82

0.96

mg/l

0.66

190

1198

Superficial injury of neck

211

1308

1.85

12.02

2.1

1.8

1.12

1.01

mg/l

0.14

149

957

Antepartum haemorrhage, not elsewhere classified

893

7110

1.33

12.01

1.8

1.7

0.89

0.77

mg/l

0.73

664

5276

Benign intracranial hypertension

122

652

2.32

12.01

2.2

1.7

0.73

0.81

mg/l

0.22

460

Other bursitis, not elsewhere classified

107

539

2.39

12.00

1.8

1.6

1.17

1.27

mg/l

0.10

418

Drug-induced osteoporosis

134

738

2.22

12.00

3.2

1.7

1.72

1.17

mg/l

0.93

112

575

Selective deficiency of immunoglobulin G [IgG] subclasses

468

2.67

11.98

2.9

2.0

1.40

1.08

mg/l

0.42

357

Operations for atrial fibrillation

159

921

2.07

11.98

2.4

1.7

1.92

1.34

mg/l

1.06

123

724

Acute lymphocytic leukaemia

377

2.80

11.95

11.8

2.3

1.79

0.96

mg/l

1.16

275

Haemangioma and lymphangioma, any site

836

6607

1.35

11.94

1.9

1.8

1.27

1.17

mg/l

0.29

640

4980

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

142

800

2.17

11.87

2.6

1.7

0.77

1.01

mg/l

1.32

115

610

Spermatocele

610

4605

1.40

11.86

1.9

1.8

1.02

1.53

mg/l

5.38

456

3606

Malignant neoplasm of urinary organs

806

6333

1.35

11.85

1.7

1.60

1.45

mg/l

0.57

653

4953

Gout due to impairment of renal function

111

575

2.38

11.82

2.8

1.7

1.41

1.45

mg/l

0.07

448

Congenital malformations of genital organs

941

7502

1.32

11.78

1.8

2.0

0.91

0.96

mg/l

0.24

730

5473

Inflammatory disorders of breast

645

4952

1.40

11.73

1.7

1.8

1.11

0.97

mg/l

0.54

476

3651

Other and unspecified types of non-Hodgkin lymphoma, hilmo

366

2562

1.57

11.72

2.0

1.8

1.85

1.38

mg/l

1.08

301

1985

Benign neoplasm: Duodenum

244

1581

1.76

11.72

2.0

1.6

1.26

1.30

mg/l

0.08

191

1226

Right hemicolectomy

502

3703

1.46

11.71

2.4

1.7

2.24

1.40

mg/l

2.85

415

2881

Haemangioma, any site

779

6121

1.36

11.69

1.9

1.8

1.29

1.15

mg/l

0.44

598

4624

Medical treatment for female infertility

2233

19352

1.20

11.68

1.8

1.7

1.00

0.79

mg/l

1.80

1726

14266

Congenital malformations of the respiratory system

178

1068

1.94

11.64

3.1

2.6

1.32

1.23

mg/l

0.12

132

833

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

217

1353

1.78

11.61

1.9

1.7

2.92

1.37

mg/l

3.40

183

1048

Emotional disorders starting during childhood or adolescence

437

3117

1.49

11.58

2.5

2.3

1.48

0.99

mg/l

0.64

271

2095

Thrombotic microangiopathy

372

2.84

11.56

4.7

1.6

1.83

0.94

mg/l

2.86

300

Carcinoma in situ of skin of scalp and neck

187

1131

1.87

11.53

1.7

1.6

1.50

1.46

mg/l

0.08

154

889

Other chondrocalcinosis

127

696

2.22

11.49

1.8

1.7

1.24

1.42

mg/l

0.52

101

563

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3959

27713

1.14

11.48

1.8

1.7

2.13

1.21

mg/l

26.23

3263

21327

Benign neoplasm: Rectosigmoid junction

359

2520

1.57

11.45

1.8

1.7

1.32

1.33

mg/l

0.04

290

1975

Focal brain injury

526

3896

1.43

11.44

1.6

1.59

1.34

mg/l

0.67

389

2971

Pedestrian injured in collision with pedal cycle

316

2167

1.62

11.43

1.9

1.8

1.10

1.12

mg/l

0.05

236

1654

Other and unspecified haemorrhagic conditions

172

1029

1.96

11.43

2.5

1.7

1.17

1.14

mg/l

0.06

140

783

Ulcer of vagina/vulva

264

1754

1.71

11.40

1.9

1.7

0.76

0.99

mg/l

2.08

197

1314

Urethral stricture

456

3316

1.47

11.38

1.7

1.44

1.52

mg/l

0.11

328

2587

Non-small cell lung cancer, adenocarcinoma

512

3803

1.45

11.38

1.7

1.6

2.29

1.52

mg/l

1.81

430

2995

Non-small cell lung cancer, adenocarcinoma, helper endpoint

512

3803

1.45

11.38

1.7

1.6

2.29

1.52

mg/l

1.81

430

2995

Papilloedema, unspecified

232

1495

1.77

11.37

2.1

1.8

1.93

1.07

mg/l

0.52

176

1111

Melanocytic naevi of trunk

1101

9020

1.28

11.36

2.0

1.8

1.14

1.15

mg/l

0.04

813

6792

Inguinal or femoral hernia, bilateral

869

6919

1.32

11.34

1.8

1.24

1.37

mg/l

0.57

669

5416

Disorders of plasma-protein metabolism, not elsewhere classified

406

2.67

11.34

2.5

1.7

1.46

1.07

mg/l

0.50

306

Postpartum haemorrhage

2668

20435

1.17

11.31

1.8

1.7

1.20

0.83

mg/l

6.09

2028

14981

Other congenital malformations of skin

398

2853

1.53

11.29

2.0

1.9

1.20

1.12

mg/l

0.11

306

2115

Macular pucker

1207

9985

1.27

11.26

1.6

1.7

1.65

1.46

mg/l

0.46

937

7829

Malignant neoplasm of kidney, except renal pelvis

742

5815

1.35

11.20

1.7

1.61

1.46

mg/l

0.51

601

4533

Panniculitis, unspecified

112

590

2.28

11.20

1.9

1.6

0.80

1.18

mg/l

2.26

455

Respiratory disorders in diseases classified elsewhere

152

888

2.05

11.18

2.8

1.7

1.85

1.20

mg/l

1.31

124

698

Traumatic subarachnoid haemorrhage

287

1922

1.62

11.18

1.6

1.5

1.78

1.39

mg/l

0.89

217

1453

Personal history of risk-factors, not elsewhere classified

139

784

2.08

11.17

3.0

1.8

1.95

0.99

mg/l

0.56

110

575

Benign neoplasm: Skin of eyelid, including canthus

1378

11555

1.25

11.14

1.7

1.20

1.27

mg/l

0.41

1048

8904

Lactose intolerance, other/unspecified

273

1824

1.66

11.13

1.8

1.47

1.07

mg/l

0.88

198

1350

Secondary polycythaemia

226

1453

1.76

11.12

1.9

1.7

0.88

1.18

mg/l

2.36

171

1129

Injury of other and unspecified intrathoracic organs

554

4184

1.42

11.07

1.7

1.60

1.23

mg/l

1.21

427

3165

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

309

2.84

10.99

1.6

2.0

1.71

0.83

mg/l

1.83

216

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

4694

27839

1.13

10.99

1.6

1.7

1.17

0.94

mg/l

6.35

3608

21110

Complications of genitourinary prosthetic devices, implants and grafts

247

1625

1.71

10.97

1.9

1.6

1.09

1.10

mg/l

0.01

196

1225

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

4694

27843

1.13

10.95

1.6

1.7

1.17

0.94

mg/l

6.35

3608

21113

Renal tubulo-interstitial disorders in diseases classified elsewhere

109

577

2.31

10.92

3.1

1.6

1.43

1.10

mg/l

0.80

441

Other and unspecified mononeuropathies of lower limb

278

1879

1.66

10.90

1.8

1.6

1.09

1.18

mg/l

0.15

208

1425

Nontraumatic intracranial haemmorrhage

1688

14386

1.21

10.90

2.2

1.7

1.60

1.44

mg/l

1.12

1375

11118

Congenital malformations of gallbladder, bile ducts and liver

110

587

2.32

10.90

8.1

2.6

1.79

1.39

mg/l

0.44

460

Dystonia

524

3948

1.44

10.89

2.0

1.8

1.03

1.12

mg/l

0.33

380

2997

Hypertrophic scar

526

3962

1.43

10.89

1.9

1.7

0.91

0.99

mg/l

0.26

394

2919

Chronic lymphocytic leukaemia

248

1633

1.70

10.86

1.8

1.6

1.90

1.42

mg/l

0.69

206

1283

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

105

552

2.36

10.84

2.2

1.8

3.31

1.34

mg/l

0.60

437

Oral leukoplakia and related diseases, including avohilmo

790

6285

1.34

10.77

1.8

1.10

1.26

mg/l

1.03

609

4820

Other and unspecified psoriasis

593

4547

1.40

10.76

1.9

1.8

1.49

1.18

mg/l

1.25

455

3487

Parodontitis, operation under 40 years and operation codes

846

6756

1.31

10.75

2.1

1.8

1.01

0.92

mg/l

0.23

593

4588

Abscess of lung

148

861

2.00

10.72

2.3

1.8

1.69

1.28

mg/l

0.50

128

676

Abnormal findings on diagnostic imaging of central nervous system

422

3083

1.49

10.68

2.1

1.8

1.10

1.06

mg/l

0.08

315

2295

Toxic effect of other and unspecified substances

138

788

2.04

10.66

2.1

1.8

0.87

0.96

mg/l

0.25

103

583

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

102

533

2.35

10.65

2.2

1.7

1.82

1.24

mg/l

0.80

431

Benign neoplasm of breast

1140

9443

1.27

10.63

1.7

1.03

1.01

mg/l

0.09

849

7105

Other diseases of spinal cord

289

1976

1.62

10.62

2.5

1.7

1.15

1.12

mg/l

0.07

232

1510

Systemic sclerosis (FG)

233

1524

1.72

10.61

2.1

1.7

1.51

1.08

mg/l

0.63

189

1146

Parodontitis, under 40 years and operation codes

844

6750

1.31

10.60

2.1

1.8

1.01

0.92

mg/l

0.22

591

4583

Malignant neoplasm of testis

156

921

1.93

10.56

1.7

2.0

1.30

mg/l

0.01

119

659

Benign neoplasm of urinary organs

381

2734

1.51

10.54

1.8

1.7

1.71

1.17

mg/l

1.41

294

2096

Endometriosis ASRM stages 3,4

2376

20891

1.18

10.52

1.7

1.09

1.00

mg/l

0.40

1745

15782

Ulcerative rectosigmoiditis

783

6235

1.33

10.50

1.8

1.7

1.21

1.05

mg/l

0.99

598

4646

Hypoparathyroidism

341

2417

1.56

10.48

2.8

1.7

1.49

1.30

mg/l

0.33

268

1850

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

563

4300

1.40

10.46

1.8

1.07

1.12

mg/l

0.15

434

3266

Carcinoma in situ of skin of upper limb, including shoulder

200

1270

1.80

10.45

1.7

2.48

1.40

mg/l

0.77

160

1011

Alcohol-induced acute pancreatitis

326

2287

1.57

10.43

1.8

1.38

1.21

mg/l

0.37

251

1775

Non-seminoma of testis

317

2.75

10.41

1.6

2.1

1.71

1.14

mg/l

0.82

229

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

489

3593

1.42

10.40

2.8

2.5

1.69

1.11

mg/l

0.84

341

2503

Disorders of magnesium metabolism

380

2.64

10.37

1.7

1.71

1.43

mg/l

0.45

304

Chalazion

1051

8646

1.27

10.37

1.7

1.8

0.92

1.17

mg/l

3.39

778

6520

Dipeptidyl peptidase 4 (DPP-4) inhibitors

988

8077

1.28

10.36

1.8

1.7

1.54

1.36

mg/l

0.54

794

6251

Entropion and trichiasis of eyelid

668

5213

1.35

10.34

1.9

1.6

1.45

1.52

mg/l

0.15

518

4064

Vitamin B12 deficiency anaemia

904

7308

1.30

10.34

1.7

1.6

1.72

1.38

mg/l

1.14

713

5663

Conduct disorder

210

1341

1.74

10.33

2.4

2.1

0.84

0.93

mg/l

0.26

153

929

Childhood allergy (age < 16)

1350

9308

1.23

10.33

2.2

1.47

1.03

mg/l

1.13

882

6243

Clear cell adenocarcinoma of kidney

391

2842

1.50

10.28

1.7

1.82

1.38

mg/l

1.27

329

2226

Other noninflammatory disorders of cervix uteri

448

3320

1.46

10.27

1.9

1.7

1.03

1.33

mg/l

1.94

334

2558

Volvulus

230

1503

1.69

10.26

1.8

1.7

1.48

1.28

mg/l

0.35

190

1176

Malignant neoplasm of mesothelium and soft tissue

370

2660

1.51

10.23

2.1

1.6

2.01

1.35

mg/l

1.35

309

2078

Infections of genitourinary tract in pregnancy

943

7693

1.29

10.22

1.7

0.79

0.99

mg/l

2.32

723

5709

Inguinal hernia, bilateral

843

6775

1.31

10.20

1.8

1.25

1.37

mg/l

0.47

650

5310

Pedestrian injured in transport accident

632

4921

1.37

10.19

1.8

1.19

1.10

mg/l

0.30

462

3704

Other juvenile arthritis

371

2661

1.50

10.16

2.2

2.1

1.11

1.15

mg/l

0.08

279

1868

Molar incisor enamel hypoplasia

236

1515

1.66

10.16

6.8

2.9

2.26

1.20

mg/l

1.00

188

1030

Anankastic personality disorder

381

2765

1.51

10.13

1.6

1.7

0.87

0.98

mg/l

0.43

280

2049

Manic episode

298

2066

1.59

10.13

2.0

1.7

1.13

1.02

mg/l

0.39

227

1524

Benign neoplasm of eye and adnexa

877

7110

1.30

10.09

1.9

1.8

1.04

1.27

mg/l

2.24

659

5476

Other disorders starting during childhood or adolescence

428

3113

1.45

10.09

3.0

2.7

1.86

1.16

mg/l

0.88

293

2146

Herpesviral keratitis and keratoconjunctivitis

400

2927

1.49

10.06

1.8

1.7

1.12

1.19

mg/l

0.18

302

2221

Benign neoplasm: Liver

228

1510

1.72

10.06

2.2

1.7

1.05

1.06

mg/l

0.01

179

1133

Open wound of abdomen, lower back and pelvis

289

1995

1.59

10.05

2.1

1.8

1.41

1.06

mg/l

0.76

217

1461

Hypotension due to drugs

132

758

2.03

10.04

1.8

1.7

1.21

1.45

mg/l

0.44

105

608

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

647

5066

1.36

10.03

1.8

0.97

0.99

mg/l

0.08

448

3710

Inflammatory disease of cervix uteri

625

4885

1.37

10.03

1.6

1.7

0.77

1.11

mg/l

5.73

470

3750

Amputation of foot

212

1373

1.73

9.99

2.0

1.8

1.92

1.53

mg/l

0.65

185

1089

Implicit parasitic Sepsis

276

3.01

9.99

2.5

2.0

1.44

1.02

mg/l

0.48

216

Crohn disease (strict definition, all UC cases excluded)

481

3622

1.43

9.99

1.7

1.8

0.99

1.00

mg/l

0.04

333

2662

Chronic hepatitis, not elsewhere classified

329

2337

1.55

9.98

2.0

1.7

1.72

1.01

mg/l

3.20

264

1769

Drug-induced systemic lupus erythematosus

467

2.49

9.96

2.9

1.8

1.30

0.91

mg/l

0.77

357

Pilonidal cyst

816

6561

1.31

9.93

1.9

1.8

1.00

0.98

mg/l

0.10

610

4769

Malignant neoplasm of colon

1214

10161

1.24

9.92

1.7

1.84

1.45

mg/l

2.82

992

7891

Benign neoplasm: Skin of ear and external auricular canal

326

2301

1.54

9.90

1.7

1.6

1.51

1.16

mg/l

0.92

252

1759

Crohn's disease of large intestine

496

3756

1.42

9.89

1.8

1.09

1.00

mg/l

0.33

360

2792

Benign leiomyoma with endometriosis

1462

12462

1.22

9.88

1.6

1.7

1.12

1.06

mg/l

0.16

1076

9459

Mixed disorders of conduct and emotions

223

1456

1.68

9.88

2.0

2.5

0.88

0.93

mg/l

0.15

154

953

Ulcerative enterocolitis

312

2196

1.56

9.85

2.1

1.7

1.46

0.99

mg/l

1.03

246

1633

Crohn disease (strict definition, require KELA, min 2 HDR)

596

4630

1.37

9.85

1.8

0.99

1.00

mg/l

0.05

411

3403

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

127

725

2.04

9.84

2.6

1.7

1.88

1.19

mg/l

2.20

112

565

Diabetic retinopathy

3085

17419

1.15

9.84

1.8

1.9

1.36

1.31

mg/l

0.29

2453

13705

Ulcerative proctitis

579

4483

1.38

9.82

1.8

1.7

1.03

0.99

mg/l

0.10

451

3320

Lichen sclerosus et atrophicus

903

7373

1.29

9.79

1.7

1.10

1.15

mg/l

0.31

695

5624

Crohn disease (strict definition, require KELA)

606

4722

1.37

9.79

1.8

0.98

1.00

mg/l

0.09

420

3465

Oesophageal obstruction

297

2066

1.57

9.78

1.8

1.7

1.68

1.30

mg/l

1.18

240

1628

Bullous disorders

493

3737

1.42

9.75

2.1

1.7

1.64

1.29

mg/l

0.72

385

2875

Acquired clawhand, clubhand, clawfoot and clubfoot

276

2.87

9.73

1.6

0.63

0.97

mg/l

1.79

210

Carcinoma in situ of skin of trunk

244

1640

1.65

9.71

1.8

1.6

1.44

1.43

mg/l

0.03

187

1290

malignant neoplasm of female genital organs

1358

11532

1.23

9.70

1.6

1.7

1.98

1.22

mg/l

6.85

1092

8833

Microscopic polyangiitis

354

2.73

9.70

2.4

1.9

2.92

1.38

mg/l

1.22

279

Fall involving bed

254

1721

1.63

9.69

2.2

1.8

1.41

1.40

mg/l

0.01

206

1342

Mental and behavioural disorders due to cannabinoids

273

1869

1.59

9.68

2.3

2.0

1.26

0.89

mg/l

0.95

168

1257

Infectious mononucleosis

809

6517

1.30

9.67

2.1

1.9

0.87

0.90

mg/l

0.12

548

4589

Livedoid vasculitis

219

3.38

9.66

1.8

1.6

1.01

1.38

mg/l

0.87

177

Other sexually transmitted chlamydial diseases

634

4967

1.35

9.65

1.9

1.8

0.80

0.87

mg/l

0.47

431

3446

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

3184

23194

1.14

9.64

1.6

1.7

1.18

0.99

mg/l

3.92

2450

17676

Non-small cell lung cancer

1233

10346

1.24

9.62

1.6

1.7

1.85

1.49

mg/l

1.81

1036

8089

Benign neoplasm: Liver/bile ducts

248

1688

1.65

9.58

2.1

1.7

1.02

1.05

mg/l

0.05

195

1271

Flatulence and related conditions

105

569

2.16

9.58

3.3

1.6

0.75

1.00

mg/l

1.50

429

Alcoholic liver disease

810

6540

1.30

9.55

1.8

2.45

1.28

mg/l

7.77

680

5105

Atopic conjunctivitis

420

3122

1.45

9.50

2.2

1.8

0.81

1.00

mg/l

1.22

311

2302

Postpartum hemorraghe, all women as controls

2668

23668

1.16

9.50

1.8

1.7

1.20

0.83

mg/l

5.88

2028

17469

Burns and corrosions confined to eye and internal organs

271

1874

1.60

9.48

1.9

1.8

0.74

1.01

mg/l

1.66

199

1400

Hereditary hypogammaglobulinemia

241

3.25

9.46

2.1

1.7

0.89

1.38

mg/l

0.56

189

Carcinoma in situ of skin of ear and external auricular canal

108

589

2.10

9.45

1.7

1.6

2.31

1.44

mg/l

0.79

471

Venous complications and haemorrhoids in the puerperium

133

790

2.03

9.43

2.0

1.8

2.21

0.90

mg/l

0.92

101

605

Acne

934

7648

1.27

9.43

2.1

1.9

0.82

0.95

mg/l

1.29

656

5306

Unspecified threat to breathing

116

661

2.12

9.40

2.2

0.84

1.08

mg/l

0.92

490

Hypoplasia of dental enamel , including avohilmo

218

1412

1.66

9.39

7.1

2.8

2.39

1.18

mg/l

1.06

172

953

Seropositive rheumatoid arthritis, strict definition

1411

12046

1.22

9.38

1.7

1.53

1.17

mg/l

2.81

1144

9202

Parodontitis, under 40 years, or operation codes

883

7201

1.28

9.34

2.1

1.9

1.02

0.92

mg/l

0.27

616

4899

Parodontitis, under 40 years

881

7186

1.28

9.31

2.1

1.9

1.01

0.92

mg/l

0.26

614

4889

Motor disorders, excluding more controls

114

599

2.00

9.29

6.4

4.0

1.18

1.69

mg/l

0.59

404

Effects of other external causes

275

1910

1.58

9.28

1.9

2.0

0.94

1.06

mg/l

0.31

195

1393

Alzheimer disease, excluding more controls

1329

7473

1.22

9.24

1.6

1.86

1.79

mg/l

0.19

1003

5881

Chronic conjunctivitis

290

2042

1.57

9.23

1.9

1.8

1.00

1.12

mg/l

0.32

232

1552

Spinal osteochondrosis

116

657

2.05

9.21

1.7

1.6

0.93

1.14

mg/l

0.51

483

Femoral hernia

384

2826

1.46

9.20

1.8

1.7

1.29

1.22

mg/l

0.16

296

2183

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

721

5790

1.32

9.16

1.9

1.8

1.04

1.18

mg/l

0.82

552

4422

Complications of labour and delivery

6931

35931

1.09

9.15

1.7

1.03

1.01

mg/l

0.28

5298

26781

Benign mammary dysplasia

1344

11462

1.22

9.14

1.7

1.03

1.14

mg/l

0.88

1039

8769

Organic, including symptomatic, mental disorders

4337

28569

1.12

9.12

1.7

1.59

1.45

mg/l

1.38

3406

22220

Necrotizing fasciitis

247

2.96

9.10

2.6

1.5

1.93

1.54

mg/l

0.48

193

Behavioural disorders

206

1351

1.68

9.10

2.4

2.1

0.84

0.96

mg/l

0.34

151

932

Pedal cyclist injured in other and unspecified transport accidents

997

8273

1.26

9.06

1.7

1.8

1.08

1.15

mg/l

0.38

762

6177

Other abnormal findings of blood chemistry

393

2921

1.46

9.03

2.0

1.7

1.56

1.16

mg/l

0.96

297

2233

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1973

14461

1.18

9.00

1.7

1.93

1.32

mg/l

4.71

1641

11206

Erythema multiforme

225

1517

1.66

8.99

1.8

1.7

1.00

1.07

mg/l

0.24

169

1148

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

346

2514

1.49

8.99

2.1

1.7

1.94

1.17

mg/l

1.48

279

1907

Xerosis cutis

146

894

1.89

8.95

2.5

1.7

1.12

1.30

mg/l

0.50

115

695

Alcohol withdrawal state with delirium

589

4624

1.35

8.94

1.7

1.37

1.27

mg/l

0.40

470

3592

Personal history of allergy to drugs, medicaments and biological substances

121

706

2.02

8.91

2.1

1.7

1.39

1.02

mg/l

0.22

544

Generalized epilepsy

416

3123

1.43

8.88

1.7

2.0

1.33

1.02

mg/l

0.46

310

2318

Previous suicide attempt

109

617

2.09

8.88

2.2

1.8

1.04

0.95

mg/l

0.19

454

Car occupant injured in noncollision transport accident

345

2516

1.49

8.88

1.9

1.8

1.16

1.04

mg/l

0.39

276

1862

Benign neoplasm: Kidney

287

2028

1.55

8.87

1.8

1.7

1.84

1.19

mg/l

1.29

222

1539

Benign neoplasm: Parotid gland

649

5162

1.33

8.82

1.7

1.54

1.13

mg/l

1.68

497

3918

Drug-induced polyneuropathy

543

2.22

8.80

5.7

1.9

2.42

1.31

mg/l

0.43

437

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

128

756

1.94

8.79

2.1

1.7

2.69

1.36

mg/l

0.86

112

577

Assault by unspecified means

202

1336

1.69

8.78

1.9

1.8

1.11

1.00

mg/l

0.23

138

979

Toxic effect of corrosive substances

296

2.69

8.78

1.6

1.9

0.59

1.02

mg/l

1.91

209

Secondary parkinsonism, excluding more controls

198

1292

1.67

8.78

1.9

1.6

1.53

1.57

mg/l

0.04

156

1002

Benign neoplasm: Pancreas

236

1619

1.63

8.77

2.0

1.7

1.53

1.32

mg/l

0.36

184

1280

210

1400

1.67

8.77

1.9

1.6

1.11

0.88

mg/l

0.46

154

1029

Anorexia (incl.atypical)

591

4653

1.34

8.72

2.1

1.8

0.89

0.98

mg/l

0.54

398

3369

Cushing syndrome

127

759

1.98

8.71

2.3

1.7

0.79

1.12

mg/l

1.74

101

583

Superficial injuries involving multiple body regions

252

1747

1.59

8.70

1.9

1.8

1.10

1.08

mg/l

0.05

190

1298

Malignant immunoproliferative diseases

526

2.18

8.68

3.2

1.8

2.43

1.13

mg/l

0.72

414

Other acute viral hepatitis

132

795

1.94

8.67

1.7

1.08

1.13

mg/l

0.11

107

596

Guillain-Barre syndrome

158

994

1.81

8.66

2.1

1.7

1.64

1.19

mg/l

0.56

128

764

Other and unspecified vaccines and biological substances

431

2.38

8.64

4.0

1.8

1.09

0.96

mg/l

0.13

329

Oral lichen ruber planus wide, hypothyreosis or thyroxin

479

3693

1.40

8.64

1.7

1.8

0.99

1.19

mg/l

1.15

362

2856

Other autoimmune haemolytic anaemias

125

745

1.98

8.63

3.1

1.7

3.31

1.38

mg/l

1.27

108

576

Contact with and exposure to communicable diseases

3199

28799

1.13

8.60

2.0

1.8

0.91

0.99

mg/l

0.64

2174

21091

Pneumonia derived septicemia

294

2095

1.52

8.60

2.0

1.9

1.83

1.25

mg/l

1.35

237

1589

Diffuse brain injury

304

2166

1.50

8.59

1.7

1.6

1.76

1.26

mg/l

0.81

214

1606

Eosinophilia

163

1038

1.80

8.58

2.7

1.9

1.40

1.27

mg/l

0.21

128

797

Disorders of porphyrin and bilirubin metabolism

116

673

2.00

8.58

2.3

1.8

1.18

1.11

mg/l

0.11

507

Other orthopaedic follow-up care

505

3910

1.38

8.58

1.9

1.7

1.00

1.07

mg/l

0.25

386

2940

Other misadventures during surgical and medical care

202

1348

1.69

8.57

2.2

1.7

1.53

1.15

mg/l

0.69

160

1047

Ehlers-Danlos syndrome

116

680

2.04

8.57

3.0

1.7

0.81

0.82

mg/l

0.01

495

Benign neoplasm: Other and unspecified parts of small intestine

156

982

1.82

8.57

2.5

1.6

1.04

1.10

mg/l

0.15

133

756

Pyoderma

187

1224

1.71

8.56

1.9

0.86

1.08

mg/l

1.15

136

941

Chronic myeloproliferative disease

134

815

1.92

8.54

2.0

1.7

1.48

1.32

mg/l

0.25

103

640

Whooping cough

374

2.43

8.52

1.9

1.7

1.02

1.04

mg/l

0.02

276

ILD and respiratory illness in diseases classified elsewhere

303

2.71

8.51

2.2

1.7

1.57

1.33

mg/l

0.19

246

Disorders of phosphorus metabolism and phosphatases

261

2.80

8.50

2.5

2.1

1.50

0.85

mg/l

0.97

192

Dependence on enabling machines and devices, not elsewhere classified

106

595

2.04

8.49

7.4

2.4

4.80

1.72

mg/l

1.43

470

Laparoscopic right hemicolectomy

455

3488

1.40

8.48

1.6

1.7

1.39

1.44

mg/l

0.14

360

2734

Short Achilles tendon (acquired)

239

1642

1.59

8.47

1.8

1.5

0.95

1.05

mg/l

0.22

200

1219

Pregnancy, childbirth and the puerperium

3146

14820

1.14

8.46

1.7

1.11

1.22

mg/l

1.12

2360

10895

Scar conditions and fibrosis of skin

385

2885

1.44

8.44

2.3

1.7

0.99

1.00

mg/l

0.03

296

2161

Other forms of systemic lupus erythematosus

101

572

2.15

8.44

2.1

1.7

1.59

0.94

mg/l

1.28

442

Arthropod-borne viral fevers and viral haemorrhagic fevers

854

7039

1.27

8.44

1.7

1.14

1.16

mg/l

0.12

667

5369

285

2.80

8.44

2.1

1.8

1.60

1.33

mg/l

0.21

231

Oral leukoplakia and related diseases

485

3751

1.38

8.44

1.8

1.20

1.25

mg/l

0.16

386

2902

Acquired coagulation factor deficiency

5.02

8.43

8.0

1.7

1.18

mg/l

0.00

Contact with heat and hot substances

473

3640

1.39

8.43

1.9

2.0

1.26

1.13

mg/l

0.41

345

2719

Social phobias

743

6020

1.29

8.40

1.9

1.7

1.00

0.97

mg/l

0.12

513

4287

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

896

7403

1.26

8.40

1.7

1.77

1.37

mg/l

2.60

727

5734

Other neurotic disorders

446

3407

1.40

8.40

1.8

1.6

1.43

1.20

mg/l

0.55

323

2603

Puerperal sepsis

1246

10643

1.22

8.38

1.6

1.7

0.93

1.01

mg/l

0.55

941

8115

Kyphosis

124

737

1.93

8.37

2.0

1.7

1.05

1.28

mg/l

0.74

101

564

Benign neoplasm of middle ear and respiratory system

671

5392

1.31

8.36

1.9

1.8

1.28

1.30

mg/l

0.07

538

4144

Congenital malformations of the urinary system

506

3933

1.37

8.36

2.2

2.03

1.11

mg/l

1.36

408

2903

Hypersomnia

150

943

1.83

8.35

1.8

0.86

1.07

mg/l

0.55

108

702

Personal history of malignant neoplasm

333

2442

1.48

8.34

2.0

1.7

1.20

1.16

mg/l

0.11

262

1844

Status epilepticus

296

2118

1.50

8.33

2.2

1.8

1.41

1.34

mg/l

0.14

242

1632

Injury of nerves at forearm level

137

842

1.88

8.33

2.7

1.6

0.69

1.18

mg/l

3.87

629

Personal history of certain other diseases

190

1256

1.69

8.33

2.4

1.8

1.07

0.90

mg/l

0.47

141

923

Benign lipomatous neoplasm of other sites/unspecified

765

6242

1.29

8.33

1.6

1.8

1.28

1.30

mg/l

0.07

601

4830

Presbyopia

581

4609

1.34

8.32

1.8

1.7

0.98

1.03

mg/l

0.10

445

3520

Parkinson's disease, strict definition

1098

9262

1.23

8.29

1.7

1.45

1.53

mg/l

0.29

882

7242

Isolated proteinuria

261

1839

1.56

8.28

1.9

1.8

1.40

1.24

mg/l

0.42

217

1381

Other obstructive and reflux uropathy

394

2960

1.42

8.27

1.7

1.40

1.04

mg/l

1.68

319

2186

Use of levodopa decarboxylase inhibitor

1029

8633

1.24

8.27

1.7

1.37

1.54

mg/l

0.87

822

6765

Central retinal artery occlusion

177

1148

1.70

8.26

1.9

1.7

1.50

mg/l

0.00

145

907

Alzheimer’s disease (Early onset)

166

2563

0.61

8.26

1.5

1.6

2.04

1.42

mg/l

0.40

111

1990

Achalasia of cardia

169

1090

1.74

8.24

1.8

1.7

0.91

1.16

mg/l

1.38

141

844

Carcinoma in situ of skin

631

5051

1.32

8.23

1.8

1.7

1.62

1.49

mg/l

0.40

488

3932

Parkinson's disease, including avohilmo

1239

10568

1.22

8.20

1.7

1.41

1.51

mg/l

0.50

991

8254

Conductive hearing loss, unspecified

739

6017

1.29

8.20

2.2

1.8

1.33

1.17

mg/l

0.60

576

4546

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

292

2093

1.51

8.20

2.6

2.7

1.75

1.16

mg/l

1.18

227

1538

Background retinopathy and retinal vascular changes

190

1261

1.68

8.16

1.8

1.7

1.22

1.25

mg/l

0.10

160

984

Arthropathy in ulcerative colitis

138

856

1.87

8.16

1.8

1.7

1.06

1.05

mg/l

0.02

110

651

Dermatopolymyositis (FG)

133

811

1.86

8.15

2.2

1.6

1.24

1.16

mg/l

0.13

100

616

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

880

7252

1.26

8.13

1.8

1.6

1.82

1.44

mg/l

1.66

727

5654

Carcinoma in situ of skin of scalp and neck

187

1238

1.68

8.12

1.7

1.50

1.57

mg/l

0.14

154

995

Hyperaldosteronism

256

1809

1.56

8.12

1.8

1.7

0.91

1.18

mg/l

1.37

193

1390

Loose body in joint

214

1452

1.61

8.11

1.5

1.7

0.89

1.29

mg/l

2.04

152

1085

Foreign body or object entering through skin

554

4374

1.34

8.09

1.8

1.29

1.09

mg/l

0.40

417

3260

Shoulder region

134

825

1.87

8.08

1.9

1.8

1.45

1.21

mg/l

0.27

101

639

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

309

2257

1.50

8.08

1.8

2.54

1.16

mg/l

4.58

260

1726

Idiopathic urticaria

209

1423

1.64

8.07

2.1

1.7

0.81

0.95

mg/l

0.62

170

1048

Chronic tubulo-interstitial nephritis

348

2578

1.45

8.07

1.8

1.6

1.21

1.07

mg/l

0.54

266

1927

Problems related to social environment

258

1817

1.54

8.07

1.9

1.7

1.00

1.13

mg/l

0.46

209

1364

Other acquired deformities of musculoskeletal system and connective tissue

426

3260

1.40

8.04

1.9

1.7

0.97

1.12

mg/l

1.06

339

2469

Benign neoplasm: Anus and anal canal

236

1638

1.58

8.03

1.8

1.6

1.23

1.09

mg/l

0.42

186

1239

Spondylopathies in diseases classified elsewhere

108

625

1.99

8.02

2.5

1.6

1.30

1.47

mg/l

0.29

502

Disorders of adrenal gland, other and/or unspecified

303

2.63

8.00

2.0

1.8

0.74

0.90

mg/l

0.49

235

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

223

2.92

7.98

2.0

1.7

1.25

1.14

mg/l

0.15

168

Benign neoplasm: Tongue

240

1677

1.57

7.95

1.9

1.7

1.14

1.11

mg/l

0.06

184

1259

Contracture of joint

119

708

1.91

7.95

1.6

1.5

1.28

mg/l

0.00

530

Infection due to other mycobacteria

137

846

1.82

7.93

3.1

1.6

1.79

1.28

mg/l

0.40

114

647

Thyroiditis, unspecified

166

1083

1.75

7.93

2.2

1.7

0.86

1.00

mg/l

0.52

123

809

Polyhydramnios

460

3567

1.38

7.91

1.8

1.7

0.83

0.73

mg/l

0.64

361

2606

Pedal cyclist injured in transport accident

2042

18098

1.16

7.90

1.8

1.05

1.13

mg/l

0.88

1536

13572

Follicular lymphoma, hilmo

362

2715

1.44

7.90

2.0

1.6

1.27

1.35

mg/l

0.21

296

2120

Foreign body in respiratory tract

458

3544

1.38

7.89

2.0

1.9

0.95

1.15

mg/l

1.06

321

2661

Acquired absence of organs, not elsewhere classified

115

682

1.94

7.88

1.9

1.7

1.68

1.24

mg/l

0.72

532

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

138

858

1.82

7.88

1.7

1.5

0.96

1.21

mg/l

0.59

112

659

Drug-induced headache, not elsewhere classified

369

2.45

7.84

1.9

1.7

0.91

0.76

mg/l

0.24

285

Twin gestation

892

7444

1.26

7.84

1.8

1.7

1.04

0.77

mg/l

2.95

700

5556

Monoplegia

150

957

1.79

7.84

3.8

1.7

1.17

1.19

mg/l

0.03

117

755

Other specified/unspecified hearing loss

660

5329

1.30

7.83

2.0

1.8

1.51

1.36

mg/l

0.38

505

4110

Congenital iodine-deficiency syndrome/hypothyroidism

286

2071

1.51

7.83

1.7

1.00

1.17

mg/l

1.04

222

1570

Transient global amnesia

771

6346

1.28

7.82

1.7

1.24

1.38

mg/l

0.37

586

4933

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

823

6821

1.27

7.79

1.5

1.7

1.93

1.19

mg/l

3.70

655

5207

Other and unspecified injuries of abdomen, lower back and pelvis

148

942

1.78

7.76

2.0

1.7

1.25

1.08

mg/l

0.20

111

689

Other retinal artery occlusion

194

1305

1.64

7.75

1.6

1.7

1.21

1.34

mg/l

0.41

148

1027

Pulmonary eosinophilia, not elsewhere classified

123

750

1.90

7.74

2.0

1.7

1.03

1.14

mg/l

0.33

588

Benign neoplasm of major salivary glands

796

6567

1.27

7.73

1.7

1.53

1.18

mg/l

1.64

611

4991

Congenital malformations of great veins

156

3.33

7.73

7.0

5.2

1.75

2.80

mg/l

0.37

126

Benign neoplasm of meninges

872

7274

1.26

7.71

1.9

1.7

1.46

1.23

mg/l

0.47

672

5576

Benign neoplasm: Parathyroid gland

111

661

1.98

7.71

1.7

1.6

1.03

0.97

mg/l

0.13

505

Caught, crushed, jammed or pinched in or between objects

426

3274

1.39

7.71

1.8

1.9

0.89

1.07

mg/l

1.37

310

2418

Haemolytic-uraemic syndrome

154

3.54

7.68

4.4

2.0

5.64

0.83

mg/l

0.97

121

Benign neoplasm: Other and unspecified parts of mouth

295

2151

1.49

7.67

1.8

1.9

1.11

1.16

mg/l

0.11

227

1620

Impetigo

389

2952

1.41

7.67

2.7

2.1

0.89

1.10

mg/l

1.31

296

2143

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

256

2.81

7.66

1.8

1.6

1.33

0.95

mg/l

0.48

204

Acute drug-induced interstitial lung disorder

418

2.26

7.65

3.7

1.7

1.52

1.35

mg/l

0.19

320

Malignant melanoma, excluding all cancers (controls excluding all cancers)

1403

12153

1.19

7.65

1.8

1.7

1.50

1.22

mg/l

0.96

1093

9291

Parkinson's disease

1185

10132

1.21

7.65

1.7

1.43

1.52

mg/l

0.37

951

7915

Other and unspecified follicular disorders

354

2660

1.44

7.63

2.5

1.7

0.90

1.06

mg/l

1.08

274

1991

Carrier of infectious disease

231

1622

1.58

7.61

1.9

1.7

1.69

1.08

mg/l

0.56

167

1236

Unspecified event, undetermined intent

235

1652

1.56

7.60

2.5

1.8

1.00

1.08

mg/l

0.23

170

1223

Type 1 diabetes, wide definition, subgroup 2

942

0.41

7.57

1.5

2.1

1.70

1.32

mg/l

0.26

721

Other salmonella infections

332

2469

1.45

7.57

1.9

1.7

1.10

1.17

mg/l

0.22

251

1867

Lesion of sciatic nerve

361

2710

1.42

7.57

1.7

1.48

1.39

mg/l

0.19

296

2098

Alkalosis

112

3.86

7.56

3.0

1.6

1.25

0.91

mg/l

0.41

IgA nephropathy (IgA glomerulonephritis)

220

1532

1.59

7.53

2.8

1.7

1.67

1.12

mg/l

1.61

184

1157

Other disorders of male genital organs

294

2139

1.47

7.49

1.8

2.0

1.10

1.24

mg/l

0.29

214

1586

Multiple gestation

916

7697

1.25

7.48

1.8

1.7

1.04

0.76

mg/l

3.17

719

5748

Aspergillosis

489

2.15

7.44

3.4

1.7

1.60

1.36

mg/l

0.24

398

Benign neoplasm of ovary

1633

14360

1.18

7.41

1.7

1.06

1.11

mg/l

0.33

1280

11005

Viral haemorrhagic fevers, not elsewhere classified/unspecified

700

5740

1.28

7.39

1.6

1.8

1.14

1.16

mg/l

0.10

543

4366

Defects in the complement system

447

2.20

7.35

3.3

2.3

0.95

1.11

mg/l

0.30

335

Anomalies of dental arch relationship, including avohilmo

1772

14032

1.17

7.35

2.3

1.9

0.99

1.06

mg/l

0.28

1275

10271

Hyperosmolality and hypernatraemia

115

693

1.87

7.35

1.8

1.7

1.75

1.36

mg/l

0.61

531

Complications of the puerperium, not elsewhere classified

424

3295

1.39

7.33

2.5

1.7

1.07

0.77

mg/l

1.47

323

2429

Disorder of pancreatic internal secretion, other and/or unspecified

463

2.18

7.31

1.6

1.8

1.12

1.42

mg/l

0.39

360

Inflammation of lacrimal passages (acute and unspecified)

170

1133

1.68

7.30

2.3

1.6

1.46

1.15

mg/l

0.46

140

882

Follow-up care involving plastic surgery

360

2732

1.42

7.29

1.7

0.86

0.95

mg/l

0.47

261

2075

Benign neoplasm: Cerebral meninges

790

6568

1.26

7.29

1.9

1.7

1.50

1.22

mg/l

0.51

608

5024

Moderate visual impairment, binocular

249

1776

1.52

7.27

1.9

1.7

1.29

1.40

mg/l

0.29

176

1361

Mature T/NK-cell lymphomas, hilmo

127

793

1.83

7.27

2.6

1.7

1.88

1.31

mg/l

1.58

112

628

Viral agents as the cause of diseases classified to other chapters

212

1480

1.59

7.26

2.4

1.9

1.13

1.11

mg/l

0.04

175

1129

Marfan's syndrome

313

2.46

7.26

2.3

1.7

2.13

0.99

mg/l

1.25

244

Vertigo of central origin

143

917

1.76

7.26

1.8

1.7

0.97

1.27

mg/l

0.82

101

711

Other disorders of pigmentation

379

2899

1.40

7.21

1.8

1.23

1.32

mg/l

0.16

287

2216

Autonomic disorders

206

1430

1.59

7.20

2.0

1.6

2.06

1.11

mg/l

0.49

152

1097

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

536

2.04

7.19

1.9

1.7

1.56

1.03

mg/l

1.06

406

Prurigo nodularis

226

1598

1.56

7.19

2.0

1.7

1.57

1.20

mg/l

0.41

179

1252

Family history of certain disabilities and chronic diseases leading to disablement

435

3391

1.37

7.16

1.9

1.7

0.73

0.98

mg/l

2.27

313

2490

Sudden idiopathic hearing loss

852

7136

1.25

7.16

1.9

1.7

1.08

1.30

mg/l

1.67

625

5504

Other disorders of optic disc

131

830

1.81

7.15

2.2

1.7

2.55

1.10

mg/l

0.50

101

633

Other benign neoplasms of connective and other soft tissue

840

7027

1.25

7.11

1.7

1.15

1.04

mg/l

0.28

648

5273

Other meningitis

159

1052

1.70

7.09

1.9

1.7

1.40

1.07

mg/l

0.58

118

787

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

386

2973

1.40

7.08

1.7

1.8

0.87

0.79

mg/l

0.39

306

2224

Colorectal cancer

1913

17005

1.15

7.08

1.7

1.96

1.42

mg/l

5.70

1563

13240

Other specified disorders of kidney and ureter

299

2219

1.46

7.08

2.7

1.8

1.79

1.17

mg/l

2.00

233

1711

Injury of intra-abdominal organs

226

1597

1.54

7.07

2.0

1.8

1.61

1.13

mg/l

1.16

167

1201

Carcinoma in situ of other and unspecified sites

254

1827

1.50

7.07

1.7

1.6

1.70

1.32

mg/l

0.82

200

1412

Other and unspecified iridocyclitis

383

2944

1.39

7.06

1.9

1.7

1.01

1.08

mg/l

0.25

309

2190

Paralytic strabismus

591

4783

1.30

7.06

1.8

1.7

1.37

1.31

mg/l

0.15

458

3692

Cystic kidney disease

288

2125

1.47

7.04

2.2

1.9

2.72

1.13

mg/l

1.40

236

1611

Anomalies of pupillary function

204

1422

1.59

7.04

1.8

1.7

1.68

0.99

mg/l

0.51

143

1079

Injury of nerves at lower leg level

102

607

1.95

7.03

1.8

1.7

1.31

1.23

mg/l

0.07

476

Ulcerative ileocolitis

382

2936

1.39

7.03

2.0

1.7

1.61

0.97

mg/l

1.87

289

2193

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

133

847

1.78

7.02

1.9

1.8

0.83

1.06

mg/l

0.89

102

642

Other osteochondropathies

650

5319

1.29

7.00

1.8

0.84

1.04

mg/l

2.53

485

4006

Left side

288

2.63

7.00

1.9

1.8

1.05

1.43

mg/l

0.69

226

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

142

919

1.74

6.98

1.8

1.6

1.64

1.23

mg/l

1.03

114

705

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1512

13245

1.17

6.97

1.6

1.7

1.98

1.32

mg/l

6.10

1231

10249

Meningitis

453

3565

1.35

6.96

1.7

1.8

1.09

1.07

mg/l

0.05

341

2682

Fracture of neck

469

3701

1.34

6.95

1.8

1.7

1.30

1.33

mg/l

0.10

354

2851

Carcinoma in situ of other and unspecified digestive organs

197

1362

1.59

6.93

2.6

1.6

2.15

1.26

mg/l

1.06

162

1051

Hypermetropia

590

4777

1.30

6.92

2.0

2.2

1.06

1.21

mg/l

0.61

435

3543

Delivery, wide proxy

3585

17474

1.11

6.90

1.7

1.18

1.17

mg/l

0.02

2714

12865

Seminoma of testis, excluding all cancers (controls excluding all cancers)

516

1.99

6.89

1.8

1.7

1.27

0.98

mg/l

0.42

370

Acne vulgaris

715

5900

1.26

6.89

2.1

1.9

0.79

0.93

mg/l

1.15

501

4079

Chronic myeloid leukaemia [CML], BCR/ABL-positive

544

2.00

6.87

1.9

1.7

1.56

1.27

mg/l

0.44

412

Poisoning by medicine, drug-induced

143

934

1.74

6.87

1.9

1.8

0.81

0.97

mg/l

0.62

105

719

Toxic effect of contact with venomous animals

358

2740

1.40

6.86

2.0

1.8

1.14

1.07

mg/l

0.14

258

2065

Perforation of tympanic membrane

856

7199

1.24

6.86

1.8

1.07

1.21

mg/l

0.93

638

5417

UC patients in KELA-register (code 208), prior to 1994

398

3089

1.38

6.85

1.9

1.7

1.31

1.11

mg/l

0.76

334

2364

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

329

2481

1.42

6.84

2.4

2.2

1.58

1.08

mg/l

0.39

245

1784

Systemic sclerosis

233

1674

1.53

6.83

2.1

1.7

1.51

1.00

mg/l

0.81

189

1288

Medicines for HER+ breast cancer

3432

30715

1.11

6.83

1.6

1.7

1.20

1.14

mg/l

0.72

2654

23640

Drug-induced dystonia

161

3.11

6.82

1.5

1.6

0.87

0.93

mg/l

0.08

124

Ankylosing hyperostosis [Forestier]

118

732

1.82

6.81

1.8

1.7

1.41

1.40

mg/l

0.01

573

Mesothelioma, excluding all cancers (controls excluding all cancers)

108

654

1.86

6.78

1.8

1.6

1.82

1.48

mg/l

0.62

514

Symptoms and signs involving appearance and behaviour

546

1.99

6.78

2.1

1.7

0.90

1.06

mg/l

0.39

407

Myasthenia gravis

159

1064

1.68

6.77

1.8

1.46

1.17

mg/l

0.59

126

815

Other and unspecified glaucoma

542

4361

1.31

6.76

1.6

1.88

1.45

mg/l

1.18

418

3396

Other specified disorders of external ear

304

2275

1.44

6.75

1.6

1.7

1.11

1.36

mg/l

0.83

236

1789

Graves disease, strict definition

940

7996

1.23

6.75

2.0

1.7

0.77

0.98

mg/l

3.38

708

6027

Insulin, fast-acting (human)

1335

11630

1.18

6.75

1.8

0.95

1.08

mg/l

1.59

1024

8515

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

563

4560

1.30

6.75

1.8

1.07

1.21

mg/l

0.62

434

3499

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

407

2.18

6.73

2.3

1.7

2.39

1.22

mg/l

0.44

319

Malnutrition

168

1133

1.64

6.72

2.9

2.2

1.61

1.28

mg/l

1.00

136

867

Other and unspecified disorders of autonomic nervous system

242

2.68

6.71

2.5

1.8

0.57

0.97

mg/l

2.21

182

Retinal detachment with retinal break

1054

9035

1.21

6.71

2.1

1.7

1.25

1.35

mg/l

0.58

833

7004

Benign neoplasm: Skin of ear and external auricular canal

326

2465

1.41

6.70

1.7

1.6

1.51

1.26

mg/l

0.56

252

1911

Personal history of medical treatment

540

1.98

6.68

2.9

1.9

1.16

1.17

mg/l

0.01

412

Sequelae of injuries of head

453

3580

1.34

6.68

1.8

1.34

1.12

mg/l

0.48

323

2682

Sub-endpoint used in defining T1D endpoints

2756

24630

1.12

6.67

1.9

1.8

1.19

1.23

mg/l

0.28

2113

18376

Ectropion of eyelid

281

2069

1.44

6.67

1.8

1.6

2.14

1.61

mg/l

0.73

224

1610

Pulmonary oedema

140

904

1.70

6.67

3.6

1.7

1.76

1.40

mg/l

0.74

116

722

Malignant immunoproliferative diseases

573

1.97

6.66

3.2

1.8

2.43

1.38

mg/l

0.53

452

Other disorders of cornea

805

6757

1.24

6.65

1.7

1.8

1.33

1.20

mg/l

0.39

610

5124

Benign neoplasm of breast

1140

9860

1.20

6.65

1.7

1.03

1.08

mg/l

0.27

849

7471

Use of ropinirole

298

2233

1.44

6.65

1.9

1.6

1.36

1.40

mg/l

0.09

236

1747

Injury of nerves and spinal cord at neck level

199

1394

1.57

6.65

1.8

1.55

1.20

mg/l

0.25

151

1080

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

302

2269

1.44

6.64

1.8

1.9

0.84

1.11

mg/l

1.43

232

1690

Calculus of lower urinary tract

401

3117

1.36

6.63

1.7

1.28

1.47

mg/l

0.56

315

2430

Other superficial mycoses

196

1370

1.58

6.63

1.9

1.7

0.80

1.04

mg/l

1.31

137

1010

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

323

2443

1.41

6.60

1.9

1.6

1.34

1.10

mg/l

0.69

267

1836

Hypertrophy of (infrapatellar) fat pad

102

616

1.89

6.60

2.2

1.7

0.59

1.09

mg/l

5.63

470

Chronic nephritic syndrome

342

2612

1.40

6.60

2.3

1.8

1.67

1.16

mg/l

2.88

289

2005

Burns and corrosions of multiple and unspecified body regions

203

1428

1.56

6.58

2.1

1.9

1.11

1.21

mg/l

0.25

151

1072

Other and unspecified nail disorders

193

1350

1.58

6.57

2.6

1.6

1.01

1.08

mg/l

0.20

147

1024

Amputation of ankle bones

175

1194

1.60

6.55

2.2

1.7

1.57

1.40

mg/l

0.39

146

949

Other specified and unspecified retinal disorders

292

2184

1.44

6.54

2.6

1.7

1.16

1.23

mg/l

0.18

226

1669

Alcoholic gastritis

133

858

1.72

6.52

2.0

1.7

1.38

1.25

mg/l

0.18

109

672

Acquired absence of limb

489

2.00

6.51

1.9

1.6

1.18

1.32

mg/l

0.25

390

Maternal care for known or suspected malpresentation of fetus

1870

12428

1.15

6.51

1.8

1.7

0.84

0.78

mg/l

0.55

1384

9073

Benign neoplasm of bone and articular cartilage

709

5891

1.26

6.51

1.8

1.03

0.98

mg/l

0.13

545

4381

Impacted cerumen

782

6558

1.24

6.51

1.8

1.32

1.39

mg/l

0.21

558

5036

Disorders of eyelid in diseases classified elsewhere

296

2221

1.44

6.50

2.3

1.7

1.03

1.15

mg/l

0.41

220

1672

Other and unspecified intracranial injuries

252

1839

1.47

6.50

1.8

0.91

1.18

mg/l

1.45

191

1398

Benign neoplasm: Choroid

462

3673

1.33

6.49

2.0

1.8

0.98

1.20

mg/l

1.55

352

2803

Defect, injury or illness of neck

327

2.33

6.48

1.7

1.8

0.95

0.96

mg/l

0.01

250

Other appendicitis

769

6446

1.25

6.48

1.6

1.8

1.24

1.12

mg/l

0.37

591

4893

Benign neoplasm: Parathyroid gland

111

695

1.86

6.47

1.7

1.6

1.03

1.17

mg/l

0.30

548

Hypersplenism

245

2.58

6.43

3.0

1.6

1.59

1.03

mg/l

0.65

191

Histrionic personality disorder

322

2.35

6.43

2.0

1.7

0.75

1.04

mg/l

0.92

253

Intentional self-harm by sharp object

228

1641

1.50

6.42

2.5

1.9

0.83

0.93

mg/l

0.39

154

1166

Other bursitis of elbow

441

2.07

6.42

3.5

1.6

1.53

1.36

mg/l

0.28

338

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

212

1516

1.54

6.41

1.9

1.7

0.68

0.66

mg/l

0.06

158

1127

Juvenile arthritis (FINNGEN)

411

3220

1.35

6.40

2.1

2.0

1.08

0.98

mg/l

0.32

315

2261

Premenstrual syndrome

120

764

1.78

6.38

1.6

1.5

0.52

0.81

mg/l

2.59

566

Amputation of thigh

203

1426

1.52

6.36

3.5

1.6

2.31

1.53

mg/l

2.20

180

1129

Foreign body entering into or through eye or natural orifice

684

5677

1.26

6.36

1.9

1.8

1.16

1.15

mg/l

0.02

489

4230

Tracheo-bronchomalasia

236

2.51

6.36

2.0

1.6

0.45

0.58

mg/l

0.72

184

Scleritis

127

822

1.76

6.35

1.9

1.7

0.94

0.93

mg/l

0.03

630

Orthopaedic devices associated with adverse incidents

157

1065

1.66

6.34

1.8

1.6

1.76

1.26

mg/l

0.59

114

846

Suppurative otitis media, unspecified

231

1670

1.49

6.33

1.6

1.8

0.92

1.15

mg/l

1.16

166

1221

Allergic contact dermatitis due to drugs in contact with skin

212

1520

1.54

6.32

1.9

1.6

0.91

1.12

mg/l

0.90

155

1172

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

135

876

1.69

6.32

2.3

1.7

1.58

1.32

mg/l

0.63

113

673

Late syphilis

123

790

1.76

6.29

1.8

1.7

1.18

1.30

mg/l

0.24

623

Use of antiglaucoma preparations and miotics

633

5218

1.27

6.26

1.6

1.7

1.59

1.48

mg/l

0.22

494

4057

Other specific arthropathies, wide

196

1383

1.55

6.25

1.7

1.6

1.10

1.13

mg/l

0.07

149

1043

Measles

123

795

1.76

6.21

1.7

0.63

0.77

mg/l

0.61

599

Congenital deformities of feet

228

1654

1.49

6.20

2.1

1.9

1.53

0.94

mg/l

0.51

170

1212

Other endocrine disorders

437

3332

1.33

6.19

2.9

2.6

2.11

1.21

mg/l

0.94

316

2440

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1155

10031

1.19

6.19

1.6

1.7

1.53

1.21

mg/l

0.87

901

7691

Benign neoplasm: Other and unspecified parts of small intestine

156

1063

1.65

6.19

2.5

1.6

1.04

1.22

mg/l

0.60

133

827

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

530

1.95

6.17

1.8

1.7

1.36

1.29

mg/l

0.11

418

Osteopathy in diseases classified elsewhere

397

2.13

6.17

3.1

2.0

2.25

1.19

mg/l

0.66

318

Fistulae involving female genital tract

154

1043

1.64

6.17

1.6

1.7

2.02

1.16

mg/l

0.52

111

794

Toxic effect of ethanol

364

2828

1.37

6.17

1.7

1.9

1.48

1.04

mg/l

1.08

266

2073

Inguinal hernia, unilateral

230

1673

1.49

6.16

1.9

1.7

1.20

mg/l

0.01

175

1292

Inguinal of femoral hernia, unilateral

230

1673

1.49

6.16

1.9

1.7

1.20

mg/l

0.01

175

1292

Femoral hernia, unilateral

230

1673

1.49

6.16

1.9

1.7

1.20

mg/l

0.01

175

1292

Injury of muscle and tendon at forearm level

176

1223

1.58

6.16

1.6

1.8

1.24

1.06

mg/l

0.49

134

910

Other intracranial haemorrhages

231

1675

1.48

6.15

2.2

1.6

2.01

1.52

mg/l

0.81

187

1326

Carcinoma in situ, bladder

233

1695

1.48

6.15

1.7

1.6

1.60

1.34

mg/l

0.49

180

1314

Other conditions related to polyarteritis nodosa

132

3.25

6.13

1.7

1.6

1.26

1.09

mg/l

0.21

109

Deficiency of other B group vitamins

182

1271

1.56

6.12

2.1

1.6

1.35

1.21

mg/l

0.24

142

994

Dependent personality disorder

205

1472

1.54

6.12

1.8

1.7

1.07

1.12

mg/l

0.12

153

1118

Disturbances of smell and taste

361

2810

1.37

6.11

1.9

1.7

1.05

1.20

mg/l

0.39

281

2177

Benign neoplasm: Conjunctiva

267

1991

1.44

6.10

1.7

0.85

1.12

mg/l

1.38

189

1505

Dislocation, sprain and strain of joints and ligaments of elbow

557

4553

1.28

6.09

1.9

0.86

1.04

mg/l

1.24

421

3337

Pneumococcal septicemia

279

2095

1.43

6.09

1.9

1.81

1.23

mg/l

1.27

224

1594

Serous carcinoma of ovary

309

2365

1.41

6.09

1.8

2.54

1.15

mg/l

4.70

260

1824

Open wound of hip and thigh

285

2150

1.42

6.02

1.9

1.8

1.14

1.04

mg/l

0.26

226

1563

Neovascular glaucoma

329

2529

1.38

6.01

1.9

1.7

1.46

1.24

mg/l

0.84

270

1946

Other prurigo

114

730

1.78

6.01

1.8

1.6

1.77

1.17

mg/l

0.35

570

Glaucoma suspect

3186

29337

1.11

6.00

1.8

1.7

1.25

1.33

mg/l

0.63

2433

22734

399

3114

1.33

6.00

1.9

1.7

1.32

1.42

mg/l

0.20

320

2410

IBD (strict) with PSC

603

1.86

6.00

2.5

2.2

1.73

0.90

mg/l

1.31

446

Delayed milestone in childhood

125

725

1.69

5.99

5.8

3.34

1.80

mg/l

1.02

102

508

Burn and corrosion confined to eye and adnexa

222

1617

1.50

5.98

1.9

1.8

0.63

1.03

mg/l

5.27

161

1208

Calcaneal spur

112

710

1.77

5.98

1.7

1.5

0.98

1.12

mg/l

0.23

549

Colitis due to radiation

548

1.89

5.98

2.5

1.7

1.76

1.44

mg/l

0.23

432

Colitis, primary sclerosing

133

880

1.69

5.98

2.2

2.0

1.90

0.96

mg/l

2.22

111

656

Restrictive cardiomyopathy

213

2.68

5.95

5.6

1.9

1.12

1.19

mg/l

0.12

173

Unspecified maternal hypertension

128

846

1.73

5.94

1.8

1.7

1.08

0.64

mg/l

1.98

101

618

Erectile dysfunction

592

4877

1.27

5.93

11.0

1.6

1.74

1.63

mg/l

0.25

477

3844

Other contact dermatitis

738

6213

1.24

5.92

1.9

1.8

1.00

1.11

mg/l

0.57

533

4707

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

443

3533

1.31

5.92

2.2

1.6

2.86

1.34

mg/l

5.77

368

2755

L02BG Aromatase inhibitors

2640

24149

1.12

5.92

1.6

1.7

1.26

1.18

mg/l

0.86

2048

18641

Benign neoplasm: Larynx

244

1798

1.45

5.91

1.7

0.93

1.15

mg/l

1.36

193

1374

Abnormal reflex

332

2.26

5.91

1.9

1.7

0.69

1.28

mg/l

1.94

268

Oral lichen ruber planus, including avohilmo

510

4156

1.30

5.91

1.6

1.8

0.97

1.13

mg/l

0.82

383

3194

Carcinoma in situ of skin of ear and external auricular canal

108

680

1.77

5.90

1.7

1.6

2.31

1.51

mg/l

0.72

546

Glaucoma secondary to other eye disorders

331

2554

1.38

5.89

1.8

1.7

1.46

1.23

mg/l

0.91

271

1971

Exposure to other and unspecified man-made environmental factors

156

1072

1.62

5.88

2.2

1.7

0.90

1.14

mg/l

0.74

116

805

Thyrotoxicosis with toxic multinodular goitre

506

4121

1.30

5.86

1.9

1.7

1.35

1.25

mg/l

0.36

398

3188

Other protozoal intestinal diseases

137

917

1.67

5.85

1.8

1.9

1.56

1.06

mg/l

0.60

100

697

Social disorders starting during childhood or adolecense, excluding more controls

360

2.06

5.85

2.2

2.3

0.73

0.81

mg/l

0.23

240

Other and unspecified injuries of thorax

167

1162

1.58

5.84

1.9

1.7

1.34

1.12

mg/l

0.41

127

881

Autoimmune thyroiditis

188

1341

1.55

5.83

1.8

1.7

0.89

0.98

mg/l

0.25

135

1000

Contact with other sharp object(s)

566

4656

1.27

5.83

1.8

0.89

0.98

mg/l

0.55

408

3399

Other congenital malformations of nervous system

615

1.83

5.82

1.7

2.1

0.80

0.97

mg/l

0.36

433

Patellar tendinitis

155

1060

1.59

5.78

2.0

1.7

1.17

0.96

mg/l

0.32

109

772

Tooth eruption problems

1242

10776

1.17

5.78

2.3

2.0

1.16

0.99

mg/l

0.83

874

7553

Other and unspecified bullous disorders

603

1.85

5.78

2.2

1.9

1.92

1.18

mg/l

0.51

467

Other lesions of median nerve

238

1760

1.46

5.77

1.6

1.15

1.23

mg/l

0.21

187

1357

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

706

5938

1.24

5.77

2.1

1.8

1.20

1.04

mg/l

0.46

536

4448

Other congenital malformations of circulatory system

232

1715

1.47

5.77

2.4

1.8

1.39

1.17

mg/l

0.39

190

1291

Injury of muscle and tendon at wrist and hand level

1171

10238

1.18

5.77

1.9

1.8

0.95

1.17

mg/l

1.55

894

7837

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

173

2.74

5.75

2.1

2.7

1.09

0.92

mg/l

0.20

127

All dysplastic lesions of the vulva

408

3260

1.34

5.75

1.9

1.7

0.96

0.88

mg/l

0.37

315

2440

Family history of malignant neoplasm

956

8248

1.20

5.75

1.6

1.05

0.96

mg/l

0.45

740

6214

Assault by blunt object

135

903

1.66

5.74

1.8

0.98

mg/l

0.00

656

Carcinoma in situ of skin of lower limb, including hip

155

1066

1.60

5.74

1.7

1.6

3.01

1.32

mg/l

0.85

112

831

Non-Hodgkin lymphoma, all

292

2221

1.40

5.74

2.3

1.7

2.10

1.48

mg/l

1.35

245

1739

Alzheimer’s disease, wide definition

1418

13408

0.87

5.73

1.6

1.95

1.63

mg/l

1.68

1075

10533

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

583

1.87

5.72

1.9

1.6

1.57

1.00

mg/l

1.95

456

Degenerative diseases of the nervous system

2199

18266

0.89

5.71

1.6

1.7

1.85

1.58

mg/l

1.82

1672

14410

Postpartum hemorraghe, parous women as controls

2668

21402

1.12

5.70

1.8

1.7

1.20

0.81

mg/l

6.53

2028

16002

Other bursal cyst

133

886

1.66

5.70

1.4

1.7

0.89

1.16

mg/l

1.08

694

Other disorders of central nervous system

118

771

1.73

5.69

2.0

1.8

0.83

1.22

mg/l

1.53

594

Benign neoplasm of urinary organs

381

3013

1.34

5.69

1.8

1.7

1.71

1.29

mg/l

0.96

294

2337

Disorders in reading

136

908

1.64

5.69

3.2

2.6

0.83

0.98

mg/l

0.38

616

Fasciculation

114

740

1.75

5.66

2.2

1.8

0.70

1.15

mg/l

2.27

566

Psoriasis (vulgaris), strict definition

278

2113

1.41

5.65

1.7

1.8

1.32

1.03

mg/l

0.50

213

1578

Other and unspecified acquired haemolytic anaemias

560

1.87

5.65

5.0

1.8

2.44

1.38

mg/l

0.53

438

Systemic sclerosis, icd10

228

1689

1.47

5.65

2.1

1.7

1.52

1.01

mg/l

0.79

187

1311

Benign neoplasm of other and unspecified intrathoracic organs

101

636

1.80

5.65

2.5

1.6

1.25

1.01

mg/l

0.38

493

Localized adiposity

353

2.20

5.64

2.2

1.7

1.07

0.97

mg/l

0.13

277

Lichen simplex chronicus

300

2306

1.39

5.63

1.7

1.6

1.25

1.10

mg/l

0.45

236

1777

Congenital malformations of ovaries, fallopian tubes and broad ligaments

560

4635

1.27

5.62

1.7

1.8

0.87

0.82

mg/l

0.17

447

3420

Carcinoma in situ of skin, other sites/unspecified

613

1.80

5.56

1.9

1.7

1.47

1.27

mg/l

0.29

477

Assault by other specified means

608

1.82

5.56

2.1

1.8

2.74

0.94

mg/l

0.56

451

Other rupture of muscle

342

2.12

5.55

1.8

1.6

1.30

1.21

mg/l

0.10

271

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

155

1071

1.58

5.55

3.1

1.7

2.12

1.08

mg/l

0.84

123

808

Alzheimer disease

1875

15700

0.88

5.54

1.5

1.7

1.91

1.62

mg/l

1.66

1413

12394

Other and unspecified diseases of spleen

253

2.41

5.54

1.5

1.8

1.27

0.89

mg/l

0.42

201

Burn and corrosion of head and neck

190

1365

1.51

5.53

1.7

1.9

1.11

1.17

mg/l

0.10

144

1012

Use of donepezil

1125

12365

0.85

5.52

1.5

1.6

1.82

1.64

mg/l

0.52

851

9668

Abnormality of white blood cells, not elsewhere classified

519

1.91

5.52

2.3

1.7

1.28

1.16

mg/l

0.19

398

Injury of nerves at hip and thigh level

233

2.48

5.49

1.8

0.56

1.44

mg/l

3.19

184

Erectile dysfunction, exclusion

176

2.63

5.48

19.4

1.6

1.72

2.28

mg/l

0.39

143

Pyoderma gangrenosum

451

1.98

5.48

2.5

1.7

1.33

1.13

mg/l

0.33

344

Malignant neoplasm of thymus

200

2.66

5.47

2.0

1.7

1.39

1.16

mg/l

0.31

161

Motor disorders

114

732

1.68

5.47

6.4

4.9

1.18

1.89

mg/l

0.99

496

Burns classified according to extent of body surface involved

579

1.83

5.46

2.3

1.8

1.25

1.49

mg/l

0.33

442

Fibrosis of liver

399

2.06

5.46

2.9

1.8

1.34

1.27

mg/l

0.09

317

Other bursitis of knee

120

790

1.68

5.45

3.3

1.7

1.35

1.24

mg/l

0.15

608

Androgenic alopecia

585

1.86

5.44

1.7

0.99

0.82

mg/l

0.29

441

Injury of nerves and spinal cord at thorax level

303

2.23

5.44

1.9

1.30

1.52

mg/l

0.26

238

Dementia in Alzheimer disease

975

9627

0.85

5.43

1.5

1.6

2.14

1.69

mg/l

1.40

721

7544

Surgical ablation of atrial fibrillation

343

2.18

5.40

3.0

1.7

2.05

1.33

mg/l

0.76

274

Major anomalies of jaw size

252

1904

1.43

5.40

2.0

1.9

1.07

mg/l

0.01

189

1423

Specific developmental disorder of motor function

114

723

1.67

5.39

6.4

4.7

1.18

1.62

mg/l

0.54

483

Benign neoplasm of other and unspecified sites

272

2075

1.40

5.39

1.8

1.7

1.08

1.09

mg/l

0.04

211

1580

Retinal breaks without detachment

1333

11820

1.16

5.38

1.7

1.05

1.28

mg/l

2.46

1000

9116

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

316

2463

1.37

5.38

2.7

1.6

1.33

1.16

mg/l

0.36

250

1859

Seminoma of testis

556

1.82

5.38

1.8

1.27

1.39

mg/l

0.15

411

Traumatic ischaemia of muscle

126

845

1.67

5.37

3.0

1.7

1.57

1.15

mg/l

0.37

644

Pre-eclampsia superimposed on chronic hypertension

395

2.07

5.37

2.0

1.7

0.83

0.58

mg/l

0.61

290

Abscess of external ear

138

944

1.63

5.35

1.9

1.8

1.02

1.11

mg/l

0.26

101

707

Lipomatosis, not elsewhere classified

168

2.81

5.34

1.9

1.6

0.98

0.90

mg/l

0.12

126

Eclampsia

162

2.86

5.32

2.2

1.8

1.69

0.70

mg/l

1.76

128

Benign leiomyoma with endometriosis

1462

13058

1.15

5.32

1.6

1.7

1.12

1.13

mg/l

0.01

1076

10004

Other factor of the environment

122

816

1.68

5.31

2.0

1.7

1.02

1.07

mg/l

0.14

102

622

Benign neoplasm: Hypopharynx

263

2.31

5.30

1.5

2.0

1.21

1.38

mg/l

0.26

209

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

758

6452

1.21

5.28

1.7

1.33

1.24

mg/l

0.40

585

4977

Other disorders of peripheral nervous system

365

2.08

5.28

1.8

1.7

0.94

1.30

mg/l

0.73

292

Paraplegia, diplegia of upper limbs

193

1404

1.49

5.27

2.4

1.8

1.41

1.21

mg/l

0.61

155

1075

Benign neoplasm: Kidney

287

2217

1.39

5.27

1.8

1.7

1.84

1.27

mg/l

1.06

222

1716

Disorders of optic nerve, not elsewhere classified

179

1288

1.52

5.26

1.8

1.7

1.73

1.23

mg/l

0.72

138

991

Hereditary erythropoietic porphyria

6.01

5.26

2.5

1.8

1.83

1.36

mg/l

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

549

4559

1.26

5.25

2.2

1.8

1.19

1.01

mg/l

0.40

422

3421

Anuria and oliguria

371

2.03

5.24

2.4

2.1

1.12

1.43

mg/l

0.74

288

Benign neoplasm: Other parts of oropharynx

555

1.83

5.24

1.8

1.6

1.91

0.88

mg/l

0.87

427

Struck by thrown, projected or falling objec

401

3221

1.31

5.23

1.8

1.9

0.96

1.06

mg/l

0.24

282

2387

Iliotibial band syndrome

107

695

1.72

5.22

1.7

1.6

0.76

1.04

mg/l

1.33

528

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1655

12377

1.14

5.21

1.6

1.7

2.01

1.33

mg/l

4.33

1383

9595

Contact with other hot fluids

264

2016

1.40

5.21

1.9

2.2

1.04

1.11

mg/l

0.19

189

1489

Embedded teeth, including avohilmo

816

7003

1.21

5.21

2.0

1.9

1.18

0.97

mg/l

0.92

582

4955

Exposure to other specified electric current

123

825

1.65

5.21

2.2

1.00

0.95

mg/l

0.06

593

Spinal enthesopathy

198

1425

1.45

5.21

1.5

1.61

mg/l

0.01

157

1117

Other injuries of lower limb, level unspecified

495

1.89

5.20

2.1

1.9

1.03

1.38

mg/l

0.64

394

Alopecia areata

245

1856

1.42

5.19

1.8

2.1

1.10

0.99

mg/l

0.24

184

1396

Benign neoplasm: Parotid gland

649

5477

1.24

5.19

1.7

1.8

1.54

1.26

mg/l

0.92

497

4211

Polypectomy (DHB20)

565

4708

1.25

5.18

1.7

1.20

1.24

mg/l

0.07

426

3615

Habit and impulse disorders

153

1072

1.56

5.17

2.2

1.7

0.87

0.98

mg/l

0.20

106

764

Hypertension, portal

170

2.73

5.17

2.4

1.7

3.11

1.20

mg/l

1.25

131

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

2538

14170

1.11

5.16

1.6

1.8

1.67

1.30

mg/l

3.32

1981

11069

Pustular psoriasis

410

3316

1.31

5.15

1.7

1.8

1.11

1.10

mg/l

0.03

322

2526

Striae atrophicae

112

742

1.71

5.15

2.0

1.7

1.26

0.92

mg/l

0.57

557

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

125

839

1.63

5.14

1.6

1.64

1.19

mg/l

1.26

105

646

Other congenital malformations of upper alimentary tract

444

1.95

5.14

2.0

1.8

1.65

1.48

mg/l

0.11

338

Other specified and unspecified disorders of eyelid

127

863

1.64

5.13

1.7

1.6

1.10

1.24

mg/l

0.30

106

673

Meningitis, viral

274

2.27

5.13

1.5

1.7

0.59

0.68

mg/l

0.36

204

Other disorders of prostate

245

1845

1.40

5.12

1.7

1.20

1.66

mg/l

2.07

198

1453

Tetraplegia

428

1.95

5.11

1.9

2.1

1.65

1.35

mg/l

0.25

347

Impaction of intestines

366

2.01

5.09

2.3

1.7

0.79

1.22

mg/l

2.07

289

Unspecified nephritic syndrome

196

1439

1.48

5.08

2.1

1.7

1.94

1.19

mg/l

1.59

158

1112

Primary open-angle glaucoma

2641

23678

1.11

5.07

1.8

1.7

1.53

1.47

mg/l

0.29

2037

18472

Mixed conductive and sensorineural hearing loss

1000

8735

1.18

5.06

1.7

1.30

1.36

mg/l

0.18

774

6759

Encephalopathy

559

1.80

5.06

2.0

1.7

2.25

1.41

mg/l

0.76

437

Vascular syndromes of brain in cerebrovascular disorders

345

2733

1.33

5.06

2.1

1.6

1.31

1.43

mg/l

0.32

270

2127

Benign neoplasm: Hypopharynx

268

2.26

5.05

1.5

1.8

1.21

1.01

mg/l

0.45

210

Benign neoplasm: Tongue

240

1822

1.42

5.03

1.9

1.6

1.14

1.18

mg/l

0.10

184

1397

Crossbite

528

4049

1.25

5.02

3.5

2.3

1.48

1.10

mg/l

0.60

367

2901

Eustachian salpingitis and obstruction

718

6127

1.22

5.01

1.7

0.82

0.88

mg/l

0.33

523

4406

Burn and corrosion of other internal organs

192

2.55

5.01

1.5

1.6

1.28

1.16

mg/l

0.07

149

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

158

2.72

5.01

2.1

1.6

3.21

1.03

mg/l

0.51

124

Other abnormal findings in urine

134

923

1.60

4.99

2.0

1.7

2.04

1.33

mg/l

0.80

108

732

Maze procedure for atrial fibrillation

293

2.23

4.99

2.2

1.7

1.49

1.59

mg/l

0.10

236

Primary open-angle glaucoma, strict

2146

19547

1.12

4.99

1.8

1.7

1.53

1.46

mg/l

0.36

1642

15272

Contracture of muscle

226

2.36

4.97

1.7

1.5

1.17

1.32

mg/l

0.15

175

Polymyositis

525

1.84

4.96

2.3

1.7

1.34

1.22

mg/l

0.16

422

Sexual dysfunction

137

949

1.59

4.96

1.9

1.7

0.64

1.16

mg/l

5.12

107

717

Melanocytic naevi of upper limb, including shoulder

199

1471

1.46

4.96

2.0

1.7

2.43

1.01

mg/l

0.82

151

1105

Benign neoplasm: Other/unspecified site

137

949

1.59

4.95

1.7

1.25

0.96

mg/l

0.65

101

738

LSIL lesion of the cervix uteri, vagina or vulva

1349

12049

1.15

4.94

1.7

0.88

0.86

mg/l

0.11

983

9012

Folate deficiency anaemia

478

1.86

4.91

2.1

1.6

1.35

1.37

mg/l

0.03

377

Inflammatory disorders of male genital organs, not elsewhere classified

105

685

1.68

4.91

1.7

1.69

1.44

mg/l

0.16

517

Other specified/unspecified disorders of bone/cartilage

245

1870

1.40

4.91

1.7

1.28

1.07

mg/l

0.38

188

1430

Male infertility

354

2815

1.31

4.90

2.4

1.9

1.45

0.93

mg/l

0.71

246

1964

Gonococcal infection

288

2247

1.37

4.90

1.8

1.9

1.14

1.01

mg/l

0.40

206

1674

Epileptic seizures related to drugs

166

2.63

4.89

2.1

1.8

1.03

0.92

mg/l

0.11

126

Drug-induced Cushing's syndrome

4.25

4.89

2.2

1.6

0.55

0.72

mg/l

0.61

Benign neoplasm: Pituitary gland, craniopharyngeal duct

427

3484

1.29

4.89

1.8

1.7

1.11

0.99

mg/l

0.32

322

2591

Sixth [abducent] nerve palsy

268

2071

1.38

4.88

1.7

1.8

1.53

1.32

mg/l

0.35

212

1596

Other nonthrombocytopenic purpura

543

1.81

4.88

1.9

1.58

1.13

mg/l

0.42

430

Chorioretinal scars

208

2.45

4.88

2.7

2.1

0.95

1.34

mg/l

0.64

159

Melanocytic naevi of other and unspecified parts of face

496

4110

1.26

4.86

2.0

1.8

1.11

0.97

mg/l

0.45

377

3074

Left hemicolectomy

192

1415

1.47

4.85

2.2

1.7

1.87

1.30

mg/l

2.23

165

1122

Other primary thrombocytopenia

252

2.31

4.84

2.1

1.39

1.01

mg/l

0.50

196

Atypical mycobacterium lung infection

104

685

1.70

4.84

2.5

1.6

1.34

1.29

mg/l

0.05

544

Use of biperiden

456

3752

1.28

4.84

1.7

1.03

1.08

mg/l

0.21

368

2852

Mental retardation, excluding more controls

298

2288

1.35

4.83

2.1

2.3

1.39

1.22

mg/l

0.43

241

1712

Perforation of oesophagus

256

2.21

4.82

1.8

1.7

2.13

1.32

mg/l

0.47

203

L02BX Other hormone antagonists and related agents

369

2967

1.31

4.81

1.6

1.7

2.41

1.62

mg/l

2.14

308

2375

Localized skin eruption due to drugs and medicaments

112

754

1.67

4.81

1.8

0.90

1.20

mg/l

0.59

591

Otorrhagia

399

1.97

4.81

2.9

1.8

1.16

1.33

mg/l

0.26

308

Lifestyle-related condition

111

745

1.67

4.80

2.0

1.7

1.05

1.11

mg/l

0.16

563

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

346

2760

1.32

4.80

1.6

1.31

1.26

mg/l

0.13

267

2106

Drug-induced obesity

610

1.76

4.79

1.7

1.22

0.91

mg/l

0.85

445

Parapsoriasis

170

1233

1.50

4.78

2.1

1.8

1.31

1.17

mg/l

0.16

137

934

Alzheimer’s disease (undefined)

502

0.37

4.78

1.3

1.6

1.12

1.49

mg/l

0.69

396

Endocrine disorders, other/unspecified

185

1362

1.48

4.78

1.7

1.02

1.03

mg/l

0.03

126

1038

Benign neoplasm: Connective and other soft tissue, unspecified

109

728

1.67

4.77

1.7

0.93

mg/l

0.00

552

Embolic stroke with flimmer

175

1263

1.47

4.77

2.1

1.6

1.39

1.68

mg/l

0.94

134

1008

Contusion of toe(s) with damage to nail

102

671

1.70

4.77

1.9

0.90

1.08

mg/l

0.45

495

Ankylosing spondylitis, strict definition

396

3217

1.30

4.76

1.8

1.02

0.93

mg/l

0.23

293

2353

Narcolepsy and cataplexy

404

1.92

4.76

1.9

1.6

1.18

1.31

mg/l

0.17

297

Embolic stroke

334

2646

1.32

4.76

2.1

1.6

1.60

1.62

mg/l

0.05

261

2071

N06DA Anticholinesterases

2094

18557

0.90

4.76

1.5

1.6

1.79

1.60

mg/l

1.04

1585

14651

Use of anticholinesterases

2094

18557

0.90

4.76

1.5

1.6

1.79

1.60

mg/l

1.04

1585

14651

Deformity of finger(s)

353

2.00

4.73

1.8

1.5

1.57

0.99

mg/l

0.68

265

Melanocytic naevi, other sites/unspecified

649

5522

1.22

4.73

2.1

1.8

1.00

0.98

mg/l

0.09

507

4132

Benign neoplasm: salivary glands, exclude unknown (D119)

716

6143

1.21

4.72

1.7

1.8

1.52

1.27

mg/l

0.84

547

4714

Congenital malformations of the nervous system

197

1464

1.45

4.72

1.9

2.5

0.83

1.16

mg/l

1.12

150

1074

Motorcycle rider injured in other and unspecified transport accidents

475

3924

1.26

4.71

1.9

2.0

1.13

0.99

mg/l

0.43

348

2775

Amblyopia ex anopsia

332

2641

1.32

4.71

2.0

2.1

1.28

1.20

mg/l

0.09

236

1951

Dislocation of lens

110

731

1.63

4.71

1.7

1.6

1.64

1.37

mg/l

0.24

577

Prolapse and hernia of ovary and fallopian tube

306

2385

1.34

4.71

1.6

1.7

1.50

1.65

mg/l

0.25

243

1820

Other and unspecified primary disorders of muscles

446

1.88

4.70

2.1

2.2

2.46

1.20

mg/l

0.46

352

Acute epiglottitis

136

950

1.56

4.70

2.1

1.7

2.26

1.14

mg/l

0.58

103

744

Ulcerative colitis (strict) with PSC

484

1.83

4.70

2.3

2.2

1.84

0.97

mg/l

1.10

358

533

1.80

4.69

2.2

1.6

1.17

0.93

mg/l

0.23

415

Erosion and ectropion of cervix uteri

248

1907

1.39

4.69

2.0

1.7

0.92

1.27

mg/l

1.71

181

1457

Benign neoplasm: Other and unspecified parts of mouth

295

2325

1.35

4.69

1.8

1.7

1.11

1.18

mg/l

0.17

227

1789

Endometroid carcinoma of ovary

616

1.75

4.65

1.9

1.6

1.57

1.02

mg/l

1.81

476

Diphtheria

3.46

4.65

2.1

1.06

0.94

mg/l

0.12

Other and unspecified injuries of neck

549

1.78

4.64

1.9

1.8

0.77

1.22

mg/l

1.31

405

Intussusception

186

1375

1.46

4.64

1.7

0.95

1.07

mg/l

0.30

138

1050

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

612

1.72

4.63

1.6

1.7

2.17

1.09

mg/l

1.06

484

Dermatopolymyositis

135

947

1.57

4.63

2.2

1.8

1.24

1.13

mg/l

0.21

101

747

Disorders of myoneural junction and muscle in diseases classified elsewhere

505

1.83

4.62

2.2

1.6

1.16

0.99

mg/l

0.39

402

Evidence of alcohol involvement determined by level of intoxication

103

684

1.67

4.61

1.8

1.7

0.97

1.07

mg/l

0.21

504

Pneumoconiosis due to asbestos and other mineral fibres

144

1012

1.51

4.59

1.6

1.7

1.20

1.69

mg/l

1.47

105

814

Benign neoplasm: Anus and anal canal

236

1811

1.40

4.57

1.8

1.6

1.23

1.22

mg/l

0.02

186

1393

Intracranial and intraspinal abscess and granuloma

102

679

1.68

4.57

2.0

1.7

1.93

1.29

mg/l

0.80

523

Generalized epilepsy, mode (most common among epilepsy diagnosis)

285

2240

1.35

4.57

1.7

2.0

1.51

1.09

mg/l

0.42

210

1668

Other and unspecified disorders of pigmentation

442

1.87

4.57

2.0

1.7

0.74

1.16

mg/l

1.83

335

Transient synovitis

453

1.82

4.57

2.9

1.7

0.98

1.11

mg/l

0.20

332

Stenosis and insufficiency of lacrimal passages

772

6678

1.20

4.56

1.6

1.8

1.16

1.27

mg/l

0.52

577

5085

Polyarteritis nodosa

395

1.91

4.56

2.0

1.8

0.96

1.50

mg/l

1.77

318

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

2073

18242

1.12

4.55

1.6

1.7

1.23

1.05

mg/l

1.65

1603

13889

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

123

853

1.60

4.53

1.8

1.6

1.10

1.09

mg/l

0.02

666

Alzheimer disease, including avohilmo

2271

17856

0.90

4.53

1.5

1.7

1.83

1.59

mg/l

1.54

1741

14107

Sequelae of infectious and parasitic diseases

652

5567

1.21

4.53

1.9

1.7

1.04

1.09

mg/l

0.15

501

4208

L02BA Anti-estrogens

1504

13582

1.14

4.53

1.6

1.7

1.15

1.06

mg/l

0.55

1150

10399

Colon adenocarcinoma

896

7832

1.18

4.52

1.7

1.77

1.46

mg/l

1.71

727

6108

Carcinoma in situ of colon

111

753

1.64

4.52

1.8

1.7

2.29

1.10

mg/l

0.75

592

Thalassaemia

221

2.32

4.52

5.5

2.4

1.16

1.20

mg/l

0.03

165

Benign neoplasm: Bronchus and lung

105

701

1.64

4.52

1.7

1.6

1.32

1.01

mg/l

0.51

550

Other vitreous opacities

312

2484

1.33

4.51

1.9

1.7

1.41

1.22

mg/l

0.21

245

1914

Arthropathy in Crohn disease

100

666

1.69

4.51

1.8

1.6

0.78

0.93

mg/l

0.43

505

Pustulosis palmaris et plantaris

369

2998

1.30

4.51

1.6

1.7

1.11

mg/l

0.00

289

2274

Abscess of tendon sheath

328

2.00

4.51

2.0

1.6

0.87

1.24

mg/l

1.20

255

Nontoxic single thyroid nodule

629

5367

1.22

4.50

2.1

1.7

0.97

1.11

mg/l

0.74

500

4109

Valgus deformity, not elsewhere classified

426

1.85

4.49

3.1

1.6

1.45

1.00

mg/l

0.67

313

Malignant neoplasm of breast, HER2-negative

4895

33974

1.07

4.48

1.6

1.7

1.20

1.10

mg/l

1.37

3768

26102

Other hereditary haemolytic anaemias

368

1.96

4.48

6.0

1.8

1.00

1.24

mg/l

0.44

277

Tic and related disorders

650

1.65

4.48

3.1

2.4

1.21

0.95

mg/l

0.45

453

Abscess of Bartholin gland

262

2051

1.37

4.47

1.8

1.6

0.94

0.85

mg/l

0.30

190

1521

Prophylactic surgery

485

1.82

4.46

1.5

1.6

0.80

0.85

mg/l

0.10

372

Injury of nerves at ankle and foot level

453

1.85

4.46

2.1

1.7

0.86

1.10

mg/l

0.58

346

All dysplastic lesions of the cervix uteri, vagina or vulva

2932

27101

1.10

4.46

1.7

0.94

0.89

mg/l

0.45

2165

20195

Pediculosis, acariasis and other infestations

485

4050

1.25

4.41

2.1

1.8

1.02

1.04

mg/l

0.07

374

3022

Lower leg

387

1.95

4.41

1.7

2.0

1.19

1.15

mg/l

0.03

298

Viral encephalitis, not elsewhere classified/unspecified

174

1285

1.46

4.41

2.0

1.7

0.83

1.22

mg/l

2.73

138

979

Carcinoma in situ of other and unspecified sites

254

1976

1.36

4.40

1.7

1.70

1.49

mg/l

0.37

200

1560

Gastrojejunal ulcer

103

689

1.64

4.40

1.8

1.20

1.28

mg/l

0.11

538

HSIL lesion of the vulva

161

1181

1.50

4.40

1.7

1.6

0.92

mg/l

0.00

127

892

Other disorders of bone density and structure

231

1779

1.39

4.40

2.0

1.8

0.73

1.06

mg/l

3.47

170

1327

Systemic disorders of connective tissue in diseases classified elsewhere

245

2.22

4.39

5.2

1.9

1.18

1.01

mg/l

0.21

184

Other abnormal auditory perceptions

110

753

1.64

4.39

1.7

1.8

0.80

1.12

mg/l

1.01

566

Benign neoplasm of major salivary glands

796

6925

1.19

4.38

1.7

1.8

1.53

1.29

mg/l

0.92

611

5316

Diabetic retinopathy, strict definition

1516

12051

1.14

4.38

1.9

2.0

1.23

1.28

mg/l

0.25

1193

9472

Chondromalacia

261

2047

1.36

4.37

1.6

1.7

0.90

1.06

mg/l

0.33

192

1565

Other disorders of choroid

119

823

1.58

4.36

2.5

1.7

1.11

1.29

mg/l

0.49

645

Lupus erythematosus

216

1653

1.41

4.35

1.8

1.7

0.96

1.10

mg/l

0.55

179

1259

Benign neoplasm: Appendix

605

1.70

4.35

1.9

1.6

1.29

1.02

mg/l

0.56

470

Pemphigoid

204

1544

1.41

4.35

1.6

1.7

1.55

1.36

mg/l

0.50

161

1213

Blood alcohol or alcohol intoxication level

213

1623

1.40

4.34

1.9

1.8

1.08

1.06

mg/l

0.03

171

1191

Chronic iridocyclitis

417

3440

1.27

4.34

1.8

1.7

1.67

1.12

mg/l

0.91

314

2585

Benign neoplasm: Oesophagus

105

711

1.64

4.33

1.8

1.7

1.00

1.01

mg/l

0.04

559

Open wound of shoulder and upper arm

167

1227

1.47

4.33

1.9

1.8

1.32

1.09

mg/l

0.39

129

906

Juvenile osteochondrosis

289

2291

1.33

4.32

2.0

1.9

0.92

1.01

mg/l

0.37

215

1660

Reduction defects of lower limb

141

2.66

4.32

1.8

2.4

1.37

0.93

mg/l

0.51

102

Sequelae of other and unspecified infectious and parasitic diseases

499

4193

1.24

4.31

1.9

1.7

0.89

0.93

mg/l

0.08

371

3141

Cholesteatoma of external ear

451

1.84

4.30

1.5

1.8

1.13

1.45

mg/l

0.70

361

Disseminated intravascular coagulation [defibrination syndrome]

183

2.44

4.29

3.6

1.7

5.49

1.05

mg/l

1.49

143

Syphilis

217

1662

1.40

4.29

1.8

1.16

mg/l

0.00

168

1287

Oral lichen ruber planus, hypothyreosis or thyroxin

149

1085

1.52

4.29

1.7

1.5

0.95

1.06

mg/l

0.28

116

844

Benign neoplasm of other and unspecified intrathoracic organs

101

682

1.65

4.28

2.5

1.7

1.25

1.21

mg/l

0.05

539

Malignant neoplasm of breast

5052

34509

1.07

4.27

1.6

1.7

1.20

1.10

mg/l

1.65

3889

26480

Benign neoplasm: Connective and other soft tissue, unspecified

109

747

1.62

4.27

1.7

1.6

0.93

1.14

mg/l

0.68

587

Tarsal tunnel syndrome

102

692

1.66

4.27

1.7

1.6

1.57

0.98

mg/l

0.47

529

Complications following abortion and ectopic and molar pregnancy

309

2480

1.32

4.26

1.7

1.8

1.26

1.09

mg/l

0.31

225

1917

Burn and corrosion of trunk

246

1918

1.36

4.24

1.9

1.22

1.15

mg/l

0.13

177

1451

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

813

7112

1.18

4.23

1.9

1.7

1.03

0.86

mg/l

1.00

600

5296

Benign neoplasm: Other parts of oropharynx

587

1.71

4.23

1.8

1.7

1.91

1.22

mg/l

0.50

466

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

628

5385

1.21

4.23

2.1

1.8

1.15

1.03

mg/l

0.29

484

4028

Macular hole

416

3443

1.27

4.22

2.2

1.8

1.07

1.44

mg/l

3.00

326

2696

Systemic sclerosis,strict definition

630

1.69

4.22

2.0

1.7

1.22

0.90

mg/l

0.88

488

Carcinoma in situ of other and unspecified digestive organs

197

1494

1.42

4.21

2.6

1.7

2.15

1.32

mg/l

0.97

162

1174

Retained placenta and membranes, without haemorrhage

1122

10020

1.15

4.18

1.7

1.05

0.92

mg/l

0.88

850

7487

Nontoxic diffuse goitre

277

2199

1.34

4.18

2.0

1.6

1.15

1.06

mg/l

0.21

209

1691

Corneal scars and opacities

219

1687

1.39

4.17

1.8

1.7

1.08

1.21

mg/l

0.37

165

1289

Dental caries 3 and operation codes, only avohilmo

3574

16799

1.09

4.17

1.8

2.0

1.09

1.19

mg/l

0.98

2614

12779

Other congenital malformations, not elsewhere classified

491

1.76

4.17

2.9

2.6

1.76

1.05

mg/l

0.45

357

Pathological resorption of teeth

247

1929

1.36

4.16

1.7

1.6

1.04

1.14

mg/l

0.33

190

1489

Mesothelioma

108

741

1.60

4.15

1.8

1.7

1.82

1.62

mg/l

0.33

592

Acute and transient psychotic disorders

1048

9317

1.16

4.15

1.9

1.8

1.26

1.02

mg/l

2.17

797

6980

Adult respiratory distress syndrome

109

750

1.60

4.14

3.2

1.7

1.83

1.41

mg/l

0.59

590

Malignant neoplasm of heart, mediastinum and pleura

101

684

1.62

4.13

2.2

1.7

1.61

1.50

mg/l

0.17

538

Other disorders of electrolyte and fluid balance, not elsewhere classified

467

1.76

4.12

2.0

1.6

1.23

1.08

mg/l

0.16

363

Malignant neoplasm of breast, HER-positive

3150

29058

1.09

4.12

1.6

1.7

1.18

1.14

mg/l

0.30

2422

22408

Other facial nerve disorders

243

1901

1.36

4.11

1.8

1.6

0.81

1.11

mg/l

2.50

180

1422

Alzheimer’s disease (undefined), excluding more controls

456

0.40

4.11

1.3

1.5

1.12

1.81

mg/l

1.46

358

Carcinoma in situ, bladder

233

1811

1.37

4.11

1.7

1.60

1.48

mg/l

0.19

180

1429

136

935

1.49

4.11

2.5

5.1

1.80

1.76

mg/l

0.04

633

Fourth [trochlear] nerve palsy

191

1450

1.42

4.09

1.8

1.7

1.20

1.18

mg/l

0.03

145

1113

Cysts of oral region, not elsewhere classified

352

2869

1.28

4.09

2.0

1.7

1.33

1.29

mg/l

0.08

274

2226

Contact with blunt object, undetermined intent

387

1.88

4.07

1.8

1.7

0.76

1.03

mg/l

0.58

293

Cholera

350

2859

1.29

4.06

1.7

1.8

1.04

1.23

mg/l

0.83

277

2230

Selective deficiency of immunoglobulin A [IgA]y

282

2.08

4.05

2.1

1.26

0.85

mg/l

0.70

217

Acute hepatitis B

266

2.09

4.05

1.8

1.7

1.14

1.00

mg/l

0.23

211

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

104

714

1.61

4.03

2.1

1.6

2.21

1.04

mg/l

0.66

544

Calcification and ossification of muscle

139

2.62

4.03

2.1

1.6

1.31

1.56

mg/l

0.22

109

Unequal limb length (acquired)

484

1.72

4.02

2.2

2.0

0.62

0.94

mg/l

1.86

319

Disorders of brain, other and unspecified

567

1.68

4.02

2.5

1.7

1.64

1.17

mg/l

0.75

441

Other secondary coxarthrosis

279

2227

1.33

4.02

1.6

1.7

1.54

1.14

mg/l

1.91

219

1707

Other specified and unspecified disorders of conjunctiva

569

1.69

4.01

4.0

1.7

2.57

1.31

mg/l

0.41

440

Schizophrenia

1437

13020

1.13

4.01

1.8

1.09

1.05

mg/l

0.22

1068

9725

Unspecified visual impairment (binocular)

126

897

1.53

4.00

1.7

1.9

1.13

1.21

mg/l

0.15

691

Torticollis

138

994

1.49

4.00

1.9

1.8

0.72

1.01

mg/l

1.29

737

Haemorrhagic disorder due to circulating anticoagulants

623

1.64

4.00

4.8

1.7

1.89

1.51

mg/l

0.41

490

Melanoma in situ

290

2324

1.32

3.99

2.3

1.6

1.91

1.31

mg/l

0.42

220

1798

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

223

1730

1.37

3.98

1.9

1.7

1.40

1.21

mg/l

0.59

174

1342

Family history of other conditions

118

832

1.55

3.97

1.7

1.9

1.13

1.04

mg/l

0.11

620

Other/unspecified crystal arthropathies

359

1.91

3.96

1.8

1.7

1.35

1.32

mg/l

0.04

280

Malignant neoplasm of other connective and soft tissue

187

1420

1.41

3.96

2.3

1.7

2.26

1.29

mg/l

0.96

159

1117

Acute appendicitis, with complications

1768

16190

1.11

3.95

1.8

1.44

1.17

mg/l

1.69

1356

12476

Contact with other specified venomous animals

405

1.84

3.95

1.8

1.44

1.16

mg/l

0.17

300

Burn and corrosion of hip and lower limb, except ankle and foot

197

1507

1.40

3.95

2.0

1.9

1.95

1.09

mg/l

0.43

133

1120

Other bullous disorders

227

1772

1.37

3.94

2.0

1.8

1.35

1.17

mg/l

0.21

174

1366

Melanocytic naevi of upper limb, including shoulder

199

1528

1.40

3.94

2.0

1.7

2.43

1.13

mg/l

0.72

151

1157

Other benign neoplasms of connective and other soft tissue

840

7395

1.17

3.94

1.7

1.8

1.15

1.16

mg/l

0.02

648

5609

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

352

1.91

3.94

1.9

1.7

1.54

1.14

mg/l

0.82

272

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

222

1731

1.37

3.93

2.0

1.7

1.78

1.01

mg/l

1.14

177

1281

Complications peculiar to reattachment and amputation

373

1.86

3.93

2.7

1.6

1.39

1.23

mg/l

0.25

305

Multifocal fibrosclerosis

407

1.84

3.92

1.8

1.6

1.46

1.32

mg/l

0.14

326

Benign neoplasm of other and unspecified sites

272

2173

1.33

3.91

1.8

1.7

1.08

1.15

mg/l

0.21

211

1679

Congenital malformations of spine and bony thorax

351

1.89

3.91

3.4

2.8

1.03

0.83

mg/l

0.38

262

Peptic ulcer

545

1.68

3.91

2.1

1.6

1.15

1.22

mg/l

0.11

429

Occupational exposure to risk-factors

267

2128

1.33

3.90

1.8

1.7

1.11

1.27

mg/l

0.45

207

1647

Demyelinating diseases of the central nervous system

794

6975

1.18

3.90

1.7

1.8

0.84

0.96

mg/l

1.02

578

5185

Chromosomal abnormalities, not elsewhere classified

175

1315

1.42

3.89

1.9

3.0

1.04

1.28

mg/l

0.49

137

974

Other hyperalimentation

213

2.27

3.89

1.6

1.7

0.90

1.10

mg/l

0.29

168

Failed attempted abortion

126

906

1.53

3.88

1.8

1.6

1.04

0.74

mg/l

0.40

672

Carcinoma in situ of skin, other sites/unspecified

671

1.61

3.87

1.9

1.7

1.47

1.52

mg/l

0.06

532

Other bacterial agents as the cause of diseases classified to other chapters

640

1.64

3.87

4.7

2.0

1.32

1.28

mg/l

0.06

495

Carcinoma in situ of skin of lower limb, including hip

155

1152

1.46

3.86

1.7

1.6

3.01

1.41

mg/l

0.79

112

903

Use of selegiline

342

2799

1.28

3.85

1.8

1.7

1.27

1.44

mg/l

0.64

271

2198

Adenocarcinoma and papillary adenocarcinoma of stomach

109

1548

0.67

3.83

1.5

1.7

2.38

1.43

mg/l

2.37

1213

Contact with lifting and transmission devices, not elsewhere classified

155

1152

1.45

3.82

1.7

1.8

1.49

1.19

mg/l

0.35

113

865

Mantle cell lymphoma

487

1.73

3.82

2.5

1.8

1.89

1.58

mg/l

0.22

377

Scabies

366

3022

1.27

3.82

2.1

1.8

0.95

0.99

mg/l

0.13

280

2215

Intrahepatic Cholestasis of Pregnancy (ICP)

675

5878

1.19

3.81

1.9

1.7

0.94

0.79

mg/l

1.07

500

4334

Chronic hepatitis NAS

125

901

1.53

3.81

1.9

1.7

2.24

1.08

mg/l

2.05

102

697

Benign neoplasm: Skin of scalp and neck

200

1540

1.38

3.81

1.5

1.6

1.63

1.00

mg/l

1.27

151

1158

Hypothyroidism due to medicaments and other exogenous substances

102

709

1.60

3.81

1.8

1.7

1.85

1.16

mg/l

0.82

566

Other specified and unspecified disorders of lens

494

1.71

3.81

1.6

1.13

1.33

mg/l

0.46

387

Benign neoplasm: Orbit, unspecified

362

1.87

3.80

2.4

1.8

1.40

1.05

mg/l

0.33

279

Other disorders of amino-acid metabolism

263

2.03

3.80

4.9

1.6

10.62

0.98

mg/l

1.31

198

Cerebral palsy

144

1057

1.46

3.79

2.9

2.3

3.23

1.06

mg/l

1.38

114

751

Injury of muscle and tendon at ankle and foot level

212

1650

1.37

3.78

1.5

1.7

0.91

1.03

mg/l

0.18

152

1237

Other infective (teno)synovitis

250

2.08

3.77

1.6

1.5

1.06

1.10

mg/l

0.03

194

Brain meningioma, excluding all cancers (controls excluding all cancers)

402

3356

1.25

3.76

1.7

1.8

1.60

1.15

mg/l

0.47

313

2547

Acquired pure red cell aplasia [erythroblastopenia]

257

2.05

3.76

2.7

1.7

0.78

1.36

mg/l

1.48

189

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

229

2.16

3.76

2.5

1.6

3.27

1.59

mg/l

0.33

185

Thyrotoxicosis with toxic single thyroid nodule

572

1.67

3.75

2.2

1.7

0.92

1.07

mg/l

0.48

440

Carcinoma in situ of vulva

500

1.73

3.74

1.5

1.7

0.78

0.86

mg/l

0.21

376

Exposure to other and unspecified forces of nature

350

1.89

3.73

2.0

1.9

2.00

1.17

mg/l

0.63

270

Other injuries of spine and trunk, level unspecified

506

1.71

3.73

2.1

1.9

1.06

1.17

mg/l

0.18

394

Sequelae of intentional self-harm, assault and events of undetermined intent

419

1.79

3.73

2.4

1.9

0.94

0.79

mg/l

0.31

321

Other renal tubulo-interstitial diseases

213

1663

1.37

3.72

1.9

1.7

1.23

0.95

mg/l

0.86

164

1245

Benign neoplasm: Skin of upper limb, including shoulder

161

1208

1.43

3.72

1.7

1.6

1.02

1.03

mg/l

0.02

126

909

Malignant neoplasm of retroperitoneum and peritoneum

453

1.77

3.72

2.1

1.7

1.78

1.20

mg/l

1.76

357

Qualitative platelet defects

245

2.11

3.72

3.3

2.0

2.16

0.95

mg/l

0.69

194

Diastasis of muscle

458

1.74

3.71

1.7

1.6

0.90

1.05

mg/l

0.39

352

Pedal cyclist injured in noncollision transport accidents

951

8468

1.15

3.71

1.8

1.9

1.07

1.11

mg/l

0.23

719

6331

Premature rupture of membranes

2129

14467

1.10

3.71

1.7

0.84

0.83

mg/l

0.07

1533

10552

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

187

2.31

3.71

1.5

1.8

1.66

1.40

mg/l

0.15

157

237

1879

1.34

3.69

1.9

1.7

0.75

0.96

mg/l

1.40

168

1421

Benign neoplasm: Choroid

462

3915

1.23

3.69

2.0

1.8

0.98

1.26

mg/l

2.42

352

3022

Fall on and from ladder

590

5093

1.20

3.69

1.9

1.7

1.48

1.33

mg/l

0.42

477

3954

Oral lichen ruber planus

207

1617

1.37

3.68

1.6

1.7

0.90

1.16

mg/l

1.41

162

1233

Diabetes insipidus

574

1.65

3.65

1.9

1.7

1.15

1.10

mg/l

0.08

440

Malignant neoplasm of other and unspecified female genital organs

125

912

1.52

3.64

1.7

1.6

2.47

1.08

mg/l

4.15

107

712

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

323

2650

1.28

3.64

1.9

1.7

1.34

1.22

mg/l

0.30

267

2037

Recurrent and persistent haematuria

534

1.68

3.64

1.9

1.7

0.85

1.26

mg/l

1.75

413

Other and unspecified disorders of adult personality and behaviour

391

1.82

3.64

2.3

1.6

0.66

0.73

mg/l

0.27

289

Other degenerative diseases of the basal ganglia

122

881

1.51

3.64

1.4

1.7

1.40

1.42

mg/l

0.01

703

Other and unspecified medical devices associated with adverse incidents

323

1.94

3.64

2.3

1.8

1.15

1.40

mg/l

0.43

259

Dissection of cerebral arteries, nonruptured

453

1.74

3.64

1.6

0.62

1.05

mg/l

1.90

353

Endometriosis of fallopian tube

510

1.70

3.63

1.6

0.53

0.93

mg/l

2.76

383

Injury of cranial nerves

374

1.82

3.62

1.7

0.80

1.20

mg/l

1.25

288

Melanocytic naevi of lower limb, including hip

355

2943

1.26

3.61

2.3

1.7

0.91

1.05

mg/l

0.66

258

2206

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

322

1.91

3.61

1.7

1.05

0.99

mg/l

0.08

256

Benign neoplasm: Other/unspecified site

137

1010

1.47

3.61

1.7

1.25

1.12

mg/l

0.24

101

795

Other mycoses, not elsewhere classified/unspecified

189

2.28

3.60

5.6

1.9

2.53

1.21

mg/l

0.76

145

Varus deformity, not elsewhere classified

689

1.57

3.60

1.4

1.9

0.90

1.29

mg/l

1.11

520

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

230

1812

1.33

3.59

1.6

1.29

1.36

mg/l

0.15

175

1414

Liposarcoma, excluding all cancers (controls excluding all cancers)

575

1.64

3.59

1.9

1.7

1.38

1.09

mg/l

0.71

444

Other nonscarring hair loss

644

1.61

3.58

3.1

1.7

0.99

0.79

mg/l

0.37

492

Drug-induced hypoglycaemia without coma

131

957

1.47

3.58

1.8

1.27

1.21

mg/l

0.06

722

Gilbert syndrome

438

1.74

3.58

1.8

1.06

1.09

mg/l

0.05

334

Foreign body on external eye

1218

11016

1.13

3.57

1.7

1.9

1.16

1.13

mg/l

0.09

914

8300

Golimumab

293

2389

1.29

3.55

1.7

1.8

1.18

0.92

mg/l

1.06

222

1758

Hyperfunction of pituitary gland

444

3764

1.23

3.55

1.8

1.38

0.96

mg/l

0.75

337

2785

Other and unspecified myoneural disorders

241

2.09

3.55

1.7

1.6

1.08

1.30

mg/l

0.26

185

Carcinoma in situ of other and unspecified genital organs

155

1171

1.44

3.54

1.5

1.7

0.78

0.95

mg/l

0.80

118

886

Colitis, primary sclerosing, strict definition

676

1.58

3.54

2.3

1.9

1.79

0.95

mg/l

1.34

502

Villonodular synovitis (pigmented)

479

1.69

3.54

1.4

1.6

1.36

1.13

mg/l

0.20

359

Exposure to smoke, fire and flames

202

1576

1.36

3.54

1.8

1.07

1.13

mg/l

0.15

160

1196

Toxic liver disease

133

980

1.47

3.53

2.3

1.7

1.66

1.10

mg/l

0.71

106

748

Failure of sterile precautions during surgical operation

161

2.37

3.53

1.7

1.8

1.20

1.13

mg/l

0.06

136

Alzheimer’s disease (Atypical or mixed), excluding more controls

480

3516

1.21

3.52

1.5

2.01

1.91

mg/l

0.13

348

2763

Use of rasagiline

200

1563

1.37

3.52

1.9

1.6

1.96

1.37

mg/l

0.94

162

1233

Other conjunctival vascular disorders and cysts

193

1501

1.37

3.51

1.7

1.6

0.86

1.17

mg/l

2.42

154

1157

Benign neoplasm: Conjunctiva

267

2159

1.31

3.50

1.7

0.85

1.14

mg/l

2.27

189

1649

Poor fetal growth

1197

10845

1.13

3.50

2.1

1.7

1.14

0.81

mg/l

3.04

885

7908

Convergent concomitant strabismus

510

4374

1.21

3.50

2.1

1.9

0.97

1.05

mg/l

0.31

400

3198

Combined immunodeficiencies

669

1.57

3.49

2.6

1.8

1.26

1.17

mg/l

0.16

528

Vascular dementia (subcortical)

193

1493

1.36

3.49

1.7

1.6

1.30

1.57

mg/l

1.14

160

1159

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

576

1.60

3.46

1.6

1.7

2.12

1.29

mg/l

1.45

451

Endometriosis in cutaneous scar

213

2.14

3.46

1.9

1.7

0.72

0.76

mg/l

0.06

159

Benign neoplasm: Pineal gland

127

2.53

3.46

1.9

1.8

0.65

1.00

mg/l

0.48

Perioral dermatitis

196

1533

1.37

3.46

1.9

1.8

0.82

0.90

mg/l

0.28

140

1155

604

1.60

3.45

1.9

1.10

1.02

mg/l

0.11

439

Haematosalpinx/Haematoma of broad ligament

100

2.74

3.45

1.9

0.45

0.74

mg/l

1.20

Disorders of iron metabolism

118

855

1.50

3.44

1.8

1.7

1.26

1.13

mg/l

0.17

659

Autoimmune hepatitis

501

1.68

3.44

2.1

1.8

1.89

0.94

mg/l

1.53

391

Other disorders of Eustachian tube

245

1968

1.32

3.42

1.9

1.7

0.84

1.09

mg/l

1.53

184

1489

malignant neoplasm of male genital organs

3208

19135

1.08

3.42

1.6

1.8

1.79

1.54

mg/l

1.97

2521

15117

Other superficial injuries of ankle and foot

389

1.78

3.41

1.8

2.1

1.16

1.09

mg/l

0.08

299

Iridocyclitis in diseases classified elsewhere

154

1166

1.42

3.41

1.7

1.9

1.30

1.18

mg/l

0.22

116

885

Malignant neoplasm of bone and articular cartilage

525

1.65

3.41

4.1

1.9

1.30

1.42

mg/l

0.16

402

Motorcycle rider injured in noncollision transport accidents

241

1927

1.31

3.40

1.9

0.96

1.11

mg/l

0.54

186

1371

Noonan syndrome

3.50

3.39

3.4

6.1

0.70

1.93

mg/l

—

Migraine, unspecified, drug-induced

496

1.69

3.38

2.0

1.7

1.49

0.81

mg/l

0.68

382

Personal history of allergy to analgesic agent

367

1.81

3.38

1.7

2.12

0.87

mg/l

0.37

285

Primary biliary cholangitis (PBC)

186

1448

1.37

3.38

2.2

1.5

1.97

1.12

mg/l

2.43

153

1117

Placenta praevia

418

3543

1.23

3.38

1.8

1.7

1.21

0.69

mg/l

2.52

305

2621

Malignant neoplasm of corpus uteri

663

5821

1.18

3.38

1.5

1.7

1.96

1.27

mg/l

2.69

528

4498

Rickettsioses

2.82

3.37

1.8

1.7

0.73

0.99

mg/l

0.44

Persistent delusional disorders

626

5467

1.18

3.37

1.7

1.8

1.13

1.14

mg/l

0.04

484

4124

Unspecific neurodegenerative disorder

2812

20683

0.93

3.37

1.6

1.7

1.72

1.57

mg/l

0.99

2156

16300

Benign neoplasm of bone and articular cartilage

709

6248

1.17

3.35

1.8

1.7

1.03

1.07

mg/l

0.12

545

4686

Neuroendocrine tumor and carcinoma of pancreas

369

1.81

3.34

1.9

1.8

1.54

1.35

mg/l

0.29

296

Benign neoplasm: Skin of trunk

327

2710

1.26

3.34

2.1

1.7

0.91

1.08

mg/l

0.80

241

2042

Granulomatous disorders of skin and subcutaneous tissue

227

1814

1.33

3.34

2.6

1.7

1.21

1.09

mg/l

0.24

173

1364

Hereditary corneal dystrophies

251

2028

1.31

3.34

1.7

1.6

1.45

1.25

mg/l

0.47

183

1568

Routine general health check-up of defined subpopulation

172

1320

1.37

3.33

2.0

1.5

1.26

0.87

mg/l

0.65

130

993

Certolizumab pegol

155

1181

1.41

3.33

1.9

1.7

1.20

0.97

mg/l

0.72

123

865

Other disorders of iris and ciliary body

206

1624

1.34

3.33

1.5

1.7

0.99

1.20

mg/l

1.03

154

1226

Bullous pemphigoid

159

1213

1.40

3.32

1.6

1.7

1.38

1.40

mg/l

0.04

124

965

Thyrotoxicosis factitia

210

2.15

3.31

1.6

1.8

0.52

1.17

mg/l

2.66

170

Wide developmental disorders, excluding more controls

189

1448

1.34

3.31

1.9

2.4

0.68

1.22

mg/l

2.41

124

986

Operations 1 for CAVS

143

2.37

3.31

10.5

3.3

2.38

1.78

mg/l

0.17

119

Mild or no visual impairment, binocular

275

1.92

3.30

2.3

1.9

1.33

1.28

mg/l

0.03

210

Contact urticaria

186

2.17

3.30

1.4

1.7

0.55

0.80

mg/l

1.66

141

Sequelae of burns, corrosions and frostbite

275

1.92

3.29

2.1

1.7

1.27

1.29

mg/l

0.01

207

Migraine without aura, drug-induced

113

823

1.50

3.29

2.5

1.7

0.91

0.79

mg/l

0.24

609

Aphakia

110

787

1.48

3.28

1.7

1.35

1.18

mg/l

0.24

615

Postdysenteric arthropathy

604

1.59

3.28

1.6

1.7

0.70

1.20

mg/l

2.81

452

Other localized connective tissue disorders

169

1306

1.39

3.28

2.1

1.6

0.83

1.07

mg/l

1.49

131

981

Benign neoplasm: Oesophagus

105

755

1.52

3.27

1.8

1.00

1.26

mg/l

0.95

598

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

441

1.70

3.27

1.7

1.76

0.96

mg/l

1.00

347

Dissocial personality disorder

139

1043

1.43

3.26

1.9

1.8

1.55

1.01

mg/l

1.17

107

774

Hypertrophy of tongue papillae

110

798

1.51

3.26

1.7

1.24

1.22

mg/l

0.02

619

Congenital absence, atresia and stenosis of large intestine

3.03

3.26

5.4

4.9

1.13

0.86

mg/l

0.25

Mucinosis of skin

3.64

3.24

1.6

1.8

0.21

0.72

mg/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

572

1.59

3.22

1.5

1.7

1.21

1.34

mg/l

0.24

446

Tuberculosis, IBD comorbidity

535

4630

1.19

3.19

2.0

1.7

1.61

1.50

mg/l

0.19

420

3597

Isolated patent ductus arteriosus

167

2.24

3.19

2.5

1.7

0.54

0.97

mg/l

1.54

110

Benign neoplasm: Appendix

650

1.56

3.18

1.9

1.7

1.29

1.27

mg/l

0.02

506

Respiratory tuberculosis, confirmed

139

1043

1.41

3.17

2.1

1.7

1.32

1.36

mg/l

0.06

107

822

Small cell lung cancer, helper endpoint

1230

0.67

3.17

1.5

1.7

1.80

1.51

mg/l

0.58

974

Small cell lung cancer

1230

0.67

3.17

1.5

1.7

1.80

1.51

mg/l

0.58

974

Macular cyst

193

1523

1.35

3.16

1.6

1.15

1.32

mg/l

0.48

148

1201

Mixed specific developmental disorders

145

1015

1.39

3.16

3.4

3.9

1.19

1.45

mg/l

0.38

112

681

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

813

7265

1.15

3.15

1.9

1.7

1.03

0.89

mg/l

0.76

600

5420

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

333

1.80

3.15

1.7

1.8

1.04

1.26

mg/l

0.44

254

Other and unspecified thalassaemias

2.87

3.15

4.2

3.5

0.90

1.16

mg/l

0.23

148

1064

1.38

3.14

2.9

4.8

2.54

1.70

mg/l

0.58

707

Other specified/unspecified deforming dorsopathies

157

1205

1.39

3.14

1.7

1.05

1.06

mg/l

0.02

111

900

Hypothermia

140

1057

1.41

3.14

1.6

1.8

1.55

1.34

mg/l

0.39

108

821

Exposure to unspecified smoke, fire and flames

593

1.58

3.13

2.0

1.8

1.42

1.34

mg/l

0.08

444

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

692

1.52

3.12

3.0

1.8

2.27

1.18

mg/l

0.51

531

Maternal care for cervical incompetence

354

2986

1.24

3.12

1.8

1.27

1.00

mg/l

1.00

269

2249

Unspecified renal colic

399

1.73

3.12

2.0

1.6

1.07

mg/l

0.01

310

Contact with other and unspecified heat and hot substances

390

1.73

3.11

1.7

1.8

1.40

1.35

mg/l

0.03

297

Paranoid personality disorder

165

1280

1.38

3.10

1.9

1.6

0.95

1.08

mg/l

0.47

126

963

LSIL lesion of the cervix uteri

1048

9499

1.13

3.10

1.6

1.7

0.88

0.85

mg/l

0.19

769

7031

Torsion of testis

132

984

1.41

3.09

2.1

2.5

1.18

1.14

mg/l

0.04

675

Certain conditions originating in the perinatal period

659

5134

1.16

3.09

2.7

2.4

1.68

1.08

mg/l

1.03

469

3540

Right side

378

1.77

3.09

2.4

1.8

0.98

1.36

mg/l

1.11

312

Other and unspecified acne

121

898

1.45

3.08

2.8

1.9

0.98

0.92

mg/l

0.11

644

Convergence insufficiency and excess

128

960

1.44

3.08

2.3

1.8

0.61

1.01

mg/l

2.39

101

703

Respiratory tuberculosis, bacteriologically and histologically confirmed

143

1083

1.39

3.08

2.1

1.7

1.31

1.35

mg/l

0.06

110

849

Myositis ossificans

161

2.20

3.07

1.9

1.7

0.76

1.48

mg/l

2.00

132

Collapsed vertebra, not elsewhere classified

422

1.68

3.06

2.2

1.7

1.46

1.48

mg/l

0.02

336

Malignant melanoma

1153

10497

1.12

3.06

1.8

1.7

1.53

1.35

mg/l

0.42

910

8113

Adenocarcinoma of pancreas

116

1560

0.71

3.06

1.6

1.7

3.19

1.47

mg/l

2.89

102

1226

Benign neoplasm: Tonsil

704

1.51

3.06

1.7

0.80

0.96

mg/l

0.63

554

Burns and corrosions of multiple body regions

520

1.60

3.05

2.0

1.8

1.21

1.62

mg/l

0.70

403

Abnormality of red blood cells

314

1.82

3.03

1.7

1.9

1.91

1.26

mg/l

0.32

245

Benign neoplasm: Pituitary gland, craniopharyngeal duct

427

3662

1.21

3.03

1.8

1.7

1.11

1.09

mg/l

0.04

322

2753

Drug-induced fever

108

2.67

3.03

1.3

1.7

0.99

1.10

mg/l

0.11

Benign neoplasm: Nasopharynx

522

1.60

3.03

1.7

1.01

0.98

mg/l

0.09

388

Other and unspecified corneal deformities and disorders

269

2215

1.28

3.03

1.6

1.7

1.36

1.09

mg/l

0.33

205

1673

Tuberculosis

448

3841

1.20

3.02

2.0

1.6

1.37

1.52

mg/l

0.46

358

2980

Other congenital malformations of intestine

522

1.60

3.02

3.0

2.3

0.90

1.12

mg/l

0.50

398

Viral conjunctivitis

185

1462

1.35

3.02

1.9

1.7

0.89

0.99

mg/l

0.30

142

1109

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

339

1.79

3.02

1.7

1.05

1.09

mg/l

0.06

278

Perichondritis of external ear

144

1101

1.40

3.02

1.8

1.7

1.47

1.24

mg/l

0.33

117

854

Optic neuritis

381

3243

1.23

3.00

1.8

1.7

0.76

0.96

mg/l

1.81

282

2409

Bullous keratopathy

457

1.64

2.99

1.9

1.7

1.69

1.32

mg/l

0.27

371

Lesion of medial popliteal nerve

254

1.94

2.99

2.0

1.7

0.62

1.05

mg/l

1.86

206

Other and unspecified acute skin changes due to ultraviolet radiation

199

1585

1.32

2.99

1.7

1.6

1.39

1.25

mg/l

0.30

157

1231

Other acute skin changes due to ultraviolet radiation

279

2306

1.27

2.99

1.8

1.7

1.17

1.13

mg/l

0.11

216

1768

Injury of blood vessels at lower leg level

276

1.87

2.98

2.1

1.7

1.82

1.24

mg/l

0.64

217

Other disorders of binocular vision

120

895

1.44

2.98

1.9

0.97

0.92

mg/l

0.07

659

Melanocytic naevi of other and unspecified parts of face

496

4308

1.19

2.97

2.0

1.7

1.11

1.06

mg/l

0.14

377

3254

Factitial dermatitis

316

1.80

2.95

1.8

1.7

0.77

1.08

mg/l

0.93

252

Synovial hypertrophy, not elsewhere classified

590

1.55

2.95

1.6

0.71

1.01

mg/l

1.34

434

Benign neoplasm: Skin of lower limb, including hip

219

1769

1.30

2.94

1.9

1.7

1.13

1.03

mg/l

0.22

169

1326

Benign neoplasm: Pineal gland

136

2.34

2.94

1.9

1.8

0.65

0.67

mg/l

0.03

102

Injury of nerves at wrist and hand level

309

2584

1.25

2.94

1.8

0.98

1.05

mg/l

0.25

225

1944

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

915

8246

1.13

2.93

1.7

2.09

1.26

mg/l

4.73

749

6372

Malignant neoplasm of ovary

376

3206

1.22

2.92

1.9

1.8

1.94

1.14

mg/l

3.51

310

2468

Other hypertrichosis

225

1.99

2.92

1.9

2.0

0.76

0.70

mg/l

0.08

173

Hereditary nephropathy, not elsewhere classified

181

2.15

2.92

4.6

1.6

0.98

1.09

mg/l

0.17

142

Personality and behavioural disorders due to brain disease, damage and dysfunction

125

940

1.42

2.91

1.8

1.27

mg/l

0.01

100

735

Epiphora

181

1435

1.34

2.91

1.7

0.87

1.18

mg/l

2.26

143

1117

Pseudomembranous colitis

561

1.57

2.90

1.7

1.6

1.08

1.07

mg/l

0.01

427

Other complications of labour and delivery, not elsewhere classified

1066

9343

1.12

2.90

1.7

1.05

0.77

mg/l

2.54

789

6599

Benign neoplasm: Larynx

244

1996

1.28

2.89

1.7

0.93

1.31

mg/l

3.38

193

1561

conjunctival degenerations and deposits

175

1381

1.34

2.89

1.8

1.6

0.73

1.20

mg/l

5.67

139

1083

Rheumatoid lung disease

241

1.94

2.89

2.8

1.7

2.68

1.62

mg/l

0.46

193

Unspecified multiple injuries

203

2.03

2.88

1.8

0.87

1.16

mg/l

0.53

150

Palindromic rheumatism

627

1.52

2.88

1.9

1.5

0.79

1.20

mg/l

1.94

479

Benign neoplasm: Floor of mouth

202

2.01

2.87

1.7

1.8

1.05

0.93

mg/l

0.23

154

Alzheimer’s disease (Early onset), excluding more controls

165

1993

0.76

2.87

1.5

2.04

1.68

mg/l

0.20

111

1535

Nosocomial condition (hospital)

309

1.77

2.86

2.3

1.8

1.48

1.37

mg/l

0.12

244

Injury of blood vessels at abdomen, lower back and pelvis level

241

1.92

2.86

2.6

1.8

1.40

1.04

mg/l

0.36

183

Atypical virus infections of central nervous system

613

1.54

2.86

1.5

1.8

1.24

1.12

mg/l

0.08

472

Other zoonotic bacterial diseases, not elsewhere classified

3.03

2.86

1.6

1.40

1.04

mg/l

0.28

Social disorders starting during childhood or adolescence

444

1.62

2.86

2.2

2.8

0.73

1.13

mg/l

0.85

292

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

296

1.82

2.86

4.1

2.0

0.87

1.32

mg/l

1.49

235

Asymmetry of jaw

131

997

1.41

2.85

1.8

1.9

0.76

0.87

mg/l

0.38

741

Other and unspecified injuries of forearm

455

1.63

2.85

2.1

1.9

0.86

1.11

mg/l

0.38

340

Injury of urinary and pelvic organs

161

1259

1.35

2.83

2.0

1.8

1.66

1.20

mg/l

0.82

125

949

Other injuries of upper limb, level unspecified

664

1.51

2.83

2.0

1.9

1.35

1.20

mg/l

0.16

495

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

675

6011

1.16

2.83

1.9

1.7

0.94

0.82

mg/l

0.70

500

4444

Other proliferative retinopathy

249

1.89

2.83

1.6

1.8

1.19

1.27

mg/l

0.07

189

Colorectal adenocarcinoma

1512

13977

1.10

2.83

1.6

1.7

1.98

1.43

mg/l

4.34

1231

10936

Alzheimer’s disease (Late onset)

1304

12172

0.90

2.82

1.6

1.7

1.87

1.66

mg/l

1.08

993

9565

Secondary parkinsonism+Parkinsonism in other disease

202

1623

1.31

2.82

1.9

1.7

1.51

1.33

mg/l

0.28

160

1263

Neuroendocrine tumor and carcinoma of lung

457

1.63

2.82

1.7

1.76

1.08

mg/l

0.79

360

Benign neoplasm: Bronchus and lung

105

774

1.46

2.82

1.7

1.32

1.24

mg/l

0.10

613

Atrioventricular septal defect

242

1.90

2.81

4.3

3.4

1.44

1.45

mg/l

0.01

192

Labyrinthitis

181

2.06

2.81

4.0

1.6

1.28

1.06

mg/l

0.25

142

Sequelae of other and unspecified effects of external causes

337

1.76

2.81

1.8

1.7

1.46

1.30

mg/l

0.13

269

CR(E)ST syndrome

137

1056

1.40

2.81

2.0

1.6

1.75

1.02

mg/l

0.71

116

825

Vascular dementia (multiple infarctions)

618

0.57

2.80

2.4

1.6

1.05

1.44

mg/l

1.35

489

Nonalcoholic steatohepatitis

483

1.61

2.80

2.3

1.7

0.93

1.06

mg/l

0.28

381

Carcinoma in situ of colon

111

830

1.45

2.79

1.8

1.7

2.29

1.37

mg/l

0.52

659

Tuberculosis, wide

548

4804

1.17

2.78

2.0

1.7

1.58

1.49

mg/l

0.15

431

3732

Helminthiases

146

1132

1.37

2.78

2.8

1.8

1.25

1.16

mg/l

0.16

104

867

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

450

1.63

2.78

1.4

1.7

1.38

0.96

mg/l

0.74

357

Other/unspecified mastoiditis and related conditions

265

1.83

2.78

1.6

1.8

2.40

1.30

mg/l

0.34

208

Generalized epilepsy, strict definition

194

1557

1.31

2.77

1.7

2.1

1.75

1.19

mg/l

0.37

140

1151

Separation of retinal layers (serosa)

326

2757

1.23

2.76

2.2

1.7

1.54

1.11

mg/l

0.64

250

2107

Secondary parkinsonism

198

1592

1.31

2.76

1.9

1.7

1.53

1.32

mg/l

0.34

156

1239

Other specified and unspecified disorders of choroid

213

1.97

2.76

3.3

1.8

1.33

1.21

mg/l

0.12

169

182

2.03

2.76

2.3

1.7

1.20

0.64

mg/l

0.70

141

Horner syndrome

104

770

1.46

2.75

1.8

1.7

3.10

1.19

mg/l

0.53

605

Testicular dysfunction, other/unspecified

227

1.90

2.75

1.8

1.7

0.77

1.69

mg/l

1.34

175

Disorder of the sleep-wake schedule

145

1125

1.37

2.74

2.2

2.1

1.03

1.18

mg/l

0.35

102

830

Benign neoplasm: Skin of lip

111

830

1.44

2.74

1.6

1.25

0.96

mg/l

0.52

622

Open wounds involving multiple body regions

221

1.94

2.74

2.1

1.8

1.01

1.21

mg/l

0.23

182

Pemphigus

419

1.64

2.73

2.5

1.8

3.59

1.23

mg/l

0.85

331

Abnormal findings in cerebrospinal fluid

184

2.06

2.73

1.9

1.7

0.74

0.87

mg/l

0.17

146

Superficial frostbite

419

1.64

2.72

1.9

1.8

0.63

1.24

mg/l

2.92

313

Hyphaema and other vascular disorders of iris and ciliary body

146

1134

1.36

2.72

1.6

1.7

1.06

1.21

mg/l

0.55

110

859

Carcinoma in situ of vulva

539

1.57

2.70

1.5

1.8

0.78

0.91

mg/l

0.35

408

Benign neoplasm: Orbit, unspecified

397

1.67

2.69

2.4

1.8

1.40

1.22

mg/l

0.15

306

Common variable immunodeficiency

414

1.65

2.69

1.8

1.01

0.96

mg/l

0.08

314

Myocardial infarction, unclassifiable

1704

14125

1.09

2.67

2.3

1.7

1.50

1.61

mg/l

0.68

1361

11066

Disorders of male genital organs in diseases classified elsewhere

330

1.71

2.67

1.9

0.77

1.33

mg/l

1.58

246

Chronic mastoiditis

204

1654

1.30

2.67

1.6

1.7

1.32

1.35

mg/l

0.07

151

1277

Donors of organs and tissues

112

843

1.42

2.65

2.0

1.7

1.00

1.01

mg/l

0.02

616

Sulfonylureas

2974

22467

1.07

2.64

1.8

1.7

1.50

mg/l

0.03

2381

17416

Other disorders of binocular movement

199

1614

1.30

2.64

2.2

1.9

0.74

1.05

mg/l

2.16

156

1212

Gastrointestinal stromal tumor and sarcoma

692

1.48

2.64

1.6

1.7

2.17

1.33

mg/l

0.73

555

Effects of other deprivation

164

2.12

2.64

1.7

2.0

0.70

1.11

mg/l

0.76

117

Desensitization to allergens

465

4057

1.18

2.63

2.0

0.69

0.86

mg/l

1.98

319

2898

Alzheimer’s disease (Late onset), excluding more controls

1017

6158

1.12

2.63

1.6

1.80

1.82

mg/l

0.08

784

4851

Assault by sharp object

140

1088

1.37

2.63

1.8

1.7

1.85

0.99

mg/l

0.49

105

796

Chorioretinal inflammation

232

1914

1.27

2.61

2.4

1.7

1.17

1.10

mg/l

0.12

179

1447

Dental caries 1 and operation codes, only avohilmo

3022

14379

1.07

2.61

1.8

2.0

1.15

1.23

mg/l

0.61

2215

11007

Burn and corrosion of ankle and foot

115

872

1.41

2.61

1.8

1.08

1.42

mg/l

0.81

669

Migraine with aura, drug-induced

102

762

1.45

2.61

1.8

1.7

0.88

0.89

mg/l

0.02

586

Disorders of orbit

362

3106

1.21

2.61

2.0

1.8

1.17

1.14

mg/l

0.06

267

2338

Blindness, monocular

522

1.55

2.61

2.2

1.7

1.89

1.39

mg/l

0.32

406

Other congenital malformations of urinary system

286

1.77

2.60

2.4

2.7

1.45

0.90

mg/l

0.63

213

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

299

2512

1.23

2.60

1.7

1.6

2.21

1.36

mg/l

2.85

235

1961

Motor- or nonmotor-vehicle accident in traffic area

415

1.62

2.59

1.5

1.9

0.65

1.10

mg/l

1.52

316

Contact with sharp glass

314

2662

1.23

2.59

1.8

1.9

0.75

0.98

mg/l

2.66

214

1934

Delivery

4179

21110

1.06

2.59

1.7

1.12

1.15

mg/l

0.20

3199

15634

Behçet disease

195

1.99

2.59

2.5

1.7

1.20

0.88

mg/l

0.20

148

Respiratory tuberculosis, confirmed and not-confirmed

384

3300

1.20

2.58

2.0

1.6

1.34

1.44

mg/l

0.27

299

2557

Ill-defined and unknown causes of mortality

345

4035

0.83

2.58

1.9

1.7

1.83

1.47

mg/l

0.90

271

3160

Phakomatoses, not elsewhere classified

727

1.45

2.58

1.9

2.3

1.10

0.98

mg/l

0.16

548

Respiratory tuberculosis

384

3301

1.20

2.58

2.0

1.6

1.34

1.44

mg/l

0.27

299

2558

Effects of heat and light

415

1.61

2.57

1.8

1.7

1.67

1.30

mg/l

0.31

325

Any dementia

2653

19785

0.93

2.57

1.6

1.7

1.68

1.56

mg/l

0.73

2038

15572

Toxic effect of carbon monoxide

141

1102

1.36

2.56

1.9

1.7

0.91

1.18

mg/l

1.34

110

839

Oher contracture of tendon (sheath)

186

1.96

2.56

1.6

0.77

1.19

mg/l

1.30

150

Laparoscopic left hemicolectomy

137

1069

1.37

2.56

1.9

1.7

1.73

1.28

mg/l

0.71

113

839

Benign neoplasm: Spinal cord

113

857

1.41

2.56

1.7

1.8

1.07

0.97

mg/l

0.17

643

Other and unspecified disease of Bartholin gland

246

2049

1.26

2.56

1.7

1.8

1.12

1.11

mg/l

0.03

171

1579

Disorders of other and unspecified cranial nerves

311

1.72

2.56

2.1

1.6

0.84

1.48

mg/l

1.29

247

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

115

872

1.40

2.55

2.0

1.9

1.34

1.18

mg/l

0.29

676

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

459

1.59

2.55

1.4

1.7

1.38

1.14

mg/l

0.35

369

Alzheimer’s disease, wide definition, excluding more controls

1096

6803

1.11

2.54

1.6

1.84

1.76

mg/l

0.21

838

5363

Erythrasma

114

2.31

2.54

1.2

2.0

1.24

1.16

mg/l

0.07

Ulcer of oesophagus, drug-induced

272

1.77

2.53

1.6

1.7

1.98

1.50

mg/l

0.25

215

Cardiovascular disorders originating in the perinatal period

155

2.01

2.53

4.3

6.8

1.31

2.59

mg/l

0.85

121

Other lack of coordination

136

1061

1.37

2.52

2.0

1.8

0.76

1.17

mg/l

3.17

102

811

Other acquired deformities of ankle and foot

492

1.55

2.52

1.6

1.12

1.03

mg/l

0.10

362

Sequelae of malnutrition and other nutritional deficiencies

129

2.22

2.52

2.0

1.8

1.32

1.67

mg/l

0.34

110

Foreign object accidentally left in body during surgical and medical care

197

1.97

2.51

1.6

2.11

0.78

mg/l

0.83

157

Enduring personality changes

242

1.83

2.50

1.9

1.8

0.73

0.86

mg/l

0.31

182

Status post-ami

359

3440

0.84

2.50

1.7

1.6

1.64

1.95

mg/l

0.53

268

2654

Gender identity disorders

774

0.64

2.50

1.7

1.8

0.49

0.82

mg/l

1.98

514

Unspecified abortion

446

3903

1.18

2.49

2.0

1.7

0.94

0.86

mg/l

0.17

331

2992

Congenital malformations of eye, ear, face and neck

528

4663

1.16

2.49

2.0

2.2

1.15

1.03

mg/l

0.27

382

3413

Drug-induced myopathy

174

2.02

2.49

2.2

1.7

3.63

1.26

mg/l

0.63

142

Cholinergic urticaria

314

1.72

2.49

1.8

1.6

0.77

1.05

mg/l

0.47

242

Pigmented purpuric dermatosis

649

1.48

2.48

1.7

1.6

1.56

1.34

mg/l

0.23

494

Benign neoplasm: Nasopharynx

545

1.52

2.48

1.7

1.8

1.01

1.30

mg/l

0.84

425

Other diseases caused by chlamydiae

111

847

1.41

2.48

2.1

1.7

1.38

0.79

mg/l

1.28

651

Haemorrhagic and haematological disorders of fetus and newborn

108

773

1.39

2.48

6.6

5.7

1.33

1.89

mg/l

0.87

550

Mental retardation

298

2522

1.22

2.47

2.1

2.8

1.39

1.27

mg/l

0.27

241

1860

Myotonic disorders

512

1.54

2.47

1.4

1.9

1.16

1.01

mg/l

0.16

397

L02BB Anti-androgens

575

5102

1.15

2.46

1.6

2.37

1.69

mg/l

1.92

462

4063

Dental caries 2 and operation codes, only avohilmo

7801

46875

1.04

2.46

1.8

1.9

1.01

1.10

mg/l

1.69

5621

35107

Open bite

413

3592

1.19

2.46

2.2

2.1

0.79

0.93

mg/l

1.06

302

2592

Osteosarcoma, excluding all cancers (controls excluding all cancers)

212

1.88

2.45

7.2

1.9

2.07

1.30

mg/l

0.58

160

Unspecified parasitic disease

504

1.54

2.45

2.1

1.7

1.21

mg/l

0.01

392

Disorders of pituitary gland, other and/or unspecified

381

1.64

2.45

1.5

1.7

0.85

1.21

mg/l

1.05

293

Congenital malformations of uterus and cervix

195

1596

1.29

2.44

1.8

1.7

0.82

0.80

mg/l

0.06

153

1168

Frostbite

656

1.46

2.44

1.9

1.8

1.16

1.29

mg/l

0.16

495

Maternal care for known or suspected disproportion

406

3538

1.19

2.43

1.6

1.7

0.72

0.68

mg/l

0.14

298

2643

Carcinoma in situ of other and unspecified genital organs

155

1240

1.34

2.43

1.5

1.6

0.78

0.97

mg/l

1.16

118

947

Apocrine sweat disorders, other sweat gland disorders

269

1.78

2.43

2.0

1.7

0.88

0.94

mg/l

0.11

219

Benign neoplasm: Skin, unspecified

301

2560

1.22

2.42

1.7

0.99

1.16

mg/l

0.57

240

1928

Psoas tendinitis

252

1.79

2.42

1.6

1.5

0.67

0.98

mg/l

0.90

193

Benign neoplasm: Tonsil

736

1.43

2.41

1.7

0.80

1.22

mg/l

2.19

587

Other infiltrative disorders of skin and subcutaneous tissue

301

1.72

2.41

2.4

1.8

1.35

1.20

mg/l

0.15

235

Use of rotigotine

703

1.45

2.41

2.2

1.6

0.89

1.29

mg/l

1.82

548

Calcific tendinitis

564

1.50

2.41

1.9

1.7

1.04

1.21

mg/l

0.34

436

Other assisted single delivery

161

1294

1.32

2.41

1.8

1.05

0.74

mg/l

0.49

106

963

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

2.76

2.41

3.9

2.2

1.08

0.70

mg/l

—

Drug-induced thyroiditis

147

2.14

2.41

2.2

1.6

2.00

1.08

mg/l

0.69

115

Short stature, not elsewhere classified

151

1117

1.32

2.41

5.1

4.2

2.32

1.39

mg/l

0.52

112

766

Disorders of purine and pyrimidine metabolism

316

1.69

2.40

3.4

1.7

1.51

1.40

mg/l

0.12

246

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

155

1235

1.32

2.40

1.5

1.7

1.25

1.07

mg/l

0.49

121

949

Undescended testicle

466

1.52

2.40

3.2

4.4

1.74

1.83

mg/l

0.07

337

Benign neoplasm of other and unspecified female genital organs

353

3048

1.20

2.40

1.6

1.8

0.92

1.03

mg/l

0.47

264

2286

HSIL lesion of the cervix uteri, vagina or vulva

1894

17793

1.08

2.39

1.7

1.00

0.88

mg/l

0.78

1407

13278

Primary angle-closure glaucoma

328

2812

1.21

2.39

1.6

1.29

1.40

mg/l

0.24

261

2195

Other and unspecified mental retardation

119

916

1.37

2.39

2.0

3.9

1.52

1.70

mg/l

0.20

693

Other adrenocortical overactivity

340

1.65

2.39

2.5

3.1

0.95

1.40

mg/l

0.58

236

Mental and behavioural disorders due to hallucinogens

308

1.69

2.39

1.7

1.6

1.06

0.86

mg/l

0.28

223

Increased muscle tone

441

1.58

2.38

1.7

2.0

1.61

1.30

mg/l

0.22

344

All dysplastic lesions of the cervix uteri

2521

23836

1.07

2.38

1.7

0.94

0.87

mg/l

0.53

1860

17716

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

293

1.71

2.38

2.8

1.8

1.82

1.09

mg/l

0.77

231

Malignant neoplasm of anus and anal canal

295

1.74

2.37

2.0

1.7

1.14

1.21

mg/l

0.10

238

Disorder of thyroid, unspecified

109

834

1.40

2.37

1.8

1.6

1.08

1.01

mg/l

0.10

645

Hyperprolactinaemia

310

2653

1.22

2.37

1.8

1.7

0.92

0.89

mg/l

0.08

234

1979

Toxic erythema

103

2.33

2.37

1.7

1.6

0.58

0.88

mg/l

0.77

Carcinoma in situ of oral cavity, oesophagus and stomach

293

1.71

2.36

1.6

1.40

1.29

mg/l

0.11

218

Melanoma in situ of other and unspecified parts of face

618

1.47

2.36

2.0

1.7

1.33

1.25

mg/l

0.11

483

Benign neoplasm: Skin of scalp and neck

200

1645

1.28

2.35

1.5

1.8

1.63

1.20

mg/l

0.73

151

1261

Melanocytic naevi, other sites/unspecified

649

5834

1.14

2.34

2.1

1.8

1.00

1.07

mg/l

0.42

507

4395

Embedded and impacted teeth

2380

19116

1.07

2.34

2.0

1.9

0.94

0.99

mg/l

0.32

1693

13420

Necrobiosis lipoidica, not elsewhere classified

385

1.62

2.34

2.4

1.6

0.85

0.79

mg/l

0.12

285

Burn and corrosion of wrist and hand

297

2532

1.22

2.33

1.8

1.9

0.95

1.11

mg/l

0.67

218

1864

Other and unspecified nonscarring hair loss

469

1.56

2.33

2.0

1.7

0.98

0.79

mg/l

0.26

347

Lymphangioma, anys site

475

1.54

2.33

3.1

2.0

2.06

1.05

mg/l

0.48

353

MS-disease / Multiple Sclerosis

652

5866

1.14

2.33

1.7

1.8

0.80

0.91

mg/l

0.86

477

4351

Unspecified hairloss

2.69

2.33

2.2

1.5

1.52

1.00

mg/l

0.56

Benign neoplasm: Floor of mouth

216

1.85

2.33

1.7

1.05

1.24

mg/l

0.26

173

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

111

2.26

2.32

1.4

1.6

1.00

1.43

mg/l

0.31

Benign neoplasm: Endocrine pancreas

361

1.64

2.32

1.6

1.8

2.37

1.03

mg/l

0.95

277

Marginal zone B-cell lymphoma

528

1.51

2.32

1.7

1.36

1.29

mg/l

0.09

418

Polyglandular dysfunction

164

2.04

2.31

3.1

1.8

1.28

1.14

mg/l

0.09

125

Juvenile rheumatoid arthirtis

186

1520

1.28

2.30

1.9

1.8

1.04

0.97

mg/l

0.16

153

1094

LSIL lesion of the vulva

267

2268

1.24

2.30

2.0

1.7

0.96

0.82

mg/l

0.51

202

1707

Other demyelinating diseases of the central nervous system

324

2792

1.21

2.28

1.6

1.8

0.89

0.91

mg/l

0.04

216

2081

Pityriasis rosea

486

1.52

2.28

1.9

1.7

1.68

0.96

mg/l

0.36

358

733

1.41

2.28

1.9

1.7

1.26

1.23

mg/l

0.06

581

Open wound of thorax

124

970

1.35

2.26

1.9

1.7

1.24

1.13

mg/l

0.29

100

732

Congenital deformities of hip

143

1137

1.32

2.25

2.3

2.5

1.37

1.12

mg/l

0.26

103

820

Labour and delivery complicated by fetal stress [distress]

2451

15485

1.07

2.25

1.8

1.7

0.80

0.76

mg/l

0.48

1808

11126

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

190

1561

1.27

2.25

1.5

1.7

1.35

1.22

mg/l

0.29

146

1206

Cysticercosis

7.84

2.25

2.4

1.5

0.33

0.69

mg/l

—

Disorders of parathyroid gland, other and/or unspecified

456

1.55

2.24

1.8

1.6

2.36

1.14

mg/l

0.44

368

LeFortI or BSSRO operation

356

3093

1.19

2.24

1.5

1.7

0.69

0.88

mg/l

1.81

253

2280

Allergic colitis

155

1240

1.30

2.23

2.1

3.5

1.16

1.44

mg/l

0.41

112

843

Mitochondrial myopathy

259

1.76

2.23

2.2

2.0

3.38

0.89

mg/l

0.44

202

Hypersensitivity pneumonitis due to organic dust

135

1072

1.34

2.23

2.0

1.7

1.11

1.25

mg/l

0.32

110

839

Inhalation and ingestion of other objects causing obstruction of respiratory tract

363

1.60

2.21

2.0

1.9

2.72

1.26

mg/l

0.36

296

Other and unspecified papulosquamous disorders

364

1.61

2.21

2.2

2.0

1.54

1.25

mg/l

0.31

284

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

339

1.63

2.21

3.3

1.8

2.13

1.25

mg/l

0.43

261

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

480

1.51

2.21

1.3

1.6

0.92

1.13

mg/l

0.52

361

Congenital lactase deficiency

166

1.98

2.21

2.2

1.6

5.28

0.93

mg/l

0.51

124

Other fibroblastic disorders

227

1.79

2.20

1.6

1.5

0.82

1.11

mg/l

0.64

180

Drug-induced gout

234

1.76

2.20

1.6

1.10

1.76

mg/l

1.42

182

Dacryoadenitis

499

1.51

2.20

2.5

1.7

0.74

1.12

mg/l

1.69

390

Papillary adenocarcinoma of thyroid gland

425

3745

1.17

2.20

2.3

1.7

1.29

1.09

mg/l

0.34

329

2860

Exfoliative dermatitis

625

1.44

2.19

2.2

1.7

1.88

1.49

mg/l

0.40

494

Benign neoplasm: Long bones of lower limb

257

2179

1.23

2.19

1.9

1.8

1.06

0.90

mg/l

0.66

198

1594

Universal erythroderma, KELA reimbursement

117

914

1.36

2.19

1.7

1.34

1.21

mg/l

0.16

703

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

240

2019

1.23

2.19

1.7

1.6

2.00

1.31

mg/l

2.14

199

1568

Crushing injury of lower leg

159

2.00

2.18

1.8

1.7

0.86

1.06

mg/l

0.35

134

Femoral hernia, bilateral

189

1.89

2.18

2.0

1.8

0.81

1.18

mg/l

1.23

158

Other abnormal immunological findings in serum

158

1280

1.30

2.18

2.4

1.8

1.08

mg/l

0.00

119

958

Relapsing polychondritis

152

2.05

2.18

2.7

1.7

0.52

1.33

mg/l

1.73

123

Mental retardation, wide definition

314

2702

1.20

2.17

2.0

2.7

1.42

1.26

mg/l

0.37

251

1998

Other fusion of spine

100

2.33

2.17

1.5

0.76

1.02

mg/l

0.56

Other specified/unspecified disorders of middle ear and mastoid

160

2.02

2.17

1.3

2.0

1.98

1.21

mg/l

0.35

129

Contact with sharp object, undetermined intent

173

1415

1.28

2.17

2.0

1.8

1.14

1.05

mg/l

0.14

124

1041

Injury of heart

114

2.18

2.16

1.4

1.6

1.03

1.26

mg/l

0.26

Glaucoma-related operations

402

3530

1.17

2.16

1.6

1.34

1.44

mg/l

0.25

308

2751

Acquired keratosis [keratoderma] palmaris et plantaris

277

1.71

2.16

2.0

1.6

0.94

1.25

mg/l

0.53

219

Other nutritional anaemias

565

1.46

2.16

2.2

1.8

1.89

1.43

mg/l

0.43

435

Pseudopolyposis of colon

174

1.92

2.16

1.5

1.7

0.75

0.83

mg/l

0.14

142

Thalassaemia trait

2.88

2.16

1.8

2.8

1.99

0.69

mg/l

—

Myelodysplastic syndrome

456

1.51

2.16

1.9

1.7

2.40

1.52

mg/l

1.12

366

Malignant neoplasm of endocrine gland

581

5220

1.14

2.16

2.1

1.8

1.24

1.14

mg/l

0.22

445

3971

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

364

1.58

2.16

1.7

2.10

1.37

mg/l

0.77

280

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

699

6329

1.13

2.15

1.6

1.7

2.17

1.30

mg/l

3.59

570

4884

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

110

855

1.37

2.15

1.8

1.6

0.84

0.94

mg/l

0.23

631

Glaucoma, exfoliation

792

7217

1.12

2.15

1.5

1.7

1.65

1.56

mg/l

0.23

632

5629

Lagophthalmos

724

1.40

2.15

1.6

1.23

mg/l

0.01

573

Acne varioliformis

160

1.99

2.14

1.9

1.7

0.94

0.99

mg/l

0.04

133

Benign neoplasm: Skin of upper limb, including shoulder

161

1311

1.29

2.14

1.7

1.6

1.02

1.13

mg/l

0.37

126

1012

Diseases caused by chlamydiae

101

779

1.40

2.14

2.0

1.7

1.47

0.76

mg/l

1.49

595

Telogen effluvium

123

2.17

2.13

6.7

1.7

1.31

0.76

mg/l

0.48

Cardiomyopathies, Secondary/extrinsic

324

1.61

2.13

8.8

1.8

2.29

1.40

mg/l

0.53

261

Benign neoplasm: Vagina

111

867

1.37

2.13

1.4

1.6

0.94

0.85

mg/l

0.15

657

Chronic suppurative otitis media

526

4697

1.15

2.12

2.4

1.8

1.14

1.31

mg/l

0.66

389

3515

Injury of nerves at shoulder and upper arm level

674

1.42

2.11

2.0

1.7

0.76

1.21

mg/l

2.66

512

Intentional self-harm by hanging, strangulation and suffocation

344

0.51

2.11

4.1

1.8

0.89

1.39

mg/l

0.45

271

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

2367

13439

1.07

2.10

1.6

1.8

1.69

1.32

mg/l

3.08

1854

10573

Toxic encephalopathy

123

2.13

2.10

1.5

1.7

6.05

1.26

mg/l

0.85

101

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

536

1.47

2.09

1.7

1.6

1.21

1.20

mg/l

0.01

410

Melanoma in situ

290

2496

1.21

2.09

2.3

1.6

1.91

1.36

mg/l

0.38

220

1943

Exophthalmic conditions

684

1.41

2.09

1.8

1.7

1.57

1.18

mg/l

0.41

533

Postinfectious hypothyroidism

387

1.58

2.09

1.7

1.6

0.85

1.07

mg/l

0.57

310

Actinomycosis

198

1.81

2.08

1.7

1.62

0.91

mg/l

0.66

155

Urticaria due to cold and heat

555

1.46

2.08

2.4

1.6

0.79

0.78

mg/l

0.02

418

Other disorders affecting eyelid function

530

1.48

2.08

1.7

0.78

1.06

mg/l

0.99

416

Lesion of femoral nerve

496

1.49

2.08

1.7

1.6

1.49

1.00

mg/l

0.72

391

Contact with other hot metals

119

938

1.34

2.07

2.1

1.9

1.50

1.32

mg/l

0.22

716

Other mosquito-borne viral fevers

139

2.06

2.07

1.4

1.7

1.31

1.25

mg/l

0.04

113

Adenocarcinoma and ductal carcinoma of pancreas

160

1955

0.79

2.07

1.6

1.7

3.50

1.44

mg/l

2.45

143

1543

Anisometropia and aniseikonia

247

2100

1.22

2.07

2.2

1.9

1.26

1.18

mg/l

0.12

177

1593

Malignant neoplasm of digestive organs

3075

28915

1.06

2.06

1.7

2.21

1.40

mg/l

14.46

2518

22495

Monosomies and deletions from the autosomes, not elsewhere classified

130

2.03

2.06

3.1

5.9

1.47

2.61

mg/l

0.35

103

Pterygium

208

1741

1.24

2.06

1.7

1.6

1.87

1.39

mg/l

0.46

161

1369

Schizotypal disorder

202

1689

1.25

2.05

1.9

1.7

1.99

0.94

mg/l

0.64

142

1255

Other perinatal digestive system disorders

3.51

2.04

13.1

8.5

2.21

1.80

mg/l

—

Malignant melanoma of skin

855

7848

1.11

2.04

1.7

1.61

1.32

mg/l

0.53

680

6070

Disorders of visual cortex

4.19

2.04

3.4

4.2

0.53

0.65

mg/l

—

Other disorders of thyroid

111

872

1.36

2.04

1.8

1.7

1.15

1.05

mg/l

0.16

661

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

673

6103

1.12

2.03

1.6

1.7

2.18

1.31

mg/l

3.37

547

4723

Pityriasis lichenoides chronica

249

1.73

2.03

1.9

2.0

1.12

1.57

mg/l

0.42

193

Benign neoplasm: Lip

153

1244

1.29

2.02

1.7

1.6

1.10

1.14

mg/l

0.07

113

936

Hereditary spherocytosis

154

1.93

2.02

2.0

2.3

1.13

0.80

mg/l

0.38

118

Benign neoplasm of brain and other parts of central nervous system

480

4282

1.15

2.01

1.8

1.20

1.10

mg/l

0.22

357

3225

Benign neoplasm: Skin of lip

111

873

1.35

2.01

1.6

1.7

1.25

1.21

mg/l

0.06

677

Isolated proteinuria with specified morphological lesion

733

1.39

2.01

2.1

1.8

1.89

1.16

mg/l

0.56

569

Drug-induced tremor

381

1.56

2.01

1.9

0.89

1.30

mg/l

1.07

311

Autism spe, excluding more controls

140

1123

1.29

2.00

2.0

0.64

1.02

mg/l

2.18

761

Melanocytic naevi of lower limb, including hip

355

3114

1.18

2.00

2.3

1.7

0.91

1.07

mg/l

1.01

258

2368

Senility

381

1.50

2.00

1.5

4.26

1.45

mg/l

0.52

296

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

274

1.67

1.99

1.4

1.7

1.47

1.13

mg/l

0.19

217

Tic and related disorders

765

1.36

1.99

3.1

2.8

1.21

1.03

mg/l

0.26

524

Benign neoplasm: Endocrine pancreas

374

1.57

1.99

1.6

1.8

2.37

1.50

mg/l

0.52

292

Other specified/unspecified disorders of ear

163

1.89

1.97

1.9

1.8

0.82

0.84

mg/l

0.03

118

Other obstructed labour

672

6119

1.12

1.97

1.6

1.7

0.86

0.91

mg/l

0.24

501

4596

Carcinoma in situ of oral cavity, oesophagus and stomach

307

1.61

1.96

1.6

1.7

1.40

1.54

mg/l

0.13

236

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

1129

0.74

1.96

1.5

1.6

1.80

1.41

mg/l

0.88

881

Myopia

1084

10065

1.10

1.96

1.9

1.00

1.03

mg/l

0.15

774

7383

Other drug-induced secondary parkinsonism

562

1.44

1.95

2.0

1.7

0.93

1.35

mg/l

1.59

448

Certain zoonotic bacterial diseases

147

1199

1.29

1.95

1.7

1.11

1.22

mg/l

0.23

122

906

Other and unspecified disorders of binocular movement

358

1.57

1.95

2.4

2.1

1.13

1.29

mg/l

0.18

271

Infections of breast associated with childbirth

328

2869

1.18

1.95

1.8

1.7

1.16

0.84

mg/l

1.08

245

2106

Contact with nonpowered hand tool

331

2892

1.18

1.94

1.8

1.02

1.20

mg/l

0.58

258

2158

Other operation for atrial fibrillation

326

1.61

1.94

2.1

1.7

2.22

1.56

mg/l

0.32

256

Lymphangioma, anys site

493

1.47

1.94

3.1

2.3

2.06

1.19

mg/l

0.39

377

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

392

1.54

1.94

1.9

1.7

0.75

1.09

mg/l

1.39

293

Benign lipomatous neoplasm of of intra-abdominal organs

180

1.84

1.93

1.9

1.6

0.67

1.07

mg/l

1.11

140

Normotensive glaucoma

615

5578

1.13

1.93

1.6

1.7

1.61

1.46

mg/l

0.33

465

4335

Dementia due to Parkinsons disease, excluding more controls

126

1005

1.30

1.93

1.7

1.5

1.77

1.87

mg/l

0.09

793

Epidural haemorrhage

490

1.45

1.93

1.5

1.8

1.16

1.34

mg/l

0.35

372

Ovarian dysfunction, other/unspecified

402

1.54

1.93

2.5

1.8

1.22

0.86

mg/l

0.31

292

Guttate psoriasis

120

960

1.33

1.91

1.5

1.7

1.17

1.03

mg/l

0.20

723

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

169

1399

1.26

1.91

1.6

1.7

1.59

1.18

mg/l

1.18

131

1068

Benign neoplasm: Central nervous system, other parts/unspecified

212

1.75

1.91

1.6

1.7

0.86

1.23

mg/l

0.69

168

Other porphyria

105

2.18

1.91

1.8

1.5

1.27

0.86

mg/l

0.20

Acute mastoiditis

563

1.43

1.91

1.9

1.8

0.72

1.17

mg/l

1.59

435

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

4.01

1.90

1.8

2.5

2.35

1.92

mg/l

—

Urethral discharge

2.51

1.90

2.0

1.8

1.28

1.61

mg/l

—

Chronic suppurative otitis media, including avohilmo

619

5618

1.13

1.90

2.3

1.9

1.09

1.28

mg/l

0.93

456

4185

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

108

852

1.34

1.89

1.5

1.8

0.74

1.24

mg/l

2.22

621

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

269

1.65

1.89

3.7

1.7

1.45

1.34

mg/l

0.10

211

Juvenile Open Angle Glaucoma

386

1.53

1.88

1.9

1.7

0.79

0.97

mg/l

0.38

295

Disorders of amino-acid transport

2.22

1.88

1.8

1.5

7.75

0.70

mg/l

0.48

Disorders of glossopharyngeal nerve

113

2.11

1.88

3.5

1.9

1.02

1.41

mg/l

0.37

Retinoschisis and retinal cysts

174

1449

1.25

1.88

1.7

1.01

1.24

mg/l

0.79

132

1152

Other acantholytic disorders

151

1.93

1.87

5.3

1.8

0.88

1.47

mg/l

1.16

121

Benign neoplasm: Connective and other soft tissue of thorax

270

1.65

1.87

1.8

1.6

1.11

1.09

mg/l

0.02

208

Bradycardia, unspecified, drug-induced

142

1.91

1.86

1.6

1.9

2.17

1.60

mg/l

0.33

116

Adrenogenital disorders

270

1.64

1.85

1.8

0.85

1.45

mg/l

0.89

209

Adenocarcinoma and Papillary adenocarcinoma of kidney

637

1.40

1.85

1.5

1.7

1.21

1.37

mg/l

0.36

506

Primary ovarian failure

172

1437

1.26

1.84

1.9

1.8

0.80

0.77

mg/l

0.09

126

1075

Hypertensive encephalopathy

223

1.72

1.83

2.1

1.7

0.87

1.51

mg/l

1.64

181

Benign lipomatous neoplasm of of intra-abdominal organs

183

1.80

1.83

1.9

1.8

0.67

1.03

mg/l

1.32

153

Acute alcohol intoxication ICD-9

251

2158

1.20

1.83

1.6

1.7

1.18

1.27

mg/l

0.24

196

1686

Nail dystrophy

414

1.50

1.83

2.5

1.9

1.04

1.08

mg/l

0.07

314

Cutis laxa senilis

527

1.45

1.82

1.5

1.7

0.75

1.04

mg/l

0.95

424

Benign neoplasm: Skin of lower limb, including hip

219

1869

1.22

1.81

1.9

1.7

1.13

1.10

mg/l

0.05

169

1433

Scarlet fever

404

1.49

1.81

1.4

1.8

0.68

0.92

mg/l

0.49

293

Other and unspecified neuropathies

247

1.66

1.81

1.8

1.9

1.36

1.54

mg/l

0.15

193

Tic disorders

714

1.35

1.81

3.1

2.7

1.12

1.04

mg/l

0.10

496

Glaucoma secondary to eye inflammation

525

1.43

1.80

2.0

1.8

1.19

1.32

mg/l

0.22

405

Sleepwalking [somnambulism]

160

1.85

1.80

1.5

2.0

0.65

0.74

mg/l

0.26

114

Neuroendocrine tumor and carcinoma of stomach

281

1.62

1.79

1.4

1.8

1.47

1.55

mg/l

0.04

225

Renal cell carcinoma of kidney

230

1967

1.21

1.79

1.6

1.7

1.29

1.40

mg/l

0.32

175

1553

Pedestrian injured in other and unspecified transport accidents

100

790

1.35

1.79

1.8

1.7

1.03

1.11

mg/l

0.11

610

Exposure to ignition of highly flammable material

256

1.64

1.79

1.5

1.8

0.86

1.29

mg/l

0.80

199

Hirsutism, drug-induced

131

2.01

1.78

2.0

1.7

0.59

0.76

mg/l

0.31

104

Benign neoplasm: Respiratory system, unspecified

122

2.00

1.78

1.8

1.7

2.25

1.16

mg/l

0.30

Lumbosacral root disorders, not elsewhere classified

773

1.34

1.77

1.8

1.7

1.35

1.27

mg/l

0.06

618

Other and unspecified atrophic disorders of skin

291

1.61

1.77

1.8

1.7

1.19

1.16

mg/l

0.04

234

Drug-induced aplastic anaemia

2.20

1.77

1.9

1.8

1.17

1.19

mg/l

0.01

Alcohol induced polyneuropathy

588

1.40

1.77

1.9

1.6

1.15

1.42

mg/l

0.64

472

Otorrhoea

169

1.82

1.76

2.6

1.61

1.54

mg/l

0.03

130

Dementia in other diseases classified elsewhere

301

2631

1.18

1.76

1.8

1.6

1.47

1.44

mg/l

0.04

222

2056

Other specified acquired deformities of limbs

281

1.60

1.76

1.7

2.2

1.67

1.01

mg/l

0.47

209

Bacterial meningitis

277

2413

1.19

1.76

1.6

1.7

0.96

1.11

mg/l

0.63

210

1828

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

177

1486

1.24

1.76

2.1

1.6

1.17

0.99

mg/l

0.27

118

1132

Severe visual impairment, binocular

256

1.62

1.76

1.7

1.34

1.51

mg/l

0.19

208

Amoebiasis

340

1.54

1.75

1.6

1.9

0.86

1.12

mg/l

0.42

264

Intermittent heterotropia

454

4074

1.14

1.75

2.2

1.11

1.17

mg/l

0.16

331

2960

Chronic myeloid leukaemia

250

1.65

1.74

2.0

1.7

1.49

1.26

mg/l

0.23

199

Ankylosis of joint

272

1.58

1.74

1.4

1.5

0.72

1.20

mg/l

1.64

203

Shigellosis

193

1.74

2.1

1.5

1.42

1.19

mg/l

0.13

153

Benign neoplasm: Skin of trunk

327

2883

1.17

1.74

2.1

1.7

0.91

1.19

mg/l

1.69

241

2196

Atlantoaxial subluxation

400

1.49

1.73

1.9

1.6

1.32

1.25

mg/l

0.13

308

Aortic arch syndrome [Takayasu]

132

1.98

1.73

2.6

1.6

0.76

1.15

mg/l

0.69

100

Optic atrophy

139

1143

1.27

1.73

2.0

1.9

1.30

1.25

mg/l

0.10

100

871

Acute poliomyelitis

108

865

1.32

1.73

1.5

1.7

1.33

1.21

mg/l

0.10

659

Subarachnoid haemorrhage

789

7277

1.10

1.72

1.8

1.6

1.59

1.33

mg/l

0.98

634

5615

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

477

1.44

1.72

1.9

1.7

1.69

1.16

mg/l

0.65

372

Severe visual impairment, monocular

521

1.42

1.72

1.7

1.06

1.33

mg/l

0.54

401

Foreign body granuloma of skin and subcutaneous tissue

202

1.72

1.71

1.7

1.56

1.17

mg/l

0.26

156

Organ-limited amyloidosis

201

1.70

1.71

1.9

1.7

1.73

1.56

mg/l

0.15

158

Accidental poisoning by and exposure to other gases and vapours

317

1.55

1.71

2.1

1.7

1.28

1.33

mg/l

0.04

248

Varicella [chickenpox]

360

3194

1.16

1.71

2.3

2.0

1.34

1.01

mg/l

0.45

279

2373

Occlusion and stenosis of arteries, not leading to stroke

692

1.34

1.71

1.6

1.50

mg/l

0.00

547

Schizoid personality disorder

145

1200

1.27

1.71

1.6

1.8

0.93

1.13

mg/l

0.79

117

918

Melanocytic naevi of scalp and neck

188

1593

1.23

1.70

1.9

1.7

1.15

0.92

mg/l

0.49

146

1186

Pemphigus vulgaris

140

1.91

1.70

3.4

1.9

5.36

1.35

mg/l

0.48

114

Reduction defects of upper limb

147

1.86

1.69

2.3

3.3

2.04

1.97

mg/l

0.02

120

Postpartum haemorrhage due to retained placenta

1187

11137

1.08

1.69

1.8

1.7

1.33

0.80

mg/l

5.01

925

8311

Moderate visual impairment, monocular

252

1.63

1.69

1.7

1.8

0.83

0.98

mg/l

0.34

199

Secondary systemic amyloidosis

171

1.78

1.68

2.0

1.5

6.22

1.11

mg/l

0.71

131

Maxillary hypoplasia

203

1.70

1.67

1.8

2.3

0.74

0.87

mg/l

0.13

148

Hyperkinetic disorders (excl. ADHD)

123

989

1.28

1.67

2.4

2.8

1.56

1.07

mg/l

0.40

676

Other abortion

613

1.38

1.67

2.1

1.9

1.28

0.83

mg/l

0.63

462

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

109

1355

0.78

1.66

1.5

1.7

2.38

1.34

mg/l

2.68

1040

Congenital malformations of lung

140

1.87

1.66

2.5

2.7

2.29

1.14

mg/l

0.28

115

Malignant neoplasm of prostate

3054

18499

1.05

1.66

1.6

1.7

1.81

1.55

mg/l

1.89

2404

14688

Tuberculosis of other organs

155

1293

1.25

1.66

2.0

1.6

2.51

1.31

mg/l

1.03

124

1009

Hydatidiform mole

127

1043

1.28

1.65

1.4

1.6

0.77

0.78

mg/l

0.01

102

784

Carcinoma in situ, other/unspecified

3.03

1.65

1.4

1.6

3.23

1.21

mg/l

—

Other specified and unspecified disorders of iris and ciliary body

245

1.63

1.65

1.4

2.0

0.58

0.91

mg/l

1.08

188

Benign neoplasm: Spinal meninges

622

1.37

1.64

2.0

1.6

1.00

0.99

mg/l

0.02

479

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

513

1.39

1.64

1.5

1.6

1.38

1.29

mg/l

0.13

417

Benign neoplasm: Connective and other soft tissue of thorax

279

1.58

1.63

1.8

1.6

1.11

1.29

mg/l

0.26

223

Other deformity of hallux (acquired)

491

1.42

1.63

1.8

1.7

1.35

1.16

mg/l

0.21

363

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

120

974

1.28

1.62

1.7

1.14

1.45

mg/l

1.10

759

Combined immunodeficiency, unspecified

2.43

1.62

2.2

2.4

1.26

1.16

mg/l

—

Onychogryphosis

149

1.83

1.62

1.9

1.7

0.93

1.10

mg/l

0.19

119

Evidence of alcohol involvement determined by blood alcohol level

120

980

1.29

1.62

1.9

1.7

1.13

1.14

mg/l

0.01

729

Labour and delivery complicated by umbilical cord complications

438

3951

1.14

1.62

1.6

1.8

0.80

0.87

mg/l

0.27

326

2936

Anorexia

125

1026

1.28

1.62

2.3

1.8

1.29

1.05

mg/l

0.36

758

Unspecified severe protein-energy malnutrition

2.13

1.62

3.6

2.1

1.69

0.76

mg/l

1.68

Diaper [napkin] dermatitis

2.13

1.62

1.5

3.5

1.54

1.44

mg/l

—

Benign neoplasm: Vagina

111

902

1.30

1.61

1.4

1.6

0.94

0.96

mg/l

0.02

694

Malignant neoplasm of vulva

599

1.38

1.61

1.9

1.7

1.27

1.12

mg/l

0.36

464

Procedures for purposes other than remedying health state

211

1817

1.21

1.61

1.6

1.00

0.94

mg/l

0.17

154

1364

Secondary lactase deficiency

2.28

1.60

2.4

1.4

10.18

0.74

mg/l

—

Other benign neoplasms of uterus

402

3610

1.14

1.60

1.7

1.8

1.35

1.32

mg/l

0.08

305

2755

Protein-energy malnutrition of moderate and mild degree

493

1.41

1.60

3.3

2.0

1.87

1.42

mg/l

0.68

371

Vitiligo

722

1.33

1.59

1.8

1.7

1.05

1.12

mg/l

0.11

556

Impacted teeth

1596

14066

1.07

1.59

2.0

1.9

0.84

0.98

mg/l

1.91

1147

9691

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

408

1.46

1.59

1.9

1.8

0.75

1.09

mg/l

1.43

303

Other congenital malformations of limb(s)

466

1.42

1.59

3.3

2.6

1.30

0.78

mg/l

0.68

330

Other or unspecified common variable immunodeficiency

232

1.65

1.59

1.7

1.9

0.75

0.64

mg/l

0.18

174

Acanthosis nigricans

206

1.67

1.58

1.6

1.8

0.63

1.05

mg/l

1.13

156

Carcinoma in situ, other/unspecified

2.85

1.58

1.4

1.6

3.23

1.92

mg/l

—

Other benign neoplasm of uterus: Cervix uteri

409

1.46

1.58

1.7

0.99

0.84

mg/l

0.21

312

Birth trauma

312

1.51

1.58

2.5

3.2

2.52

1.10

mg/l

0.38

227

Malignant neoplasm of pancreas

327

3683

0.87

1.57

1.5

1.7

3.28

1.48

mg/l

3.49

272

2880

Mandibular retrognathia

529

4804

1.12

1.57

2.0

0.82

0.95

mg/l

0.60

387

3530

Hereditary motor and sensory neuropathy

538

1.39

1.57

1.5

1.8

0.71

1.23

mg/l

2.59

422

Vertical strabismus

264

2314

1.18

1.57

1.8

1.25

1.22

mg/l

0.04

202

1755

Acute otitis externa, noninfective

129

1066

1.27

1.57

1.6

1.7

0.96

1.20

mg/l

1.16

107

807

Other ill-defined and unspecified causes of mortality

309

3491

0.87

1.56

1.9

1.7

1.92

1.50

mg/l

0.98

241

2727

Melanoma in situ of other and unspecified parts of face

663

1.35

1.56

2.0

1.7

1.33

1.42

mg/l

0.12

532

Neonatal jaundice from other and unspecified causes

601

1.34

1.56

7.5

6.4

1.27

2.15

mg/l

1.29

435

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.38

1.56

2.0

3.4

3.84

2.41

mg/l

—

Carcinoma in situ of rectum

461

1.42

1.55

4.5

1.7

2.49

1.06

mg/l

1.97

371

Benign neoplasm: Central nervous system, other parts/unspecified

224

1.64

1.55

1.6

1.8

0.86

1.41

mg/l

1.03

185

Malignant neoplasm of head and neck

573

5241

1.11

1.55

1.6

1.7

1.41

1.43

mg/l

0.05

432

4086

Crohn's disease (strict) with PSC

105

2.01

1.55

3.7

1.9

0.62

0.63

mg/l

0.02

Benign neoplasm of other and unspecified female genital organs

353

3158

1.15

1.54

1.6

1.8

0.92

1.06

mg/l

0.64

264

2409

Colorectal neuroendocrine tumor and carcinoma

110

897

1.29

1.54

1.8

1.7

0.84

1.22

mg/l

1.28

687

Viral infections of central nervous system, not elsewhere classified/unspecified

762

1.32

1.54

1.6

0.99

1.04

mg/l

0.11

567

Vitreous prolapse

152

1.80

1.53

1.7

1.6

1.60

1.11

mg/l

0.21

119

Benign neoplasm: Spinal cord

113

925

1.29

1.53

1.7

1.8

1.07

1.16

mg/l

0.16

702

Other dermatomyositis

308

1.52

1.53

1.7

1.8

1.29

1.16

mg/l

0.15

242

Toxoplasmosis

368

1.48

1.52

2.0

1.8

0.99

1.11

mg/l

0.19

292

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

771

1.31

1.52

1.5

1.7

1.14

1.35

mg/l

0.50

611

Osteomalacia

586

1.37

1.52

1.9

1.7

0.75

1.12

mg/l

1.21

453

Carcinoma in situ of breast, lobular

464

1.42

1.51

1.5

1.6

1.98

0.93

mg/l

0.49

353

Malignant neoplasm of thyroid gland

537

4911

1.12

1.51

2.1

1.8

1.24

1.13

mg/l

0.21

416

3737

Other effects of reduced temperature

137

1.85

1.51

1.9

1.8

0.86

1.18

mg/l

0.35

106

Generalized pustular psoriasis

260

1.59

1.51

2.2

2.4

1.70

1.43

mg/l

0.16

211

Postpartum haemorrhage due to anatomy

978

9162

1.09

1.50

1.8

1.7

1.12

0.90

mg/l

1.50

741

6745

Distal bite

250

2170

1.17

1.50

2.6

2.4

0.92

1.01

mg/l

0.22

178

1525

Other and unspecified hypertrophic disorders of skin

421

1.44

1.50

1.7

1.6

1.03

0.99

mg/l

0.04

321

Acute nephritic syndrome

164

1392

1.22

1.49

2.3

1.8

1.68

1.22

mg/l

0.94

134

1060

Foreign body in ear

143

1199

1.24

1.49

1.6

2.1

0.83

1.14

mg/l

1.64

103

894

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

586

1.36

1.49

4.1

1.8

1.67

1.16

mg/l

0.77

433

Henoch-Schönlein purpura nephritis (HSPN)

226

1.62

1.49

2.1

1.8

0.88

1.29

mg/l

0.50

180

Hypothyroidism, autoimmune, DX-based

260

1.58

1.49

1.7

2.0

0.71

1.11

mg/l

0.52

189

Benign neoplasm: Peripheral nerves and autonomic nervous system

115

945

1.27

1.48

1.8

1.7

0.94

1.05

mg/l

0.22

713

Muscle wasting and atrophy, not elsewhere classified

334

1.48

1.9

1.6

1.30

1.46

mg/l

0.22

265

Secondary sideroblastic anaemia due to drugs and toxins

2.66

1.47

1.4

1.6

1.82

0.91

mg/l

—

Disorders of peritoneum in infectious diseases classified elsewhere

3.75

1.47

1.8

1.49

1.23

mg/l

—

Placental disorders

651

1.34

1.47

2.1

1.8

0.84

0.71

mg/l

0.46

472

Overjet

158

1328

1.22

1.47

3.1

2.9

1.02

1.05

mg/l

0.04

115

936

Prolonged pregnancy

1249

12068

0.93

1.47

1.6

1.7

0.98

0.81

mg/l

1.45

933

8745

Brain meningioma

384

3462

1.14

1.46

1.7

1.63

1.22

mg/l

0.39

300

2676

Abscess of mediastinum

1.99

1.46

5.1

2.3

1.46

1.17

mg/l

0.35

Other congenital malformations of female genitalia

607

1.35

1.45

1.7

1.8

0.72

0.76

mg/l

0.08

431

Vitamin A deficiency

277

1.53

1.45

2.0

1.8

1.06

1.29

mg/l

0.35

223

Other specified and unspecified strabismus

741

1.31

1.44

1.9

2.1

2.10

1.44

mg/l

0.23

557

Xanthelasma of eyelid

591

1.35

1.44

1.8

1.6

0.92

1.17

mg/l

0.72

471

Graves ophthalmopathy, strict

181

1558

1.21

1.44

2.1

1.7

0.92

1.00

mg/l

0.20

131

1196

Maternal care for (suspected) damage to fetus from alcohol

246

1.59

1.43

1.9

1.7

0.77

0.70

mg/l

0.08

180

Tuberculosis of other organs, strict

170

1451

1.21

1.43

1.9

1.6

2.34

1.34

mg/l

0.91

136

1134

Reiter disease

382

1.44

1.40

1.8

0.75

1.33

mg/l

1.57

302

Unspecified protein-energy malnutrition

296

1.50

1.39

2.0

1.7

1.50

1.14

mg/l

0.57

236

Disorders of puberty, other/unspecified

203

1.60

1.39

1.6

3.5

1.18

1.11

mg/l

0.07

140

Tularaemia

100

817

1.29

1.39

1.8

1.7

1.09

1.26

mg/l

0.28

623

Disorders of lacrimal system and orbit in diseases classified elsewhere

198

1720

1.19

1.39

2.0

1.7

0.86

1.04

mg/l

0.56

144

1315

Ankyloglossia

103

838

1.27

1.38

4.1

3.5

0.97

1.42

mg/l

0.85

574

Melanoma in situ of upper limb, including shoulder

392

1.43

1.37

3.0

1.7

0.94

1.06

mg/l

0.23

297

Need for immunization against single bacterial diseases

116

1.84

1.37

3.4

5.2

1.92

3.71

mg/l

0.47

Other transepidermal elimination disorders

3.75

1.37

2.4

1.8

1.38

1.99

mg/l

—

Malignant neoplasm of cervix uteri

128

1075

1.25

1.37

1.7

1.6

2.14

0.87

mg/l

1.17

101

816

118

0.39

1.37

13.6

7.8

0.91

2.92

mg/l

—

Melanoma in situ of lower limb, including hip

367

1.44

1.37

4.1

1.7

5.57

0.99

mg/l

0.56

288

Respiratory and cardiovascular disorders specific to the perinatal period

126

934

1.24

1.37

3.7

5.2

1.48

1.92

mg/l

0.62

651

Sunburn

125

1.84

1.37

1.8

1.6

1.33

0.80

mg/l

0.37

100

Scissor bite

167

1422

1.20

1.36

2.7

1.27

1.09

mg/l

0.36

116

976

Cervical root disorders

436

1.40

1.36

1.6

1.7

2.01

1.24

mg/l

0.59

346

Bus occupant injured in other and unspecified transport accidents

428

1.41

1.36

1.8

1.41

0.98

mg/l

0.65

332

Superficial injury of ankle and foot, unspecified

315

1.48

1.36

1.8

1.9

0.89

0.87

mg/l

0.02

238

Unspecified transport accident

255

1.53

1.35

1.9

1.8

1.08

0.94

mg/l

0.16

199

Unspecified contracted kidney

341

1.45

1.35

2.9

1.9

1.55

1.43

mg/l

0.15

267

Hyperchylomicronaemia

109

1.87

1.35

3.2

1.4

3.93

1.12

mg/l

0.82

Idiopathic peripheral autonomic neuropathy

206

1.61

1.35

1.9

1.7

1.34

0.86

mg/l

0.50

168

Other and unspecified water transport accidents

206

1.61

1.35

2.0

1.6

0.63

1.11

mg/l

0.99

169

Benign neoplasm: Vulva

167

1437

1.21

1.34

1.8

1.7

0.95

1.07

mg/l

0.32

124

1072

Malignant neoplasm of oral cavity

238

2098

1.17

1.34

1.5

1.7

1.38

1.29

mg/l

0.22

179

1634

Relapsing fevers

109

1.85

1.34

2.3

2.0

0.96

0.99

mg/l

0.02

Divergent concomitant strabismus

641

5943

1.10

1.33

1.8

1.9

1.10

1.06

mg/l

0.12

477

4427

Other specified/unspecified nutritional deficiencies

455

1.38

1.33

1.7

1.6

0.70

1.21

mg/l

2.38

349

Benign neoplasm: Brain, supratentorial

118

985

1.25

1.32

2.0

1.7

1.43

1.06

mg/l

0.53

727

Acute myringitis

429

1.39

1.32

3.4

2.0

1.19

1.09

mg/l

0.11

326

Disorders of globe

173

1491

1.20

1.32

1.6

1.7

1.28

1.26

mg/l

0.07

136

1156

Other congenital malformations of tongue, mouth and pharynx

751

1.28

1.32

4.6

3.3

2.23

1.38

mg/l

0.32

521

Acquired stenosis of external ear canal

571

1.34

1.32

1.3

1.8

1.01

1.43

mg/l

1.06

453

HSIL lesion of the vagina

115

962

1.26

1.31

1.7

1.6

1.00

0.91

mg/l

0.28

735

Acquired atrophy of ovary and fallopian tube

183

1.64

1.31

2.0

1.8

1.62

0.90

mg/l

1.00

136

Disorders of puberty, all

115

956

1.24

1.31

2.4

2.9

2.41

0.98

mg/l

0.58

625

Bilateral sagittal split ramus osteotomy operation

284

2538

1.15

1.30

1.6

1.7

0.71

0.89

mg/l

1.27

204

1863

Other disorders originating in the perinatal period

525

1.34

1.30

2.7

5.2

4.22

1.49

mg/l

0.50

385

Benign neoplasm: Ill-defined sites within the digestive system

343

1.44

1.30

2.1

1.6

1.27

1.07

mg/l

0.21

264

Cytomegaloviral hepatitis

167

1.68

1.30

2.0

1.8

1.16

0.81

mg/l

0.28

135

Benign neoplasm: Respiratory system, unspecified

135

1.77

1.29

1.8

1.6

2.25

1.39

mg/l

0.23

106

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

104

858

1.26

1.29

1.7

1.6

2.63

1.21

mg/l

2.88

680

Findings of drugs and other substances, not normally found in blood

250

1.52

1.28

1.8

0.87

1.19

mg/l

0.58

196

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

116

1385

0.81

1.28

1.6

3.19

1.31

mg/l

3.37

102

1076

Malignant neoplasm of small intestine

149

1275

1.21

1.28

2.0

1.7

1.60

1.28

mg/l

0.82

120

1002

Pyogenic granuloma

131

1109

1.23

1.28

1.7

1.18

1.16

mg/l

0.03

100

847

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

772

1.28

2.0

1.5

1.01

0.71

mg/l

0.81

568

Other degenerative disorders of eyelid and periocular area

185

1.64

1.27

1.7

1.6

0.67

1.13

mg/l

1.22

147

268

1.50

1.27

1.5

1.7

0.94

0.82

mg/l

0.12

209

Chronic respiratory disease originating in the perinatal period

110

1.81

1.27

2.9

7.4

2.12

2.07

mg/l

0.02

Nystagmus and other irregular eye movements

107

890

1.26

1.27

2.1

2.3

1.44

1.18

mg/l

0.32

681

Injury of blood vessels at wrist and hand level

442

1.38

1.26

1.8

1.6

0.67

1.21

mg/l

3.33

341

Toxic effect of organic solvents

234

1.53

1.26

1.6

1.8

0.80

1.22

mg/l

0.68

174

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

218

1.56

1.25

1.8

1.6

1.16

0.78

mg/l

0.49

176

Malignant otitis externa

1.93

1.25

2.1

1.6

0.39

1.30

mg/l

—

Complicated migraine, drug-induced

2.12

1.25

2.1

1.8

1.01

1.24

mg/l

0.13

Wrist or foot drop (acquired)

3.15

1.25

1.4

1.8

1.40

1.58

mg/l

—

HSIL lesion of the cervix uteri

1700

16270

1.06

1.25

1.7

1.00

0.85

mg/l

0.99

1256

12116

Colour vision deficiencies

225

1.52

1.24

1.3

1.8

0.84

0.98

mg/l

0.27

170

Beningn neoplasm: Meninges, unspecified

114

956

1.24

2.2

1.6

1.21

1.24

mg/l

0.05

738

Carcinoma in situ of breast

313

1.46

1.24

1.4

1.6

0.71

1.00

mg/l

1.00

242

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

720

1.28

1.24

2.0

1.7

1.01

1.03

mg/l

0.03

553

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

399

1.39

1.24

1.5

1.7

1.46

0.96

mg/l

0.57

297

Other corneal oedema

434

1.37

1.24

2.0

1.7

1.27

1.29

mg/l

0.02

346

Benign neoplasm: Long bones of lower limb

257

2292

1.15

1.23

1.9

1.8

1.06

1.02

mg/l

0.13

198

1705

Galactorrhea

731

1.28

1.23

2.2

1.6

0.70

0.80

mg/l

0.33

532

Congenital absence, atresia and stenosis of small intestine

2.12

1.23

10.8

3.3

0.81

0.71

mg/l

0.10

Malignant neoplasm of stomach

263

2947

0.88

1.23

1.6

1.7

2.16

1.47

mg/l

2.08

215

2300

Injury of blood vessels at neck level

219

1.54

1.22

1.6

1.5

0.88

1.16

mg/l

0.37

167

Hepatocellular carcinoma

122

1029

1.23

1.22

1.6

1.7

3.24

1.64

mg/l

1.62

102

820

Carcinoma in situ of breast, intraductal

637

5932

1.09

1.22

1.8

1.7

1.00

1.01

mg/l

0.01

482

4502

Defects in post-translational modification of lysosomal enzymes

2.76

1.21

1.3

1.4

0.62

1.12

mg/l

—

Blindness or visual impairment, binocular

261

1.48

1.21

2.7

1.9

1.30

1.33

mg/l

0.02

210

Toxic effect of other gases, fumes and vapours

321

1.43

1.21

2.2

1.8

1.18

1.19

mg/l

0.00

254

Benign neoplasm: Bone and articular cartilage, unspecified

489

1.35

1.21

1.4

1.6

0.66

0.96

mg/l

1.30

367

Human immunodeficiency virus [HIV] disease resulting in other conditions

131

1115

1.22

1.21

1.9

1.8

2.15

1.05

mg/l

0.42

101

845

Keratosis punctata

2.38

1.20

2.0

1.9

0.70

1.43

mg/l

—

Small plaque parapsoriasis

162

1.64

1.19

2.1

1.7

0.70

1.17

mg/l

1.21

134

Hydrocephalus

538

4978

1.10

1.19

1.9

1.7

1.66

1.40

mg/l

0.60

419

3839

Familial erythrocytosis

279

1.46

1.19

1.4

1.7

1.67

1.24

mg/l

0.15

212

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS